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Yale Medicine 
Great Golgi, Page 14 | An antiviral pioneer, Page 22 | Mighty mice, Page 26 
On the cover: On Match Day 1998, Robert Gifford obliged 
us by posing for a portrait to accompany an article on his 
then-imminent (and already delayed) retirement as 
associate dean. As things turned out, Gifford stayed on for 
nearly another two years, helping the school to reassess its 
educational mission and to recruit his replacement in the 
newly created position of deputy dean for education. 
He also had a chance to work on his slap shot with fellow 
members of the Yale Medical Hockey Club. For a look back 
at the Gifford years at YSM, please turn to page 32. 
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The view from inside the 
Golgi complex 
One of cell biology’s leading lights, newly arrived from 
London, takes a bit of the mystery out of cell division. 
By Michael Fitzsousa 
Medicine, politics and the 
2000 campaign 
A veteran analyst of American health care takes 
the pulse of presidential politics. 
Interview by Michael Fitzsousa 
Hi 
A lifetime making mischief with DNA 
Creator of both the first antiviral compound and a 
landmark AIDS drug, William Prusoff is a study in 
the quiet pursuit of science. 
By John Curtis 
The mouse that roared 
Once the stuff of myth and science fiction, 
the transgenic mouse, first created at Yale, 
has conquered the world ol biomedicine. 
By Marc Wortman 
Student News 
Alumni News 
Reunion 1999 
Obituaries 
Bookend 
o 
Goodbye, Dr. Gifford 
After 33 years at Yale and two false starts as a retiree, 
a roundly admired medical educator calls it a day. Sort of. 
By John Curtis 
On Campus 
Letters 
Scope 
Capsule 
Faculty News 
New Books 
I 
ON CAMPUS 
A high-level visit, a warning on Medicare 
Q Over the next 30 years, the elderly in the United States will 
increase from 40 million to 70 million. That simple statistic 
imperils the 35-year-old Medicare system, Health and Human 
Services Secretary Donna E. Shalala told the audience that 
packed the medical school’s Fitkin Amphitheater in October. "We 
are facing a demographic tidal wave,” said Shalala. “We are about 
to double the number of people in Medicare on a relatively nar¬ 
row financial base." 
Shalala, to whom Dean David A. Kessler, M.D., reported in his 
previous position as Food and Drug Administration commission¬ 
er, was on campus to deliver the annual Samuel O.Thier, M.D., 
Lecture. Later in the day she spoke at the Yale Law School on 
patient records and privacy. In her talk in Fitkin, Shalala outlined 
what has been done to save Medicare and what remains to be 
done. So far the government has increased the Medicare trust 
fund; cracked down on fraud, waste and abuse; and instituted 
reforms such as competitive bidding and a modern billing 
system. Strengthening the system, she said, will require still 
more. She called for a modern benefits package that stresses 
preventive measures, such as screenings and vaccinations, and 
includes coverage of medications and a competitive and efficient 
financial structure. "This is a fundamental debate,” she said, 
“about whether we will continue to guarantee quality health 
care for seniors.” 
With the CEO of ‘Genome, Inc.’ 
O Just over a year ago, biologist I. Craig Venter, Ph.D., launched a 
scientific race with the claim that his company, Celera Genomics, 
could sequence the entire human genome by the year 2001 — 
four years shy of the original end-date projected for the federally 
funded Human Genome Project. The National Center for Human 
Genome Research (led by Yale Ph.D. Francis Collins), which had 
already shortened the span of the 15-year endeavor through 
improved sequencing technology, has further accelerated its pace 
in the face of Venter’s challenge. The NIH plans to finish its proj¬ 
ect by 2003, with a working draft of the genome ready by 2001. 
(In November Celera and the NIH were reported to be consider¬ 
ing a collaboration on the genome project). 
As for Venter, who gave a talk to the Department of Genetics 
in June, critics say the maverick scientist’s "shotgun” approach — 
shredding bits of DNA into tiny fragments, then reassembling 
them with the help of computers — will leave gaps in the 
genome. But so do traditional sequencing methods, and those 
gaps can be filled in later, says Venter. “Across species,” he noted, 
"nearly half the candidate genes that have been identified 
cannot be assigned a biological role.” 
An Icelander decodes the data 
Q Discovered in the Middle Ages by Scandinavian explorers, 
Iceland offered its early settlers a harsh and barren landscape 
punctuated by the occasional volcanic explosion. So inhospitable 
was the island that all but a handful of its 270,000 inhabitants 
can trace their lineage to a few thousand ancestors. Over the 
centuries, that isolation has created a virtual treasure of genetic 
knowledge waiting to be mined. 
Native son and geneticist Kari Stefansson, M.D., very likely will 
be the first to plumb that mine. His company, deCode Genetics, 
has joined forces with the pharmaceutical industry to search for 
mutant genes, isolate them and devise therapies for disease. 
Stefansson’s ambitions have riled privacy advocates in Iceland 
and elsewhere, and many are worried his data will fall into the 
wrong hands. Much ado about nothing, Stefansson said when he 
stopped at Yale in June to deliver the Abraham Ribicoff Lecture at 
psychiatry grand rounds: Safeguards, such as encryption of 
patient records, are built into his project. Besides, the benefits of 
the work are enormous. It will create high-tech jobs in Iceland, 
modernize the country’s medical data systems and, most impor¬ 
tant, improve human health, he said. 
Brazelton urges support for parents 
Q T. Berry Brazelton, M.D., one of the nation’s leading pediatri¬ 
cians and child development experts, urged physicians to bring 
parents into the fold by viewing them as members of a team 
concerned about children’s welfare. "We have lost a sense of 
community and protective envelope around every family," 
he said. “Our preventive health care system for children is failing 
miserably in this country.” Brazelton spoke to teachers, parents 
and policy makers at the 10th annual conference of the School of 
the 21st Century program at Yale in July. 
FALL 1999 | WINTER 2000 
LETTERS 
A world revealed 
To the Editor: 
Many thanks for Cathy Shufro’s inspir¬ 
ing profile of neurosurgeon Nozipo 
Maraire [“The Many Worlds of Nozipo 
Maraire,” Summer 1999]. She was a res¬ 
ident while I was a medical student at 
Yale and was then, as she is now, a real 
inspiration to me. Her small stature 
belied a lioness of a woman, who was 
perpetually thinking of the next 
project, be it business or medicine. 
I wish her much success and 
joy, both in her profession and her 
personal life. 
M. Kathleen Figaro, M.D. ’96 
New York 
Yale science for a broader audience 
To the Editor: 
Notwithstanding the fact that my only 
Yale degree is an undergraduate one, 
and that in English, about two years 
ago 1 began to receive quarterly copies 
of Yale Medicine. It’s unclear to me how 
I got on the mailing list, but 1 must say 
that it’s a wonderful publication, even 
for (at best) a scientific dilettante like 
me who gleans most of what he knows 
about science from the pages of The 
New York Times. 
I write this by way of a gloss on what 
I perceive as a tremendous increase in 
scientific research done at Yale today 
compared with my era, recognizing that 
this phenomenon may reflect as much 
an increase in Yale’s effort to publicize 
that research and the fruits thereof as it 
does actual increments in the volume 
of Yale’s scientific undertakings. 
Given the excellence of Yale Medicine 
as an information vehicle for what’s 
going on in a particular area at Yale, I 
wonder whether consideration has been 
or should be given to a broader jour¬ 
nal/magazine about Yale science. 
If Yale Medicine can intrigue and 
make this humanities alumnus feel even 
more positively about his alma mater 
than he does naturally, an even broader 
publication may be worthwhile. 
Ronald G. Sampson, B.A. 63 
Boston 
An interesting proposal and well worth 
considering. As for the mysterious arrival of 
Yale Medicine, the magazine is sent to 
alumni leaders across the University as well 
as graduates of the medical school, its basic 
science departments, residency and fellow¬ 
ship programs, the School of Public Health 
and the Physician Associate Program. 
Show-stopper 
To the Editor: 
I enjoyed John Curtis’ article on the 
second-year show [“The Show Must Go 
On,” Summer 1999], and am sending 
you the poster from the 1994 produc¬ 
tion, M.D. TV to add to the medical 
school’s collection of memorabilia. As 
one of the head writers for my year, I 
thoroughly enjoyed reading about the 
history of this great tradition! 
Lisa Park, M.D. 97 
Hoboken, N.J. 
How to reach us 
Yale Medicine welcomes news and commentary. Please send letters to the editor and news 
items to Yale Medicine, P.O. Box 7612, New Haven, CT 06519-0612, or via electronic mail to 
ymm@yale.edu, and include a daytime telephone number. Submissions may be edited for 
length, style and content. 
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SCOPE 
Class of 
from all corners 
What is perhaps the most international class of medical stu¬ 
dents in Yale’s history arrived in New Haven in late August, 
hailing from the United States and as far away as Ecuador, 
Russia, Hong Kong and Ethiopia. And while the global char¬ 
acter of the Class of 2003 is more the result of happenstance 
than any international recruiting effort, according to adminis¬ 
trators, it is nonetheless a defining feature of the incoming 
crop of medical students. 
At the White Coat Ceremony, for example, there were one 
or two fewer parents in the audience to watch their children 
enter medicine. Mari Rebane’s parents in Estonia wanted to 
attend, but the distance and scheduling proved an obstacle, 
she said. Rebane, who graduated from Baylor University in 
Waco, Texas, sent them a videotape of the ceremony instead. 
Other members of the class come from Canada, Egypt, 
India, Ireland, Kenya, Korea, Mexico, Peru, South Africa, 
Taiwan and Ukraine — 15 foreign countries in all. All attended 
U.S. colleges before applying to medical school, according to 
new Director of Admissions Richard A. Silverman. The class 
is also quite diverse. Forty-four percent of the new students 
are women. Fifteen students are African Americans, 11 are 
Hispanic and 22 are Asian Americans. 
The class is one of the strongest academically in the medical 
school’s history as well. The 105 students have an average GPA 
of 3.71 and a total of 136 different majors. They come from 46 
undergraduate colleges, including Yale, Harvard, Penn, 
Princeton, Stanford, Brown, Columbia, Cornell, Dartmouth, 
Amherst, MIT, McGill, Emory, Bowdoin, Clemson, Boston 
College and Swarthmore. Nearly a quarter of the class mem¬ 
bers— 23 students — were Yale undergraduates, from a total of 
196 applicants from Yale College. 
First-year medical students under the 
tent on Harkness lawn during the 
White Coat Ceremony in September. 
From left: Neil Lester, Ryan Lieberman, 
Elin Lisska and Maya Lodish. 
1 he total number of applicants, 2,469, was down from 
3,094 the year before, reflecting both a national drop in med¬ 
ical school applications and a new application process for 
medical schools across the country. Last year Yale did not par¬ 
ticipate in the American Medical College Application Service, 
a centralized application processing service, but will be 
among 113 U.S. schools to do so this year. “It’s likely that 
applications will rise substantially as a result,’’ said Silverman. 
Public health and PA students 
Many of the 105 students enrolled in the master’s of public 
health degree program arrived with practical experience under 
their belts, including service in the Peace Corps, government 
health departments and community-based organizations. 
Members of the class come from 11 countries, 22 states and 87 
undergraduate schools. They hold degrees in 34 subjects; 44 
majored in the biological sciences. The group includes 13 
physicians, two attorneys, one veterinarian, one dentist and 
four students with master’s degrees. Students range in age 
from 20 to 50, with an average age of 25. 
The 36 students who make up the Physician Associate 
Program’s Class of 2001 include a Navy medical corpsman 
who was assigned to the presidential detail, a Columbia 
University graduate who worked on Biosphere 2 in Arizona, 
and a smattering of research technicians, paramedics and 
EMTs. The class, which began the 25-month program in early 
August, has 26 women and 10 men. Collectively, they hold 
nine bachelor’s degrees in psychology, eight in biology, two in 
medical technology, two in physiological science, as well as 
degrees in music, liberal arts, philosophy, Spanish, sociology, 
English and human development. The group also includes 
three students with master’s degrees in deafness rehabilitation, 
exercise physiology and geography. The students’ average age 
is 28. — Michael Fitzsousa and John Curtis 
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A new dean for education 
Medical school 
and health system 
form a new affiliation 
One of the Ivy League’s most highly 
regarded medical educators is stepping 
down, much to the chagrin of students 
and colleagues. 
This is true not only of Yale’s Robert 
Gifford, M.D., (see cover story, page 
32) but also his replacement. Herbert S. 
Chase Jr., M.D., will leave Columbia’s 
College of Physicans and Surgeons at 
the end of June to become deputy dean 
for medical education at Yale. 
A nephrologist who joined the 
Columbia faculty in 1980, Chase 
received Teacher of the Year honors 
from the P&S classes of 1997, 1999 and 
2001 as well as the university’s 
Presidential Teaching Award in 1996. 
Like Yale, Columbia recognizes excep¬ 
tional educators with Bohmfalk teach¬ 
ing prizes; Chase got one in 1995. 
These accolades as well as Chase’s 
skill in curriculum development and 
computer-based teaching caught the 
attention of the Yale search committee, 
headed by physiology professor Michael 
Caplan, M.D., Ph.D., and David 
Coleman, M.D., professor of medicine. 
Dean David A. Kessler, M.D., 
announced Chase’s appointment 
Nov. 2 at a meeting oi the Medical 
School Council. 
Born in New York City, Chase, 51, 
spent his undergraduate years at Brown 
and studied medicine at Mt. Sinai 
before training in internal medicine 
and nephrology at Roosevelt and Mt. 
Sinai hospitals. He was a nephrology 
fellow at Mt. Sinai and Columbia. 
His appointment completes a reor¬ 
ganization of the Office of Education 
that began in 1998 with the creation of 
the deputy dean position with Gifford 
From left: Lentz, Silverman, Angoff and Andrien 
at the helm and the selection of Nancy 
R. Angoff, M.P.H. ’81, M.D. ’90, HS 
’93, as associate dean for student affairs 
[YM, Fall 1998]. Earlier this year, 
registrar Cynthia Andrien, M.S., was 
promoted to assistant dean for student 
affairs and Thomas Lentz, M.D. 64, 
rose from assistant to associate dean 
of admissions. 
In addition, Richard A. Silverman 
was named to succeed M. Lynne 
Wootton as director of admissions fol¬ 
lowing her retirement in June. A 1970 
graduate of Yale College, Silverman 
held previous positions at Yale at the 
School of Management (SOM), where 
he served as executive director of admis¬ 
sions for the MBA program, and at Yale 
College, where he was associate director 
of undergraduate admissions. While at 
SOM, Silverman also was active nation¬ 
ally with the Graduate Management 
Admissions Council, serving as chair of 
the annual conference in 1997. Earlier 
career highlights included graduate 
work and a teaching fellowship in 
the Philosophy Department at Yale 
and service with U.S. Army Intelligence 
in Germany. 
Thirty-four years ago, Yale University 
and The New Haven Hospital laid out a 
framework for their joint activities in 
patient care, teaching and administra¬ 
tion. The hospital changed its name to 
Yale-New Haven, but the two institu¬ 
tions have remained separate entities, 
each with its own finances, governance 
and administrative structure. 
While that 1965 agreement remains 
unchanged, leaders of the two institu¬ 
tions decided several years ago that it 
was time to factor in a major new play¬ 
er: the Yale New Haven Health System, 
parent of the hospital as well as a grow¬ 
ing number of other nonprofit health¬ 
care enterprises. (The health system’s 
corporate members are Yale-New 
Haven, Bridgeport and Greenwich hos¬ 
pitals; it also has contractual relation¬ 
ships with hospitals in Norwalk, Conn., 
and Westerly, R.I.) 
A new agreement between the 
University and health system, signed 
in July by Yale President Richard C. 
Levin and Yale New Haven Health 
System President and CEO Joseph A. 
Zaccagnino, sets out guidelines for 
how the two institutions will grow 
together in the areas of medical 
education, clinical programs and 
managed-care contracting. 
"This is an exciting new partnership 
with some very tangible, immediate 
benefits for patient care as well as clini¬ 
cal research and program development,” 
said Dean David A. Kessler, M.D. “Our 
overriding goal is to help build the 
Yale-New Haven Medical Center into a 
clinical powerhouse, one that is clearly 
distinguished from its peers nationally.” 
According to Associate Dean Ruth 
Katz, J.D., M.P.H., the agreement 
includes a joint fund to develop new 
clinical programs at Yale-New Haven 
Hospital, with equal contributions com¬ 
ing from the medical school and the 
health system. A process is under way to 
identify the most likely programs for 
investment in the coming year. — M.F. 
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Tech transfer office gets a new director 
E. Jonathan Soderstrom, Ph.D., has 
been named managing director of Yale’s 
Office of Cooperative Research, suc¬ 
ceeding Gregory E. Gardiner, Ph.D., 
who stepped down at the end of August 
to pursue other interests. At the same 
time, Robert K. Bickerton, who was the 
first director of the OCR when it was 
established in 1982, has retired from his 
position as special assistant to the 
provost. All three have played an inte¬ 
gral role in bringing the OCR to its 
present position. 
The OCR evaluates the commercial 
potential of research and helps 
researchers apply for patents, negotiate 
licensing agreements, and secure 
support from business. The office has 
negotiated about 250 invention license 
agreements and Yale technology 
has helped establish about 40 new 
companies. Its School of Medicine 
office, located at I-210 in the Sterling 
Hall of Medicine, was established in 
1997 and is staffed by director Alfred 
Brown, Ph.D., and associate directors 
R. Bennett Muskin, John Swartley, 
Ph.D., and Margi McLoughlin, Ph.D. 
As the new director, Soderstrom 
intends to develop the OCR along the 
lines established by his predecessors. 
“We are nowhere near what our poten¬ 
tial is,” said Soderstrom, who formerly 
was director of program development 
for Lockheed Martin Energy Systems. 
“We have put in place a foundation on 
which we can do nothing but build. 
Yale will continue to excel in those 
areas you would expect, particularly 
the life sciences, where we have a global 
reputation for excellence.” 
—Jacqueline Weaver 
Gregory Gardiner, right, took over the Office of 
Cooperative Research in 7995 and hired E. Jonathan 
Soderstrom, left, to open a medical school satellite of 
the OCR in 7997. Soderstrom succeeded Gardiner as 
OCR executive director at the end of the summer. 
The OCR forms three new ventures, assists in mergers of others 
The Office of Cooperative Research 
pressed forward during the past year 
with the creation of three new ventures 
and provided support to a number of 
existing companies based on Yale tech¬ 
nology. In addition, 18 new licenses 
were issued to the OCR’s business part¬ 
ners. In the fiscal year ending June 30, 
royalties for Yale-licensed inventions 
rose to $40.7 million, a $7.4-million 
increase over last year’s figures. 
Of the three companies formed this 
year by the OCR, two are devoted to 
the development of chemical com¬ 
pounds. The third is an electronic mar¬ 
ketplace for ideas and inventions. 
Phytoceutica, whose medical director 
is Yung-Chi Cheng, Ph.D., Henry 
Bronson Professor of Pharmacology 
and Medicine, is studying increasingly 
popular Chinese herbal remedies so 
physicians can understand their proper¬ 
ties and their interactions with conven¬ 
tional treatments. 
Agilix, based on technology designed 
by Paul M. Lizardi, Ph.D., professor of 
pathology, will apply genome technolo¬ 
gy to agribusiness to develop more 
valuable crops, such as those able to 
resist drought and thrive in less-than- 
ideal climates. 
The Intellectual Property Exchange, 
IPTEX, is an online service of OCR 
that offers information on inventions at 
Yale and more than 175 other universi¬ 
ties and research institutions to its 330 
subscribers in biotechnology and 
pharmaceutical industries. 
The OCR continues to support 
companies formed in previous years; 
for example, assisting in the merger 
of Molecular Staging Inc. and 
polyGenomics Inc., which use similar 
techniques in work with cancer, 
infectious disease and defects in genes. 
Novirion Pharmaceuticals, a drug-dis¬ 
covery company being formed with the 
OCR’s help, is merging with Achillion 
Pharmaceuticals, which expects to 
begin operations in or near New Haven 
next year. Cellular Genomics, which 
seeks treatments for autoimmune disor¬ 
ders, formed a partnership with Oxford 
Glycosciences of England.—/.C. 
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A new doctorate for doctors 
As medicine seeks new ways to speed 
basic discoveries from the laboratory to 
bedside, there is growing concern that 
the investigators ideally equipped to 
guide that translation are becoming an 
endangered species. Three decades ago, 
nearly half of all NIH research-project 
grants went to physician-scientists with 
M.D. or M.D./Ph.D. credentials. 
Today that fraction is closer to a quar¬ 
ter and dropping as the number of 
Ph.D. investigators in the life sciences 
increases. 
Now there’s a new route at Yale for 
physicians who are interested in 
research careers to get their Ph.D.’s. 
This summer the Graduate School of 
Arts and Sciences approved a new doc¬ 
toral degree in investigative medicine — 
the first anywhere in which a Ph.D. 
program is administered by a clinical 
department. The new degree program 
grew from a proposal by the 
Department of Internal Medicine to 
create an alternative route for physi¬ 
cians who wish to combine careers in 
clinical medicine and research. Unlike 
the existing M.D./Ph.D. Medical 
Scientist Training Program, which 
trains an average of six physician-scien¬ 
tists each year, the new program is 
open only to physicians who have 
already earned their medical degrees 
and completed two years of their clini¬ 
cal training. 
“The fundamental difference is that 
in this program the candidates have 
decided substantially later in their 
careers to become physician-scientists,” 
said program director Keith Joiner, 
M.D., chief of the section of infectious 
diseases in the Department of Internal 
Medicine. “They want the same rigor¬ 
ous training that an M.D./Ph.D. stu¬ 
dent would want, but they’ve had a 
portion of their clinical training already 
and poured their heart and soul into 
patient care for three or four years. 
Here, they can be sure that their clini¬ 
cal interests are not dissociated from 
the rest of their advanced training.” 
Joiner anticipates that the program, 
which is accepting applications now for 
July 2000, 2001 and 2002, will grow to 
10 slots each year for candidates inter¬ 
ested in disease-oriented laboratory 
research, patient-focused clinical 
research, outcomes studies and epi¬ 
demiological research. Geriatrician 
Sharon Inouye, M.D., and biostatisti¬ 
cian Theodore Holford, Ph.D., will run 
the program along with Joiner. 
Convincing members of the 
Graduate School faculty that the new 
doctoral program would be sufficiently 
rigorous to merit the granting of a Yale 
Ph.D. required many months of discus¬ 
sion. “We really wrestled with it for a 
whole year,” said immunobiologist Kim 
Bottomly, Ph.D., chair of the basic sci¬ 
ence advisory committee that was asked 
to review the proposal. The committee 
made suggestions and the original 
proposal was modified. Then two 
high-profile external advisors — then- 
New England Journal of Medicine editor 
Jerome Kassirer, M.D., and Kenneth 
Shine, M.D., president of the Institute 
of Medicine — were asked to evaluate 
the plan. After a few more changes, it 
was forwarded to the faculty for 
approval with a unanimous endorse¬ 
ment from the advisory committee. 
“This is a chance to apply science to 
health,” said Bottomly, “not only by 
cloning a gene that may someday play a 
part, but by really asking questions 
about human disease, forming hypothe¬ 
ses about care and following up to see 
the outcomes.” 
“It’s phenomenal that it happened at 
Yale and testimony to the foresight of 
the basic science faculty and their will¬ 
ingness to think outside the box,” said 
Joiner. “The program’s goal is to create 
an environment that constantly inter¬ 
faces clinical science and investigation 
of disease. I think we’re well on our 
way.” — M.E 
In the ribosome, clues 
to better antibiotics 
Yale scientists have produced three- 
dimensional images of the largest com¬ 
ponent of the ribosome — the cellular 
structure responsible for synthesizing 
protein molecules in all organisms — at a 
resolution high enough that its parts can 
be identified and positioned. 
Many of the antibiotics used to fight 
bacterial infections operate by interfer¬ 
ing with the function of the bacterium’s 
ribosomes. Continued research in this 
area could eventually lead to improve¬ 
ments in the effectiveness of antibiotics, 
according to the study’s principal inves¬ 
tigator, Thomas A. Steitz, Ph.D., the 
Eugene Higgins Professor of Molecular 
Biophysics and Biochemistry. Steitz col¬ 
laborated on the study, which appeared 
in the Aug. 26 issue of Nature, with 
Peter Moore, Ph.D., the Eugene 
Higgins Professor of Chemistry. 
Structural biologists have long viewed 
the ribosome as one of their field’s pre¬ 
eminent challenges, both because of its 
intrinsic biological importance and 
because of its large size and complexity. 
The ribosome is intriguing also to 
those interested in enzymes, organic 
catalysts that enhance the rate of 
biochemical reaction. 
The research team used X-ray crystal¬ 
lography to obtain an image of the large 
ribosomal subunit from the bacterium 
Haloarcula marismortui that has a 
resolution of 5 angstroms. At that 
resolution, many of the structure’s 
proteins and RNA can be visualized. 
The team’s advance culminates a proj¬ 
ect under way at Yale for four years, and 
it derives from work on ribosome crys¬ 
tallization that began in Germany and 
Russia more than 20 years ago. Since 
the Yale research team’s publication of 
an initial announcement of a lower- 
resolution structure last year, several 
other groups have begun making 
significant progress on other ribosomal 
components. — Karen N. Peart 
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A changing of the guard 
for Humanities in Medicine 
For the past 16 years, faculty, students 
and the general public have gathered in 
the Beaumont Room one or two 
evenings a month to sip sherry and lis¬ 
ten to speakers wax eloquent on the 
connections between medicine and art, 
music, politics and even cuisine. Recent 
topics have included “Medicine, Ethics 
and the Third Reich,” “Call for the 
Doctor: A History of Country Blues 
Piano,” and “The Artist’s Vision: An 
Ophthalmologist Looks at Art.” 
Founded in 1983 by gastroenterologist 
Howard M. Spiro, M.D., and the late 
Enid R. Peschel, Ph.D., who taught 
French at Yale, the Humanities in 
Medicine lecture series was envisioned 
as part of a broader program to encour¬ 
age students and faculty to think out¬ 
side their narrow disciplines as they 
developed their careers. “My initial idea 
was to show that the humanities were 
applicable to the practice of medicine,” 
Spiro says. He first contemplated three 
elements of his humanities program: a 
lecture series, seminars for students and 
a humanities program lor residents. 
While the others succumbed to a lack 
of funding or interest, the lecture series 
took hold and has flourished, with the 
help of associate directors Clara 
Gyorgyey, M.A., M.A.T., and Mary G. 
McCrea Curnen, M.D., Dr.P.H. “We 
have tried to have a kind of mix,” said 
Spiro, who has written several books 
and more than 300 articles. “I haven’t 
really cared too much what the topics 
were. I picked the people rather than 
the topics.” 
This summer, Spiro retired from his 
teaching and was named professor 
emeritus of medicine. Thomas M. 
Duffy, M.D., a professor of medicine, 
took over as director and has plans for a 
number of new initiatives. They include 
a course in clinical ethics, a juried show 
of student photography, a subcommit¬ 
tee on the arts chaired by the Rev. Sally 
Bailey of the Divinity School, thesis 
projects on ethical issues, and involve¬ 
ment of New Haven visual artists in 
therapy programs. He believes that the 
HHMI grant to support science teaching at 
The School of Medicine plans to use a 
four-year, $300,000 grant from the 
Howard Hughes Medical Institute to 
strengthen its ongoing partnership with 
New Haven’s Career High School. 
“This new funding allows us to contin¬ 
ue to do year-round activities with stu¬ 
dents interested in going into the 
health professions from Career High 
School,” said Liza Cariaga-Lo, Ph.D., 
director of multicultural affairs and 
director of the collaboration with the 
high school. The grant is awarded to 
medical schools and research centers 
around the country to promote and 
improve science education in elemen¬ 
tary and secondary schools. 
The new funding, Cariaga-Lo said, 
will help expand a two-year-old pro¬ 
gram that brings students from Career 
High School to the medical school each 
summer for a residential program in 
biology and chemistry. It has grown 
from a rwo-week program with 15 stu¬ 
dents to a three-week program with 33 
participants. Next summer the program 
will expand to four weeks, with up to 
75 students, she said. 
In addition, the medical school plans 
to implement in the next academic year 
a scholar-fellow program called Science 
Collaboration Hands-On Learning and 
Research, SCHOLAR, to train up to 
five public-school teachers in inquiry- 
Hematologist Thomas Duffy is the new director for 
the Program for the Humanities in Medicine. 
incorporation of humanities into the 
medical curriculum will benefit both 
patients and physicians. Even as the 
medical profession is poised to make 
profound discoveries about the origins 
of life, it is under attack for neglecting 
the whole patient. “These initiatives,” 
said Duffy, “should enrich not only 
the student body and how they practice 
medicine, but also represent an 
opportunity to involve the larger 
community. ■•-j-c. 
Career High School 
based and problem-based learning tech¬ 
niques. There also will be a series of 
professional development workshops to 
train New Haven teachers in ways to 
incorporate problem-based activities 
into the classroom. “This is an opportu¬ 
nity for us to utilize the resources we 
have at the medical school and the 
University to help improve and enhance 
educational reform in New Haven, 
specifically at Career High School,” 
Cariaga-Lo said. — J. C. 
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Anesthesiologists Zeev Kain, left, 
Roberta Hines and a young patient. 
Imagine the operating room from the point of view of a child 
about to have surgery: bright lights, sharp instruments, a bat¬ 
tery of imposing machines and a succession of strangers wear¬ 
ing gowns and masks. Last year, in this country alone, chil¬ 
dren underwent 3 million operations, prompting health care 
professionals such as Zeev N. Kain, M.D., HS ’92, to find 
better ways to prepare them psychologically for surgery and 
its aftermath. 
“The overwhelming majority of kids in the United States 
who go into the operating room are awake, alone and crying,” 
said Kain, associate professor of anesthesiology, pediatrics and 
child psychiatry. But, he added, it doesn’t have to be that way. 
After a yearlong study, Kain has found that sedating chil¬ 
dren 30 minutes before surgery can cut incidents of post-sur¬ 
gical anxiety by half. “The group that got the sedative mani¬ 
fested significantly less behavioral change after surgery than 
the group that did not get the sedative,” he said. Researchers 
found fewer incidents of nightmares, aggression towards 
authority, eating problems and separation anxiety. 
Easing childrens fear may do more than simply reduce 
postoperative behavioral problems, researchers found. In stud¬ 
ies of adults, Kain and his colleagues have shown that patients 
with low anxiety levels required less pain medication after sur¬ 
gery and healed faster. A reduction in stress, he said, resulted 
in lower levels of interleukin-6, a stress hormone that, in large 
quantities, can retard healing. 
Kain began investigating fears about surgery in 1993 when 
he noticed gaps in the literature about surgical anxiety. Most 
research on the topic, he said, was done from a behavioral 
point of view. Assembling a team that included child develop¬ 
ment specialists, surgeons, anesthesiologists and a psychiatrist, 
Kain set out to address the 
ways children were prepared 
for surgery. 
Kain’s study, published in 
March in the journal 
Anesthesiology, included 86 
children, aged 2 through 7, 
who underwent elective sur¬ 
gery of the lower abdomen 
over a 12-month period. To 
eliminate other potential 
causes of psychological dis¬ 
tress, children going through 
their parents’ divorce or the death of a loved one were 
removed from the study. Half the children received the seda¬ 
tive midazolam and those in the control group received no 
interventions, either behavioral or pharmacological. For two 
weeks following surgery, researchers interviewed parents, rely¬ 
ing on a detailed survey with 27 questions about children’s 
behavior. 
Kain emphasized that the sedative is only one element of 
peri-operative intervention. Anxiety also may be reduced by 
allowing parents into the operating room as anesthesia is 
administered, exposing children to the operating room before 
surgery, explaining what will happen to them during surgery, 
and playing music in the operating room. Kain believes the 
interventions not only will ease stress, but promote faster 
healing. “That,” he said, “is the ultimate outcome.”— J.C. 
Frank Poole 
Listening to the heart 
Nursing professor Linda Pellico, M.S.N., 
R.N, taught preschoolers about human 
anatomy at the Phyllis Bodel Child Care 
Center in Harkness Hall. Accompanied 
by nursing student Catherine Hopkins, 
Pellico showed the children human 
ribs, a model of the human body 
showing organ systems, and a skull 
with a removable brain.The Bodel Center, 
which serves the children of students, 
faculty and staff, is celebrating its 20th 
anniversary this year. 
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New labs, new approach bring hope for spinal cord injuries 
Traditionally, physicians have believed that spinal cord 
injuries are irreversible. Paralysis will never go away and the 
best patients can hope lor is to learn new ways of coping with 
the world. Now, advances in neuroscience are changing that 
view. Although researchers say tangible results are still years 
away, there is evidence that recovery Irom spinal cord injuries 
is possible. 
“Ten years ago I would not have used the word ‘cure’,” said 
Stephen G. Waxman, M.D., Ph.D., professor and chair of the 
department ol neurology at the medical school. “Now it is a 
realistic objective.” Research has found that some viable nerve 
fibers may survive accidents that appear to sever the spinal 
cord. “We are taking several approaches to repairing those 
fibers,” Waxman said, “including transplantation of myelin¬ 
forming cells.” 
Two initiatives involving Yale researchers are pursuing that 
goal. One is the PVA/EPVA Neuroscience and Regeneration 
Research Center at the Veterans Aflairs Connecticut 
Healthcare System in West Haven, which Waxman directs. In 
September the center celebrated the opening of six new 
research labs. The Phil N. Allen and Mayreta V. Allen 
Laboratories for Multiple Sclerosis Research will seek new 
therapies and cures for spinal cord injuries, multiple sclerosis 
and related disorders through studies of molecular biology, 
electrophysiology, pharmacology, computer modeling and 
image analysis. Construction of the laboratories was support¬ 
ed by gifts from the Eastern Paralyzed Veterans Association 
and the Phil N. Allen Charitable Trust. 
In addition, the National Institutes of Health awarded Yale 
researchers a $4.5-million grant to continue their studies of 
Library dedicates resources on end-of-life care 
Paul M. Kennedy, the J. Richardson Dilworth Professor of History 
at Yale, and Florence Wald, former dean of the School of Nursing, 
came to the Harvey Cushing/John Hay Whitney Medical Library 
in September to dedicate the Kennedy-Wald Library Resource 
Center for Care at the End of Life. The resource includes a Web 
site (info.med.yale.edu/library/reference/endoflife/) as well as a 
collection of books, tapes and other educational materials. Wald, 
a member of a team of health professionals who founded the 
country’s first hospice, donated her professional library to form 
the nucleus of the new resource collection. Professor Kennedy’s 
wife, the late Catherine Kennedy, founded Leeway, an extended 
care facility in New Haven for patients living with AIDS. 
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olfactory ensheathing cells, which may regenerate nerves when 
implanted in the spinal cord. 
Experiments in vitro and in vivo have shown that olfactory 
ensheathing cells implanted at the site of spinal cord injuries 
stimulate the regrowth of myelin, the spinal cord’s insulation, 
and axons, long bundles of nerves that transmit information. 
“In many cases spinal cord injuries are so devastating that the 
patients have nothing to lose,” said Charles A. Greer, Ph.D., 
professor of neurosurgery and principal investigator on the 
project. “They are not going to get better without some sort 
of dramatic intervention. This is a dramatic intervention." 
Unlike other cells in the nervous system, olfactory ensheath¬ 
ing cells can regenerate. Part of the pathway that transmits 
information about odor to the brain, they are the only nerv¬ 
ous system cells exposed to the environment, and their ability 
to regenerate serves as a protective mechanism against every¬ 
day toxins and irritants such as cigarette smoke. Greer and his 
colleagues found that implanting these cells helps axons over¬ 
come an “impenetrable brick wall” of glial scar tissue that 
forms when spinal cords are injured. “We think that the 
ensheathing cells form a supportive network, in some way that 
as yet we don’t understand, that helps the axons get through 
that brick wall,” he said. 
His co-investigators are Jeffery D. Kocsis, Ph.D., professor 
of neurology and a senior investigator at the PVA/EPVA 
Research Center, and Anthony N. van den Pol, Ph.D., profes¬ 
sor of research neurosurgery. — J. C. 
SCOPE FINDINGS 
Insulin recognized as target in diabetes 
Cells that cause diabetes do so by launching aggressive attacks 
on insulin proteins, Yale researchers have found. This finding 
could lead to strategies for diverting these attacks and thwart¬ 
ing the disease. 
Published in the September issue of Nature Medicine, the 
study is the first to identify the autoantigen recognized by dia¬ 
betes-causing CD8 T cells (T lymphocytes) in the Non-Obese 
Diabetic Mouse, one of the best animal models for research of 
human diabetes. 
These findings should make it easier to discover the genetic 
and environmental influences that allow autoreactive clones 
— cells that react to the body’s own proteins — to emerge and 
thrive in people with diabetes, according to F. Susan Wong, 
M.D., Ph.D., an associate research scientist in the Section of 
Immunobiology. 
“This is the first time that the target of CD8 cells that cause 
Type i diabetes has been recognized,” said Wong, one of a 
team of a half-dozen investigators who published the study. 
“Now that we know that insulin is an important autoanti- 
genic target, we can use this knowledge to find out how to 
prevent the attacks.” — K.N.P. 
Mental health cuts found costly 
A reduction in mental health services at a large Connecticut 
corporation triggered an increase in medical-care use and sick 
leave, costing the company more money rather than less, 
according to a Yale study. 
“This is the first study to show that there exists a point 
where reducing mental health dollars can be bad for both 
employees and employers,” said Robert Rosenheck, M.D., FIS 
’77, professor of psychiatry and public health, one of several 
authors of the study, which was published in the September/ 
October issue of the journal Health Affairs. “The company’s 
plan for saving money actually backfired,” said Rosenheck. 
“The savings the company realized by cutting mental health 
services were folly offset by increased use of other services and 
lost work days.” — K.N.P. 
Telomerase and the fight against cancer 
Telomerase, an enzyme that makes cancer cells grow, is a bet¬ 
ter target for chemotherapy than previously thought, a Yale 
researcher and colleagues at the University of Colorado have 
found. Sandra L. Wolin, Ph.D., one of the authors of a study 
published in the September 9 issue of Nature, said scientists 
now have another clue as to how the enzyme is constructed 
and, therefore, where it might be vulnerable to chemotherapy. 
“Telomerase is thought to be an incredibly important 
enzyme because it is part of what makes a cancer cell a 
cancer cell,” said Wolin, associate professor of cell biology 
and of molecular biophysics and biochemistry. Wolin and her 
colleagues found that telomerase in yeast cells contained pro¬ 
teins that were thought to be unique to RNA-protein com¬ 
plexes that process messenger RNAs. What this means, said 
Wolin, is that the telomerase enzyme is assembled using a 
pathway that already is very well known to researchers. “This 
discovery is important because telomerase is a potential target 
for chemotherapy and now we know more about it.” — J. W. 
Child care and school readiness 
A six-year study at Yale and three other institutions has 
reached what appears to be a fairly obvious conclusion: 
Children who attend high-quality child care centers are better 
prepared for elementary school than children in less stimulat¬ 
ing environments. But the findings are important, according 
to the authors, because quality has never been a significant 
factor in the debate on child care. 
“For a very long time policy makers felt that investments in 
child care were satisfied if they increased the number of avail¬ 
able program slots,” said Sharon Lynn Kagan, Ed.D., a senior 
research scientist in the Yale Child Study Center and senior 
associate at the Bush Center for Child Development. “While 
recommendations to invest in quality have existed for many 
years, the imperative has never been quite as clear until now.” 
The Cost Quality and Child Outcomes in Child Care 
Centers Study followed more than 800 children from their 
penultimate year of child care through the second grade. The 
better prepared students had higher math and language skills, 
behaved better in class and were more capable of interacting 
with their peers. “This study changes the conversation from 
investments in supply to investments in supply and quality,” 
Kagan said. The researchers and U.S. Secretary of Education 
Richard Riley presented the findings at a Washington press 
conference in June. — J.C. 
Better odds with angioplasty 
Balloon angioplasty offered better odds of survival over clot¬ 
dissolving drugs for elderly heart-attack patients, according to 
a study led by a Yale researcher. But Alan K. Berger, M.D., an 
angioplasty fellow at Yale-New Haven Hospital, stopped short 
of recommending angioplasty in all cases. “Only a small pro¬ 
portion of hospitals have the resources to perform angioplasty 
24 hours a day,” Berger said. His research, reported in the 
Journal of the American Medical Association in July, studied 
more than 20,000 patients who arrived at a hospital within 12 
hours of the onset of acute myocardial infarction. Those who 
underwent balloon angioplasty within six hours of arrival had 
a 27 percent lower risk of death at 30 days and a 19 percent 
lower risk at one year, compared to patients who received clot 
dissolvers. However, for those who began treatment within 
six hours of the onset of symptoms and who were ideal 
candidates for both therapies, outcomes for angioplasty and 
thrombolysis were similar. — /. C. 
YALE MEDICINE II 
By John Curtis 
Capsule is a new Yale Medicine 
department exploring the 
School of Medicine's history. 
Send topic suggestions to 
Editor, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via 
e-mail to ymm@yale.edu 
On May 27 of this year, in a nursing home in Connecticut’s Northwest Corner, 
Anne Sheafe Miller died at the age of 90. She owed the last 57 years of her life to 
a coincidence that placed her, in 1942, in a hospital room down the hall from 
John F. Fulton, M.D. 
Medicine had failed Miller. During four weeks of treatment her temperature 
soared above 106 degrees, and no medications, not even sulfa drugs, had broken 
the fever. She was dying of streptococcal septicemia, a common infection resulting 
from miscarriage. 
Her physician, John Bumstead, M.D., also was treating Fulton, who occupied a bed 
in a nearby room, for an infection. What followed would make medical history and 
usher in the modern use of antibiotics. 
Fulton was already a clinician and researcher of renown who had done extensive 
research into the relationship between the brain and disease. (See “At Reunion, a 
Focus on Fulton,” page 46.) During the war, however, Fulton had abandoned his spe¬ 
cialty to study the effects of altitude on pilots. He also put his reputation and con¬ 
tacts to work to help a friend from his days at Oxford, where he had studied in the 
1920s. His friend was Howard Florey, an Australian researcher who expanded on 
Alexander Fleming’s 1928 discovery of penicillin by isolating its active ingredient and 
demonstrating its therapeutic properties. 
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Anne Sheafe Miller's medical chart 
from 1942, above, shows her danger¬ 
ously high fever and its retreat after 
the administration of penicillin. 
Her case marked the first use of the 
antibiotic in this country. Years after 
her recovery, Miller met with the 
discoverer of penicillin, Sir Alexander 
Fleming, far left, and the dean of 
the School of Medicine, Francis 
Oilman Blake. 
John Fulton, above, made Miller’s 
recovery possible through his 
friendship with Howard Florey, who 
in England had demonstrated the 
therapeutic potential of Fleming's 
1928 discovery and was able 
to obtain a small quantity for 
Miller's treatment. 
When German planes bombarded London in World War II, Florey sent his 
children to New Haven to live with the Fultons. Florey followed two years later and 
Fulton helped him secure support for the production of penicillin, impossible in 
wartime England. 
Anne Miller’s physician, Bumstead, went to Fulton with a plea. Aware of Fulton’s 
friendship with Florey, Bumstead asked Fulton if he could obtain a sample of peni¬ 
cillin. "Fulton got on the telephone on Thursday,” recalled Lycurgus M. Davey, M.D. ’43, 
HS ’52, "and by Saturday they had a small quantity of penicillin to give to Mrs. Miller.” 
It took several phone calls to track down officers of Merck and Co., which had pro¬ 
duced a small amount of the antibiotic. A sample was flown to New Haven from 
Washington and delivered to the hospital by a state trooper. 
The quantity was 5.5 grams. “At that time they did not know how much to give or 
how to give it because they were in the very early stages,” recalled Rocko Fasanella, 
M.D. ’43, HS ’50, then a medical student. At the time, it had saved four of six patients 
who had taken it in England, but it had never been tried in the United States. 
Miller began receiving her first dose via intravenous drip at 3:30 p.m. on a Saturday. 
The next morning her temperature, which had hovered between 103 and 106.5 
degrees, dropped to normal for the first time in four weeks. By Monday her appetite 
had returned and she had eaten four full meals. Her bacteria count dropped. 
As a student volunteer, it fell to Fasanella to administer the medicine at midnight 
and 4 a.m. When he picked up the patient's chart, now on display at the Smithsonian 
Institution, he realized she was the wife of Yale athletic director Ogden Miller, who 
years earlier, as a recruiter, had encouraged him to attend Yale College. Fasanella 
injected the yellowish liquid into the IV tube twice that night while Miller slept. “I 
would slip in quietly and give it and make off again,” said Fasanella, who would later 
became chief of the ophthalmology section in the Department of Surgery and estab¬ 
lished Yale’s first residency program in ophthalmology. 
Herbert Tabor, M.D., HS ’43, the intern with primary responsibility for injecting the 
drug, had another task. He saved Miller’s urine and sent it back to Merck, where up to 
70 percent of the scarce and costly drug could be recovered and reused. 
In his diary, Fulton noted the results. “The case of Mrs. Ogden Miller, who for four 
weeks had been going downhill with what appeared, on the basis of all previous 
experience, to be a fatal hemolytic streptococcus septicemia. She had had a tempera¬ 
ture ranging from 103 to 106.5 degrees steadily for four weeks despite liberal admin¬ 
istration of the sulfa drugs. It is still too soon to say she is cured, but the response has 
been most dramatic.” Miller went on to live a full and productive life. 
Although clinical trials were under way,Tabor, who went on to a career at the 
National Institutes of Health, believes Miller’s recovery convinced the pharmaceutical 
industry that the antibiotic was viable and worthy of mass production. “That 
was really the importance of this case,” said Tabor. “It showed people that they 
could go ahead.” YM 
John Curtis is a staff writer for Yale Medicine. 
YALE MEDICINE 13 
DISCOVERY 
The inside of a cell is a highly organized place, where structure and order allow its components 
to carry out their life-sustaining work. Nowhere is this more apparent than within the 
Golgi apparatus, the organelle that textbook authors variously describe as part factory, part 
shipping station, part switchboard and, in the words of one, “the Grand Central Station of all 
membrane traffic.” 
Imagine a stack of pancake- or pita-shaped disks through which many cell products must 
pass on their way to their final destinations. It sorts and modifies proteins, fats and sugars and 
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One of cell biology's leading lights, newly arrived from London, 
takes a bit of the mystery out of cell division. 
BY MICHAEL FITZSOUSA 
manufactures glycolipids and sphingomyelin, molecules that help protect the membrane that 
surrounds the cell. The Golgi decides whether a given protein will leave the cell or be delivered 
to the plasma membrane or another destination within the cell. Not only does it decide what 
goes where, but also how the parcels should be packaged for transport and how to apply the 
molecular tags that label them for proper delivery. It’s an extraordinarily complex task that sci¬ 
entists have painstakingly worked out during the century since Italian pathologist Camillo Golgi 
first identified the structure that bears his name. ► 
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In the images above and on the pre¬ 
ceding pages, the Colgi apparatus is 
tagged with green fluorescent protein 
(a marker derived from jellyfish) as 
it fragments and reassembles during 
cell division. Because of this process, 
equal distribution of the Colgi to the 
resulting daughter cells is assured. 
The structures stained in red are the 
microtubules of the intracellular 
cytoskeleton. 
Above: In the top row of images, the 
Colgi apparatus appears first as a 
ribbon of green near the cell nucleus. 
As the cell begins to divide, the Colgi 
disperses and its fragments move 
with one or the other of the poles of 
the forming mitotic spindle. As the 
daughter cells separate the Colgi 
begins to reassemble. 
The bottom row shows the same 
process by superimposing fluorescent 
images over conventional light 
microscopy so as to observe the divi¬ 
sion of the cell. Note the alignment 
and division of the chromosomes. 
Several years ago, Graham Warren, Ph.D., posed a new question about this remarkable 
organelle: When an ordinary cell divides, how does it provide the resulting daughter cells with 
roughly equal portions of Golgi to start them on their way in life? Over the last decade, scien¬ 
tists led by Warren have pieced together the precise choreography that allows the Golgi com¬ 
plex to disperse into roughly 10,000 tiny vesicles in a scant 10 minutes and reconstitute itself as 
two new structures in the cell’s progeny. 
His research has shed light upon many other areas of cell biology and provided fundamental 
insight into how a cell distributes its organelles during cell division, with implications for better 
understanding, and perhaps treating, human disease, especially cancers, where cell division has 
run amok. 
Warren brought this work, as well as his reputation as one of the world’s leading authorities 
in membrane transport, to Yale this summer, joining the Department of Cell Biology from his 
former position as principal scientist at the Imperial Cancer Research Fund (icrf) in London. 
A Cambridge-trained biochemist, Warren, 51, spent eight years as a group leader at the 
European Molecular Biology Laboratory in Heidelberg, then chaired the biochemistry depart¬ 
ment at the University of Dundee in Scotland before joining icrf in 1988. In June, he and his 
wife, Philippa, crossed the Atlantic and resettled in New Haven, leaving their four grown 
daughters behind in England. “A change of venue can be quite good for a scientist,” he said 
affably in his fourth-floor office overlooking Cedar Street in September, “by opening new lines 
of thought and creativity.” 
His Yale colleagues will reap equal benefit, according to department chair Pietro De Camilli, 
M.D. “Graham is an intellectual force, and we expect him to be a catalyst of intellectual energy 
in the department,” De Camilli said. “We think of him as a very rigorous presence and a 
provocative colleague who will challenge and stimulate his fellow faculty.” 
Colleagues say Warren was an excellent choice for the department founded by Nobelist 
George Palade, Ph.D., in 1974 because he links traditional approaches in cell biology to cut- 
ting-edge ideas on how to examine cells, their interior structures and their functions. “He was 
one of the first to apply molecular techniques to cell biology, and as such he fits in extremely 
well with the people who are already here,” said fellow professor Ira Mellman, Ph.D., who 
added that by combining biochemistry, structural biology and cell biology, Warren brings “an 
intellectual and methodological perspective which is fresh, new, and exciting.” 
“Graham’s work,” said Mellman, “graphically demonstrates that the most successful biomed¬ 
ical scientists in the years to come will be those who can bridge and combine such diverse areas 
of expertise.” 
What Warren has done in his own work is to lay out a blueprint for the method by which 
the Golgi divides itself. He says it is an important process that biology has largely overlooked in 
its preoccupation with understanding the sorting and distribution of DNA within the nucleus 
during mitosis. “The other organelles in the cell must have the means of assuring that they are 
partitioned equally in the cell,” he said. “It’s just not as obvious as when the chromosomes all 
get in line.” 
Michael Fitzsousa is the editor of Yale Medicine. 
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Graham Warren, who joined Yale’s cell 
biology faculty in July, and his 
research team have shown the inner 
workings of Golgi in minute detail, 
with implications for many other 
areas of cell biology. What Warren has 
done, says a colleague, "is to help us 
understand the process by which a cell 
distributes its inner parts." 
Sketching on a whiteboard in his office, he leads a visitor 
through the process by which the Golgi normally moves pro¬ 
teins from unit to unit by encapsulating them in small trans¬ 
port vesicles bound either for the cell surface, other 
organelles, or the next pita-shaped cisterna in the Golgi stack. 
He says it was this particular step, the movement of the trans¬ 
port vesicles between individual cisternae, that suggested a 
mechanism by which the large-scale fragmentation of the 
Golgi might occur during cell division. 
Warren’s experiments have shown that the vesicles are teth¬ 
ered during their journey within the Golgi stack by long 
fibers that seek out the next bit of cisterna. Warren and his 
group identified a docking protein, GM130, that allows the 
vesicles to find, then fuse with the next cisterna along the 
chain. They theorized that if the docking did not occur, then 
the tiny vesicles would continue to form (and to accumulate within the cytoplasm), but would 
not be able to fuse. Using microscopy as well as biochemical assays, they showed the process by 
which this massive fragmentation occurs and by which the thousands of vesicles are distributed 
nearly equally throughout the dividing cell. [To view animations of this process on the Web, 
see http://www.lif.icnet.uk/axp/cb/.] 
What makes the work especially exciting, says Warren, who was elected a fellow of the 
Royal Society in May, is the confluence of disciplines that are being brought to bear on these 
and similar scientific puzzles. “It brings together traditional cell biology, biochemistry, 
molecular biology and, increasingly, structural biology,” he said. “We’re all now talking the 
same language.” 
Although Warren deflects questions about the ultimate practicality of the knowledge he is 
uncovering (“it’s hard to say—these are just fundamentally interesting cell biologic processes,” 
he demurs when pressed), others are quick to point out the potential applications to medicine. 
“The ability of cells to grow and divide, along with defects in those pathways, are the funda¬ 
mental events that give rise to cancer,” said James E. Rothman, Ph.D., vice chairman of Sloan- 
Kettering Institute in New York City and chair of its cellular biochemistry and biophysics pro¬ 
gram. “What Warren has done is to help us understand the process by which a cell distributes 
its inner parts. The reason he is so well known and had such a broad impact is that his findings 
in this area have enlightened many other areas of cell biology.” 
Warren and his group also have identified the mechanism by which the crucial docking pro¬ 
tein is prevented from pulling in vesicles. Further, they’ve demonstrated that the regrowth of 
Golgi in the newly formed daughter cells requires the presence of several key molecules and 
that another protein called GRASP65 is involved in stacking the reformed cisternae to reconsti¬ 
tute the new Golgi complex. 
Warren and his colleagues will look for additional proteins involved in the formation of the 
Golgi and attempt to answer another puzzling question: As the cell prepares to divide, how 
does the Golgi know to precisely double its mass and distribute that mass equally between the 
two daughter cells? “We can explore these questions in great detail biochemically — we grow 
Golgi beautifully in vitro,” Warren said. “By breaking it down and reconstituting it in the test 
tube, we can see what components we need to add to make the Golgi grow.” YM 
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A veteran analyst of American health care takes the pulse of presidential politics. 
INTERVIEW BY MICHAEL FITZSOUSA / PHOTOGRAPHY BY FRANK POOLE 
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Ask Ted Marmor a question about medicine and public policy and you’ll get a ready answer. 
After all, this is the author of The Politics of Medicare, a much-cited 1973 analysis of America’s 
largest and longest-running health program. A professor of management, public policy and 
political science at the School of Management, Marmor has been at work revising the book’s 
content for its second edition, for publication this fall by Aldine de Gruyter. 
He began his career in the mid-1960s as a special assistant to Wilbur Cohen, secretary of the 
U.S. Department of Health, Education and Welfare, and later served as an advisor to President 
Carter and to 1984 presidential candidate Walter Mondale. A former faculty member at the 
Universities of Wisconsin, Minnesota and Chicago, Marmor is a member of the Institute of 
Medicine and, since 1993, has directed the Robert Wood Johnson Foundation’s postdoctoral 
program at Yale in health policy and social science. He has testified before Congress on health 
care reform, Social Security and related issues, and is a regular contributor to the op-ed pages 
of major U.S. newspapers, including the Wall Street Journal, New York Times, Boston Globe and 
Los Angeles Times. In addition to more than 100 scholarly articles, he is the author or co-author 
of 11 books, including the 1992 volume America’s Misunderstood Welfare State, with colleagues 
Jerry Mashaw and Phillip Harvey. 
Yale Medicine Editor Michael Fitzsousa interviewed Marmor in early September. The night 
before, Marmor had given a lecture to doctors enrolled in the Yale Management Program for 
Physicians, a new course offered jointly by the Yale Faculty Practice, the School of 
Management and the School of Public Health. On this day, he is hosting Jean de Kervasdoue, 
a visiting fellow from the Conservatoire National des Arts et Metiers in Paris and former head 
of the French hospital system. After work the two will face off on the tennis court; Marmor 
plays squash daily and won the national championship for over-6o earlier this year. We asked 
him to comment on the debate raging over Medicare in Washington, the prospects for health 
care reform and managed care, and the role that issues in health and medicine are likely to play 
in the coming 2000 presidential campaign. 
Looking at the intersection 
of health care, politics and 
economics in September 
1999, what do you see on 
the horizon? 
What are the other leading 
issues in health care, in 
terms of public interest? 
Which of them do you think 
have the potential to affect 
the 2000 presidential race? 
Turbulence is the dominant feature. And to everyone’s surprise, medical care has come back on 
the agenda of American politics. Not only in the context of Medicare reform or prescription 
drugs or the regulation of so-called managed care firms in the various states, but also as a likely 
topic of the presidential race of 2000. That, just a few years ago, would have been thought 
impossible. The prognosticators in 1995 were saying that the debacle of the Clinton health care 
reform meant that universal health insurance was off the agenda for another generation. 
The most surprising issue is whether or not the United States is going to move decisively 
towards universal health insurance in the way that President Clinton proposed in 1993. That’s 
being suggested by candidate Bradley, circled by candidate Gore, and ignored at the moment 
by contender Bush. But I don’t think it’s going to remain that way. The question of the state of 
the uninsured in America —as well as the state of the underinsured— will be topic number one 
in the public debates. 
A second topic on the agenda is that of a so-called patient’s bill of rights, which is really a crie 
de coeur about the regulation of patient choice. In a surrogate way, it’s about the regulation of 
professional choice, of what services to give to whom under various insurance plans. It’s an 
extremely complicated alignment in Washington now, with the Democrats struggling to get 15 
to 20 Republicans to favor their more interventionist line. The physician-politicians on the 
Republican side in this case are unwilling to follow party loyalty because they feel aggrieved by 
the same phenomenon that has aggrieved consumer groups and professional groups within 
medical care. 
The third topic, which was on the agenda in April, May and June and has for a moment 
fallen off, is the dispute about how to adjust Medicare both to the changing demography of 
America and to changing conceptions about what Medicare ought to provide and how it ought 
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to be organized. There’s no possibility that Medicare will not be an issue of contention in the 
2000 election. The interesting thing is that, because it’s being presented as a matter of fiscal 
politics, conservative Democrats like [Sen.] John Breaux [D-La.] have joined forces with ideo¬ 
logical opponents of Medicare like [Rep.] Bill Thomas [R-Calif.]. It’s a reminder of the align¬ 
ment that took place in the 1950s and early 1960s between Southern Democrats and 
Republicans opposed by the bulk of the Democratic party. Medicare was born as a product of 
the ’64 election that broke that conservative coalition. 
The fourth is a topic that may or may not arise, but all the ingredients are there. Namely, 
the sense of American physicians that their lives have been transformed by the events of the 
1990s in ways that they could not have imagined at the start of the decade. I can’t think of a 
more important theme for medical education, medical discussion and medical care than this. 
The elliptical way of describing this is that the early 1990s was a period of choice without 
change, and that the rest of the 1990s has been a period of change without choice. The Clinton 
debate raised every issue you could possibly imagine. Choice was everywhere. Choice about 
regulation. Choice about delivery. Choice about financing. And it was stalemated. In the wake 
of that stalemate, American doctors, instead of being hit on the left by a hammer, were hit 
on the right by 10 sledgehammers, as intermediary organizations realized that the savings the 
Clintonites had assumed would come from negotiations with the physicians and other 
providers could be found through the use of their market power as buyers. The only way 
you actually generate savings is by reducing the income of people on the other side of the 
receipt. The most important law of medical economics is that expenditures always equal 
somebody’s income. 
Ten years from now, It depends in part who wins in 2000 and in 2004. It depends on the continuation of this 
do you think the health care boom. If the boom continues or is not reversed substantially, I think the circumstances of 
system will be in American health care patients, physicians and nurses will actually improve. That is, I think 
better shape or worse? we re at the end of a trough and at the beginning of a period of realignment of forces in 
American medicine, much helped by the general well-being of Americans. If, on the other 
hand, we have a reversal, it will make a huge difference as to whether or not the reform forces 
will be on the side of cost-cutting, or whether they will be on the side of protecting the 
patients from restraints on their options arising from largely financial goals rather than medical 
care goals. 
And I think there’s no way of putting this other than bluntly, which is to say that American 
medicine is now the most highly regulated in the world, except it’s not regulated primarily by 
the government. These are blunt points that are masked by the prominence in American politi¬ 
cal discussion of the ideology of anti-government sentiment. It’s one of the reasons it’s taken 
much of this decade for the population to catch up with these changes. But there’s another rea¬ 
son which physicians and hospital administrators and educators in medical schools need to 
know about: Most people are not sick most of the time. 
If the changes in medical care that have taken place in the ’90s had taken place in American 
schools or in grocery stores, there would have been a much more rapid response. It’s physicians 
and nurses and patients who have the largest, day-to-day stakes. Most people aren’t patients 
most of the time. So there’s an imbalance in the representation between the fiscal stakes of pay¬ 
ors, the fiscal stakes of providers and the fluctuating stakes of the citizenry who from time to 
time experience the enormous hassle of American medical care. 
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The second edition 
of your book The Politics 
of Medicare will be 
published this fall. 
What has changed and 
what has remained 
the same since Medicare 
was established? 
The biggest change is that Medicare, from i960 to 1966, was regularly a front-page issue. It was 
a first-order question about the role of government — how that role ought to be financed and 
for whom its benefits should be given. And the fight was between two dramatically contending 
conceptions of the proper role of government and the proper kind of medical insurance protec¬ 
tion. That was settled decisively by the election in 1964 and the enactment in 1965. And what’s 
been true from 1966 to 1996 was that Medicare became largely a second-page issue in American 
life, of first-order significance to a medical school, to a hospital, to doctors, but not something 
that presidential elections were fought over. In 1968 we were talking about Vietnam. In 1972 
when Nixon won, national health insurance was on the agenda, not Medicare reform. Likewise 
in 1976, Carter didn’t talk about Medicare, nor in 1980 was it an issue. Nor 1984. Nor 1988 — 
then it was children’s health insurance on the Dukakis side. In 1992 it was Clinton not saying a 
word about Medicare except when forced. By 1996, he rediscovered Medicare as a partisan issue 
and beat the hell out of the Republicans with it. 
The great story of 1999 is the popularization of several myths about Medicare, which are 
announced in Washington as if they were obviously true, and they have nothing to do with the 
truth. Myth number one is that Medicare is unsustainable and unaffordable because of the 
aging of America. There is no reason to believe that aging explains very much of the increases 
in Medicare’s outlays between 1966 and the present. The population increase of the elderly is a 
relatively small component. If demography were destiny, then northern Europe already would 
have had a transformation ol all their medical care schemes, since they aged in the 1980s and 
early ’90s as much as we plan to age over the next 15 years. Why is this the case? Because what 
you spend is not simply a matter ol how many people are in any age group or in your society. 
We now know from the last three years of economic growth that it’s not the number of people 
working, but the wealth they produce. That is central to the “affordability’’ of any program. 
There is a crazy idea that ratios of workers to the elderly is the only thing you need to know. 
By this standard, Switzerland would be very poor and Swedes would be positively impoverished. 
A second myth about Medicare is that the answer to this affordability problem is to give all 
elderly people a voucher equal to the average Medicare expenditure per capita, and therefore to 
put a financial border around the Medicare program. Well, that doesn’t reduce the cost ol med¬ 
ical care to the elderly. It constrains the cost of the Medicare program to the federal govern¬ 
ment. It’s a perfect example of shifting of financial risk. It shifts the risk onto employers, on 
elderly people and on plans. 
And finally the notion that the reason we’re going to have to change things is that the rest of 
Americans are facing more constraints on their medical care choices than Medicare beneficiaries 
are. The reasoning then follows: Medicare will be unsustainable because older and disabled 
Americans experience freedom that their children don’t have and therefore are resentful. There 
is not one shred of evidence from public opinion surveys or focus groups to support this cliche. 
But there are many people in Washington who claim this to be true. With these three myths 
going around, it’s hard to find the truth, ym 
making mischief Working with his late colleague Tai-Shun Lin, William Prusoff made the basic discoveries leading to 
development of the AIDS drug d4T. 
Last year alone more than 75,000 
prescriptions were sold under the 
trade name Zerit, generating more 
than $550 million in revenues for 
Bristol-Myers Squibb and $40 million 
in royalties for Yale. 
nd and a 
landmark AIDS drug, William Prusoff is a study in the 
quiet pursuit of science. 
BY JOHN CURTIS / PHOTOGRAPH BY FRANK POOLE 
£> 
Left and below left: the molecular structures of d4T 
and thymidine, one of the four nucleosides that 
make up DNA. As it becomes incorporated into the 
viral DNA of HIV, d4T shuts down the virus’ability 
to replicate. 
As HIV prepares to replicate in fresh cells, it produces a long 
strand of polyprotein. To complete the process, this strand 
then breaks apart into smaller units made up of essential viral 
proteins and enzymes. In a circular bit of logic typical of the 
virus, it is one ol these essential enzymes — protease — that 
starts this process rolling by separating the polyprotein strands 
in the first place. 
Protease inhibitors have kept HIV at bay in many patients 
by limiting its ability to reproduce infectious virus. William 
Prusoff believes he has found a new way to keep the enzyme 
from triggering that protein fragmentation. In a laboratory 
freezer next to his office in Sterling Hall of Medicine, he 
keeps a supply of HIV protease stored at minus 80 degrees 
centigrade. Vials of boron analogs of selected tetrapeptides are 
close at hand. By chemically inserting the boron into 
polypeptides that interact with the protease, it is possible, he 
theorizes, to shut down the replication of HIV. “If one 
inhibits the cleavage of the polyproteins, a virus is made, hut 
it is not infectious,” he says, sitting in his office in the 
Department of Pharmacology. “We feel that it will be a very 
potent inhibitor.” Although Prusoff’s boronated peptides have 
shown promise in laboratory experiments, he knows it will 
take years to determine if they are effective in humans. 
At 79, Prusoff is used to this painstaking pace. He has spent 
his career making mischief with DNA. Four decades ago, his 
work led to the first antiviral drug, a compound used in the 
treatment of herpes infection of the eye. In the 1980s, he and 
his late colleague Tai-Shun Lin, Ph.D., made the discoveries 
that enabled development of d^T, a reverse transcriptase 
inhibitor marketed by Bristol-Myers Squibb under the trade 
name Zerit. In the year ending June 30, sales of Zerit generat¬ 
ed $40 million in royalties for Yale, nearly all its income from 
the licensing of intellectual property, and extended the lives of 
tens of thousands of patients with HIV. (Total sales were $551 
million, based on 76,755 prescriptions.) These successes have 
brought Prusoff, a senior researcher and professor emeritus of 
pharmacology, the respect of basic scientists and physicians 
around the world and general acknowledgement as the father 
of antiviral chemotherapy. 
Prusoff wears this crown lightly, almost reluctantly. He is 
glad to talk about his work and, if pressed, will admit to 
developing the first antiviral. “What it showed was that you 
could get a compound which would be effective clinically in a 
viral infection,” he says with enthusiasm. But call him a trail- 
blazer and he takes a step back. “I look at my career as one ol 
serendipity,” he says. This decidedly low-profile approach is 
typical of the man, his friends say. “Bill Prusoff is a very hum¬ 
ble man, a real gentleman,” says Alan C. Sartorelli, Ph.D., 
Alfred Gilman Professor of Pharmacology and Epidemiology 
and interim chair of pharmacology. “There are faculty around 
the country, at Yale even, who have this air of superiority. Not 
Bill Prusoff.” 
Although retired, Prusoff continues to probe the complexi¬ 
ties of thymidine, the molecule that has been his lifelong 
interest. One of four nucleosides in DNA, it has been the 
source of his major accomplishments since the 1950s, when he 
struck upon the therapeutic value of idoxuridine, which 
became the first antiviral compound approved by the FDA. 
His discovery gave physicians their first weapon against 
herpes and the related keratitis, then the leading infectious 
cause of blindness. Idoxuridine is a thymidine analog. Once 
incorporated into the viral DNA, it leads to the synthesis of 
abnormal RNA and proteins. “It stops the infection because 
the virus can’t reproduce properly,” Prusoff says. “People were 
looking at antivirals before then. This was the first one which 
was successful.” 
With this compound, Prusoff did more than invent a 
new drug. He turned the prevailing wisdom about antiviral 
drugs on its head. According to David Barry, M.D. ’69, 
HS ’72, founder of the drug-discovery company Triangle 
Pharmaceuticals Inc., the dogma was simple: Antivirals could 
not work. If effective, they would prove too toxic for use in 
humans. If safe for human use, they would lack the potency 
to control the virus. 
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“What Bill showed was that that was not always the case,” 
says Barry, who studied antiviral compounds in Yale’s phar¬ 
macology department, though not with Prusoff. “That major 
leap of thought is really what started antiviral chemotherapy.” 
“He showed that you could control or obliterate viral infec¬ 
tion by interfering with the nucleic acid processing,” says 
Gregory Gardiner, Ph.D., former director of the University’s 
Office of Cooperative Research. “Every antiviral drug since 
then has worked that way until protease inhibitors came 
along for AIDS.” 
Much remained to be done to develop antivirals, however. 
Although effective topically, idoxuridine was too toxic for sys¬ 
temic use, Prusoff says. Twenty years later he developed an 
amino analog of idoxuridine for systemic use against herpes 
simplex. It inhibited the virus, but left uninfected cells alone. 
“He was the first to demonstrate the feasibility of developing 
nucleoside analogs as a selective anti-herpes-virus compound,” 
says Yung-Chi Cheng, Ph.D., Henry Bronson Professor of 
Pharmacology, a long-time colleague and friend. Prusoff’s 
compound, however, had limited potency and was soon 
eclipsed by acyclovir, an antiviral nucleoside analog with a 
similar selective mechanism that proved even more effective. 
In the 1980s, when Prusoff and colleague Tai-Shun Lin 
were looking for nucleosides that inhibited HIV, they turned 
again to thymidine. “It had been shown,” Prusoff recalled, 
“that a number of nucleosides had activity against the AIDS 
virus.” Thymidine by itself had little effect on HIV, but 
Prusoff and Lin tried a different approach. “People had not 
looked at thymidine with an unsaturated bond,” Prusoff said. 
“Dr. Lin and I decided to look at this compound, which had 
been synthesized in the 1960s by Jerome Horwitz at the 
Detroit Cancer Center. It had limited anticancer activity. We 
examined it for its effect against HIV and found it was very, 
very active.” As it became incorporated into the viral DNA, 
d4T shut off the virus’s reproductive mechanism. In 1992 d^T 
became the first drug tested under the EDA’s parallel track 
policy, which gave people with life-threatening illnesses access 
to drugs still in clinical trials. Zerit received the PDA’s 
approval in 1994. “It is clearly one of the most significant 
AIDS medications and one that has lasted in terms of market 
share,” says Barry, who led the team that developed AZT, the 
first medication to slow the progress of HIV. 
Prusoff’s interest in chemistry started in high school. “It 
gave you an understanding of what the world was made of,” 
he says. “It fascinated me to learn that a piece of wood is 
made up of carbohydrates and a lot of atoms.” In 1937 he left 
his home in Miami to study chemistry at the University of 
Plorida at Gainesville. “During the Depression, when I want¬ 
ed to quit school and help out, my parents absolutely refused 
and insisted that I stay in school,” he says. His mother and 
father, Russian immigrants who had moved from New York 
John Curtis is a staff writer for Yale Medicine. 
City when he was 15, ran a small grocery store. “They had 
absolutely no education at all, yet they realized the impor¬ 
tance of an education.” After a year in Gainesville, Prusoff 
transferred to the University of Miami so he could live at 
home and save the expense of room and board. He covered 
his tuition by taking a job as an assistant in the chemistry lab. 
In typical Prusoff style, he says his older brother was the 
smarter of the two. “He majored in sororities and minored in 
fraternities and became a very successful salesman,” Prusoff 
says fondly. 
Poliowing his parents’ wishes, Prusoff applied to medical 
schools, including Yale. He was turned down. “I was disap¬ 
pointed,” he says, “but it was probably the best thing that 
happened to me. I think 1 am a much better scientist than I 
would be a physician.” World War II put his graduate studies 
on hold. His poor eyesight kept him out of the Army while 
his chemistry background led to a job inspecting fuses at a 
munitions factory. Later he worked as a health inspector, 
checking water supplies and kitchens at Miami Beach hotels 
earmarked for pilots in the Army Air Corps. 
When the war ended Prusoff traveled to New York to study 
at Columbia University, where he worked in the laboratory of 
Charles Glen King, Ph.D., studying the relationship of folic 
acid to nucleic acid biosynthesis. 
At Columbia, Prusoff noticed a familiar name on a list of 
students. He had met Brigitte Auerbach, a chemist at Merck 
and Co., when he worked in Tennessee as an ordnance inspec¬ 
tor. They eventually married and had two children, Laura, 45, 
now a photographer living in Turkey, and Alvin, 47, a father 
of three, who is a computer consultant, active in civic affairs 
and a coach in Lairfield County sports leagues. Brigitte 
Prusoff launched her own distinguished career in epidemiolo¬ 
gy and biostatistics at Yale. After her death in 1991, Prusoff 
endowed a lecture series in her honor at Epidemiology/Public 
Health and Psychiatry. 
Prusoff received his doctorate from Columbia in 1949 and 
went to Western Reserve University to work in the laboratory 
of Arnold D. Welch, M.D., Ph.D. Welch, a rising star in 
pharmacology, would later reinvigorate the pharmacology 
department at Yale. It was with Welch that Prusoff made 
both his first major contribution and first major blunder 
in pharmacology. 
The two men were trying to purify the intrinsic factor. This 
natural protein is found in gastric juices. It is necessary for the 
absorption of vitamin B12 from the gastrointestinal tract, 
which, in turn, helps the body stave off pernicious anemia. 
“We reasoned that if we were able to isolate and characterize 
the intrinsic factor, this could be given to patients who have 
pernicious anemia,” he says. A Harvard colleague, William 
Castle, M.D., whom Prusoff calls the father of the intrinsic 
factor, sent Welch two liters of gastric juices pumped from the 
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stomachs of medical students. Prusoff put the fluid through a 
vacuum freeze-drying process that separated the liquid, leav¬ 
ing a powder that contained the intrinsic factor. His next task 
was to release the vacuum. 
“When I released the vacuum I did it too fast and all the 
powder went into the condenser, with no way to recover it,” 
Prusoff says. “I had to go in and tell Dr. Welch what I had 
done. I said if he threw me out of the laboratory he would 
have been justified. He felt my remorse, and I guess had 
confidence in me and didn’t fire me.” Despite the mishap, 
Prusoff succeeded in obtaining a 5,000-fold purification 
and characterizing the intrinsic factor. Laughing, he adds, 
“That’s when we changed direction and went into nucleic 
acid chemistry.” 
With Welch, he came to Yale in 1953. Here, Prusoff began 
what has become a lifelong quest — ways to modify 
thymidine’s structure to curb disease. Even now, Prusoff is 
collaborating with researchers in Moscow and at Washington 
State University on two anti-HIV projects, one of them a 
thymidine analog. The other is based upon his hunch that 
the boronated peptides will inhibit HIV protease and prevent 
the formation of infectious viral particles. He and his col¬ 
league, Arman Pivazyan, Ph.D., an associate research scientist 
in pharmacology, are working on their second generation of 
the peptides. Unlike other protease inhibitors on the market, 
the boronated peptides not only attack the protease enzyme 
at its active site, but also prevent two enzyme subunits from 
binding and becoming active. “We hope, because the 
mechanism of action of these compounds is different, HIV 
will be less resistant to them,” says Pivazyan, who came to 
Yale from Moscow in 1990 to work with Prusoff. “We have 
shown that these compounds act as dual-mode inhibitors. 
We have shown that mutated protease is less resistant to 
this compound than commercial protease inhibitors.” Now 
he and Prusoff are working on increasing the potency of 
the compound. 
Pivazyan describes their working relationship as informal. 
He and Prusoff, he says, are two scientists working together. 
Pivazyan works alone in the laboratory and consults frequent¬ 
ly with Prusoff, who comes to his office every day. “I know 
what the general problem is,” Pivazyan says. “I work on the 
problem and we discuss the results and what to do next.” 
Prusoff and Pivazyan have applied for an NIH grant to 
continue their work. They expect it will take several years and 
many more generations of their compound before it is ready 
for in vivo tests. Once they determine its potency against 
HIV protease, it will go to the laboratory of Prusoff’s old 
friend and colleague Cheng, who will conduct further tests of 
its effect on HIV. Cheng and Prusoff first met in the early 
1970s, when Cheng arrived from Brown University to begin 
his postdoctoral work. He chose to study at Yale because of 
John Curtis (2) 
Pharmacologists from around the 
country attended a symposium in 
Prusoff’s honor last fall and a 
banquet to celebrate a new profes¬ 
sorship in his name. Although retired, 
Prusoff continues his thymidine 
research in the hopes of finding new 
antiviral compounds. “It’s better than 
contemplating one’s navel,"he says. 
“The important thing is that I enjoy 
the work.” 
Prusoff. “He was a leading authority in the antiviral area. He 
was a leading authority in the area of pyrimidine nucleoside 
analogs,” Cheng recalled. “Most importantly, he has such a 
nice personality. I saw him as a role model.” 
Cheng went on to develop 3TC for use against AIDS and is 
responsible for five of the 10 Yale-developed compounds now 
in pre-clinical or clinical trials. He considers Prusoff a giant in 
his field. “In general, you make one major break and add 
other things to it,” says Cheng, who goes on to cite Prusoff’s 
development of idoxuridine, the idoxuridine amino analog 
and dqT. “He has made three major breaks.” 
Recognizing his lifetime of accomplishment, the medical 
school has created the William H. Prusoff Chair in 
Pharmacology. Dean David A. Kessler, M.D., announced the 
chair at a symposium in Prusoff’s honor last year. After the 
symposium, colleagues and friends feted him with a dinner 
and accolades that touched on his character as well as his 
achievements. As one attendee remarked, the crowd included 
“anyone who is anyone in pharmacology.” 
“I am very, very lucky that my whole career has been a very 
happy one,” Prusoff says. Along with his family, his work has 
been the driving force in his life. He abandoned his only 
hobby, traveling, eight years ago when Brigitte died. Although 
retired, he spends time every day in his office. “It’s better than 
staying home and contemplating one’s navel,” he says. “The 
important thing is that I enjoy the work. It has been a very 
happy and productive career.” ym 
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The ancient Greeks had their myth of the fire-breathing 
chimera with its head of a lion, body of a goat and serpent’s 
tail. Modern America has its own mythical chimeras — from 
the Teenage Mutant Ninja Turtles and Spiderman to monsters 
of grade B movie fame like The Creature from the Black 
Lagoon and The Fly. Pondering the differences among organ¬ 
isms has fired the imagination with the once-seemingly-outra- 
geous notion that one species could come to share the same 
biological stuff with another. But what today’s real-world sci¬ 
entific researchers term a transgenic species — one species that 
contains one or more genes of another — has been a living 
reality since 1980. That is when Yale scientists became the first 
in history to implant a human gene successfully in another 
species — a mouse. 
While a mouse with a human brain or other phenomenal 
powers may still be only for the cartoons, the tiny, pro¬ 
grammed, transgenic rodent is having a powerful impact on 
medicine. Over the past decade, the transgenic laboratory 
mouse has emerged as an essential model for advanced bio¬ 
medical research throughout the world and has begun to pro¬ 
duce tangible benefits for healthcare. Small, easy-to-handle, 
relatively inexpensive, and quick to breed (gestating in about 
three weeks), the laboratory mouse has long been the most 
commonly used animal model for scientific research. Today, 
with one or more foreign genes implanted, the transgenic 
mouse provides an unparalleled research tool for virtually 
every field of biomedical research. The impending completion 
of the Human Genome Project to map out the entire DNA 
blueprint will make the transgenic mouse an invaluable model 
for the study of genetic functions. Many believe that the 
transgenic mouse and other transgenic species will help lead 
researchers to a biomedical revolution over the next decade or 
so that could dwarf all the achievements of the preceding cen¬ 
tury. Already, transgenic mice and other transgenic species are 
being used to produce human blood cells, hormones and 
other proteins needed to treat human disease. 
In a sense, each new transgenic mouse line, containing a 
gene from another species, is an entirely new species of 
mouse, one that never existed before. While the potential 
benefits that result can be enormous, the process itself is by 
now technically routine. The main source at Yale is the 
Section of Comparative Medicine’s Transgenic Mouse Service, 
which has a full-time technologist whose sole job is to create 
new transgenics. Supported in part by the Yale Cancer Center, 
the service produces new strains at the rate of about 30 to 50 
per year. More than a score of other laboratories around Yale 
have their own transgenic operations and probably add at 
least that many more new lines of mice each year. The mice 
are used to study a vast range of questions, including the 
workings of the immune system, the causes of cancer, ways to 
control drug addiction, how the brain and skeleton develop 
and the mechanisms of asthma. While separated by 200 
million years of evolution from humans, the mouse is also 
proving a gold mine for researchers trying to explain how 
humans evolved. 
CREATING NEW SPECIES 
Although the procedure for producing a transgenic animal is 
by now straightforward and widely employed, it is by no 
means simple. A transgenic mouse is created by individually 
injecting a copy of a foreign gene into the nucleus of a fertil¬ 
ized mouse egg. The egg containing the foreign gene is then 
reimplanted into the uterus of the mother. The work is micro¬ 
scopic and requires very pure DNA and working conditions. 
Even under the best of circumstances, only around one in five 
procedures will be successful. Each new strain of transgenic 
mouse costs about $2,000 to produce. Three weeks after the 
transgenic embryo is reimplanted, the mother delivers an 
infant mouse with the foreign gene present in the nucleus of 
all of its cells. 
A mouse is created for a specific purpose that cannot 
otherwise be accomplished by less expensive and less time- 
consuming means, such as work with cell cultures or 
computer modeling. “Human genes work pretty faithfully in 
the mouse,” says Richard A. Flavell, Ph.D., chair of the 
Section of Immunobiology and a Howard Hughes Medical 
Institute investigator. He uses transgenic mice to study the 
workings of the immune system. The transgenic mouse has 
become indispensable for deciphering human genetic 
functioning. “You can’t find out how genes work in whole 
organisms by other means.” 
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We knew we could transfer DNA into a cell tissue 
culture, ” recalls Ruddle. “We were curious about how it 
would function in a whole organism. ” 
Frank Ruddle is Sterling Professor of Molecular, Cellular and 
Developmental Biology and professor of genetics. 
While research using transgenic mice is, for most purposes, 
still in its infancy, it is already clear that enormous advances 
are in the offing. “The genetically engineered mouse,” says 
Robert Jacoby, D.V.M., Ph.D., chair of the Section of 
Comparative Medicine and director of the Yale Animal 
Resources Center, “will be the E. coli of the 21st century,” 
referring to the bacterium that was used to derive much 
of our current knowledge about how genes work. “The 
diversity of animal models has become literally infinite. 
Theoretically all genes could be studied with a transgenic 
mouse model.” Adds Flavell, “The combination of genomics 
and the transgenic approach is going to lead to massive 
medical breakthroughs.” 
The use of the mouse as a study subject is of course noth¬ 
ing new. Inbred laboratory mice have been a staple of 20th- 
century medical research, from basic biological and behavioral 
studies to trials for new medications. Even Gregor Johann 
Mendel, the monk who first derived the laws of genetics in 
the mid-i8oos through his studies of pea plants, is believed to 
have bred mice to observe inheritance of coat colors. 
Geneticists discovered early in this century that inbreeding 
among sibling mice over a span of about 50 generations could 
create a particular strain with identical inheritance characteris¬ 
tics. With no genetic variation except chromosomal differ¬ 
ences between male and female, the effects ot environmental 
manipulations and chemical reactions can be studied under 
controlled conditions, even in separate laboratories. 
Everything about the inbred laboratory mouse could be 
easily controlled and studied — everything except for the 
most fundamental aspects of life: genetic structure, function 
and variation. 
Prior to the creation of the transgenic mouse procedure, 
novel strains of mice emerged only by naturally occurring 
mutations, or a mutation could be induced by means of 
exposure to chemicals or radiation and then inbred over 50 
Marc Wortman is a contributing editor to Yale Medicine. 
generations as a novel strain. This was how most knowledge 
about the effects of chemotherapy, radiation therapy and 
most modern medications came about. Prior to the develop¬ 
ment of molecular biology techniques in the 1970s, identifica¬ 
tion of genes and their functions could come about only 
through this route. Progress was slow and often only hap¬ 
pened serendipitously. “The process took a fair amount of 
time because of the number of generations needed to breed 
genetic uniformity,” says Jacoby. The chair of neurobiology, 
Pasko Rakic, M.D., Ph.D., worked on spontaneous neurolog¬ 
ical mutations in mice in the 1970s. “Although some of the 
random mutations have proved to be very useful and tantaliz- 
ingly promising,” he recalls, “the chances of obtaining the 
next, functionally relevant mutation was unacceptably low.” 
A TRANSGENIC LANDMARK 
In the late 1970s, revolutionary new methods tor cloning and 
handling DNA were still being perfected. The laboratory of 
Frank Ruddle, Ph.D., now Sterling Professor of Molecular, 
Cellular and Developmental Biology and professor of 
genetics, had been using the new methods to pioneer 
techniques for mapping and modifying genes. The way to 
test the success of the techniques was to implant the modified 
gene in a cell in tissue culture and see how it functioned. 
“We knew we could transfer DNA into a cell in tissue 
culture,” recalls Ruddle. “We were curious about how it 
would function in a whole organism.” 
Ruddle had already shown that nuclear injection of DNA 
into cultured cells was the most effective method of gene 
transfer, so he focused on that method for transforming 
mouse embryos. In 1980, he set up a cross-disciplinary team 
to tackle the challenge. He persuaded Jon Gordon, M.D. ’80, 
Ph.D. ’78, who was finishing his medical degree at the time 
and had prior graduate training in mouse reproductive 
biology, to join the laboratory group. Ruddle constructed 
what is called a transfer gene, made from the thymidine 
kinase gene of the human herpes virus and an enhancer 
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Ruddle has used the mouse model to study evolutionary pathways between 
species. The arrows below point to locations in the mouse vertebral column 
where development has been influenced by the insertion of a Hoxc8 gene from 
the baleen whale. 
region of the simian virus 40. Gordon suggested a novel 
approach of injecting the male pronucleus containing the 
transfer gene into the one-cell mouse embryo. All previous 
attempts to transfer genes into multi-cellular embryos had 
failed, and many in the scientific community simply doubted 
that gene transfer into a living embryo could be done. Says 
Ruddle: “The most important ingredient for a technological 
breakthrough is a sustained effort in the face of probable fail¬ 
ure. I convinced the team that we should analyze no fewer 
than 100 mice before giving up. We hit pay dirt on mouse 
48.” When the mother delivered a living infant mouse with 
the foreign gene in all of its cells, Ruddle’s team had created 
the first transgenic animal in history. (Experiments elsewhere 
to create transgenic plant species were under way around the 
same time.) 
Ruddle coined the term “transgenic” for the resulting 
species. The team replicated its results and published them 
that year in the Proceedings of the National Academy of Sciences. 
That was followed by a paper in Science that showed that the 
gene was preserved through generational breeding and would 
continue to act like one of the mouse’s own genes. The 
transgenic revolution had begun. 
The technique of pronuclear injection that Gordon devel¬ 
oped for the purpose remains largely unchanged. (Gordon 
joined the faculty at the Mount Sinai School of Medicine in 
New York in 1982, where he now works on human reproduc¬ 
tion and transgenic animal models for human cancer.) When 
compared to the hoopla surrounding the one-time cloning of 
Dolly the sheep three years ago, this far-more-revolutionary 
achievement received relatively little attention. Ruddle, 
however, recognized its importance. “We understood very 
thoroughly,” he says, “what the implications were for studying 
how development occurs and the potential for spin-offs of 
understanding of disease and how to treat disease in different 
and more powerful ways. It’s gratifying how the applications 
keep multiplying.” 
Since then, Ruddle has been using the transgenic mouse 
technology to study the evolution of the so-called master 
control genes. His laboratory is focused on the Hoxc8 gene. 
This gene regulates various aspects of early development, such 
as the formation of the upper body and limbs in humans, 
and is seen across a very broad spectrum of species, from the 
primitive fishes to humans. Ruddle is interested in the evolu¬ 
tionary variations in the expression of genes that have taken 
place over the course of hundreds of millions of years. “The 
mutations in the master control gene allow transition in evo¬ 
lution from one form of species to another,” he says. To study 
how the gene is expressed in different organisms, he has cre¬ 
ated transgenic mouse species with the Hoxc8 gene from 
whales, birds and fishes. 
There are no five-ton white mice with flukes swimming 
around New Haven Harbor. In most instances, Ruddle inacti¬ 
vates the gene, using it to report on how it would be expressed 
in different organisms. In current experiments, he has 
transferred live whale genes into the mouse to see how the 
whale Hoxc8 gene affects mouse development. “We hope to 
see modifications in the vertebral column that correspond to 
the structural modifications in whale skeletal design as a result 
of adaptation to the marine habitat over the past 30 million 
years.” Early results have provided useful clues about the 
evolutionary pathways that lead from one species to another. 
Ruddle has also developed new, patented tools for targeting 
and isolating variations in coding and control regions of 
genes. Among the implications for this work is looking at 
ways that different populations respond to medications in 
order to develop new drugs that are more effective in treating 
individuals. This is part of an entirely new field called phar¬ 
macogenetics, which aims to create personalized medicines. 
Ruddle serves as an advisor to a former student of his, 
Gualberto Ruano, Ph.D. ’92, M.D. ’97, founder and chief 
executive officer of Genaissance Pharmaceuticals, a New 
Haven-based biotechnology firm pursuing applications for 
developing new disease treatments and better utilizing exist¬ 
ing therapies using genomics and information technology. 
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A MOUSE GUIDE TO HUMAN GENETICS 
Transgenics has proven of great use in the study of a wide 
range of disease mechanisms and biological processes. Among 
recent firsts at Yale, Prabir Ray, Ph.D., an associate professor 
of medicine, and Jack Elias, M.D., section chief of pulmonary 
and critical care medicine, created the first transgenic mouse 
that expresses human interleukin n in the lung, which is 
known to be a factor in the development of asthma. Thus, this 
mouse provides an important animal model for understanding 
the development of asthma. 
Immunobiologist Flavell has collaborated with Ray in his 
transgenic work. In his own laboratory he works with more 
than 50 different strains of transgenic mice to study how 
immune responses are regulated at the molecular level. 
Transgenic mice were valuable in his and colleagues’ work in 
creating LYMERix, which is the first vaccine against Lyme dis¬ 
ease and is being marketed by pharmaceutical company 
SmithKline Beecham. Flavell is now focusing on understand¬ 
ing autoimmune disease. In juvenile-onset [or insulin-depend¬ 
ent] diabetes, a potentially lethal disease that most often 
begins in childhood and affects about 750,000 Americans, the 
pancreas destroys its own insulin-making cells. Flavelfs labora¬ 
tory has created transgenic models for this process, giving 
them some of the first clues as to why it takes place. He says, 
“We now think that you get an infection, which causes the 
pancreas to fill up with immune cells that pick up the dead 
cells and turn on the immune system. It, in turn, sends lym¬ 
phocytes to clear the dead cells. You’ve started an immune 
process that leads the lymphocytes to attack other pancreatic 
cells, eventually destroying their insulin-producing function 
and causing juvenile diabetes.’’ While the system of genetic 
coding, expression and regulation of expression is overwhelm¬ 
ingly complex, involving thousands of genes, the possibility 
exists that a genetic therapy could be created to halt the 
immune response and reverse the damage to the pancreas. 
The paths that result from basic research are never entirely 
predictable. Ensign Professor of Medicine Arthur Broadus, 
M.D., section chief of endocrinology, began in the 1970s by 
studying the calcium build-up, or hypercalcemia, that is often 
seen in late stages of certain cancers. In 1988 he identified the 
parathyroid hormone-related peptide (PTHrP) as the tumor 
product responsible for hypercalcemia in cancer patients. 
Acting like a hormone, PTHrP breaks down bone, resulting 
in an often-lethal increase in blood calcium. 
Since then he and his colleagues have been using transgenic 
mice to explore the normal function of the PTHrP gene. The 
surprising results point to the importance of the gene in basic 
bone and skin formation, as well as in diseases from skeletal 
and cartilage malformations to Alzheimer’s disease. The gene 
appears to have important activity that even affects aging. “It’s 
been a gold mine,” he says. 
A competing group succeeded in knocking out or removing 
the functioning of the gene and learned that the absence of 
the gene led to lethal bone formation problems during gesta¬ 
tion because of excessive calcification. In other words, the 
gene has an essential role in the regulation of bone formation 
during development. Broadus went a step further by combin¬ 
ing the knock-out with a created transgenic replacement gene 
targeted specifically at cartilage that allowed the mice to live 
to maturity. He could then observe what deficits, if any, 
resulted in the developing mice. “It was like a gene therapy 
experiment,” he says. His research shows that the gene regu¬ 
lates a large number of physical characteristics, including 
tooth, skin and mammary-gland development. “It’s a tightly 
regulated gene,” he says. “Over- or under-expression causes 
major problems in development.” To his great shock, he says, 
“We’ve become developmental biologists.” 
More recently, he and his colleagues have discovered that 
the gene also has a vital, ongoing function of protecting neu¬ 
rons by regulating calcium in the brain. Calcium is necessary 
for brain functioning, but too much calcium can contribute 
to a wide range of very serious and common disorders, 
including Alzheimer’s, Parkinson’s and Huntington’s diseases. 
“They each have different structural targets,” he says, “but in 
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Human DNA is inserted into the embryo of a mouse by means of pro-nuclear 
injection, a technique developed in Ruddle's laboratory in 1980 by then-postdoc 
Jon Gordon. Transgenic mice, with genes either added or turned off, have been 
used by Yale scientists to better understand diabetes, asthma, Lyme disease 
and other disorders. 
all cases there is calcium-driven toxicity.” Moreover, increased 
expression of calcium is at the root of a widely credited theo¬ 
ry of aging. The transgenic mouse could potentially serve as 
an animal model for different disorders, creating new plat¬ 
forms for developing treatments, and possibly explain some of 
the biological mysteries of aging. “The implications,” he says, 
“are big.” 
Transgenic mice have opened new vistas on the brain. 
Several laboratories at Yale are studying complex brain devel¬ 
opment processes using transgenic mice. Essential cell death 
in the brain has long been known to take place after birth in 
order to allow the “sculpting” of neurons and their connec¬ 
tions that must take place for learning to occur. It was long 
believed that this cell death process only began with birth. 
Neurobiology chair Rakic and his colleagues have shown 
through their work with knock-out and transgenic mice, 
however, that specific types of cell death also must occur for 
proper development of the brain during gestation. By pre¬ 
venting cell death during embryonic brain development, they 
created a mouse with a larger-than-normal cerebral cortex. In 
another study, Rakic and his colleagues examined the effect of 
deleting the genes in the so-called JNK family that are 
involved in stress-induced cell death in the adult organism. 
Mice lacking both copies of some of these genes are resistant 
to noxious agents that in normal mice induce neuronal loss. 
This finding suggests strategies for preventing cell death in 
neurodegenerative diseases, as well as after a stroke. 
The complexities of the brain are very difficult to study in 
humans. It is ethically impossible to induce disease states in 
normal brains to study what changes occur. The transgenic 
mouse, however, can provide models for many diseases. 
Jameson Professor of Psychiatry Eric Nestler, M.D. ’80, 
Ph.D. ’82, and colleagues have looked at the genetic processes 
behind complex behaviors such as drug addiction and anxiety 
disorders. They made a double transgenic mouse — one with 
two new genes. By raising the mice on a diet that includes a 
low dose of the antibiotic tetracycline, they have inactivated a 
gene, AFosB, that regulates other genes in specific neural 
regions known to be involved in drug addiction, from nico¬ 
tine to cocaine. By then removing the tetracycline, the gene 
of interest in the brain becomes active. This process is called 
an induced transgenic mutation. Once that gene is induced, 
the animals become hypersensitive to drugs of abuse. In a 
very interesting finding, reported in the Sept. 16 edition ol 
the journal Nature, the researchers have shown that AFosB 
persists in the mouse brain far longer than similar genes. This 
may help explain why even years after addicts cease taking 
drugs they are still so susceptible to relapse. 
Although developing a therapy for drug addiction based on 
this discovery is years off, the Yale group is beginning to look 
for ways to control the gene's activity. “It’ll be a fantastic 
advance,” says Nestler, director of the Division of Molecular 
Psychiatry at Yale’s Abraham Ribicoff Research Facilities, 
“when we have the genetic basis not just for abnormal states, 
but normal functioning as well. Eventually every disease and 
normal function will be attributed to specific genes. As these 
genes are found in humans, the best way to develop new 
therapies — and even to optimize normal functioning—is to 
put the human gene in a mouse and make novel animal 
models. For the first time, we have ways to design therapies 
that will target very specific genetic functions. We’re still 
just at the beginning of that process. We’re at the tip of 
the iceberg.” ym 
Human genes work pretty faithfully 
in the mouse. You cant find out 
how genes work in whole organisms 
by other means. ” 
Richard Flavell is chair of the Section 
of Immunobiology and a Howard 
Hughes Medical Institute investigator. 
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Arriving at Yale in 1966 to com¬ 
plete his residency training, Bob 
Gifford never imagined that he 
would remain in New Haven for 
the next three decades. As iggg 
draws to a close, he finishes his 
tenure as the medical school’s 
first deputy dean for education. 
/\rter 33 years 
at Yale and 
two false starts 
as a retiree, 
a roundly admired 
medical educator 
calls it a day. 
Sort of 
For the past two years Bob Gifford’s always-impending, 
always-delayed retirement has been a running joke at the Yale 
School of Medicine. Now comes the punch line. He’s leaving. 
This time he means it. After two year-long delays, the end of 
1999 ushered in the beginning of his retirement as deputy 
dean for education. No more tasks await him. No more 
requests to stay on just another year. “I keep hoping,” says his 
colleague, mentor and friend Alvan R. Feinstein, M.D., HS 
’54, Sterling Professor of Medicine and Epidemiology, “that 
this is another announcement that will be rescinded and he 
will remain, but I doubt it.” 
After 33 years spent in a variety of 
jobs at the medical school, Robert H. 
Gifford, M.D., HS ’67, hopes to take 
on a new task as a science teacher in 
the New Haven public schools. In his 
time at Yale he’s been a resident, 
fellow, professor, section chief, and 
associate and deputy dean, all titles 
that fail abysmally at describing his 
gift to students. His real accomplish¬ 
ments may be impossible to quantify. 
The students who have known him 
carry their own measure of him in 
their hearts, and Gifford may sum it 
up best himself. “I made some differ¬ 
ence in the lives of medical students,” 
he says when asked, “helping them 
through the stress of medical school, 
developing a number of really close 
friends, making sure that medical 
students felt supported by the medical 
school in this difficult business of 
becoming a doctor.” 
In his various posts, Gifford, 67, has 
done what he’s supposed to do — over¬ 
see medical education, write dean’s let¬ 
ters for graduating students, interview 
incoming students, give speeches, and 
help students into their white coats for 
the first time. He also has played ice 
hockey with them, counseled them, 
helped them raise money for charity, 
performed in student shows with them, taken classes with 
them, even given them away at weddings. Friends report that 
the Gifford home takes in medical students every summer. 
This unlikely job description matches an equally unlikely 
career trajectory. So unlikely, in fact, that, in his early years at 
Yale, Gifford doubted there was a long-term place for him. 
His talents, he felt, pointed to teaching students and caring 
for patients, rather than to the laboratory research required 
for tenure. 
Gifford’s journey into medicine started when he was a six- 
year-old boy growing up in a Boston 
suburb, son and grandson of Methodist 
ministers. His four-year-old brother was 
dying of meningitis. “I could see my 
mother and lather and what it meant to 
them,” he says, recalling the moment 
he first considered becoming a doctor. 
But almost two decades later his 
future remained uncertain. He was an 
Air Force lieutenant helping to train 
fighter pilots in the Libyan desert and 
had time on his hands. “I started to 
think about what I really wanted to do 
with my life,” he says. He applied to 
medical school. Accepted at Cornell 
and Tufts, he lavored Cornell until he 
learned the medical campus was in 
New York City, not upstate Ithaca. In 
1957 he started medical school at Tufts, 
near his hometown of Newton, Mass. 
The optimism and enthusiasm of the 
Kennedy years swept him up in 
Washington, where he had gone for a 
pediatric residency. Friends encouraged 
him to enlist in the newly created Peace 
Corps. “My wife and I talked about it,” 
he says. “We figured there would be no 
other time in our life when we would 
be able to do that. We went to Bogota, 
Colombia, which at that time had the 
largest Peace Corps program in the 
world.” As medical director, Gifford 
was responsible for medical programs 
Along with faculty teammates, Gifford spread his 
arms in triumph (top) during a 7980 “Quiz Bowl,"a 
regular trivia contest including faculty, medical 
students and community physicians. In 1998, during 
Commencement exercises (middle), he shared the 
stage with Dean David Kessler and Assistant Dean 
Forrester Lee. At a student-faculty tea (above), 
Gifford honored medical student Caroline Harada 
for her efforts as chair of the Committee on 
Volunteer Services. 
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and the health of the 600 volunteers there. He found assign¬ 
ments for 30 volunteer nurses and created educational televi¬ 
sion shows to instruct rural families in nutrition. “We had 
volunteers out in the boondocks and they would herd the 
mothers into the schools to watch these TV programs. 
“It really changed my whole idea of medicine and the world 
and the underserved,” he says of the poverty and suffering he 
saw in his travels through the country. “I became much more 
aware of people in my own country who had nothing.” 
In 1966, at the end of his tour in Bogota, he came to Yale as 
a hospital resident. A rheumatology fellowship followed, then 
an appointment as assistant professor. The qualities that 
would endear him to students began to surface. Leo Cooney, 
M.D. 69, Humana Foundation Professor of Geriatric 
Medicine, recalls Gifford, then a resident, shepherding him 
and other medical students through the wards. “He was very 
willing to spend time with students and residents,” Cooney 
says. “The time was very valuable because in discussing 
something with Bob, you always left with a much fuller 
understanding of the problem and what your options were. 
That was not just because of his advice, but the clarity of 
his discussion.” 
Nevertheless, in those early days, Gifford felt he lacked 
research skills and was not, therefore, a good candidate for 
tenure. “I don’t think I ever would have been able to stay if it 
hadn’t been for some people who were very supportive of me,” 
he says. A collaboration with Feinstein tipped the scales in his 
favor. The two published in the New England Journal of 
Medicine a paper evaluating the use of anticoagulants in the 
treatment of myocardial infarction. “He was extremely 
generous in allowing my name to go first,” Gifford recalls. 
“It provided me with some academic credentials I wouldn’t 
have had.” 
With his foot in the door at Yale, Gifford demonstrated his 
administrative skills, to the dismay of at least one colleague. “I 
thought, ‘Here is someone who really should be seeing 
patients and teaching students how to care for patients, and 
he’s going into administration,’ ” says Arthur Ebbert, M.D. 
HS ’63, professor emeritus of medicine. ► 
Cifford was a lieutenant in the Air Force in the mid-igsos (top) when he 
decided to enter medicine. After graduating from Tufts and completing a 
pediatric residency at Ceorge Washington University, Cifford joined the 
Peace Corps and soon found himself responsible for the health of 600 
volunteer workers in Colombia. With his wife, Kariee, Cifford (seated on 
horse at right) traveled "every inch"of the South American country 
including this Andean village in Norte de Santander. In the center photo, 
he posed with family members at the cottage in Maine where he has spent 
family vacations for more than 60 years. 
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"You got the feeling that he was rooting for you” 
Ask people to tell a story about Bob 
Gifford, and a silent pause follows. 
There are so many stories, comes the 
answer, too many. More telling than a 
specific anecdote is the overall impres¬ 
sion, the qualities he conveys to those 
who know him.They recall him in the 
different roles he’s played in their lives 
and what they have learned from him. 
"He had a way of asking questions 
so that each subsequent question was 
a new start,” says former student Lee 
Goldman, M.D. ’73, M.P.H. ’73, now chair 
of the department of medicine and 
associate dean for clinical affairs at the 
University of California, San Francisco, 
School of Medicine. “The fact that you 
didn’t know the answer to the last one 
didn’t mean that he had lost faith in 
you. You got the feeling that he was 
rooting for you.” 
It was that type of interaction that 
caught the eye of then-Dean Leon E. 
Rosenberg, M.D., HS ’63. "I had seen 
him take care of patients with great 
skill and humanity and I had watched 
him with students. He set expectations 
for students and insisted that they 
meet them. But he was always very 
When the Giffords moved to West Haven from 
Colombia, their neighbor Tony (pictured here with 
Karlee Gifford) assumed they were immigrants just 
like him. 
gracious and kind about mentoring 
them and advising them,” Rosenberg 
says. “One of the best things I did as 
dean was to bring Bob into a position 
of leadership in student affairs and 
education. He had a commitment to 
education and to students’ lives that I 
felt would be exactly what the job 
required, and I was right.” 
As a resident on the wards, Elizabeth 
Bradley Muskin, M.D., HS ’91, saw a new 
side of Gifford, even though she’d 
known him since she was five years old. 
Her mother and Gifford’s wife, Karlee, 
had been the best of friends and 
Muskin had grown up with the Gifford 
children. She studied medicine at Case 
Western Reserve University with 
Gifford’s son David, now a geriatrician 
in Rhode Island. When she returned to 
New Haven for her residency, she lived 
at the Gifford home. "Most attendings 
stand in the background,” she says. 
“When we went in to visit a patient, it 
would not be unusual for him to sit 
on the bed and hold the hand of a 
90-year-old and talk to her about her 
personal issues. It would not be 
unusual for him to go back after 
rounds and talk to her again.” 
Gifford has a story of his own to tell, 
one about a neighbor, a white coat and 
what it means to be a doctor. The 
Gifford family lived in a small house 
in West Haven, and one of their 
neighbors, hearing they had just arrived 
from South America, where Gifford 
and his wife had served in the Peace 
Corps, took them to be immigrants, 
like himself. 
"He had been born and raised in 
Poland and spoke very little English,” 
Gifford said in his remarks to students 
during the White Coat Ceremony in 
1998. “He was a robust, elderly gentle¬ 
man whose hands gave unmistakable 
signs that he had worked hard all of his 
life. But Tony had something else 
inside that was very special. He cared 
about us as people. In his gnarled 
hands he brought some vegetables 
from his garden, some eggs from his 
henhouse, and a bottle of homemade 
wine from his cellar. It was an outpour¬ 
ing of caring and concern for a young 
family he felt to be in need.” 
Every morning Gifford donned his 
white coat and walked to work at the 
nearby Veterans Hospital. Tony soon 
came to a simple conclusion. Gifford 
had found a job at the ice cream parlor 
down the hill. 
“By a strange twist of fate,” Gifford 
continued,"Tony subsequently became 
seriously ill and was hospitalized, and 
there I was with my white coat on, not 
selling ice cream, but one of the doc¬ 
tors who cared for him in the hospital 
during his final days of life. And so, 
through the years, I have always come 
to associate the meaning of a white 
coat with this kind man who selflessly 
reached out to someone in need; this 
good man who cared so deeply about 
someone outside of himself; this gener¬ 
ous, empathetic man who tried to be so 
reassuring; this decent, honest soul 
who simply wanted to help another 
human being. Those are the traits that 
should be permanently bound into the 
threads of the white coat you are about 
to receive and that will hopefully be a 
constant reminder to you of what 
being a doctor is all about.” 
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“In discussing something with Bob, you always left with a much fuller understanding 
of the problem and what your options were. That was not just because of his advice, 
but the clarity of his discussion. ” 
In the early 1970s, Samuel O. Thier, M.D., then chair of 
the Department of Medicine and now the president and CEO 
of Partners HealthCare System in Boston, named Gifford 
chief of the first section of general internal medicine. In 1975 
Gifford moved to the Veterans Administration Hospital in 
West Haven as assistant chief and later chief of the medical 
service. Ten years later then-Dean Leon Rosenberg, M.D., 
asked him to return to Yale as associate dean for education 
and student affairs. Students and their concerns have been at 
the forefront of his activities ever since. Those who have 
worked with him say his compassion embraces all around 
him. “The atmosphere that he instilled in student affairs was 
a family environment,” says Cynthia Andrien, M.S., assistant 
dean for student affairs. “He made it a pleasure to work here. 
He has this uncanny ability to welcome you into his life and 
really care about so many people.” 
Carol C. Teitz, M.D. ’74, was one of those Gifford wel¬ 
comed into his life. As an undergraduate she had planned a 
career in research until she spent a summer at the lab Gifford 
shared with Stephen E. Malawista, M.D., HS ’60, professor of 
medicine. When she found more pleasure in dealing with 
pediatric patients than with laboratory rats, Gifford offered 
some advice. “He said, ‘If you want to do this with people 
instead of rats, you need a medical degree,’ ” says Teitz, now 
an associate professor of orthopaedic surgery at the University 
of Washington. A year later, when she returned to Yale as a 
first-year medical student, Gifford and his wife, Karlee, had a 
room waiting for her in their home in New Haven. “He was 
like my father,” Teitz says. “He kept an eye on who I was 
going out with.” At her wedding, Gifford stood in for her 
father, who had died when she was a child. He also showed 
her that a physician could lead a normal life. “He was the 
ultimate role model. He made it home for dinner every 
night,” says Teitz. “His relationship with Karlee and their 
kids was something 1 admired and aspired to.” 
With Karlee, who retired recently as a librarian at Yale’s 
Department of Economics, Gifford raised four children. 
One son is now a physician in Rhode Island. Another writes 
copy for national television ad campaigns. His two daughters 
are teachers. 
His departure from the medical school has taken two years. 
He had planned to retire in 1997, but agreed to stay on a year 
as associate dean for student affairs to ease the transition to 
the new administration of Dean David A. Kessler, M.D. A 
year later Kessler urged him to stay on another year as the 
first deputy dean for education. (His successor, Herbert 
Chase, M.D., was announced as Yale Medicine was going to 
press. See page 5.) “Bob’s vision and years of commitment 
have shaped this school,” Kessler said in September, while 
introducing Gifford to first-year students. “He’s been a role 
model and a leader for a generation of medical students.” 
Even in retirement, Gifford says he will maintain his links 
with Yale, as a preceptor to medical students at a homeless 
shelter. His idea of retirement is anything but passive. 
Although he plans to spend more time at his family enclave, 
a cottage on an island off the coast of Maine, during the 
school year he hopes to teach science to inner-city middle- 
and high-school students. 
Like so many things in his life, a simple description fails to 
convey the task he’s set himself. He wants to make the stu¬ 
dents think. He wants them to learn to express their 
thoughts on paper. Those skills, he believes, will serve them 
no matter what dreams they pursue. 
Teaching in an inner-city school harks back to something 
he started a few years ago. Accompanied by a handful of 
medical students, he taught science once a week in a New 
Haven high school. Gifford, who kept beehives to teach his 
own children about insect behavior, asked, for example, 
whether bees can see colors. The high-school students were 
soon devising experiments, then poking holes in them, 
pointing out alternative explanations or flaws in logic and 
reasoning. “When we did those problems, they seemed to get 
interested,” Gifford says. 
As he prepares to leave Yale, he articulates his one regret. 
When asked to name his accomplishments, he answers, 
“Certainly not in education.” He failed, he believes, to effect 
changes in teaching and curriculum he has sought. Long a 
champion of the students, he felt their curriculum had grown 
so much as to threaten elements of the Yale System —time 
for reflection and independent study and small group ses¬ 
sions rather than large lectures. In speeches at the medical 
school he vented his frustration over departmental intransi¬ 
gence when it came to integrating courses. But again, he 
returns to the students. “The friendships with medical stu¬ 
dents have been the most satisfying for me,” he says. “There 
has to be someone who cares about them and gets to know 
them, someone they feel they can talk to.” ym 
For the past several years, afford has donned a Panama hat or a tuxedo to 
solicit bids at an annual benefit for the homeless and hungry (left). He 
has also been a prime target of recent second-year shows (center photos). 
In igg8, the Class of 2000 dedicated its production to him, but not before 
having fun at the deputy dean's expense. Gifford reacted well to his 
depiction onstage and a year later bid farewell (below) from the platform 
at Commencement ?999, his last at the School of Medicine. 
Peter Casolino (3); Melanie Stengel 
FACU LTY N E WS 
Six professors 
join ranks of 
emeritus faculty 
Six senior faculty members at the 
School of Medicine attained emeritus 
status this year: Jerome M. Eisenstadt, 
Ph.D., professor of genetics; Howard 
Levitin, M.D., professor of medicine; 
Bernard Lytton, M.B.B.S., the Donald 
Guthrie Professor of Surgery (urology); 
John C. Marsh, M.D. '59, professor of 
medicine and lecturer in pharmacology; 
Howard A. Pearson, M.D., professor of 
pediatrics; and Howard M. Spiro, 
M.D., professor of medicine. 
Jerome M. Eisenstadt spent his entire 
teaching career at Yale, beginning in 
1962 as assistant professor of microbiol¬ 
ogy and advancing to professor of 
human genetics in 1977. Throughout 
this time, Eisenstadt was gaining an 
international reputation through his 
research studies of the factors involved 
in mechanisms of protein synthesis, the 
interaction of cell organelles and the 
nucleus, and cytoplasmic inheritance in 
animal cells. 
Q Howard Levitin is well known for 
his work in kidney disease and fluid bal¬ 
ance and also has been recognized for 
his administrative and organizational 
skills. He was appointed assistant pro¬ 
fessor in i960 and full professor in 1972. 
In 1966, he became the first associate 
dean in charge of curriculum at the 
medical school, a position he held until 
1980. He also served as the school’s dean 
of students, clinic chief of the 
Department of Medicine Practice Plan, 
and medical director of the Faculty 
Practice Plan. He has been medical 
director of the Yale Corporate Medical 
Program since 1989. 
Q Bernard Lytton was appointed 
assistant professor of urology in 1962. 
He instituted the program of kidney 
transplantation at Yale-New Haven 
Hospital (YNHH) in 1967 and brought 
the idea of Hospice to Connecticut 
from England. His research includes 
compensatory renal growth and 
urologic cancer. Lytton was chief of the 
section of urology at the School of 
Medicine, YNHH and the West Haven 
VA Medical Center from 1967 to 1987. 
Appointed as a full professor in 1971, 
he was named the Guthrie Professor 
in 1988. 
Alumnus John C. Marsh returned to 
Yale in 1967 as assistant professor of 
medicine and pharmacology and was 
appointed as a full professor in 1977. 
He was director of the Gastrointestinal 
Cancer Unit at Yale Cancer Center 
from 1986 to 1998. The American 
Cancer Society awarded Marsh its 
Bronze Medal in 1987. In 1998 a sym¬ 
posium was held in his honor and a 
scholarship for entering medical stu¬ 
dents was established in his name. 
Q Howard A. Pearson is an expert on 
pediatric blood diseases who pioneered 
a comprehensive program to detect 
sickle cell disease in newborns. He was 
appointed professor of pediatrics at Yale 
and attending physician at Yale-New 
Haven Hospital (YNHH) in 1968. 
Pearson chaired the Department of 
Pediatrics and was chief of YNHH’s 
pediatric service from 1974 to 1987. He 
has been medical director of Paul 
Newman’s Hole in the Wall Gang 
Camp since 1986 and served as its exec¬ 
utive director from 1989 to 1991. 
Q Howard M. Spiro joined the facul¬ 
ty in 1955 as instructor of medicine and 
established the gastrointestinal section, 
where he was chief until 1982. He 
became a full professor in 1967. In 
1963, he co-founded the Yale Affiliated 
Gastroenterology Program, which 
encompassed most hospitals in the 
state and was the precursor of the 
Yale Affiliated Hospital Program. 
In 1983, Spiro helped inaugurate 
the medical school’s Program for 
Humanities in Medicine. He was 
an editor-in-chief of the Journal of 
Clinical Gastroenterology and a book 
review editor of Gastroenterology. 
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Jonathan B. Borak, M.D., associate 
clinical professor of medicine, was 
elected in April to the board of direc¬ 
tors of the American College of 
Occupational and Environmental 
Medicine during its annual meeting in 
New Orleans. 
@ Irwin M. Braverman, M.D. 55, 
HS ’56, professor ol dermatology, was 
presented the David Martin Carter 
Mentor Award in May at the annual 
meeting of the Society for Investigative 
Dermatology. The award is presented 
annually to a member of the dermato¬ 
logical community who embodies 
those characteristics of the late Dr. D. 
Martin Carter, a former member of the 
Yale dermatology faculty who was a 
mentor to many dermatologists and 
dermatologic investigators throughout 
the world. 
Q Michael Cappello, M.D., assistant 
professor ol pediatrics (infectious dis¬ 
eases), received the New Investigator 
Award in Molecular Parasitology from 
the Burroughs Wellcome Fund. The 
grant is a three-year award that is given 
annually to junior faculty working in 
molecular parasitology in U.S. or 
Canadian universities. He gave a pres¬ 
entation of his work at the November 
meeting of the American Society of 
Tropical Medicine and Hygiene in 
Washington, D.C. 
John A. Elefiteriades, M.D. ’76, HS ’83, 
professor and chief of cardiothoracic 
surgery, was appointed chief of the sur¬ 
gical section of the First International 
Congress on Heart Disease held in 
May in Washington, D.C. He also 
began a term as governor of the 
American College of Cardiology for 
the State of Connecticut at the 
annual meeting in April. His term 
runs until 2002. 
Michael D. Ezekowitz, M.D., professor 
of medicine (cardiology), was appoint¬ 
ed chair and presenter of a session on 
antithrombotic and antiplatelet therapy 
for coronary disease and poor ventricu¬ 
lar function at the 1st International 
Congress on Heart Disease held in May 
in Washington, D.C. He also is on 
several North American Society of 
Pacing and Electrophysiology' (NASPE) 
working groups and was invited by 
NASPE to speak in June at the Xlth 
World Symposium on Cardiac Pacing 
and Electophysiology in Berlin. 
@ The W.M. Keck Foundation 
announced in July the first five grant 
recipients under its newly established 
Distinguished Young Scholars in 
Medical Research Program. Each will 
receive $1 million in research support 
for up to five years. Mark Gerstein, 
Ph.D., assistant professor of molecular 
biophysics and biochemistry, received 
an award for his research on solving key 
problems in structural biology and 
genomics, using both computational 
and theoretical approaches. 
^ Elaine E. Grant, PA-C, M.P.H. 
’92, assistant dean and program director 
of the Physician Associate Program, was 
named president-elect of the National 
Commission on Certification of 
Physician Assistants (NCCPA), effec¬ 
tive in January 2000. She will take 
office as the organization’s president in 
2001. Grant’s election includes a num¬ 
ber of firsts. She will be the first repre¬ 
sentative from the Association of 
Physician Assistant Programs to serve as 
president of the NCCPA and will be 
the organization’s first female president. 
Q Jeannette R. Ickovics, Ph.D., 
associate professor of epidemiology 
and of psychology, was named an 
Emerging Leader for Women in 
Psychology by the Committee on 
Women in Psychology of the American 
Psychological Association. The award, 
announced in August at the APA annu¬ 
al meeting in Boston, recognized her 
accomplishments and contributions to 
research, interventions and policy on 
HIV/AIDS among women. 
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Marvin Moser, M.D., clinical professor 
of medicine, was appointed editor- 
in-chief of the Journal of Clinical 
Hypertension in July. John Setaro, 
M.D., associate professor of medicine, 
joined the journal’s editorial board 
in August. 
The National Institutes of Health has 
awarded a MERIT Award to Joel L. 
Rosenbaum, professor of molecular, 
cellular and developmental biology, for 
continuation of his laboratory’s research 
on the synthesis and assembly of flagel¬ 
lar proteins. The award provides long¬ 
term support to investigators of proven 
research competence and productivity 
who are working actively in a research 
area that is of special importance or 
promise. Rosenbaum studies a bi-flagel- 
late alga called Cblamydomonas and has 
identified processes essential for the 
development and maintenance of cell 
organelles. His work could have impli¬ 
cations for numerous human illnesses 
and diseases, including cystic fibrosis. 
Sanjeev Sethi, M.D., a resident in clini¬ 
cal pathology, received a $25,000 fel¬ 
lowship as part of the College of 
American Pathologists Foundation 
1999/2000 Scholars Award Program. 
His research project will examine the 
role of N'3 polyunsaturated fatty acids 
in inflammation. 
0 Stephen Waxman, M.D., Ph.D., 
professor and chair of neurology, was 
named visiting professor in the depart¬ 
ments of anatomy and developmental 
biology, biology, and the Institute of 
Neurology at University College 
London in October. He also received 
the 1999 Landmark Research Award in 
September from the Landmark Club in 
Stamford, Conn. 
o William D. White, Ph.D., associate 
professor of public health, received the 
1999 Article-of-the-Year Award in June 
from the Association for Health 
Services Research at its annual meeting 
in Chicago. The paper, written with 
David Dranove, is entitled “Medicaid- 
Dependent Hospitals and Their 
Patients: How Have They Fared?” 
N EW BOOKS 
Breast Care: A Clinical Guidebook for 
Women’s Health Care Providers, by 
William H. Hindle, M.D. ’56, Springer- 
Verlag (N.Y.) 1998. 
Clinical Management of Hypertension, 
4th ed., by Marvin Moser, M.D., clinical 
professor of medicine, Professional 
Communications (Caddo, Okla.) 1999. 
The Disposition of the Subject: Reading 
Adorno’s Dialectic of Technology, by Eric 
L. Krakauer, M.D. ’92, Northwestern 
University Press (III.) 1998. 
Doctors Afield, edited by Howard M. 
Spiro, M.D., professor emeritus of medi¬ 
cine; Mary G. McCrea Curnen, M.D., 
D.P.H., clinical professor of epidemiolo¬ 
gy and pediatrics; and Deborah St. 
James; Yale University Press, 1999. 
Does Psychoanalysis Work? by Robert 
Galatzer-Levy, Henry Bachrach, Alan 
Skolnikoff, and Sherwood Waldron, 
M.D. ’62, Yale University Press, 2000. 
Felix d’Herelle and the Origins of 
Molecular Biology, by William C. 
Summers, M.D., Ph.D., professor of 
therapeutic radiology and molecular 
biophysics and biochemistry, and in 
the Cancer Center; Yale University 
Press, 1999. 
Prisoners of Hate: The Cognitive Basis 
of Anger, Hostility, and Violence, 
by Aaron T. Beck, M.D. ’46, 
HarperCollins (N.Y.) 1999. 
Rediscovering Croups: A Psychoanalyst’s 
Journey Beyond Individual Psychology, 
by Marshall Edelson, M.D., Ph.D., pro¬ 
fessor emeritus and lecturer in psychia¬ 
try; and David N. Berg, Ph.D., associate 
clinical professor of psychiatry, Jessica 
Kingsley Publishers (Penn.) 1999. 
Notices of new books by alumni and 
faculty may be sent to Cheryl Violante, 
Yale Medicine Publications, P.O. Box 7612, 
New Haven, CT 06519-0612. 
PRISONERS 
OF HATE 
THE COGNITIVE 
BASIS OF ANGER. 
HOSTILITY. 
AND VIOLENCE 
AARON T. BECK. M.D. 
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A covenant with medicine 
As a new year begins, students assume the 
white coat and all it represents, commune with 
cadavers and embark on the artful, humanistic 
experiment that is medicine. 
In early September, following seven years of tradition, mem¬ 
bers of the Class of 2003 donned the white coats that 
symbolize their entry into the society of healers. “Today is 
about making your covenant with medicine,” Dean David 
A. Kessler, M.D., told the students, adding that medicine is 
not a profession, but a calling. “It is something that captures 
you, entrances you, and keeps you entranced for the rest oi 
your life.” 
In her remarks, Associate Dean Nancy Angoff, M.D., urged 
students to remember why they want to practice medicine. 
“We know you will learn the facts,” she told the incoming 
students. “What we don’t want to happen is for any of you to 
forget the human element in medicine, the patient’s story. 
Never let your white coat speak for you.” 
Sounds reasonable 
This year, the medical school is offering a new course in the 
“Principles of Clinical Reasoning,” a day-long session in the 
fall, followed by four workshops throughout the year. This 
course takes the kind of material that traditionally follows 
medical school and residency training and places it at the 
beginning of the educational process. 
It asks students to think deeply about the most important 
questions that face clinicians: How can we gauge our effec¬ 
tiveness as doctors? How can we stretch the limits of our heal¬ 
ing ability? In the inaugural lecture, Professor Alvan Feinstein, 
M.D., portrayed clinical medicine as a humanistic science. 
Every act of patient care, he told the students, is analogous to 
an experiment, but an artful, humanistic experiment. 
“Human beings,” he said, “are the only subject that talks and 
can let us know what’s going on.” 
In the beginning, anatomy 
A few weeks ago, the first-year medical and physician associ¬ 
ate students sat in Hope no for an introduction to the anato¬ 
my course, with professors and second-year students describ¬ 
ing the experience of dissection and how crucial it is to 
understanding the body and human disease. Professor 
William Stewart, Ph.D., asked several veterans ol the course 
to make a few remarks. One was Margaret Bourdeaux, a sec¬ 
ond-year student who had recently returned from her second 
trip to the Balkans, where she and fellow students volunteered 
in a camp for refugees from Kosovo. 
Margaret and other second-year students helped prepare the 
new students for their first encounter with a cadaver, the 
Vaccinations were part of first-year orientation, along with meetings, 
paperwork and the White Coat Ceremony. First-year medical student 
Leah Ahoya winces as she gets a shot in the arm from Haideh Veladi, R.N. 
human body that they will come to know intimately over the 
course of the next few months. Several oi the students talked 
about shedding tears over the cadaver, or simply standing in 
silence and gratitude for this gilt to science. “1 remember sit¬ 
ting where you are, thinking how I wanted to have the per¬ 
fect initial reaction,” Margaret said. That reaction, she 
assumed, would say a lot about the student. Crying wouldn’t 
do, nor would an inappropriate display of humor. Margaret’s 
moment of truth came on the second day in the anatomy lab, 
when it was time to begin dissection and, much to her dis¬ 
may, she found hersell laughing uncontrollably. “I had to 
leave the room,” she told a relieved-looking roomlul of new 
students, who clearly appreciated the story. “What I learned 
was that initial reactions are not who you really are.” 
Assistant Dean Cynthia Andrien 
and Director of Admissions 
Richard Silverman congratulate 
Neil Lester during the White Coat 
Ceremony in September. 
Crace Suh, Maya Lodish and Stephanie 
Holler enjoy the moment as they pose 
for a class photograph on the steps of 
Sterling Hall of Medicine. 
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First-year public health students 
attended orientation in Winslow 
Auditorium at the start of the 
school year. 
EPH inaugurates full-tuition 
scholarship 
PA program graduates first class 
to receive a master’s degree 
At a ceremony in August, the 32 members of the physician 
associate Class of 1999 became the first to receive master’s 
degrees for their efforts. “If truth be told,” said Dean David 
A. Kessler, M.D., “the original proposal was that the master’s 
degree would be initiated with the Class of 2000. The faculty 
made a decision to begin with you. Never have I met a group 
who was more serious, more committed to their studies, 
more dedicated to what they were about to undertake.” Bruce Fichandler, P.A. ’73, chair of the 
P.A. admissions committee, urged the graduates to make five commitments — adhere to the 
M.D./P.A. concept; recognize the need for lifelong learning; have compassion for patients; 
try to prevent illness as well as heal it; and take time for themselves, their families and their 
communities. “Don’t forget to vote,” he said. “Plant a bush or a tree and take the time to 
watch it flourish and grow old with you. Read a book that has nothing to do with medicine. 
Take time to volunteer in a soup kitchen or an AIDS clinic. Slow down and relax. You will 
get to wherever you are destined to go soon enough.” 
NEW OFFICERS OF 
MEDICAL STUDENT COUNCIL 
Second-year students Chiraq Shah, 
Mary-Ann Btiebet and Adam Cuker 
began their terms this fall as vice 
president, president and treasurer 
of the Medical Student Council. 
Their goals are to expand the use 
of technology in medical education, 
create and develop international 
initiatives, foster intra-class 
relationships and get students more 
involved in policy and administration 
at the medical school. 
Among the 105 students beginning the master’s program in 
public health are four who are receiving full scholarships for 
their two years of study. The Public Health Opportunity 
Scholarship, offered for the first time this year, is awarded 
based on factors that include outstanding ability, a demon¬ 
strated interest and high motivation for professional achieve¬ 
ment in the field of public health, membership in an under¬ 
represented group and financial need. It covers tuition, but 
not living and other expenses. The four recipients were select¬ 
ed from the pool of applicants to the public health master’s 
program. Five students were offered the scholarship, but one 
chose to study elsewhere. “It’s a wonderful opportunity to 
bring students into the fold of public health,” said Anne 
Pistell, associate dean for student affairs at the School of 
Public Health. It is the only public health scholarship that 
covers full tuition. “I think we have picked pretty extraordi¬ 
nary people,” Pistell said. 
This new scholarship expands the number of those current¬ 
ly available to students. Merit scholarships, which are awarded 
based on academic excellence, cover half of tuition costs for 
up to five students each year. Need-based scholarships provide 
financial aid after other resources, including loans, have been 
exhausted. Last year 84 public health students received need- 
and non-need-based scholarships totaling $689,086. 
New physician associates Kimberly 
Sealy and Rebecca Takis look at the 
program before Commencement. 
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AYAM elects new officers 
and committee members 
Assisting in the search for a new alum¬ 
ni director and bringing recent gradu¬ 
ates of the school into the fold are 
among the tasks facing new officers 
and committee members of the 
Association of Yale Alumni in Medicine 
elected at the AYAM’s annual meeting 
in June. 
Q Gilbert F. Hogan, M.D. ’57, the new 
president, has served as vice president 
and has been on the AYAM Executive 
Committee for the past 15 years. 
Q Frank R. Coughlin Jr., M.D. ’52, an 
Executive Committee member for five 
years, was elected vice president. 
^ Peter N. Herbert, M.D. ’67, HS 69, 
continues as secretary. 
Q Susan J. Baserga, M.D. 88, Ph.D. 
’88, assistant professor of 
therapeutic radiology and genetics 
at the School of Medicine, and 
Q Christine A. Walsh, M.D. ’73, were 
named to the Executive Committee. 
Q Valerie E. Stone, M.D. ’84, is the 
newest representative to the AYA. 
Hogan said his major focus this fall 
will be helping with the selection of an 
executive director for the Office of 
Alumni Affairs. William Jenkins, the 
former director, left the post in June to 
take a job at Drew University in New 
Jersey. Coughlin said he would like to 
enhance relations between the medical 
school and community physicians and 
hospitals. Walsh is a pediatric cardiolo¬ 
gist at the Albert Einstein College of 
Medicine in New York. Stone, an asso¬ 
ciate professor of medicine at Brown 
University School of Medicine, said she 
is eager to involve more young people 
in the activities of the AYAM. 
* * * 
As Yale Medicine went to press, 
Yale-New Haven Hospital announced 
the appointment of AYAM Secretary' 
Q Peter N. Herbert, M.D. ’67, HS ’69, 
as its new chief of staff. Herbert spent 
eight years at the National Heart, Lung 
and Blood Institute in Bethesda before 
joining the faculty at Brown as profes¬ 
sor of medicine in 1977. He returned 
to New Haven in 1991 to become chief 
of medicine at The Hospital of St. 
Raphael. Herbert succeeds Edwin C. 
Cadman, M.D., who left YNHH to 
become dean of the University of 
Hawaii School of Medicine. 
What did the Yale System mean to you? 
We’re preparing an article on “The Yale System Through the Decades” and invite 
letters, thoughts and memories from alumni. In particular, we would like to explore 
which essential threads of Yale’s approach to medical education have remained 
unchanged over the years, as well as the evolution of the tradition from generation 
to generation. 
Letters should be brief, no more than 250 words, and touch on one major facet of 
the Yale System specific to the era in which the author experienced it as a student, 
faculty member or in some other capacity. Please send letters to Editor, Yale 
Medicine, P.O. Box 7612, New Haven, CT 06519-0612 [or via e-mail to 
ymm@yale.edu] and include a daytime phone number. A representative selection of 
essays will be published in a future issue. 
Q Donald L. Kent, M.D. ’72, HS ’76, 
professor of surgery (otolaryngology) at 
New York University, has been selected 
as the new chair of the Medical School 
Alumni Fund, succeeding Daniel L. 
Arons, M.D. ’67, of West Newton, 
Mass. Kent, of Great Neck, N.Y., was 
elected in April for a two-year term 
that began July 1. As chair of the 
Alumni Fund, he will lead class agents 
in their efforts to encourage alumni 
support for the school through annual 
fund gifts and special gifts in honor of 
reunions, important sources of funds 
for the school. 
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30S 
Robert M. Newhouse, M.D., of Long 
Beach, Calif., at age 91, writes to say 
that he fondly remembers his Yale 
fellowship in ’33-34 at the Institute of 
Human Relations. “The teaching 
program I went though at Yale was 
wonderful,” he recalls. “We had all 
the supervision and help we could 
possibly use.” 
40S 
Q Hunter H. Comly, M.D. 43, is 
working part time as a consultant in 
child and adolescent psychiatry at the 
Imperial County Mental Health Clinic 
in El Centro, Calif He says, “Love the 
work and the children. I get help with 
Spanish.” He also writes that he is 
planning a trip around the world. 
50S 
Paul N. Graffagnino, M.D., HS ’52, 
retired from the practice ol child and 
adolescent psychiatry in July 1998, but 
continues to teach at Dartmouth 
Medical School. 
H. Richard Lamb, M.D. ’54, HS 58, 
professor of psychiatry at the University 
of Southern California, received the 
Arnold L. van Ameringen Award in 
Psychiatric Rehabilitation from the 
American Psychiatric Association. He 
was recognized for playing a crucial role 
in calling attention to the need for 
improved services for people with 
chronic and severe mental illness. 
60S 
Q C.E. Anagnostopoulus, M.D., HS 
’69, is professor and chair of a cardiac 
surgical unit, which he started, at the 
University of Ioannina Hospital, 
Ioannina, Greece. He is also a professor 
at Columbia University and senior 
cardiothoracic surgeon at St. Luke’s 
Hospital in New York. He writes that 
his daughter, Anne-Marie, graduated 
magna cum laude from Yale College 
in May. 
David S. Fedson, M.D. 65, director of 
medical affairs at Pasteur Merieux MSD 
in France, the largest vaccine company 
in western Europe, writes with news of 
his children. His daughter Sairtri, 28, is 
chief medical resident at Cook County 
Hospital, Chicago and will become a 
fellow in cardiology at the University of 
Chicago (UC). His daughter Anjali, 31, 
received her M.D. and a Ph.D. in 
anthropology from UC in June and 
is now a medical resident there. She 
plans to complete her residency in 
anesthesiology at Brigham and Women’s 
Hospital in Boston. Of son Nicholas, 
5, Fedson adds: “He is a joyful, 
bilingual young man, who loves his 
Mum and Dad.” 
Eric P. Kindwall, M.D. 60, was granted 
emeritus status from the Medical 
College of Wisconsin in Milwaukee 
last year. He remains active as a 
consultant and instructor in hyperbaric 
oxygen therapy. 
Author Richard Selzer, M.D., HS ’61, 
a retired general surgeon, addressed 
first-year medical students during the 
White Coat Ceremony in August at the 
University of Medicine and Dentistry 
of New Jersey. “The effort now is to 
introduce humanism into the medical 
profession,’’ he said. “Physicians should 
not let technology come between them 
and their patients.” 
70S 
Q William T. Choctaw, M.D. ’73, HS 
’75, who in January will assume the role 
of chief of staff at Citrus Valley Medical 
Center in Covina, Calif., earned his 
juris doctorate degree in May from 
Western State University College of Law 
in Fullerton. He practices medicine full 
time and does medical-legal consulting. 
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O Alicia I. Barela, M.D. 81, an 
obstetrician and gynecologist at Kaiser 
Permanente Santa Teresa Hospital/San 
Jose, was elected to the Board of 
Trustees of Mount Holyoke College in 
South Hadley, Mass., for a five-year 
term. She writes that she has adopted 
twin girls from Peru, Karen and 
Jeraldin, age 9. 
Ina S. Cushman, PA-C ’86, a senior 
physician assistant in surgical specialties 
at Harvard Vanguard Medical 
Associates in Braintree, Mass., has been 
re-elected vice president and speaker of 
the House of Delegates of the American 
Academy of Physician Assistants 
(AAPA). She has been active in the 
AAPA since 1986. 
Robert Hartman, M.D., HS ’86, 
associate clinical professor of 
dermatology at the University of 
Southern California, is in private 
practice in Van Nuys, Calif. 
Valerie E. Stone, M.D. ’84, director of 
the HOPE Center for HIV Care and 
associate director of the primary care 
internal medicine residency program at 
Memorial Hospital of Rhode Island, 
was promoted in July to associate pro¬ 
fessor of medicine at Brown University 
School of Medicine, where she has been 
on the faculty since 1995. (Stone also 
joins the AYAM leadership as represen¬ 
tative to the AYA; see page 43.) 
Nancy Todes-Taylor, M.D. ’80, assistant 
chief of dermatology at Kaiser 
Permanente San Rafael Medical Center 
in California, was the co-chair for the 
Marin County Skin Cancer Screening 
for 1998-99. 
90S 
^ Marc E. Agronin, M.D. ’91, was 
appointed director of mental health 
services at the Miami Jewish Home and 
Hospital for the Aged. He was also 
appointed as an assistant professor of 
psychiatry at the University of Miami 
School of Medicine. He and his wife, 
Robin, live in Weston, Fla., and have 
two sons, Jacob and Max. 
Alexa F. Boer, M.D. ’94, a clinical fel¬ 
low in dermatology at the National 
Cancer Institute in Bethesda, Md., was 
married in July to Ranch C. Kimball, 
an independent investment adviser 
from Boston. 
John T. Chang, M.D., M.P.H. ’95, has 
completed his residency in internal 
medicine at Georgetown University 
Medical Center and is a fellow in the 
Division of General Internal Medicine 
and Health Services Research at the 
University of California, Los Angeles. 
Eileen Deignan, M.D. ’93, a dermatolo¬ 
gist at Dermatology Associates ol 
Concord, and Victor Hsu, M.D. ’85, 
assistant professor of medicine (rheuma¬ 
tology) at Harvard Medical School and 
a rheumatology associate at Brigham 
and Women’s Hospital, were married 
Aug. 7 in Concord, Mass. 
J. Christian Gunn, M.D. ’97, a third- 
year general surgery resident at Wayne 
State University/Detroit Medical 
Center, was married in October 1998 to 
Marissa E. Avila, a pharmaceutical rep¬ 
resentative for Bayer Corp. 
Q Thomas C. Lee, M.D. ’93, became 
partner in the Pomona Valley (Calif.) 
Hospital Anesthesia Group in July. He 
and his wife, Carol, will celebrate the 
first birthday of their daughter, Amber 
Yentean, on Dec. 8. Lee sends a “hello” 
to classmates. 
James G. Wright, M.P.H. 91, was 
appointed as inaugural R.B. Salter 
Endowed Chair of Pediatric Surgical 
Research at The Hospital for Sick 
Children and the faculty ol medicine at 
the University of Toronto. 
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Leading experts on the brain 
described the life and work of 
John Farquhar Fulton at a 
symposium at this year's 
reunion. From left, Gilbert Glaser, 
Dennis Spencer, Eugene 
Redmond, Karl Pribram and 
Lycurgus Davey. Their talks 
ranged from a biographical 
appreciation to discussion of his 
work on the limbic system. 
Fulton 
'I 
Alumni who returned to New Haven for reunion in June were rewarded with a feast of lobster 
and filet mignon, the renewing ol old friendships, and programs focusing on the career of 
John F. Fulton, the state of medical education and the activities of students who aided Kosovar 
refugees at a camp in Macedonia. 
This year’s reunion symposium honored Fulton’s contributions both to medicine and to 
Yale. Known primarily as a pioneering neurophysiologist, Fulton established the first primate 
research center in the country. He also founded the Section of the History of Medicine, serv¬ 
ing as its first chair. With his colleagues Arnold Krebs, M.D., and Harvey Cushing, M.D., he 
established the Historical Library at the Yale School of Medicine. 
Lycurgus M. Davey, M.D. ’43 March, clinical professor of neurosurgery, offered a biogra¬ 
phical appreciation in which he recalled his former teacher’s “energetic step and easy smile 
spreading over his entire face.” Speakers focused on diverse aspects of Fulton’s career, such as 
his studies of the limbic system and his work as a medical historian. 
Fulton’s life and times were exhibited at the Historical Library this summer, coinciding 
with reunion weekend. The exhibit included photographs of Fulton and those with whom he 
worked and studied, samples of the meticulous weekly diaries he dictated, copies of the books 
he wrote, and articles about his accomplishments. 
“He gave a neurophysiological basis for many clinical problems,” said Davey, one of the 
exhibit’s curators. The exhibit started with the 1920s, when Fulton went from Harvard to 
Oxford as a Rhodes scholar. At Oxford he studied under Sir Charles Scott Sherrington, who 
won the Nobel Prize in 1932 for his description of the central nervous system as an integrated 
whole that coordinated multiple pathways to produce any single action. 
During World War II, Fulton dropped his work in neurophysiology to study the effects of 
altitude on aviators. He also helped his Oxford friend Howard Florey, who had come to the 
United States to find a way to mass produce a new antibiotic called penicillin. (See page 12.) 
Fulton’s wartime activities kept him from completing a biography of his mentor, Harvey 
Cushing, until 1946. By then Fulton was in demand as a lecturer. His activities shifted from 
the laboratory to the typewriter, and in 1951 he resigned as Sterling Professor of Physiology to 
PHOTOGRAPHY BY PETER CASOLINO 
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become the first chair of the new Section of the History of Medicine. Under his direction it 
became a leading center of medical historical studies. 
Following the Fulton symposium, alumni crossed Cedar Street for a very different presenta¬ 
tion. Six medical students and a physician associate from Yale-New Haven Hospital described 
the four weeks they spent with Kosovar refugees in a camp in Macedonia. While there, the stu¬ 
dents tended to social and epidemiological needs. They surveyed the nutritional status of chil¬ 
dren and organized a play and soccer leagues. “We were able to create social space for some of 
the people to talk about their plans and their feelings,” said Margaret Bourdeaux, a second-year 
student. “People would walk up to us and say, ‘I have lost everything. I can’t find my family.’ ” 
“I was absolutely convinced when they left,” said Dean David A. Kessler, M.D., “that this 
experience would change their lives. Not only did it change the lives ol the medical students, 
but in a very great way they contributed to the lives of those in a very unfortunate situation.” 
At the annual meeting of the Association of Yale Alumni in Medicine, faculty gave an 
overview of efforts to revise the curriculum. Noting that the basics of medical education have 
changed little since the 1910 Flexner report, Ralph Horwitz, M.D., chair of the department of 
internal medicine and co-chair of the curriculum review committee, called for more small 
classes with a focus on problem-based learning, more time for independent study, and more 
integration of related courses. “Our students,” he said, “are scheduled nine half-days a week in 
classrooms, workshops and lecture halls. We need to unburden them.” 
The meeting turned to not what students will learn, but where students will learn, as 
Carolyn W. Slayman, Ph.D., deputy dean for academic and scientific affairs, provided an 
update on the new Congress Avenue building. The 440,000-square-foot teaching and research 
space is scheduled for completion in 2002. It has been designed to encourage interaction 
between different research groups. The building’s other important components include new 
teaching labs for gross anatomy and histology, a state-of-the-art magnetic resonance center to 
house new and more powerful magnets, and an improved animal-care facility. 
On Friday, alumni of Epidemiology and Public Health gathered at the Omni Hotel lor 
their reunion, which had as its theme “International Health.” In his keynote speech, Joshua I. 
Cohen, M.D., M.P.H. ’59, former advisor on health policy to the director general of the World 
Health Organization, said international health efforts require bilateral and multilateral govern¬ 
ment action, voluntary collaboration and a high degree of altruism. “Experience has to be 
shared, and the knowledge accumulated has to be adapted to the needs of dilferent countries,” 
he said. “The methods used have to be not only scientifically sound, but socially acceptable, 
and they have to be accessible at an affordable cost.” — John Curtis 
Joshua Cohen, who served as medical 
director on the ship made famous in 
the movie Exodus, gave the keynote 
speech at the public health reunion. 
The theme was opportunities in inter¬ 
national health. "Our goal would be a 
level of health that would permit 
everyone to lead a socially and eco¬ 
nomically productive life, ” he said. 
Vivian Lombillo, one of six medical 
students who traveled to Macedonia 
last spring, told alumni about her 
work with Kosovar refugees there. 
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CLASS REUNION REPORTS 
Class of 1939 
Of the 39 class members who graduated, five attended our 
6oth reunion. We cannot, however, account for some of the 
remaining members of our class. The obituaries of Norman 
Cressey and John Wentworth were recently published. Those 
attending our reunion included Harold Coppersmith and 
his wife, Estelle, John Ferguson and Pat, Jerome Greenfield 
and Phoebe, Joseph Foreman and Olivia, and Ernest Sarason 
and Dene. 
The scientific programs were of particular interest because 
of our personal contact with Drs. Fulton, Winternitz and 
Cushing. We were also impressed with the report given by the 
medical students who had visited Kosovo. 
The group thoroughly enjoyed the Friends of the 50th 
dinner at the Graduate Club, which is sponsored by the 
School of Medicine and the Association of Yale Alumni in 
Medicine. Joe Forman, who suffered a hemiplegia several 
years ago, attended with his wife and his son, Mitchell. Joe 
looked great and participated in the dinner festivities. 
It should be recorded that John Ferguson shot his age on 
the Yale Golf Course, which is no mean accomplishment. 
This brief report of the Class of 1939’s reunion must close 
on a very sad note. On June 16 Harold Coppersmith suffered 
a fatal heart attack on the streets of New York City as he and 
Estelle were on their way to pick up their visas for a vacation 
trip to Egypt. Harold and I started our Yale careers together as 
undergraduate freshman in 1931. We had looked forward to 
our 65th reunion at Yale College next year. Hal will be sadly 
missed by all of us. — Ernest L. Sarason 
Class of 1944 
The Class of 1944 enjoyed a heartwarming 55th reunion this 
year. The weather was superb and our hotel accommodations, 
arranged by Nick Spinelli, created the atmosphere of a private 
club. We had wonderful times together, with delightful 
reminiscences and stories. Because of the 58-year duration of 
our friendships, the fact that we had only 45 students in our 
class, and that the United States entered World War II just 
three months after we started medical school, it felt as if we 
were a family who had just not been together for five years. 
We have kept in touch with the help of a newsletter and 
Nick’s many efforts. 
We had 12 class members and eight spouses at our 
reunion, which was a very special occasion for all. Frank and 
Betty Ann Countryman are still at work, Frank in psychiatry 
and Betty Ann with the LaLeche League. Bob Frelick doesn’t 
see patients any more, but travels as a volunteer for Church 
World Services. He was in Honduras recently to help with 
hurricane damage. (Betty Ann Countryman and Jane Frelick 
also attended their 55th Nursing School reunion.) Carol and 
Jolene Goldenthal came. He works as a cardiologist in 
Hartford, but lacks the time to relax on his boat or at their 
country places. Raymond, an internist, and Jane James have 
retired and are living in Essex, Conn. Ron Losee is retired. 
He and Olive are happy they spent their lives in Montana. 
Tex MacKenzie came a day early to continue writing a journal 
paper about her pharmacological experiences treating 
depression at her office in New Orleans. Jose ph and Mildred 
Massaro live in Manchester, Conn. He has retired from 
general practice. Reese Matteson retired as an otolaryngologist 
in Illinois and this year visited Spain, Portugal, Monaco, 
Canada, China, Tibet and Bali. After the reunion he planned 
to visit Bob Hinkley in New Hampshire. Larry and Polly 
Pickett were present and have been traveling the country 
visiting their children. Larry and Catherine Roth described a 
group called CARD, Concerned Americans for Responsible 
Driving, which they initiated after their son’s death by an 
automobile driven by an elderly man. Larry is active playing 
in orchestras, in sports and in researching the Civil War, 
where their great-grandfathers fought. After retirement, 
Nick Spinelli continued on as an ex officio member of the 
Office of Alumni Affairs staff. Edith Jurka still has her 
Manhattan psychotherapy practice and built a house 
in Westchester County with facilities to train people in 
expanded consciousness. 
Jack and Florence Doherty could not come at the last 
minute because of family complications. The news from Bob 
Cooke is that he is active on the Board of the Kennedy 
Foundation and that his daughter Susan is attending Yale 
College this year. — Edith Jurka 
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William G. Anlyan, M.D. ’49, received the Yale Alumni in Medicine Distinguished Service Award 
at this year’s reunion. “You are one of the giants of our profession,” Dean David A. Kessler, M.D., 
told Anlyan, before presenting him with a plaque. "You are a friend to many in this room and 
you are certainly one of the role models to many of us who have grown up in your shadow.” 
The award to Anlyan was the latest in a string of accolades, including Yale’s Distinguished 
Surgeon Alumnus award in 1979 and the highest honor bestowed by the Association of 
American Medical Colleges, the Abraham Flexner Award in 1980. From 1964 to 1988, Anlyan 
served as chancellor of Duke University Medical Center and transformed it into one of the 
major private tertiary-care facilities of the Southeast. 
Class of 1949 
Our 50th reunion was an 
enormous success. The sun¬ 
shine and the closeness of 
the returnees and their 
spouses contributed to the 
great time. We opened with 
a talk by Larry Shulman, 
former director of the 
NIH’s Institute of Arthritis, 
Musculoskeletal and Skin 
Diseases. He discussed 
progress in recruiting young 
M.D.s to a future in clinical 
research investigation. 
Dinner was at the New 
Haven Lawn Club, where two-thirds of our remaining class¬ 
mates and their spouses enjoyed quail, filet mignon, swordfish 
and chocolate truffles. Those present were Bill Anlyan and 
Alex, Bud Baldwin and Michelle, Bill Bevis and Dorothy, Pete 
Cunningham and Janice, Joe Ehrenkranz, Dan Elliott and 
Betty, Paul Goldstein and Betty, Nora Gordon, Ted Gray and 
Phyllis, Dan Halvorsen and Maxine, Jack Harris and Gene, 
Gordon Jensen and Paula Kiehne, Ben Johnson, Orlando 
(Jack) Miller and Anne, Tim Noland and Barbara, Dick Otis 
and Mary, Julian Pichel and Cecile, Charlie Rennell, Carl 
Russell, Larry Shulman and Reni, Harry Tapp and Barbara, 
and Martha Vaughn. Gunnar Eng’s widow also was present. 
Letters were read from Mary Couchman, whose spouse, Phil, 
died during the year, and from Hal Halman, who was busy 
teaching and practicing quality primary care in an affordable 
setting. A moment of silence memorialized those classmates 
whom we lost over the years. 
On behalf of the class, Jack Harris presented a plaque 
to Dan Elliott to thank him for “holding the class together” 
all these years. The evening concluded with a video 
presentation produced by Bill Bevis, depicting many of us 
in our younger days. 
The highlight of the Saturday program was the presenta¬ 
tion of the Distinguished Alumni Service award to our own 
Bill Anlyan. Dinner at the Graduate Club concluded a most 
enjoyable reunion. — Paul Coldstein 
Class of 1954 
The Class of 1954 returned to celebrate the 45th anniversary 
of our graduation. Two bright sunny days were spent renew¬ 
ing friendships, reliving memories of the past, talking about 
the present and being hopeful of our futures. 
On Friday we participated in the general medical school 
festivities, followed by a clambake. Med ’54 commandeered 
three tables, where we ate, drank and rebonded. Saturday’s 
program included a presentation by Alan Covey’s nephew, 
Aaron Covey. Aaron also visited our reunion dinner at the 
Graduate Club. At dinner we observed a moment of silence 
for those no longer with us: Nick Como, Bruce Draper, Buzz 
Lind, Jim Meinhart, Sheelagh O’Connor, Ed Ranzenhofer, 
Doug Rees, David Robinson, and Bill Soderstrom. These 
members who were at our last reunion and who supported 
class activities — Robert Stein, Herb Hurwitz, and John Rose 
— have since died. John was the glue that held our class 
together and will be missed. Harry Miller will act as class 
agent and I as class secretary. 
Of 61 graduates, 48 now survive. The 15 who attended the 
reunion reported on their personal and family activities: John 
Cole and Cynthia are retired and enjoying winters in Florida 
lowering their handicaps. Alan Covey and Sylvia report that 
Alan has an internal medicine practice with his son on Long 
Island. Another son is a radiologist. Art Crovatto retired from 
the Office of Alumni Affairs but continues to teach anatomy. 
He and Janet now have six grandchildren. Donald Davis, now 
retired, and Jean, attended her 50th reunion at Barnard in 
New York City before coming to Saturday’s events. Ed Gerety 
and Peggy stopped at the reunion, en route to France for the 
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50th anniversary of his brother’s ordination to the priesthood. 
Frank Gruskay and Bette commute to Watch Hill, R.I., and 
to Milford, where Frank still practices pediatrics with his son. 
Walker Heap and Sylvia are enjoying retirement in 
Watertown, N.Y. Bob Hustead and Joy continue to orches¬ 
trate their busy family enterprise. Donald Kornfeld continues 
in psychiatry and as an academic administrator (rumored to 
be superb) at Columbia Presbyterian Hospital. Richard Lamb 
returned for his first reunion since graduation. The American 
Psychiatric Association recently honored him with the Arnold 
Ivan Ameringen Award in psychiatric rehabilitation. Herb 
Lubs, still practicing genetics, enjoyed the meeting with guest 
Dr. Betty Lou Baltzan. Harry Miller and Kari are enjoying his 
retirement as chair of the urology department at George 
Washington University. Lowell Olson and Barbara faithfully 
returned to our reunion. Lowell still practices gynecology. 
Dick Pullen, now retired, and Barbie ski in New Hampshire 
all winter. Leonard Silverman and Gail returned for the first 
time since graduation and he looks as if he just graduated! 
Len practices cardiology in Miami. 
Eva Henriksen MacLean sent a note with some pictures 
from our mini reunion in Cambridge. She said, “What lovely 
memories of John Rose and our walkabouts there! Have a 
great reunion!” 
Several classmates who were scheduled to attend cancelled 
because of unexpected family commitments: Katherine Hess 
Halloran, Samuel Hunter, Jim Nora, Bill Paule and Marty 
Vita. Kitty sent a note looking forward to the 50th. So are we 
all. Hope for 100 percent attendance! 
— Arthur Crovatto 
Nicholas M. Passarelli, 
M.D. ’59, HS ’65, (at right in 
photo), received a gift 
of a chair for his services 
as president of the 
Association of Vale Alumni 
in Medicine for the past two years. "Dr. Passarelli, you have 
given endless volunteer services to our school,” said Dean 
David A. Kessler, M.D. “I want to thank you for your extraordi¬ 
nary and fine leadership on behalf of everyone.”"! think,” 
Passarelli responded with a laugh,“that what he was trying 
to say was that I’ve been a pain in the tail.” 
Class of 1959 
The Class of ’59 gathered to celebrate its 40th reunion under 
sunny skies tempered by gentle breezes. Friday morning a gag¬ 
gle of venerable 59ers almost obstructed the entryway of 333 
Cedar Street. That stately building is still recognizable amid 
the new construction and reconfiguration of streets surround¬ 
ing the medical megaplex. 
Nick Passarelli, president of the Association of Yale 
Alumni in Medicine, and, as always, Chief Factotum and 
Organizer ot Assemblages and Feasts for the Class ol ’59, 
exceeded all his previous bacchanalian productions to cele¬ 
brate the 40th. Friday evening we enjoyed the hospitality of 
David and Joan Reed on the lawn ol their colonial home in 
Middlebury. The featured victuals were three-to-four-pound 
macrural crustaceans, genus Homarus, and piles of bivalve 
mollusks. Dancing, conversation and prevarication followed 
our banquet on Saturday evening at the Quinnipiac Club. 
The orchestra played ’50s melodies and we waltzed away the 
lovely summer evening. 
Special attendees were newlyweds Ed and Ausra 
Kaminskas and Jack and Paula Poglinco; Yale Medal awardee 
Mimi Wolf; and first-time attendees Bud and Lorraine 
Dawson, Jim Halsey, Parry and Rae Larsen, Kay Huxtable 
Lewis and Carl Smith. 
Retirees included: Bob Amick, Asa Barnes, Bill 
Butterfield, Sid Cohen, Lyall Crary, Rod Hartmann, Pete 
Molloy, Ray Mark, John Marsh, Dick Senfield, Jim Stagnone, 
Leo Von Euler and Dick Wolf (honorary member.) 
Retirement plans in process: Bob Gonyea, Gerry 
Gordon, Bill Jablowski, Herb Kaufmann, Joe Saccio and 
Dave Skinner. 
No plans to hang it up: Carol Amick, Ed Clayton, Marty 
Colodzin, Ron DeConti, Gerry Fenichel, Bob Fisher, Paul 
Friedman, Jim Halsey, Bill Heydorn, Mai Ing, John Jasaitis, 
Kris Keggi, Brian McGrath, Donald Kent Morest, Ron 
Morris, Jim O’Neill, Nick Passarelli, Dave Reed, Marc 
Schwartz, Sandy Solomon and Lisa Steiner. — Asa Barnes, Jr. 
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Class of 1964 
Our 35th gala at the New Haven Lawn Club had more spirit 
than numbers. Ten well-attired and both physically and men¬ 
tally fit classmates (including two affiliates) filled the evening 
with chestnuts, gossip and fond memories. 
Robbie Parkman, as tweedy as ever, traveled the longest 
distance, from Los Angeles, where he runs a pediatric trans¬ 
plant service. Bob Lyons, an I.D. chief in Hartford, regaled us 
with stories of Dr. Beeson. Lew and Jill Landsberg flew in 
from Chicago and also visited with their son, who is chief res¬ 
ident in medicine at Yale. Skip and Joyce Stilp came from 
Wisconsin. Skip’s stay was 
punctuated by on-the-spot 
requests for quick, diagnos¬ 
tic physicals from arthritic 
classmates. Don and Jane 
O’Kieffe looked as good as 
_ _ _ their lovely daughter, who 
joined us for dinner. Greg 
Donna Culley 
Hi 
Remo Fabbri was thrilled 
WM to introduce his new wife, 
Christianne. Diane Shrier 
attended with her daughter Lydia, who is on the Harvard fac¬ 
ulty in adolescent medicine. Diane reminded us that the 
female percentage at the Yale School of Medicine has 
increased from 5 percent in 1964 to near 50 percent in 1999. 
Mary DiGangi, who served magnificently as dinner chairper¬ 
son, reviewed her medical school wardrobe and bemoaned the 
fact that for the basic science courses, she was assigned lab 
partners alphabetically. Your loyal class scribe was selected for 
the next millennium. I also stayed until midnight, awaiting 
the Briggs and the Bravos to show up. —Joseph F.J. Curi 
- £ *' 
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Class of 1969 
Thirty years is not such a bad time to reflect on one’s career, 
report on the activities of one’s progeny, and comment on the 
state of medicine. A small but spirited group gathered on 
Saturday afternoon to gather musings of David Barry, Rob 
Marier and Charles Dinarello. Charles conversed, in his own 
inimitable style, about a career in basic research in 1999. He 
reported his recent induction into the National Academy of 
Sciences and on his activities at the University of Colorado. 
Rob Marier gave us a rare perspective on leading a medical 
school. Rob has been the dean of the Louisiana State 
University School of Medicine for the past four years. He left 
us with an optimistic view of the future of the field and its 
bright and energetic students. David Barry had the unique 
perspective of a research leader in the pharmaceutical industry. 
David has made major contributions in antiviral therapy and 
now leads his own pharmaceutical discovery company. 
Saturday afternoon’s discussion spilled over into the 
Quinnipiac Club in the evening. The group included Seth 
Charney, Tom Ciesielski, Ralph and Jean Falkenstein, Ellen 
and Leonard Milstone, Lionel Nelson, Jonelle Carey Rowe, 
David Schulek and Caroline Cambridge, Bob and Marilyn 
Belliveau, Steve Webb, Chuck Angell, as well as the aforemen¬ 
tioned Charles Dinarello, David and Gracie Barry, and Rob 
and Joanne Marier. Paul Markey was able to make the Friday 
evening clambake. 
Absent members should recognize that the high point of 
the evening is a report on all members of the class. Rather 
pointed and sometimes prejudicial comments are made about 
classmates not present to defend their honor. 
It was, all in all, a refreshing opportunity to share times 
with old friends and reflect on life thirty years after New 
Haven. The group left with anticipation of the 2004 gathering 
in New Haven. — Leo M. Cooney, Jr. 
Class of 1974 
Our 25th reunion weekend 
was filled with memories and 
laughter. The expansion of 
the medical school was quite 
impressive, although some of 
us lamented the demise of 
St. John’s Church. 
The stories and laughs 
were nonstop at our grand 
feast Saturday night at 
Adriana’s. Some of our mem¬ 
ories: Dr. Sarrel's movies. Dr. Crelin’s “Welcome to Yale 
Medical Country Club” and our Yale Medical School 
Country Club T-shirts (I brought mine to the reunion), Dr. 
Rosenberg’s clinical correlations course, Chaplain Duncomb’s 
anatomy expertise and the comfort of his office, The Bobby 
Seale Free Health Clinic, and the music during anatomy 
dissection. 
Amy Starr (formerly Schechter) reminded us of various 
happenings in anatomy class and on the wards. Amy is a pedi¬ 
atric rheumatologist in Los Angeles. 
Also flying in from California was Richard Cazen, who 
practices in San Francisco. Rob Kolodner came from 
Washington, where he is working on information systems at 
the Veteran’s Administration. Rob is doing exciting work that 
will impact the quality of health care throughout the country. 
Irl Extein and his wife, Barbara, came up from Florida, where 
Irl practices psychopharmacology. They also came to visit 
their daughter, who attends Yale College. Ralph Binder and 
his wife, Barbara, told us of their trip into the Amazon back 
country. Ralph is a pulmonologist in Bronxville, N.Y. Alan 
Silken and his wife, Karen, came from Newton, Mass., where 
Alan practices pediatric neurology. He sails in Narragansett 
Bay, R.I., and recently had an article published in Sail 
Magazine about a trip to Greece. Pete Buchin and his wife, 
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Marilyn, joined us for lunch from New York City. 
Lenny Banco and I represented Connecticut. Lenny and 
Elizabeth came from the Hartford area, where Lenny is vice 
president for regional development at the Connecticut 
Children’s Medical Center and professor of pediatrics at 
University of Connecticut. I practice psychopharmacology 
and run a group mental health practice in New Haven 
County. 
After the reunion Amy sent me a copy of the audiotape 
and program of our X-rated second-year show, Proctalgia 
Fugax. Listening to the musical will bring you back to the 
’70s. If you would like a copy, please contact the Alumni 
Office at (203) 785-4674. I hope to see you all at our 30th! 
— Douglas Berv 
Class of 1979 
Eleven members of the Class of ’79 showed up for their 
reunion, with Shirley McCarthy, professor and vice-chair of 
academic affairs in diagnostic radiology at Yale as our host. 
Michael Hausman came with his wife and two beautiful 
young daughters. He is practicing surgery in New York City. 
Bonnie Cunningham also came up from the city. She is a 
hematologist-oncologist, including bone marrow transplanta¬ 
tion, at Beth Israel. Gary Vitale lives in Louisville, Ky., and 
works as full-time academic faculty in general surgery, with 
primary interests in the liver and pancreas. He has four chil¬ 
dren and is also active as a soccer coach. John Holt is, as he 
says, "making trouble’’ in Albany, N.Y., in medical consulta¬ 
tion liaison psychiatry. 
John Holt was in Palo Alto, Calif., in January to witness 
the wedding of Jeff Dornbusch, who was at the reunion with 
his new wife, Kathy. Jeff is working as a pediatric intensivist 
in Albuquerque and continues to do a little pediatric anesthe¬ 
sia. Barbara Peters was also at Jeff’s wedding. She came to the 
reunion from Palo Alto, where she practices gynecology. She 
reports that Bruce Halperin and Michael Champeau continue 
to work in a private anesthesiology group in Palo Alto. Both 
are married, and Michael has two children. 
Shannon Kenney came from Chapel Hill, N.C., with her 
husband. They have four children. Shannon is in internal 
medicine/pediatrics at Duke and does research in infectious 
disease. She reported that David Brenner and Jill Silverman, 
who are married and have two kids, are also in Chapel Hill. 
David runs the G1 program at the University of North 
Carolina and Jill is a rheumatologist. Wes Reeves, also at 
UNC, won an award several years ago as the Best Young 
Rheumatologist in the country. 
Ed Schultz, from Nashville, is director of information 
technology at Vanderbilt. Previously, he was in clinical pathol¬ 
ogy at Dartmouth for 13 years. David Golan attended with his 
wife and is teaching and doing research in the department of 
hematology at Harvard. Eddie Reed, who came with his wife, 
works in internal medicine and cancer research at the N1H. 
— Barbara Peters 
Class of 1984 
Both Peter (Glazer) and I enjoyed some 
wonderful times with our returning class¬ 
mates! On Friday night at the clambake we 
sat with Ken Rosenblum and his wife, 
Marissa, and with Mark Stein and his wife, 
Marjorie. Ken has decided to pursue the 
family electroplating business in Minnesota 
and Mark is an urologist in New York. 
Diana Traquina stopped by for a while. She 
is living with her family in New Jersey and 
will soon take a job in ENT nearby. I also 
met Valerie Stone, who graduated with our 
class but started with the Class of 1983. She will join me in 
working closely with the Association of Yale Alumni in 
Medicine this year. 
On Saturday, we had a picnic at our house in Guilford. 
We were happy to host these classmates. Len Bell and his 
wife, Linda, attended with their children. Len has started 
Alexion, a local biotech company. Michael Caplan, a professor 
of physiology at Yale, and his wife, Joanne Burger, came with 
their children. Somehow we end up on a lot of the same com¬ 
mittees! David Frank, his wife, Sheila, and their children 
enjoyed the day. Dave is an oncologist on the faculty at 
Harvard, and runs a lab at the Dana Farber. Bruce Haffty, a 
colleague on the Yale faculty in the department of therapeutic 
radiology, came with his wife, Kathy, and their children. Bob 
and Nancy Havlik brought their children. Bob is a pediatric 
craniofacial surgeon in Indiana. Also attending were Hingge 
Hsu, who is a venture capitalist in Boston, and Jeff Katz and 
his wife, Susan Zeiger, and their children. Jeff is an academic 
rheumatologist at Harvard. Aron Wahrman, a plastic surgeon 
in the Philadelphia area, brought his girlfriend, Jennifer 
Phillips. The Rosenblums and Steins also joined us. Paul 
Rothman and his family were coming but I understand that 
he was asked to give a very important talk at Cold Spring 
Harbor, so they were not able to attend. 
We spent several pleasant hours eating filet and salmon, 
talking and chasing our children around. We all felt that basi¬ 
cally everyone was pretty much the same as they were almost 
20 years ago when we started medical school. We did take an 
unofficial class picture that prompted Rebecca, Mike and 
Joanne’s daughter, to ask if there was really only one woman 
in our medical school class. We assured her that there were 
lots of others. Hopefully, at our twentieth reunion we will 
have more members of our class attending. Thank you to 
everyone who did come; I hope that you had a great time. 
The class photo is available to anyone who wants one from 
the Alumni Office at (203) 785-4674. — Susan Baserga 
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Class of 1989 
Although I was not able to be at tbe Friday clambake, I heard 
it was a blast, and that there was a sighting of Craig Hecht 
with his wife, Suzanne. Craig is practicing orthopaedics in the 
New Haven area and reportedly has two children and one on 
the way. 
Saturday was full of activities. I met up with Dean 
Gifford, who looks great and was as friendly and caring as 
ever. He is doing very well, but sadly is retiring from Yale and 
will be teaching science in city schools. Admirable, huh? 
Stephen Bharucha, his wife, Debbie, and one-year-old 
son, Jack, were there for the day festivities only. Stephen prac¬ 
tices internal medicine and gastroenterology in the Bronx. 
Craig Hecht, who lives in the New Haven area, stood us up. 
We were all so disappointed that we were going to make a 
“class trip” to his doorstep, but then thought better of it. 
Some great class news, Lisa Quattrochi and Steve Knight 
got married — to each other. Congrats to both of you! 
Another of our class matches, Chris Gould and Carolyn Wolf, 
are living in Oneonta, N.Y., and practicing medicine together. 
At Mory’s we all had a copy of our class photo mug com¬ 
posite. Between all of us, we were able to report on where 
almost everyone is, or where they have been over the years. 
But where is Guy McChesney? 
Some shared reports: 
Gregg Koshkarian is married and practicing invasive car¬ 
diology in Tucson, Ariz. Hal Barron is director of cardiovascu¬ 
lar clinical research at Genentech in San Francisco and is still 
single. Bobby Spiero, married, with three kids, practices 
rheumatology in New York City and is as busy as ever. Sue 
Bonar is married and practicing orthopaedics in Kansas City. 
Roger Widmann lives in Westchester with a few kids and 
practices pediatric orthopaedics at Hospital for Special 
Surgery in New York City. 
The award lor coming farthest goes to Susan Carter, who 
managed to get here from California. She is doing fabulously 
as an ophthalmologist with an academic appointment in San 
Francisco. Sanjoy Sundaresan is finally finished with his long, 
long training as a neurosurgeon and is having fun operating 
in Texas. He is married, with a beautiiul two-year-old son. We 
all admired the photos. Elan Louis is married, has two sons, 
(Ravi and Devon), and is practicing neurology and epidemiol¬ 
ogy at Columbia. Dora Wang is married and living in Santa 
Fe, while practicing as a psychiatrist. She was upset that more 
of our classmates were not able to attend and may write to 
everyone before our next reunion. 
Anita Goodrich Licata, married, with two children, lives 
in Vermont and speaks often at national dermatology meet¬ 
ings since finishing her dermatology residency at Yale. Lewis 
Lipsey practices hematology/oncology at Mt. Sinai Hospital 
in New York City. Larry Kleinberg is married and practicing 
radiation therapy at John Hopkins. He has a daughter about 
one year old. Bob Levin is doing research in geriatric psychia¬ 
try at the National Institute for Mental Health in Bethesda. 
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Steve Kolenik finished his dermatology residency in Yale and 
took over for me as the dermatology-surgery fellow there. He 
now lives and practices in Westport, Conn. He and his wife 
have two children. Dave Mai is lucky enough to live in 
Hawaii and practice ophthalmology. 
Personally, I have my own dermatology practice in New 
York City and am the director of dermatology-surgery at 
Downstate Hospital. I am married and have a two-year-old 
daughter, Nicole. 
For more class news, please come to the next reunion. The 
more that come, the more fun it is. Hope everyone is doing 
well and look forward to seeing you at the 20th! — Amy Lewis 
Class of 1994 
At our reunion, typical of most fifth-year reunions, many 
classmates were not given the luxury of enough time off to 
make the trip to New Haven to celebrate. The clambake was 
attended by Belinda Chan and her husband Peter. They have 
since relocated to the area, where Peter will be an economics 
professor at Yale and Belinda will be practicing internal medi¬ 
cine. I also ran into Kate Dee, who was here to celebrate her 
10th reunion at Yale College as well. She reports being enam¬ 
ored of the Pacific Northwest and hopes to settle there after 
completing her radiology fellowship. Kirk Essenmacher drove 
down from Boston for the class dinner. He has moved back 
east to attend Harvard Business School. Business school has 
an eerie sense of deja vu for Kirk; classmates include 
Christopher Gilligan, Greg Licholai and Myles Greenberg. 
Many of the class ol ’94 who could not attend sent messages 
regarding their whereabouts. A more detailed digestion of 
these will be included in the next class newsletter, to be issued 
shortly. Regards to all! — Bonnie E. Could Rothberg 
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OBITUARIES 
ROBERT BYCK 
Robert Byck, M.D., a prominent brain 
researcher in the Department of 
Psychiatry, died from complications 
of a stroke on Aug. 9 in Boston. He 
was 66. 
Byck received his medical degree 
in 1959 from the University of 
Pennsylvania. In 1969 he came to Yale 
for training as a psychiatrist and also 
joined the faculty as a lecturer in phar¬ 
macology. Byck was appointed profes¬ 
sor of psychiatry and pharmacology in 
1977. His research on smokable cocaine 
led him to testify before the House 
Select Committee on Narcotics Abuse 
and Control in 1979 to warn of the 
possibility of a future epidemic, a pre¬ 
diction that was manifested by the pro¬ 
liferation of crack cocaine in the 1980s. 
Byck’s research with Yale colleague J. 
Murdoch Ritchie, Ph.D., on marijuana 
use demonstrated its harmful effects 
upon nerve cells. He also helped to 
identify the negative effects of 
monosodium glutamate (MSG), which 
led to its removal from baby foods in 
the early 1970s. 
JOSEPH E. COLEMAN 
Joseph E. Coleman, M.D., Ph.D., of 
Hamden, Conn., died on June 28 in 
New Haven. He was 68. 
Coleman received his medical degree 
from the University of Virginia in 1957 
and a Ph.D. from Massachusetts 
Institute of Technology in 1963. He 
trained as an intern and resident at the 
Peter Bent Brigham Hospital in Boston 
before joining the Yale faculty as an 
assistant professor of biochemistry 
in 1964. 
Coleman concentrated his research 
and teaching on areas ranging from 
biophysics to medicine. Specifically, he 
was involved in research on protein 
chemistry, enzymology and DNA-pro- 
tein interactions. He authored more 
than 150 scientific articles on these and 
other subjects. Coleman developed an 
area of knowledge about the chemistry 
of metalloproteins and was a leader in 
the use of nuclear magnetic resonance 
for the study of biomolecules. 
Throughout his career, he guided many 
medical and doctoral students. He 
served as acting chair of the 
Department of Biochemistry from 
1966-69, director of the Medical 
Scientist Training Program from 1970- 
75 and chair of the Department of 
Molecular Biophysics and Biochemistry 
from 1976-82. He became a full profes¬ 
sor in 1975. 
HAROLD H. COPPERSMITH 
Harold H. Coppersmith, M.D. ’39, 
died June 16 after suffering a heart 
attack in New York City. He was 84. 
Coppersmith, a graduate of both Yale 
College and the School of Medicine, 
did his internship from 1940 to 1942 at 
Bellevue Hospital, Columbia Division. 
During World War II, he was a captain 
in the Army Medical Corps, serving in 
the South Pacific and reaching the rank 
of major. Coppersmith returned to 
Bellevue Hospital as chief resident for 
one year and continued his affiliation as 
a visiting physician. He was on the fac¬ 
ility of Columbia University College of 
Physicians and Surgeons from 1946 to 
1967, as assistant clinical professor of 
medicine since i960. Coppersmith was 
also an assistant professor of clinical 
medicine at New York University 
School of Medicine for almost 30 years. 
He practiced medicine for 45 years until 
his retirement in 1992. 
RICARDO F. GAUDINEZ 
Ricardo F. Gaudinez, M.D., of 
Branford, Conn., died in New Haven 
on June 22 after a drowning accident in 
Long Island Sound. He was 35. 
Gaudinez received his medical degree 
from the University of Southern 
California in 1989. He came to Yale in 
1994 as a clinical instructor in the 
Department of Orthopaedics and 
Rehabilitation, advancing to assistant 
clinical professor in 1998. Colleagues at 
Yale said Gaudinez was on the cutting 
edge of spinal surgery and was one of 
the first in Connecticut to use the mini¬ 
mally invasive endoscopic spine surgery. 
NICHOLAS A. HALASZ 
Nicholas A. Halasz, M.D. ’54, of La 
Jolla, Calif., died July 16 of esophageal 
cancer. He was 68. 
Halasz, a native of Hungary, studied 
education in Budapest before immigrat¬ 
ing to the United States, where he 
received a Sc.B. degree in 1950 from 
Trinity College in Hartford, Conn. 
After receiving his medical degree from 
Yale four years later, he remained in 
New Haven to continue his training in 
general, cardiovascular and thoracic sur¬ 
gery. Halasz became a captain in the 
Army, serving as a surgical officer from 
1956 to 1958. He joined the surgical 
faculty at the University of California, 
Los Angeles, in 1963. As professor of 
surgery and head of the division of 
anatomy, Halasz was one of the found¬ 
ing faculty members of the University of 
California, San Diego (UCSD), School 
of Medicine in 1967, where he devel¬ 
oped the UCSD Transplantation 
Program and performed the first kidney 
transplant in San Diego County. He 
also changed the way anatomy classes 
were taught at UCSD by using sur¬ 
geons, instead of anatomists, as instruc¬ 
tors. For the past five years Halasz led 
the Veterans Administration Medical 
Center Surgical Service in San Diego. 
HARVEY W. KAETZ 
Harvey W. Kaetz, M.D., the first med¬ 
ical director of Yale University Health 
Services, died Aug. 19 at his home in 
Wallingford, Conn. He was 85. 
Born in Malden, Maine, Kaetz gradu¬ 
ated from Tuffs University in 1936 and 
from Tuffs Medical School in 1940. He 
interned at the former Grace Hospital in 
New Haven and did postgraduate work 
in hematology-oncology at the New 
England Center Hospital in Boston. 
Kaetz was an associate clinical professor 
of medicine at Yale from 1968 to 1979 
and a clinical professor until his death. 
When the state’s first HMO, Yale 
University Health Services facility, was 
created in 1971, Kaetz was hired as its 
first internist. He was also the first chief 
of medicine from 1971 to 1976 and 
- 
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served as medical director from 1971 to 
1979. Kaetz continued to practice as an 
internist and oncologist until 1984. 
He later returned to the Health 
Services and retired in 1990. 
MYRON LOTZ 
Myron Lotz, M.D. ’58, of McLean, 
Va., died July 11 of peripheral T-cell 
lymphoma at Inova Fairfax Hospital. 
He was 67. 
Lotz, a native of Ohio, majored in 
zoology at Yale College and was a cum 
laude graduate of the School of 
Medicine. He studied cellular biology 
and pathology at Oxford and did his 
residency at Massachusetts General 
Hospital. He served as a senior surgeon 
in the Navy at the National Heart 
Institute’s Public Health Service, attain¬ 
ing the rank of commander. 
Lotz, a general internist and specialist 
in endocrinology, had a private practice 
in Vienna, Va., for 19 years until his 
retirement in 1987. He was appointed 
assistant professor of medicine at 
Georgetown University School of 
Medicine (GUSM) in 1965 and served 
as chief of medicine at the Georgetown 
University Medical Service at D.C. 
General Hospital. He also served as 
deputy director of the Food and 
Drug Administration’s laboratory of 
clinical pharmacology at GUSM from 
1965 to 1968. 
During his retirement, Lotz was 
involved in medical missionary work 
in Mexico, Central America and 
South America. 
HENRY PACKER 
Henry Packer, Dr.P.H. ’36, died July 1 
of heart failure at St. Peter Villa in 
Memphis, Tenn. He was 91. 
Born in Montreal, Packer worked his 
way through medical school at McGill 
by playing classical piano. After gradu¬ 
ating from Yale, he moved to Memphis, 
where he worked for three years with 
the Tennessee Department of Public 
Health. Packer then joined the 
University of Tennessee at Memphis 
(UT-M) faculty as professor of preven¬ 
tive medicine. He served as chair of the 
department from 1948 until his retire¬ 
ment in 1972 and continued to teach 
until 1987. During his career at UT-M, 
he established the Chronic Disease 
Detection Unit, now known as the 
Prevention Center Clinic. 
In 1989 the Tennessee Health 
Department, where he served as a con¬ 
sultant after his retirement, named the 
Packer Clinic in his honor. 
JOHN H. ST. ANDRE 
John H. St. Andre, M.D. ’61, died Aug. 
29 at his home in Readfield, Maine. He 
was 65. 
St. Andre was born and raised in Sea 
Cliff, N.Y., and graduated from 
Williams College in 1956. After receiv¬ 
ing his medical degree from Yale, he 
served his internship at Central Maine 
General Hospital in Lewiston, Maine, 
and his residency in Warren, Penn., and 
in the Panama Canal Zone. St. Andre 
worked as a staff psychiatrist in the 
New York State hospital system for 13 
years before moving to Maine in 1977. 
He was a psychiatrist at the Veterans 
Administration Hospital in Togus for 
22 years. 
St. Andre had a strong interest in 
land preservation and was an active 
member of the Kennebec Land Trust. 
He also had a fascination with 
Maine’s historic barns and owned an 
antiques business. 
MARGO SOMMERS 
Margo Sommers, M.D. ’36, died June 
28 at her home in Cambridge, Mass. 
She was 87. 
Born and raised in St. Paul, Minn., 
Sommers did post-graduate training at 
the New York Psychoanalytic Institute 
after graduating from Yale. From 1938 
to 1940, she was a clinical instructor in 
psychiatry at New York University 
Medical School; from 1941 to 1942 she 
was an assistant clinical instructor at 
New York Hospital. She taught at Yale 
from 1950 to 1956, reaching the rank of 
clinical assistant professor. 
Sommers had a private psychiatric 
practice for almost 50 years, starting in 
New York City in 1941, moving to 
Stamford and Old Greenwich, Conn., 
and ending in Cambridge in 1990. She 
married Walther Prokosch in 1936, a 
Yale architectural graduate. 
MYRON P. WALZAK, JR. 
Myron P. Walzak Jr., M.D. ’55, died 
June 23 at John Dempsey Hospital in 
Farmington, Conn. He was 69. 
Walzak graduated from Yale College 
in 1951 before embarking on his medical 
education at the School of Medicine. He 
completed his urology residency at 
Cornell and served as an Army captain 
in Vietnam. He then joined the faculty 
ot the University of Virginia Medical 
School in Charlottesville, where he 
became an associate professor of urology. 
Walzak founded the department of 
urology at Creighton University Medical 
School in Omaha, Neb., and served as 
its chair for 10 years. In 1981 he 
became professor and chair of the 
division of urology at the University 
of Connecticut Health Center, 
retiring in 1996 as professor emeritus. 
HERMAN YANNET 
Herman Yannet, M.D. ’29, died on July 
31 at his home at Heritage Village in 
Southbury, Conn. He was 95. 
After graduation, Yannet remained at 
Yale to complete his pediatrics training. 
He then joined the faculty and conduct¬ 
ed research on the Rh factor, as well as 
electrolyte imbalance in dehydrated 
children. In 1941 he became the first 
medical director of the Southbury 
Training School for mentally retarded 
children, where he served for more than 
30 years. 
In the early 1960s, Yannet participated 
in a White House Conference on 
Children’s Health and also accompanied 
Eunice Kennedy Shriver on a tour of 
British institutions for the mentally 
retarded. As an emeritus professor at 
Yale, he conducted a pediatric neurology 
clinic and was active as a consultant 
and lecturer. 
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10,000 house calls and counting 
There's only one reason to treat patients at home: They need your care. 
By Donald E. Moore, M.D. '8i, M.P.H. ’81 
The familiar, rhythmic tones interrupted my pre-dawn reverie 
that early-spring morning. I rolled out of bed and made one long 
step to the dresser, where the beeper lay among the contents of 
pockets emptied the night before. It was 4:15 a.m. and Peggy 
Hooper wanted me to make a house call. 
Ms. Hooper is a woman whose vague complaints have led us 
to try more than 15 prescription medicines over the years with 
very little measurable effect. I have treated her in the hospital, in 
the office and many times in her home. Going there was not a 
problem — I am a doctor who makes house calls — but, with 6 
a.m. hospital rounds looming, there just wasn’t time. 
Since I began my career in medicine in the early 1980s, I have 
made house calls for one simple reason: Patients need and want 
them. Historically, before the wide availability of acute-care hos¬ 
pital beds, the home was often the most appropriate venue for 
treatment. There were fewer physicians’ offices and clinics in the 
first half of this century, and, even today, getting to the doctor 
can be difficult for the bedridden or homebound patient. It costs 
society a lot less to transport a healthy physician to the bedside 
of an infirm patient than to transport that patient to a doctor’s 
office or hospital. 
I told Ms. Hooper (as I will call her to protect her privacy) that I 
couldn’t come to her home just then because I would soon be on 
my way to the hospital."I know that,” she barked."That’s why I 
called you so early. Come now.” 
With apologies, I offered to visit her that evening but she 
angrily declined. "I’ll take you to court,” she yelled into the phone 
as she hung up. I imagined the headline: “New York City doctor 
sued for failure to make 430 a.m. house call.” 
* * * 
Around 4 o’clock on a steamy Friday afternoon, I drove into 
Harlem and parked in front of the six-story, walk-up apartment 
building. The five young men who occupied the stoop continued 
their conversation as I collected my black bag and locked the 
rented Lincoln Town Car. I uttered a greeting as I maneuvered my 
way up the crowded steps, and a few of the men grunted back. I 
never saw their eyes. 
In the dark apartment the old man was very ill, with an irregu¬ 
lar heartbeat, difficulty breathing and profound weakness. His 
wife said that they would be returning to their home in South 
Africa soon. Adjusting his medications, I prescribed a large supply 
of pills that might be difficult to obtain overseas. As I hurried 
back to the car, I once again had to pass by the men on the stoop. 
This time they cleared a path and glanced up at me, revealing not 
only their eyes but the faintest of smiles as well. As my car door 
was about to close, I heard one of the men say, “Have a good day, 
Dr. Moore." 
I looked around in an attempt to identify the source that had 
revealed my name. All I could see was a small envelope, lying incon¬ 
spicuously on the back seat, visible only to deeply inquiring eyes. 
* * * 
I walked up the icy wheelchair ramp of the house in Brooklyn and 
entered the small apartment on the first floor. The bedroom stank 
of necrotic tissue and urine. 
The patient was a 23-year-old man who had been paralyzed by 
a bullet seven years earlier. Buster Black had adapted well to his 
medical disabilities but he was plagued by recurrent pressure 
ulcers that would not heal. He was very knowledgeable about his 
condition, and he and his wife managed the complications 
remarkably well. 
The bedside tray table had been set up with gauze pads, saline, 
disinfectant and dressing tape by his wife, who for religious rea¬ 
sons did not show herself in my presence. Buster was particularly 
concerned about the condition of his wounds that day, and for 
good reason. One ulcer had penetrated down to the hipbone, 
making it necessary to hospitalize him immediately. 
It was after 9 p.m. when I left. As I headed to Queens to see a 
95-year-old woman with severe osteoporosis, it occurred to me 
that I might not get to my last call of the day in Manhattan 
before 11. As my old Jeep hugged the slippery Interboro Parkway, 
my thoughts drifted to why I was making house calls on a wintry 
Friday night after a week of more than 30 hospital bedside visits 
and 140 office visits. It occurred to me that, during my 15 years in 
medicine, I had made well over 10,000 house calls. Why? The 
answer came quickly: Practically no one else was doing it. 
* * * 
Buster Black died this year after a long hospitalization. He had 
spent an unhappy period before this in a nursing home — an 
option that he had opposed and resisted from the very beginning 
of his disability. He had done well at home but, in the end, this 
resourceful, spirited young man lost his will to live. Maybe he had 
lost faith in my ability to provide the necessary medical services 
that kept his fragile health intact. 
As an alumnus of Yale, I sometimes feel that my contribution to 
medicine should be made on the pages of journals like The Lancet 
or The New England Journal of Medicine. But then I remember 
Francis Weld Peabody, who wrote that "the secret of the care of 
the patient is in caring for the patient.” We show patients and 
their families that we care when we go into their homes to heal. 
Donald E. Moore, M.D. ’8i, M.P.H. ’81, is a family practitioner and 
emergency medicine specialist in Brooklyn, N.Y., and a faculty mem¬ 
ber at Weill Medical College of Cornell University. He also serves as 
an AYAM representative to the Association of Yale Alumni. 
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The Program for Humanities in Medicine 
1999-2000 Lecture Series 
Lectures, free and open to the public, begin at 5 p.m. in the Beaumont Room, 333 Cedar Street. 
For information call Clara Gyorgyey at (203) 785-5494 or 785-4744. Remaining lectures in the series 
are as follows: 
January 6 
WHAT CHILDREN REALLY THINK 
WHEN PSYCHE OR SOMA FAIL 
THE ENID PESCHEL LECTURE - 
Real Medical TV 
Kyle D. Pruett, M.D. 
Clinical Professor of Psychiatry 
Yale Child Study Center 
January 20 
TRADITIONS OF CONSOLATION 
Leslie Brisman, Ph.D. 
Professor of English 
Yale University 
February 3 
MIRACLES AND HEALING 
FROM THE BIBLE THROUGH 
MAIMONIDES TO THE PRESENT 
Richard L. Eisenberg, M.A. 
Rabbi of Congregation 
B’nai Jacob 
Woodbridge, Conn. 
February 17 
COMMUNICATING IN HEALTH 
CARE: WHAT’S ALL THE FUSS? 
THE BAYER LECTURE 
Suzanne Kurtz, Ph.D. 
Professor of Communication 
Faculty of Education 
& Medicine, 
University of Calgary 
Calgary, Alberta, Canada 
March 2 
PROBLEM GAMBLING: 
ADDICTION, PREVALENCE & 
SOCIAL COSTS 
Marvin A. Steinberg, Ph.D. 
Addiction Psychiatry Fellow 
Connecticut Council on 
Problem Gambling 
Guilford, Conn. 
Mark Potenza, M.D., Ph.D. 
Professor of Psychiatry 
Yale University 
Connecticut Mental 
Health Center 
March 16 
MEDICAL ETHICS IN HUNGARY: 
A DRAMATIC PERSPECTIVE 
Andrew Bock, M.A. 
Doctoral Candidate in 
Comparative Literature 
University of Iowa 
Iowa City, Iowa 
March 30 
MENTORING RELATIONSHIPS: 
HITCHING ONE’S WAGON 
TO A STAR 
Thomas Duffy, M.D. 
Professor of Medicine 
Yale University School 
of Medicine 
April 13 
A PRIVATE PRACTICE: DIARIES 
OF PHYSICIAN-AUTHORS 
lliana Semmler, Ph.D. 
Lecturer Emerita in English 
State University of New York 
Albany, N.Y. 
April 27 
EROS & THANATOS: 
DYSFUNCTIONAL SEXUALITY 
IN THOMAS MANN’S PROSE 
Krisztina Miko, Ph.D. 
Professor Emerita of 
Comparative Literature 
Peter Pazmany University 
Budapest, Hungary 
May 4 
HUMAN SIDE OF 
TERRORISM: FAMILIES, 
GOVERNMENT & MEDIA 
Leila F. Dane, Ph.D. 
Clinical Psychologist/Director 
Institute for Victims of Trauma 
McLean, Va. 
May 11 
ALEXANDRA DAVID-NEEL: 
EXPLORER OF TIBET & 
THE HUMAN PSYCHE 
Barbara Foster, M.A., M.L.S. 
Associate Professor of 
Library Science 
City University of New York - 
Hunter College 
February 5 
(Saturday) 
"Snoring and Sleep Apnea” 
Foxwoods Resort and 
Conference Center 
Ledyard, Conn. 
Course Director: 
Douglas A. Ross, M.D. 
March 3 
(Friday) 
"Advances in HIV 
Therapeutics: AIDS at 
the Millennium” 
Harkness Auditorium 
Course Directors: 
Gerald H. Friedland, M.D., and 
Ann Williams, R.N. 
March 30-31 
(Thursday-Friday) 
"Clinical and Molecular 
Basis of Immunomodulatory 
Effect of Allogeneic Blood 
Transfusion” 
Hotel Washington 
Washington, D.C. 
Course Director: 
Edward L. Snyder, M.D. 
April 1 
(Saturday) 
“Behavioral Medical Psychology" 
Foxwoods Resort and 
Conference Center 
Ledyard, Conn. 
Course Director: 
Jeffrey Levine, M.D. 
For information, contact the Office of Postgraduate and Continuing Education, Yale University School of Medicine, 
333 Cedar Street, P.O. Box 208052, New Haven, CT 06520-8052;Tel: (203) 785-4578. 
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With the arrival of spring—and the reappearance of 
mosquitoes—New York City is bracing for the possi¬ 
ble recurrence of West Nile fever, a virus not seen in 
the Western Hemisphere before 1999. Investigators 
believe the mosquito species Culex pipiens (cover) is 
the most likely vector of the disease, which killed 
seven people at the end of last summer and may 
have crossed the Atlantic in birds. At Yale, a molecu¬ 
lar approach to vector-borne illnesses promises to 
reveal new targets for intervention. Page 16. 
| “ ‘S^SThe protozoan responsible for malaria, r r 
which kills two million people each year. 
Copyright © 2000 
Yale University School of Medicine. 
All rights reserved. 
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As the school takes an excep¬ 
tionally thorough look at both 
how and what it teaches, we 
invited alumni to reminisce 
about the Yale System of 
their day. 
f medical 
iducation 
Alumni News 
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Eight decades of 
the Yale System 
Letters 
Scope Chronicle 
Rounds 
On Campus 
Findings 
Capsule 
To the vector go the s 
By breaking down the com¬ 
plex cycle that allows mosqui¬ 
toes, tsetse flies, ticks and oth¬ 
er arthropods to transmit 
fatal disease, Yale scientists 
are providing new ammuni¬ 
tion in the fight against 
malaria and other vector- 
borne illnesses. 
The breathtaking discoveries 
of the last three decades and 
rapid change across all of 
medicine have called tradi¬ 
tional models of education 
into question. At Yale, the 
Faculty News 
Student News 
Alumni Reunion Weekend 
wmr ' m 
In search of medicine s 
shifting frontier 
The- 
n elusive 
target for teachers, students 
and clinicians.That doesn't 
bother Herb Chase, the 
school's new deputy dean for 
education. 
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LETTERS 
Another side of Bob Gifford 
To the Editor: 
John Curtis’ article on Robert 
Gifford [“Goodbye, Dr. Gif¬ 
ford,” Fall i999lWinter 2000] 
captures many ot my best 
memories of Yale. Like many 
others, I was fortunate enough 
to have Bob Gifford as a men¬ 
tor during my first two years 
ot medical school. He made 
the transition into medicine 
so fascinating and inspiring 
for us that it was no coinci¬ 
dence that my med school 
chum Jim Sullivan, M.D. ’73, 
and I became rheumatologists. 
The only other teacher- 
physician who made a deep 
impression on me was the late 
infectious disease specialist 
and chief of medicine at 
Waterbury Hospital, George 
Thornton, M.D. Oddly 
enough, he grew up with Bob 
and went to church where 
Bob’s father was the minister. 
Dr. Thornton related to me 
(and many others, I’m sure) 
that Bob was something of a 
choirboy growing up. Howev¬ 
er, this choirboy was caught 
throwing spitballs down on 
the congregants, apparently 
incurring his father’s wrath. 
I think Bob never lost that 
free spirit that enables him to 
connect with students. Role 
models like him are extraordi¬ 
narily rare. 
I hope the dean can con¬ 
vince him to unretire one 
more time. 
Gary V Gordon, M.D. 73 
Philadelphia, Penn. 
The first use of penicillin 
To the Editor: 
Your story on John F. Fulton 
[“Fulton, penicillin and 
chance,” Fall i999lWinter 
2000] brought back memo¬ 
ries. Perhaps you will permit 
me to add a few facts. 
Dr. Fulton was Sterling Pro¬ 
fessor of Physiology at the 
time and not a clinician. The 
clinician who engineered the 
obtaining of some penicillin 
was Dr. Francis G. Blake, 
Sterling Professor of Medicine 
as well as the medical school’s 
dean. 
I recall many a night, as a 
senior intern on the isolation 
ward, walking from Fitkin 
(Dr. Blake’s office) to Brady, 
where a filter was available 
courtesy of Dr. Morris Tager 
of Bacteriology, and back to 
isolation with the “precious 
product.” It was necessary to 
filter the solution made from 
the yellow powder received 
from Merck in Rahway, N.J., 
to be certain there were no 
residual bacteria. This was 
then given to the patient, 
5,000 units intravenously 
every four hours. Today we 
think nothing of giving a mil¬ 
lion or more units several 
times daily. 
One of my clear memories 
is that of Dr. Wilder Tileson 
on rounds that Monday 
morning looking at the very 
graph of Mrs. Miller’s chart 
you published and mumbling 
just loud enough for those of 
us close enough to hear, 
“Black magic!” 
Your comment from Herb 
Tabor, M.D., was pertinent. 
You might have added that in 
addition to his distinguished 
career as a research bio¬ 
chemist, he has been senior 
editor of the Journal of Biolog¬ 
ical Chemistry for many years. 
Charles M. Grossman, 
M.D., HS '44 
Portland, Ore. 
More facts on Fulton 
To the Editor: 
I recently received the Fall 
i999lWinter 2000 issue of 
Yale Medicine. On page 12, 
there is a picture of Drs. 
Fleming and Blake. I am not 
sure, but I think Dr. Blake is 
on the left and Fleming is on 
the right. The article mentions 
that Dr. Fulton was in the 
hospital at the same time Mrs. 
Miller was being treated for 
postpartum infection. It does 
not mention what Dr. Fulton 
was being treated for. We were 
told years ago that he had 
developed coccidioidomycosis 
following a visit to California 
and that the penicillin was 
originally intended for him, 
but he got well without it and 
it was then used for Mrs. 
Miller. 
Finally I must make a com¬ 
ment about which I imagine 
you can do nothing. Having 
had bilateral cataract surgery 
recently and several changes of 
eyeglasses, I find that I still 
cannot see clearly. The print 
in the magazine is so small I 
must use a bright light and a 
magnifying glass to read it. 
Even this is only of partial 
assistance. I wonder if other 
older alumni have this prob¬ 
lem and if it might be possible 
to use larger type? 
Paul R. Bruch, M.D. 5/ 
Southbury, Conn. 
Thanks to Dr. Bruch and others 
who wrote to correct the identi¬ 
fication in the photograph. Dr 
Blake is indeed pictured on the 
left. As for the size of Yale Med¬ 
icine’s body type, we are contin¬ 
uing to experiment with 
improvements to legibility. In 
addition, readers with access to 
the Internet may read the arti¬ 
cles online (and control the type 
size via their Web browser) at 
info, med.yale. edu/ymm. 
2 
Easing children 
through surgery 
To the Editor: 
This letter is written is 
response to your article about 
the work of Zeev Kain. [“Eas¬ 
ing childrens minds about 
surgery,” Fall i999lWinter 
2000.] 1 trained at Yale in the 
late 1950s, when there were no 
pediatric surgeons on the staff. 
After completing my training, 
including a year at Pittsburgh 
Children’s Hospital, I returned 
to practice with Dick Selzer. 
1 was the first surgeon 
trained as a pediatric surgeon 
and had quite a time convinc¬ 
ing the hospital and Blue 
Cross that outpatient surgery 
was a good thing for children 
and deserved coverage. Drs. 
Pickett, Toloukian and 
Seashore followed and estab¬ 
lished an excellent pediatric 
surgery section. 
Besides the use of sedation, 
as the article mentioned, there 
are many other ways of reduc¬ 
ing stress. Playing children’s 
music in the operating room 
makes a big difference, too. It 
relaxes the children and the 
staff. However, I was deemed 
an explosion hazard the first 
time I showed up with my 
tape recorder, in the 1970s, 
when cyclopropane and ether 
were still in vogue. 
I also have found that chil¬ 
dren are excellent subjects for 
hypnosis and that simple sto¬ 
ries and suggestions will often 
change their attitudes toward 
surgery. A statement such as 
How to reach us 
“You’ll be going out” can be 
scary if it is understood to 
mean “out of control.” On the 
other hand, “You will go to 
sleep in the OR” induced 
sleep in several of my young 
patients almost instantly as 
they were wheeled to surgery. 
I often spoke to children and 
adults while under anesthesia 
because they hear and respond 
to the suggestions and infor¬ 
mation given them. I was con¬ 
sidered crazy until the benefi¬ 
cial effects were seen. Then I 
got to present anesthesia 
grand rounds. As a matter of 
fact, my greatest compliment 
came from Dr. Jake Goldstein, 
who declared I was equal to 10 
cc’s of Pentothal. 
Hopefully the surgeons are 
less of a problem today than 
in the past. If not, there are 
drugs available that could be 
helpful. Perhaps preoperative 
sedation for surgeons should 
be the next study undertaken. 
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$500 million for medicine 
After two years of incremental approvals, the Yale Corporation 
voted at its February meeting to construct a major new 
research and teaching facility on Congress Avenue as part of a 
plan to invest at least $500 million in medical school facilities 
over the next 10 years. 
Excavation of the site—a full block bounded by Congress and 
Howard avenues and Cedar and Gilbert streets—began in early 
March following demolition of the eight-story brick building at 
350 Congress Ave. and several adjacent structures. University 
officials have signed a $176 million contract for construction of 
the new Congress Avenue Building (CAB), with occupancy 
expected in March 2003. It is anticipated that the project will 
be supported in part by philanthropy. 
“This is the largest single investment in a facility in Yale’s 
history,” President Richard C. Levin said of the new building 
when the decision was announced Feb. 24 before a large crowd 
of faculty and staff in the Medical Historical Library. “This is 
only the beginning of an important period of investment in the 
School of Medicine. By the end of the decade, we will have 
invested half a billion dollars in facilities here and have a scien¬ 
tific research capability that is second to none.” 
The decision came a month after the announcement that the 
University would invest another $500 million to construct and 
improve science and engineering facilities on the central cam¬ 
pus, bringing the new investment in science during the next 
decade to $1 billion. According to Levin, “For Yale to remain 
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among the very best universi¬ 
ties, to be the best university 
in the world, we must be 
among the best in science. 
That is an imperative for the 
21st century.” 
The Congress Avenue 
Building—actually two wings 
joined by an atrium and cen¬ 
tral courtyard—will contain 
six floors of laboratories for 
disease-oriented research, core 
facilities for genomics and 
magnetic resonance imaging, a 
140-seat auditorium, and 
state-of-the-art teaching space 
for anatomy and histology. In 
the final blueprints, the build¬ 
ing measures 450,000 gross 
square feet and includes 
136,600 net square feet of wet- 
bench laboratory, lab-support 
and research-office space. 
Overall, the facilities plan will 
increase lab space at the med¬ 
ical school by 25 percent. 
The announcement of the 
new building generated excite¬ 
ment across the medical 
school campus, which first 
looked to the Congress 
Avenue site for relief from its 
space shortage more than a 
decade ago. Dean David A. 
Kessler, M.D., drew a loud 
round of applause when he 
announced the March 2003 
move-in date. 
“There is no doubt,” he 
told the crowd, “that this 
investment will affect the 
future of the medical school 
and quicken the pace at which 
we can bring discoveries in the 
laboratories to the benefit of 
our patients. It will enhance 
our research space, our educa¬ 
tional programs and the 
opportunities we can afford 
students, and it will help us 
sustain a brilliant and creative 
faculty as they literally trans¬ 
form the face of medicine.” 
The decade-long facilities 
plan includes provisions to 
renovate existing laboratories 
throughout the medical school 
and to look carefully at the 
future use of space that will be 
made available when the 
future occupants of CAB 
move to the new building. 
Kessler said that the depart¬ 
ments will have an opportuni¬ 
ty to put forward requests and 
participate in the planning 
based on the school’s academic 
needs and priorities. 
Smoke signals 
Research unit to investigate 
why some tobacco users 
simply can’t quit. 
For many, nicotine gum or 
the patch has tipped the bal¬ 
ance in the struggle to quit 
smoking. Others try hypnosis 
or break the habit cold turkey. 
But for a significant subgroup 
of smokers who would like to 
stop, nothing seems to work. 
Yale researchers recently 
received a $10 million grant to 
find out why. 
The grant, from the 
National Institute on Drug 
Abuse, the National Cancer 
Institute and the Robert 
Wood Johnson Foundation, is 
part of a five-year, $84 million 
nationwide plan to create 
tobacco research centers 
around the country in an 
effort to reduce tobacco use. 
Six other institutions have 
been awarded grants. 
The new Transdisciplinary 
Tobacco Use Research Center 
at Yale, led by Stephanie 
O’Malley, Ph.D., professor of 
psychiatry, will undertake five 
research projects. “The goal of 
our center is to improve 
tobacco addiction treatment 
by studying why current treat¬ 
ments fail and developing new 
behavioral and drug treat¬ 
ments that address these fac¬ 
tors,” said O’Malley. The Yale 
studies will focus on three 
groups who are giving up 
smoking at a slower rate than 
the nation as a whole: female 
smokers, smokers with depres¬ 
sion and smokers who drink 
heavily. 
Robert B. Innis, M.D., 
Ph.D., professor of psychiatry 
and pharmacology, will use 
PET and SPECT imaging to 
improve understanding of 
brain systems altered by smok¬ 
ing. Suchitra Krishnan-Sarin, 
Ph.D., assistant professor of 
psychiatry, will study behav¬ 
ioral, biochemical and 
endocrine responses that fol¬ 
low smoking cessation. Peter 
Salovey, Ph.D., professor of 
psychology and of epidemiol¬ 
ogy and public health and in 
the Cancer Center, will com¬ 
pare the effectiveness of anti¬ 
smoking messages that 
emphasize the benefits of quit¬ 
ting and those that emphasize 
the risks of not quitting. 
Marina R. Picciotto, Ph.D., 
assistant professor of psychia¬ 
try and pharmacology, will 
study the biological bases of 
depression, heavy drinking 
and female gender in resist¬ 
ance to smoking cessation. 
O’Malley will expand on pre¬ 
vious studies that suggest that 
the drug naltrexone, used for 
alcohol dependence, may also 
help smokers quit when com¬ 
bined with a nicotine patch. 
“It is critically important that 
more effective smoking cessa¬ 
tion treatments be developed,” 
O’Malley said, “because most 
smokers try to quit only once 
every three to four years.” 
et cetera 
I 
THE INSTITUTE OF 
MEDICINE has honored 
two from Yale with senior 
membership. Pasko Rakic, 
M.D., Sc.D., the Dorys 
McConnell Duberg Pro¬ 
fessor of Neuroscience 
and chair of the Section 
of Neurobiology, and 
Lewis P. Rowland, M.D. 
’48, HS ’50, professor of 
neurology at Columbia 
University in New York, 
were elected to the sen¬ 
ior ranks in October. 
Among the 55 new mem¬ 
bers of the institute were 
four Yale alumni, includ¬ 
ing Yale College gradu¬ 
ates David Ginsburg, 
M.D., Richard Hodes, M.D., 
and Jeffrey P. Koplan, 
M.D., M.P.H.; and Nancy 
Hopkins, Ph.D., a biologist 
who did her graduate 
work at Yale. 
FAREWELL TO YPI 
After almost 70 years, the 
Yale Psychiatric Institute 
is closing its doors, a vic¬ 
tim of the new economics 
of health care. YPI’s func¬ 
tions will transfer from 
the School of Medicine to 
Yale-New Haven Hospital 
as soon as the change is 
approved by the state’s 
>>> 7 
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Medical school 
gears up for 
Yale’s 300th 
With its own bicentennial 
only a decade away, the 
medical school has its sights 
set on a more immediate 
cause for celebration and 
reflection: the 300th anniver¬ 
sary of the founding of Yale 
College in 1701. The first of 
three University-wide Ter¬ 
centennial weekend celebra¬ 
tions is planned for Oct. 21 of 
this year along the theme of 
“New Haven and Yale,” with a 
number of open houses in 
laboratories, museums, 
classrooms and theaters across 
the University. 
The second anchor celebra¬ 
tion will take place April 
20-22, 2001, around the theme 
“300 Years of Creativity and 
Discovery” at Yale. The 
culminating events of the 
Tercentennial will occur Oct. 
5-7, 2001, the weekend closest 
to the anniversary of the 
signing of Yale’s charter. 
The medical campus will 
join in the opening of the 
Tercentennial in October with 
events exploring the themes 
of “Community Outreach,” 
“Teaching What We Do” and 
“Engaging the Public.” In a 
series of exhibits, demonstra¬ 
tions, hands-on activities and 
lectures, the public will have a 
chance to learn how to con¬ 
duct a physical exam, explore 
the body using virtual anato¬ 
my software and peer at mole¬ 
cules through an electron 
microscope. A photographic 
exhibit will chronicle the 
activities of students and fac¬ 
ulty who volunteer their time 
and skills in service of New 
Haven. Under the category of 
“Teaching What We Do,” the 
public is invited to a series of 
activities which include a visit 
to the Magnetic Resonance 
Center and an anatomy class 
for young children. The His¬ 
torical Library is planning 
tours and a display of prints 
from the Clements C. Fry 
Print collection. 
In November playwright 
and performer Anna Deveare 
Smith will create a theater 
piece based on interviews with 
patients, physicians, caregivers 
and others at Yale-New Haven 
Hospital and the School of 
Medicine. She will perform 
the piece at grand rounds dur¬ 
ing the week of Nov. 13. 
Harris Building 
opens its doors 
The Yale Child Study Center, 
which has a long and distin¬ 
guished history of research 
and clinical work with chil¬ 
dren and families from around 
the world, dedicated the new 
Neison and Irving Harris 
Building in October. 
Founded in 1911 by Arnold 
Gesell, the center has expand¬ 
ed its mission over the years to 
include a wide array of pro¬ 
grams ranging from basic 
studies of developmental neu¬ 
robiology and genetics to ther¬ 
apeutic programs in schools 
and the community. The new 
2i,ooo-square-foot Harris 
Building will house many of 
the center’s research and com¬ 
munity programs including 
the Child Development and 
Community Policing Pro¬ 
gram, the Comer School 
Development Program, and 
the range of research and clin¬ 
ical programs for very young 
children. 
The building was the gift of 
Neison and Irving Harris, Yale 
College graduates who have 
had a long-standing interest in 
the welfare of children and 
have been friends and sup¬ 
porters of the Child Study 
Center for many years. The 
Harris family and many others 
have joined together in their 
concern for children and fam¬ 
ilies and their trust in the 
work of the Child Study Cen¬ 
ter. According to Director 
Donald J. Cohen, M.D. ’66, 
the building will help raise the 
profile of children’s issues. 
“The idea is that medical stu¬ 
dents and undergraduates will 
see the Yale Child Study Cen¬ 
ter and recognize that the 
child and family are essential 
to their education, regardless 
of what field they go into.” 
Guests at the opening on 
Oct. 14 included Irving and 
Joan Harris, New Haven 
Mayor John DeStefano, Dean 
David A. Kessler, and Yale 
President Richard C. Levin. 
Guests at the 
opening of the 
new Harris 
Building filled 
its auditorium 
to capacity. 
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YCC director will guide revision of National Cancer Act 
In the 29 years since the Nixon administration and 
Congress declared war on cancer with the passage of the 
National Cancer Act, physicians and scientists have dis¬ 
cerned cancer’s origins, found ways to treat it and made 
previously lethal forms of it manageable. Now a Senate 
advisory committee is looking at ways to update the act 
to incorporate this new knowledge. Leading the com¬ 
mittee as co-chair is Vincent T. DeVita Jr., M.D., direc¬ 
tor of the Yale Cancer Center and one of the nation’s 
leading cancer experts. “Our knowledge of cancer, can¬ 
cer research and cancer control have changed substan¬ 
tially since the original National Cancer Act was enact¬ 
ed,” says DeVita, who believes cancer may someday be 
managed as a chronic disease. He served as director of the National Cancer Institute for nine years under 
presidents Carter and Reagan. “I look forward to uniting the cancer community to formulate a new blue¬ 
print for the war on cancer.” 
The 20-member committee, which will meet monthly throughout the year, includes physicians, scien¬ 
tists, business leaders, insurance executives and people with cancer. Sen. Dianne Feinstein, a Democrat 
from California, asked DeVita to serve on the committee. The advisory committee will work with the 
National Dialogue on Cancer (NDC), of which DeVita is also a member. The NDC is led by former 
President George Bush and brings together people in public, private and non-profit organizations dedicat¬ 
ed to eradicating cancer. 
DeVita 
Work of early cancer virologist celebrated at symposium 
The human papilloma virus (HPV) infects thousands of men and women each year. Symptoms seldom 
appear, but for women it remains a potential threat later in life. Under certain conditions, its presence can 
suggest a higher risk of cervical cancer. 
Because it serves as an example of a link between viruses and cancer, HPV was chosen as the topic of a 
symposium in December to honor Francesc Duran i Reynals, M.D., one of the first researchers to explore 
cancer’s viral origins. Duran i Reynals was a member of the Yale faculty from 1938 until his death from 
cancer in 1958. The Francesc Duran i Reynals Symposium, sponsored by the Yale Cancer Center, com¬ 
memorated the centenary of the physician’s birth in Barcelona in 1899. 
While still a medical student in Spain, Duran i Reynals joined 
the microbiology laboratory of renowned researcher Ramon Turro. 
In 1925, Duran i Reynals became the first Spanish scientist to cul¬ 
ture bacterial viruses. He became convinced that viruses could 
cause cancer and secured a fellowship at Rockefeller University 
to pursue his research. His work there and in New Haven shaped 
the study of tumor biology. 
Speakers at the symposium included Jose Costa, M.D., 
professor and vice chair of pathology; Josep M. Borras, M.D., 
director of the Catalan Institute of Oncology; Xavier Bosch, 
M.D., chief of epidemiology service at the Catalan Institute of 
Oncology; Daniel DiMaio, M.D., professor and vice chair of 
genetics; and Carlos Cordon-Cardo, M.D., director of the 
Division of Molecular Pathology at Memorial Sloan-Kettering 
Cancer Center. Dean David A. Kessler offered closing remarks 
for the symposium, which was attended by members and 
friends of the Duran i Reynals family. 
Maria Luisa Duran i Reynals attend¬ 
ed the symposium honoring her late 
husband.The locket, engraved with 
the date of the event, was a gift 
from the Cancer Center. 
Office of Health Care 
Access. William H. Sledge, 
M.D., assistant chief of 
psychiatry at the hospital, 
will be medical director of 
the new facility, which 
will be known as the Yale- 
New Haven Psychiatric 
Hospital and will occupy 
the same Frank Gehry- 
designed building on the 
corner of Cedar Street 
and Congress Avenue. 
Sledge said three factors 
led to the decision to 
close YPI. Yale-New Haven 
Hospital has more access 
to patients through its 
medical services and can 
participate in federal pro¬ 
grams such as Medicare 
and Medicaid more fully 
than a free-standing psy¬ 
chiatric hospital. "The 
other part of it is that it is 
very inefficient to have 
two psychiatric services 
operating side by side 
and duplicating a lot of 
the overhead and other 
support services,” Sledge 
said. And, he added, a 
free-standing psychiatric 
institute lacks the negoti¬ 
ating clout of a hospital 
that’s part of a larger 
health care system. 
A SPINOFF 
FROM THE LAB 
The Office of Cooperative 
Research has struck a 
deal with a Science Park 
biotech firm to distribute 
new reagents created 
during the course of Uni¬ 
versity research. Recombi¬ 
nant Technologies, found¬ 
ed by associate research 
scientist Pazhani Sun- 
daram, Ph.D., of the 
School of Public Health, 
will work with the Uni¬ 
versity to identify com¬ 
mercially viable reagents 
and negotiate their distri¬ 
bution to researchers. 
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SCOPE ROUNDS 
Malaria, trans¬ 
mitted by mos¬ 
quitoes but 
rarely seen in 
the developed 
world, kills 1.5 
million people 
each year in 
southern Asia, 
Africa and Latin 
America. The 
two cases 
reported in 
New Haven in 
late 1999 were 
contracted 
abroad. 
/ j,;. 
Malaria makes 
a comeback, 
even in the U.S. 
When two cases of malaria surfaced in New 
Haven late last year, they were of interest to 
clinicians not because of any epidemiological 
threat, but for the treatment problems they 
posed. Both cases were imported, rather than 
transmitted within North America. Both 
patients had contracted malaria during visits 
to West Africa to visit family. One was 24 
weeks pregnant and one was found to be 
HIV-positive. 
The clinicians treating the HIV-positive 
patient, according to Frank J. Bia, M.D., 
M.P.H., professor of medicine and laboratory 
medicine, speaking at grand rounds in January, 
were concerned about the interactions between 
HIV infection and malaria. In the case of the 
pregnant patient, noted Marissa Wilck, M.D., 
Winchester Fellow in Clinical Microbiology, 
clinicians were interested in the interaction of 
hemoglobinopathy and malaria. Ultrasound 
revealed the woman’s fetus to be healthy. 
A distant memory in the developed world, 
malaria is thriving in 91 countries (See cover 
story, page 16). In southern Asia, Africa and 
Latin America, malaria affects about 300 mil¬ 
lion people annually and kills as many as 1.5 
million each year, mostly children. Malaria has 
defeated eradication efforts, which were aban¬ 
doned 30 years ago in favor of control strate¬ 
gies. It has become resistant to synthetic cures 
such as chloroquine and, with increased ease 
of travel, threatens to reach places where it 
was thought to be done away with. It is not 
unusual to see imported cases at Yale-New 
Haven Hospital, Wilck said. New York City, 
with its large population of immigrants, 
Bia said, has reported cases of transmitted, as 
well as imported, malaria. 
Western medicine first found a remedy for 
malaria in the 17th century, when a Jesuit mis¬ 
sionary in Peru was cured with the bark of the 
cinchona tree. It was thereafter known as 
Jesuit’s bark or Peruvian bark. Its active ingre¬ 
dient was quinine. 
The pathogen’s portal into the body 
remained a mystery until 1898, when Ronald 
Ross, a British physician with the India Med¬ 
ical Service, identified the female Anopheles 
mosquito as a vector. Malaria is believed to 
be 30 million years old, and humans are not 
its only vertebrate target. Other primates, 
even birds, have their own forms of malaria 
infection. 
Ultrasound provides an 
alternative to amnio 
Yale scientists have devised a test for fetal ane¬ 
mia that eliminates the risks of invasive proce¬ 
dures such as amniocentesis or cordocentesis. 
The test uses Doppler ultrasound to measure 
fetal blood velocity in the cerebral circulation. 
Anemic fetuses have a higher blood flow veloc¬ 
ity in arteries and veins. “Invasive procedures 
place the fetus in unnecessary danger,” said 
Giancarlo Mari, M.D., associate professor of 
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obstetrics and gynecology and lead author of 
the study. “In more than 70 percent of cases, 
the fetuses tested were either non-anemic or 
mildly anemic, and an invasive procedure 
could have been either avoided or delayed.” 
The study was published in the Jan. 6 issue of 
The New England Journal ofMedicine. 
is it ever right to 
practice on the dying? 
Early in 1998 a student approached Lauris C. 
Kaldjian, M.D., HS ’91, with a question about 
something disturbing seen on the wards. The 
student, said Kaldjian, wondered if it was ethi¬ 
cal to use a dying patient to practice inserting 
a femoral-vein catheter, even though the pro¬ 
cedure offered no 
therapeutic value. 
“There was enough 
of a concern to do a 
proper study of the 
question,” said Kald¬ 
jian, a clinical 
instructor in medi¬ 
cine who co-directs a 
Kaldjian program on ethics for 
hospital residents and 
is pursuing a doctorate in ethics at Yale’s 
Department of Religious Studies. In the fall 
of 1998 Kaldjian surveyed 234 residents at 
three training programs encompassing five 
hospitals in Connecticut. “I was surprised that 
as many as a third of the respondents thought 
it was appropriate to use one patient for the 
sake of other patients,” he said. “The impor¬ 
tant thing to remember is that the people who 
believe this is OK are doing this for noble 
reasons. The question is, ‘Can one have good 
motivations and still be doing something 
that is inappropriate?’” 
In a paper published in the Dec. 30 issue of 
The New England Journal of Medicine, Kaldjian 
reported that 34 percent of respondents believe 
it is sometimes appropriate to insert femoral- 
vein catheters for practice during cardiopul¬ 
monary resuscitation, 26 percent had observed 
such insertions and 16 percent had attempted 
the procedure themselves. “We don’t see any 
reason to doubt that results would be different 
elsewhere,” Kaldjian said. 
The dilemma, he says, is to reconcile the 
needs of the patient with the larger need of 
society to have well-trained doctors. “I would 
argue that, as a clinician, my first responsibility 
is to the patient who is immediately in front 
of me. We cannot use one patient to serve 
other patients,” he said, noting that there are 
alternatives to this way of training. “You learn 
to do this procedure on people who have to 
have it done.” 
Breast-cancer genes 
factor into treatment 
Young women with breast cancer who carry 
either of two mutated genes may be at higher 
risk for a new cancer years after initial treat¬ 
ment, according to a study by Yale researchers. 
“Our findings reveal that if these women elect 
breast-conserving therapy—radiation and 
lumpectomy—there is possibly a greater risk 
of developing a second tumor in the conserva¬ 
tively treated breast,” said Bruce G. Haffty, 
M.D., associate professor of therapeutic 
radiology. The genes, BRCAi and BRCA2, are 
passed from mother to daughter, and previous 
studies have shown that women who carry 
them have higher-than-normal rates of breast 
cancer. “Young age is often associated with 
BRCA abnormalities. If these women are 
predisposed to cancer, then trying to suppress 
it in some fashion would make sense,” Haffty 
said. The findings were published in the 
October issue of the Journal of Clinical 
Oncology. Haffty has begun a larger 
study, looking at up to 150 women aged 
42 or younger. 
BRCAI 
N-terminus NLS 
Transcriptional activation 
C-terminus 
BARD1 BRCA2 
BAP1 HDACl/2 
RHA 
CtIP 
Women who carry the BRCAi gene, 
shown above in a schematic repre¬ 
sentation, have higher-than-normal 
rates of breast cancer. 
DR. DOE DECISION 
IS REVERSED 
Connecticut’s Supreme 
Court has thrown out a 
$12.2 million award to a 
former hospital intern 
who was infected with 
HIV after an accidental 
needle prick. In dismiss¬ 
ing the damage award, 
the court also ordered a 
new trial in the case. The 
intern, known in court 
papers as Dr. Doe, sued 
the University and Yale- 
New Haven Hospital 
and claimed that the inci¬ 
dent was the result of 
inadequate training and 
supervision. She pricked 
herself in 1988 while 
inserting a line into a 
patient with AIDS. 
The state Supreme 
Court ruled that the origi¬ 
nal trial judge erred in 
ruling out the University’s 
claim of immunity under 
workers’ compensation 
laws. The judge also 
failed to instruct the jury 
that its verdict must be 
based on expert testimo¬ 
ny, the court ruled. 
BRING IN THE 
MARINE SPONGES 
§ A Yale chemistry profes- 
\ sor is looking at natural 
2 products from a Western 
E Pacific marine sponge as 
° a potential source of 
t chemotherapeutic 
i agents. David J. Austin, 
l Ph.D., has received a 
= three-year, $150,000 
“ grant from the Johnson 81 
° Johnson Focused Giving 
£ Program, which funds 
\ health care and medical 
research by academic sci¬ 
entists. Austin plans to 
use the grant to synthe¬ 
size palau’mine, a sponge 
found off the Palau 
Islands, and evaluate its 
biological effects. 
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Aspirin in com¬ 
bination with 
the blood-thin¬ 
ning agent 
Coumadin has 
been widely 
regarded as an 
effective meas¬ 
ure to prevent 
clotting in the 
coronary arter¬ 
ies after a heart 
attack. Yale 
investigators 
examined data 
from 5,000 cas¬ 
es over a six- 
year period and 
concluded that 
aspirin alone 
works just as 
well as the 
combination 
therapy. 
Aspirin, on its own, shown 
to reduce heart-attack risk 
An aspirin a day is as effective alone as with a 
powerful drug at preventing blood clotting in 
coronary vessels after a heart attack, Yale 
researchers have found. The six-year study of 
more than 5,000 subjects found no difference 
between heart-attack sufferers who used aspirin 
alone and those who used it in combination 
with the anti-clotting drug Coumadin. “There 
was no difference between the two groups in 
terms of total mortality, cardiovascular mortali¬ 
ty, non-fatal myocardial infarction and non- 
fatal stroke,” said Michael Ezekowitz, M.D., 
professor of medicine and cardiology. Aspirin 
is cheaper than Coumadin and does not 
require monitoring. The study was presented 
at the American Heart Association meeting in 
November. 
Antibody test is a reliable 
screen for ehrlichiosis 
A collaboration between scientists at Yale and 
the State of Connecticut has yielded a simpler 
and more reliable blood test to diagnose 
ehrlichiosis. The disease, carried by the same 
deer tick that spreads Lyme disease, causes flu¬ 
like symptoms such as headache, fever and 
muscle cramps. It is not known if it can cause 
any long-term health problems. Jacob IJdo, 
M.D., and Erol Fikrig, M.D., collaborated 
with Louis Magnarelli, Ph.D., vice director of 
the Connecticut Agricultural Experiment Sta¬ 
tion in New Haven, in developing a test that 
seeks out antibodies specific to ehrlichiosis. 
Their findings were published in the Novem¬ 
ber issue of the Journal of Clinical Microbiology. 
Much heralded medication 
for autism is ineffective 
A drug thought to work marvels on autistic 
children has no more effect than a placebo, 
according to a Yale psychiatrist. In an editorial 
commenting on a study published Dec. 9 in 
The New England Journal of Medicine which 
found secretin no more effective than a place¬ 
bo, Fred Volkmar, M.D., professor of child 
psychiatry, noted the considerable interest in 
the use of secretin, a hormone used to treat 
gastrointestinal problems, generated by the 
media. “There is no evidence that it works,” 
Volkmar said. “There is no reason to think 
that it would have worked in the first place.” 
Autism, which affects one child in 2,000, is a 
brain disorder that results in impaired or 
delayed social and communication skills. There 
is no known cure, but early educational and 
behavioral intervention can significantly facili¬ 
tate outcome. 
A new therapy 
for prostate cancer 
A new radioactive isotope, palladium-103, used 
for radiation implant therapy for early prostate 
cancer has proven as effective as an older and 
more common therapy, but with fewer long¬ 
term side effects, a Yale study has found. “The 
overall cure rates using palladium-103 or 
iodine-125 appear very similar,” said Richard 
Peschel, M.D., professor of therapeutic radiol¬ 
ogy. “However, the newer palladium-103 treat¬ 
ment was better than iodine-125 at preventing 
both moderate and severe long-term complica¬ 
tions.” Peschel tracked 150 patients over seven 
years for his study, which was published in the 
Oct. 29 issue of Radiation Oncology Investiga¬ 
tions. Peschel attributed the difference in side 
effects to the higher dose rate for palladium- 
103. Palladium doses are given over two 
months as opposed to six months for iodine. 
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SCOPE ON CAMPUS 
RAMOS-HORTA HASELTINE VERMA 
Human rights in East Timor 
Freedom for East Timor has come at a heavy price. When an 
overwhelming majority of East Timorese cast ballots for inde¬ 
pendence in August, retribution from their Indonesian con¬ 
querors was swift. A wave of violence left between 70 and 80 
percent of the country’s buildings in ashes and up to 10 percent 
of its 850,000 inhabitants missing or displaced. In November, 
resistance leader Jose Ramos-Horta stopped at Yale to speak 
at a conference on East Timor sponsored by the Yale-Griffin 
Center for Health and Human Rights and the Health and 
Human Rights Committee of the Department of Epidemiology 
and Public Health. He was once asked, he said, if the struggle 
for freedom was worth a single human life. “If the people of 
East Timor manage to build a society that is free of abuse, a 
country based on the rule of law, a country of genuine equali¬ 
ty,” said Ramos-Horta, co-winner of the 1996 Nobel Peace 
Prize, “if we are able to build a country where everyone has 
basic necessities, where everyone has access to education, health 
care and good nutrition, then maybe I will say it was worth it.” 
Is sex important? 
Getting women’s health issues on the national radar, Florence 
Haseltine, M.D., said during a visit to Yale in October, first 
meant taking sex out of the equation. “Ten years ago, two 
headlines related to women,” she quipped, “PMS leads to mur¬ 
der and the pill causes cancer.” Haseltine, a gynecologist and 
director of the Center for Population Research at the National 
Institute of Child Health and Human Development, said 
health institutions dominated by men and the largely male 
U.S. Congress were leery of anything related to sex. The key to 
bringing attention to women’s health issues resided in a simple 
statistic. Most medications for women are taken by women 
over 50. Researchers decided to eliminate from study women 
under 50, Haseltine said. “That got rid of sex,” she told mem¬ 
bers of the Yale-New Haven Hospital Auxiliary, which spon¬ 
sored her talk, “Is Sex Important?” “You don’t have kids, you 
don’t have abortions and you don’t have sex. That’s wrong, but 
it’s the reality in Washington.” 
HIV as a cure rather than a threat 
When Inder Verma, Ph.D., proposed HIV as a vector for 
gene therapy two years ago, the response was swift. “‘This guy 
must be nuts,’” Verma said, describing the initial reaction. 
‘“Why would he put HIV vectors into people?’” But Verma, a 
researcher at the Salk Institute for Biological Studies, saw that 
HIV could overcome problems inherent in other viral vectors 
because it can both elude the immune system and integrate 
into non-dividing cells such as those in the liver and brain. He 
has had some success with the HIV vector in animal models. In 
his talk in November sponsored by the Department of Molecu¬ 
lar Biophysics and Biochemistry, he said he has eliminated the 
proteins in HIV that make it pathogenic. “We believe it is as 
safe as we can make it in terms of its ability to cause disease.” 
Prions, mad cows and the Nobel Prize 
For Stanley B. Prusiner, M.D., vindication came in 1997 
when he won the Nobel Prize in Physiology or Medicine for 
his discovery of the potentially infectious proteins he called pri¬ 
ons. During the 20 years leading up to the honor, Prusiner was 
seen as a heretic for his view that “rogue” proteins could cause 
disease. “How is it that a protein can be infectious?” asked 
Prusiner, professor of neurology, virology and biochemistry at 
the University of California, San Francisco, during a visit to the 
medical school in November. The ubiquitous and normally 
harmless prions, Prusiner found, can take on an abnormal con¬ 
formation and set off a chain reaction of malformed cells that 
trigger diseases of the brain, such as scrapie in sheep, mad cow 
disease and Creutzfeldt-Jakob disease. Prusiner is now looking 
for compounds that will thwart prions’ pathogenesis. 
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SCOPE FINDINGS 
In yeast studies, 
a mutated DNA reveals 
location, function of genes 
Scientists in 
the Depart¬ 
ment of Phar¬ 
macology are 
the first to 
have recorded 
electrical activi¬ 
ty in mitochon¬ 
dria of living 
cells. BELOW: the 
pathway used 
to stimulate 
and record elec¬ 
trical activity in 
mitochondria. 
Yale researchers have discerned the functions 
of a third of the genes in the yeast genome, 
using a novel method of DNA insertion that 
can be applied to other organisms. The new 
tool will allow researchers not only to identify 
genes, said principal investigator Michael 
Snyder, Ph.D., but figure out what they do. 
“That is going to be the next big challenge,” 
he said. Snyder and his interdisciplinary 
team followed, using chemical markers, a 
mutated, bacterially derived strain of DNA 
as it interacted with yeast genes and proteins. 
They observed at what point in the yeast’s 
life cycle genes were expressed, where in the 
cell proteins were located and what disrup¬ 
tions the mutated DNA caused. Their results 
were published in the Nov. 25 issue of the 
journal Nature. 
Mitochondrial voltage 
and neural connections 
Mitochondria are not only the energy packs of 
each living cell, but also judge and jury, decid¬ 
ing whether cells live or die. Given that power, 
aberrant mitochondria have long been suspects 
in degenerative diseases such as Parkinson’s, in 
which cells die and crucial neural connections 
are lost. The strength of those connec¬ 
tions depends on electrical activity in 
the mitochondria—the higher the 
activity, the stronger the links. 
Now Yale researchers have 
become the first to record 
electrical activity in the 
mitochondria of living 
cells. 
By inserting microscop¬ 
ically thin glass pipettes 
into squid cells, which are 
large and easy to manipu¬ 
late, researcher Elizabeth A. 
Jonas, M.D., was able to stimu¬ 
late the nerve cells with electricity for one or 
two seconds. Mitochondria in those cells 
seemed to “remember” the stimulation for 30 
seconds or more. “Mitochondria have had less 
attention paid to them than they deserve,” 
said principal investigator Leonard Kaczmarek, 
Ph.D., professor of pharmacology. “We think 
they are very important in determining the 
strength of the connections.” The study was 
published in the journal Science on Nov. 12. 
A role for serotonin 
in long-term memory 
Yale scientists have discovered a new mecha¬ 
nism for strengthening synapses that store 
long-term memories. Applying the neurotrans¬ 
mitter serotonin to pre-synaptic and post- 
synaptic cells in the sea slug Aplysia strength¬ 
ened the synapse if both cells received the 
serotonin within 15 minutes of each other. 
Researchers had previously determined that 
serotonin, which is linked to aggression and 
depression in mammals, also would strengthen 
synapses when applied in sufficient quantities 
to pre-synaptic cells. In the more recent exper¬ 
iments, the researchers applied to both pre- 
synaptic and post-synaptic cells amounts of 
serotonin too small to induce long-term mem¬ 
ory when applied to one cell alone. “It’s a new 
way of signal processing within a cell that is 
different than what we had thought of before,” 
said neurobiologist Carolyn Sherff, Ph.D., a 
postdoctoral associate and co-author of the 
study with Thomas Carew, Ph.D., professor of 
psychology and molecular, cellular and devel¬ 
opmental biology. Their study was published 
Sept. 17 in the journal Science. 
At last, a close-up view of 
the transcription process 
In a discovery that offers insights into funda¬ 
mental cellular processes, Yale researchers have 
observed for the first time the transcription of 
genetic information from a DNA template to 
viral RNA. “In general,” says Thomas A. 
Steitz, Ph.D., professor of molecular bio¬ 
physics and biochemistry, “the initiation of 
transcription of DNA into RNA is one of the 
12 
Scrunch time: X-ray crystallography reveals new 
details of the transcription process. These images 
show the movement of an RNA template as it 
accumulates genetic information. 
most heavily regulated steps in cells. It is what 
makes one cell different from another.” 
Steitz called the initiation events, observed 
through X-ray crystallography, “scrunching.” 
The DNA, he said, coils like a rope inside the 
enzyme polymerase, accumulating in the 
enzyme’s active site as the first short 
RNA transcript is being synthesized. The 
findings were published in the journal 
Science on Dec. 17. 
Shedding light on 
Salmonella's Trojan Horse 
To invade and occupy a cell. Salmonella first 
deploys a Trojan horse, a protein called SopE 
that instructs the cell to internalize the bacteri¬ 
um. If left unchecked, however, this protein 
will destroy the host and deny the Salmonella a 
safe haven from which to replicate, penetrate 
deeper tissues and ward off attacks from the 
immune system. Researchers in Yale’s Section 
of Microbial Pathogenesis, who previously dis¬ 
covered a second Salmonella protein, SptP, 
have now discerned its function. SptP protects 
Salmonellas new home by reversing the 
destructive process started by SopE. “These 
findings bring us closer to understanding the 
complex mechanisms by which these bacteria 
cause disease and may lead to development of 
new therapeutic and prevention strategies,” 
said Jorge E. Galan, Ph.D., who heads the sec¬ 
tion. The findings were published Sept. 16 in 
the journal Nature. 
New role found for B Cells 
in gastrointestinal disease 
A team of Yale researchers has traced a path of 
cellular development that may lead to gastroin¬ 
testinal and other ailments, including 
Creutzfeldt-Jakob disease, which is related to 
mad cow disease. The trail starts with the B 
cell, once thought capable only of producing 
serum antibodies and activating T lympho¬ 
cytes. Now researchers have found that B cells 
are necessary for development of the M cell, 
an intermediary between the body and organ¬ 
isms in the gut. Only some of the M cell’s 
functions have been discerned. “M cells play a 
role in sensitizing the immune system to gas¬ 
trointestinal flora,” said Mark Shlomchik, 
M.D., Ph.D., associate professor of laboratory 
medicine and immunobiology, “but they are 
also a portal of entry since many pathogens 
seem to enter the body through M cells.” The 
work, done in collaboration with a team at 
Jackson Labs, was published in the Dec. 2 
issue of the journal Science. 
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DR. MEL’S DOCTORS 
Connecticut’s best-known 
meteorologist is donating 
the proceeds from his 
best-selling book, The 
Complete Idiot’s Guide to 
the Weather, to the Yale 
Cancer Center. Dr. Mel 
Goldstein was diagnosed 
three years ago with a 
rare cancer of the bone 
marrow and credits his 
care at the cancer center 
with keeping him alive 
since then. His treatment 
has included a combina¬ 
tion therapy using 
thalidomide, the com¬ 
pound that caused birth 
defects when used by 
pregnant women in the 
early 1960s, but which 
recently has shown prom¬ 
ise as a cancer drug. Pro¬ 
ceeds from the book will 
benefit the Dr. Mel Gold¬ 
stein Multiple Myeloma 
Research Fund. 
INFORMATICS 
INITIATIVE 
The Center for Medical 
Informatics plans to use a 
$1.5 million grant it was 
awarded last year to 
develop a computer sys¬ 
tem to analyze and com¬ 
pare tumor cells. The 
grant from the National 
Library of Medicine will 
allow researchers to test 
the Next Generation 
Internet using PathMas- 
ter, a software being 
developed at Yale to ana¬ 
lyze cell images. Lym¬ 
phoma and thyroid cells 
will be studied. As part of 
the project, the center 
will expand its database 
of malignant-cell images 
from 500 to 30,000 over 
the next three years, 
according to Director 
Perry L. Miller, M.D., Ph.D. 
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A tragedy’s medical aftermath 
Sorting through her late father’s papers, the daughter of Albert S. Atwood, M.D. ’45, found a letter written 
shortly after the Hartford circus fire of 1944, in which 168 people died. Atwood and five med school classmates 
dropped everything and drove to Hartford to tend to the hundreds of burn victims. When his letter surfaced, 
Atwood's classmates began exchanging reminiscences of the fire. 
By John Curtis 
July 6, 1944, a month after D-Day: More than 6,000 people sat 
under the Ringling Brothers Circus big top in Hartford, wait¬ 
ing for the Flying Wallendas to begin their trapeze act. Lions, 
tigers and leopards had just leapt into their cages. Almost no 
one noticed the tiny flame that crept up a side wall in a corner 
of the tent. A policeman described it as no bigger than a ciga¬ 
rette burn until it burst into flame. 
The fire raced up the sides and along the top of the tent. 
Burning patches of canvas fell on the screaming spectators, who 
rushed in all directions looking for a way out. Within minutes, 
the tent was gone and hundreds of people lay piled on the 
ground, some dead, others dying, hundreds severely burned. 
Word of the tragedy reached Louise H. Burr, M.D. ’45, at 
Nick’s Restaurant, a popular student eatery on Congress 
Avenue where dinner could be had for less than 50 cents. “Joe 
Stanton, a classmate, and I decided that with so many casual¬ 
ties there would no doubt be a great need for people trained to 
do blood counts, give plasma infusions, etc.,” Burr wrote to her 
family a few days later. 
“We hopped into a car, bringing our microscopes, blood¬ 
counting equipment and hematocrit tubes with us, and were 
off,” wrote Albert S. Atwood, M.D. ’45. The unsung hero of 
the adventure was Michael W. Lau, M.D. ’45, who had a Ford 
John Curtis is a staff writer for Yale Medicine. 
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convertible and, more important, coupons for 
rationed wartime gasoline. 
The students went first to Hartford Hospi¬ 
tal, where they were shocked to find 40 doc¬ 
tors and residents lounging on the grass out¬ 
side. Only a few patients had arrived and there 
was nothing for them to do, the doctors and 
residents told the students. They continued to 
the now-defunct Hartford Municipal Hospital. 
“We arrived there to confront total chaos,” 
wrote James D. Gardam, M.D. ’45. “Relatives, 
cops, spectators, newspeople, untreated 
patients waiting for assistance.” 
Two students were assigned to each of the 
three floors handling burn victims. Atwood 
went to the fifth floor with Stanton, where “it 
looked as if all bedlam had broken loose. 
Nurses and nurses’ aides were everywhere, as 
well as bewildered parents.” Hospital staff 
assigned the students to check vital signs and 
administer parenteral fluids where needed. “It 
sounded very easy but we were soon to find 
that it was anything but that,” Atwood wrote. 
Emergency-room doctors had applied pres¬ 
sure dressings to the burns, which blocked 
access to veins for injections and blood-pres¬ 
sure readings. “On only a few could we get 
blood pressures because practically all arms 
and legs were in plaster casts,” Burr wrote. 
“They had received the following treatment: 
morphine, tetanus shots, vaseline gauze with 
plaster casts (for pressure), plasma and, later, 
sulfa-diazine.” 
At 1 a.m. the medical students were reas¬ 
signed to assist staff members on the floors. 
They made rounds with the patients while 
hospital staff prescribed sulfa drugs and fluids. 
At 3:30 most of the hospital staff left, leaving 
the wards in the hands of the six students. “It 
was really amazing,” wrote Atwood, “for we 
couldn’t imagine anyone leaving their hospital 
floors in complete charge of strangers who said 
that they were medical students.” 
Not all hospital staff left. Nurses and aides 
stayed, as did a doctor in industrial medicine 
at Colt Firearms Company. A Navy corpsman 
home on furlough who was helping out said 
nothing he had seen on Guadalcanal affected 
him as much as the fire victims. 
opposite PACE: Within minutes of its eruption, the fire that engulfed 
the big top in Hartford on July 6,1944, laid open the tent’s framework 
and sent those who could run scurrying for safety. A photograph taken 
during the first few minutes shows the enclosure filling with smoke. 
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Fortunately for the medical students, shortly 
before the hospital staff retired, nine class¬ 
mates arrived to help. “We did blood counts, 
hematocrits, gave plasma and sulfa-diazine 
infusions, ordered oxygen tents, morphine and 
sponges,” Burr wrote. “It seemed as if most of 
our time was spent trying to get needles into 
tiny foot veins. Several of the children died 
during the night and that, of course, was 
heartbreaking.” 
Orangeade, coffee, sandwiches and donuts 
kept the students going. “About 4 a.m. I began 
to get my second wind,” Burr wrote. “By eight 
o’clock I was feeling fine except for blurry eyes 
and an occasional feeling that I wanted to cry 
on somebody’s shoulder.” 
The students left at 11 a.m. and took a 
detour to the scene of the fire before returning 
to New Haven. The fire’s final tally was 168 
dead, with hundreds more injured. For years 
the cause of the fire remained the subject of 
speculation—a carelessly tossed cigarette, an 
electrical short-circuit—until in 1950 a man 
admitted to setting the fire. He later recanted, 
however, saying his confession was coerced. At 
the time five circus managers were charged 
with manslaughter and sent to prison. Rin- 
gling devoted its profits for the next 10 years 
to paying off claims from victims’ families. 
“It was a tremendous experience,” Burr said 
during an interview 55 years later. “It made me 
feel good that we did it and were able to help. 
It made me glad that I decided to go into 
medicine.” 
Gardam said two distinct lessons came 
out of the experience. “Never give up 
veinous access," he said, “and have somebody 
in command.” 
Program ° Features 
PHOTOS•STORIES•COMICS 
TWENTY FIVE CENTS EDIT 
above: A program and ticket stub from 
the July 6 performance. 
below: Within hours, news of the dis¬ 
aster had reached New Haven and 
prompted six Yale medical students 
(including Louise Burr, inset) to hop in 
a car and try to help the injured and 
dying. A nurse in one of Hartford’s 
hospitals cared for a bandaged young 
patient, one of the less severely injured. 
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PUBLIC HEALTH 
BY BREAKING DOWN THE COMPLEX CYCLE THAT 
ALLOWS MOSOUITOES, TSETSE FLIES, TICKS AND 
OTHER ARTHROPODS TO TRANSMIT FATAL DISEASE, 
YALE SCIENTISTS ARE PROVIDING NEW AMMUNITION 
IN THE FIGHT AGAINST MALARIA AND OTHER VECTOR- 
BORNE illnesses. By Cathy Shufro 
To the vector go the spoils 
mer, West Nile encephalitis would kill not 
only the zoo’s birds and thousands of crows, 
but humans as well. Six New Yorkers and a 
Canadian tourist were dead, and 52 others had 
fallen ill. 
The sudden appearance of West Nile in 
New York is yet another indication that the 
battle against infectious disease is far from 
over, says Durland Fish, Ph.D., an associate 
professor of epidemiology who has been a fre¬ 
quent commentator on the West Nile out¬ 
break. A generation ago, as medicine marveled 
at the dramatic successes of antibiotics and the 
first effective vaccines, it seemed that commu¬ 
nicable disease was on the way out. But in the 
last decade, the emergence of new maladies in 
the industrialized world, along with new 
strains of bacteria resistant to antibiotics, has 
changed that picture. 
Many of the emerging diseases are vector- 
borne, which is to say that they rely on a com¬ 
plex cycle of transmission enabled by interme¬ 
diaries. These “vectors” include mosquitoes 
(which carry the West Nile virus and the pro¬ 
tozoan responsible for malaria), sand flies, ticks 
and other arthropods. Vector-borne illnesses 
from Lyme disease to African sleeping sickness 
have been on the rise around the globe and 
resurgent in places where they had once been 
controlled. 
“The wealthiest people in the world, living 
near New York City, and amongst the poorest 
ABOVE: Irene 
Kasumba, left, 
and Leyla 
Akman hold 
cages for rear¬ 
ing tsetse flies 
in the newly 
constructed 
insectary at the 
School of Public 
Health. The 
$700,000, 
state-of-the-art 
containment 
facility also 
holds the only 
colony of tsetse 
flies in North 
America. 
opposite page: 
A helicopter 
sprays for mos¬ 
quitoes in New 
York City last 
September dur¬ 
ing the height 
of concern over 
West Nile virus 
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Boxes of dead 
crows piled up 
on the door¬ 
step of state 
wildlife pathol¬ 
ogist Ward 
Stone, above, 
as veterinarians 
from around 
the New York 
City region 
shipped them 
to his lab in 
Delmar, N.Y., 
for analysis 
last fall. 
people in the world, living in rural communi¬ 
ties in sub-Saharan Africa, all have to deal with 
vector-borne disease,” says Scott L. O’Neill, 
Ph.D., associate professor and head of the vec¬ 
tor biology section at the School of Public 
Health. It’s a universal problem.” 
Vector-borne diseases are re-emerging, not 
only because insects have developed resistance 
to pesticides, and pathogens to medication, 
but also because war, human migration, pover¬ 
ty and complacency have undermined many of 
the disease-control strategies that were once 
effective. In addition, diseases are spreading to 
new places through international trade, travel 
and refugee resettlement. Patterns of disease 
may also be altering because of global warm¬ 
ing, deforestation and even reforestation (as in 
New England, where the growth of new forest 
brings deer hosts for the tick responsible for 
Lyme disease into close contact with people). 
The human cost of West Nile is dwarfed by 
the devastation caused by other vector-borne 
diseases, major killers. Malaria sickens 300 to 
500 million people each year, according to the 
World Health Organization, and kills an esti¬ 
mated 2 million people annually—roughly the 
population of metropolitan Denver. Half of 
those who die are children. Other serious dis¬ 
eases, including yellow fever and dengue, are 
transmitted by mosquitoes. Tsetse flies spread 
fatal African sleeping sickness, and sand flies 
carry the protozoan responsible for two forms 
of leishmaniasis; the less deadly form, causing 
disfiguring skin infections, was contracted by 
some Gulf War veterans. A triatomid com¬ 
monly called the “kissing bug” transmits the 
pathogen for Chagas’ disease, which can lead 
to encephalitis and heart disorders. Ticks carry 
not only the Lyme disease spirochete (which 
causes chronic neurological and joint problems 
in some patients), but also pathogens for two 
diseases newly discovered in the northeastern 
U.S., ehrlichiosis and babesiosis. 
To counter these threats, vector biologists 
at Yale are developing novel strategies, draw¬ 
ing on fundamental new information about 
the genetic and molecular bases of these dis¬ 
ease-transmission systems. It’s a strategy that 
looks at disease from many angles and incor¬ 
porates entomology, molecular biology, field 
ecology, parasitology, population genetics 
and taxonomy. 
Research into vector-borne disease calls for 
this broad approach because it requires a mul¬ 
tidisciplinary understanding of how vector and 
pathogen interact with each other as well as 
the environment. That is because vectors trans¬ 
mit disease biologically rather than mechani¬ 
cally. As O’Neill explains it, “Vectors do not 
act as simple syringes injecting pathogens from 
one human to another the way a hypodermic 
needle might pass on AIDS or hepatitis.” 
Instead, they are the vital biological links that 
allow the pathogens to spread. Bacteria and 
viruses proliferate within the shelter of the vec¬ 
tor’s body. Protozoa use the vector as a nursery 
where they multiply by completing a multi¬ 
stage life cycle. For example, the life cycle of 
the Plasmodium protozoan that causes malaria 
begins in the mosquito’s stomach, where the 
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protozoa multiply, and culminates in the mos¬ 
quito’s salivary gland. From there, Plasmodium 
parasites are passed on to a new host through 
the mosquito’s bite. In the human, these 
malaria pathogens then invade the liver, caus¬ 
ing spleen enlargement, kidney disease or 
malignancy. 
In recent years there has been a growing 
awareness of the importance of the vector- 
pathogen interaction. Yale investigators are 
looking for vulnerable points in the insect at 
which the chain of disease transmission can be 
interrupted. They are looking for ways to 
make the vector unfriendly to the disease 
pathogen or, alternatively, to prevent the 
pathogen from maturing or multiplying within 
the vector. One strategy is to make use of sym¬ 
biotic bacteria that normally live in a mosquito 
or fly. The aim is to use the bacteria to “hitch¬ 
hike” in new genes that interfere with a disease 
pathogen’s ability to multiply or to complete 
its life cycle within the vector. If it can’t mature 
or multiply within a vector, the pathogen can¬ 
not infect a new host. 
Although vector-borne diseases have plagued 
humans throughout history and, indeed, 
affected the fate of civilizations, the notion 
that they were spread by insects did not even 
arise until a century ago. The discoveries by 
Ronald Ross and Giovanni Battista Grassi in 
the late 1890s that malaria was transmitted by 
Anopheles mosquitoes, rather than “mal air," 
revolutionized epidemiology. Since then, how¬ 
ever, the complexity of the interplay between 
vector and pathogen has hindered researchers 
seeking to block disease transmission. Humans 
fighting vector-borne diseases still do pretty 
much what they have been doing for genera¬ 
tions: attempt to kill the vector. Spraying 
DDT on mosquitoes in the Solomon Islands, 
spraying deltamethrin on tsetse flies in Zaire or 
spraying malathion on mosquitoes in Queens 
are all based on the same strategy. 
“You don’t have to know much about dis¬ 
ease-transmission mechanisms to do that,” says 
O’Neill. The good news, he says, is that “we 
are at a turning point. We’re understanding on 
a more fundamental level how these organisms 
interact. This information will open up new 
approaches to disease control.” 
Associate Professor Serap Aksoy, Ph.D., pro¬ 
vides a dramatic picture of how the pace of 
research has accelerated since 1982, when she 
wrote her doctoral thesis. Her research, which 
looked at a single gene in an E. coli bacterium, 
took her three years to complete. Today it 
would require a week. “I wouldn’t even give 
it as a project to an undergraduate in my lab. 
It would be too easy,” says Aksoy, a medical 
entomologist. “If somebody told me 20 
years ago what I’d be doing now—trying to 
change the genome of an insect so it doesn’t 
transmit parasites—I’d have told them it was 
science fiction.” 
The new insectary at Yale is central to the 
work of the vector biology group. The year- 
old, $700,000 facility at the School of Public 
Health provides a controlled environment for 
the insect colonies maintained by the five prin¬ 
cipal investigators (who have come to Yale 
from four continents) and the 35 postdoctoral 
fellows, lab assistants and students who com¬ 
pose the vector biology group. Each chamber 
of the insectary is entered through a heavy, 
locked door and a thick screen zipped in place 
to contain the insects. Scientists entering and 
leaving the anteroom of the locked facility 
walk under a powerful fan designed to blow 
off any clinging insects. 
The four-chamber, 1,200-square-foot con¬ 
tainment laboratory is tightly monitored to 
maintain correct temperature and humidity; its 
lighting simulates the diurnal cycle. The 
insects here are mostly laboratory colonies 
whose ancestors were collected in Kenya, Mali, 
Thailand and India, now living in small mesh 
cages. The colonies in residence recently 
included two species of mosquitoes that can 
serve as malaria vectors; tsetse flies, which can 
carry the pathogen for African sleeping sick¬ 
ness; mosquitoes trapped at the Bronx Zoo to 
be tested for the West Nile virus; and fruit flies 
and moths that serve as experimental models. 
(Ticks, which are arthropods but not insects, 
live down the hall.) As a rule, the insects here 
are not carriers of disease, although the labora¬ 
tory does have a separate chamber and a high¬ 
er-level safety protocol for carriers, if needed. 
In one of the humid insectary chambers on 
a recent morning, white-coated research associ¬ 
ate Irene Kasumba, M.Sc., monitored a mating 
cage for Glossina palpalis palpalis, or tsetse flies. 
She pointed out two plump fly couples mating 
in the little mesh enclosure, members of the 
only colony of tsetse flies in North America 
and one of only a handful of lab colonies in 
the world. In the tray below them were a num¬ 
ber of small, black pupae, the size and shape of 
apple seeds. Kasumba moved them to closed, 
aerated dishes, where they would remain until 
“We are at a turning point,” says Scott 
O’Neill, head of the vector biology section. 
“We’re understanding on a more funda¬ 
mental level how these organisms 
(vector and pathogen) interact. This infor¬ 
mation will open up new approaches to 
disease control.” 
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emerging a month later. In the adjacent cham¬ 
ber housing mosquitoes, larvae and pupae 
wriggled in pans of water. Mosquito pupae 
ready to emerge as winged adults had graduat¬ 
ed to little bowls of water within mesh cages. 
O’Neill tells the story of a fellow graduate 
student back in Australia who coddled her 
mosquitoes by feeding them the very best 
blood: her own. Since some mosquitoes feed at 
night and are adapted to thrive on human 
blood, she would take the mosquitoes home, 
strap little mesh boxes on her arms and let 
them bite her while she slept. At Yale, 
researchers depend on hamster collaborators to 
supply the blood. The hamsters lie supine, 
anesthetized, on mesh hammocks on top of 
the insect cages, providing meals to the insects 
Hying around below. 
Other insects are stored in freezers upstairs. 
Research Scientist Leonard E. Munstermann, 
Ph.D., keeps frozen (and sometimes live) sand 
flies, the vector for the Leishmania protozoan. 
Associate Professor Fish has frozen 500 more 
Bronx Zoo mosquitoes that he is screening for 
West Nile infection. Knowing the prevalence 
of West Nile in last summer’s mosquitoes will 
give public health officials some idea of what 
to expect this summer. In May, Fish, Munster¬ 
mann and a group of public health students 
will collect more mosquitoes at the zoo, identi¬ 
fying the species and testing them for West 
Nile virus. 
“We ll know pretty early whether the virus is 
going to re-emerge or not,” says Fish. “Were 
going to have a very tight surveillance program 
there.” If the virus does reappear, Fish recom¬ 
mends “source control,” using fish, bacteria or 
insecticide to kill mosquito larvae in places like 
storm drains and catch basins. He has been 
vocal in urging lawmakers to pay attention to 
the dangers posed by mosquitoes, attending 
legislative hearings and appearing on television 
news programs. 
Vector biologists acknowledge that eradicat¬ 
ing vector-borne diseases may prove impossi¬ 
ble. Each time human beings make a new 
attempt to defeat them, vectors and pathogens 
contrive to survive the assault. “I think you 
can expect them to adapt to most things,” says 
O’Neill. “Evolution’s a pretty powerful thing. 
When you’re faced with extinction, it’s amaz¬ 
ing how quickly a population will respond or 
change for survival. It’s a continual arms race 
with biological organisms.” YM 
TAKING AIM AT MOSQUITOES, 
AT THE LEVEL OF MOLECULES 
Vector biologists at the 
School of Public Health are 
developing new approaches to 
disease control by studying 
the interaction between 
arthropod vectors and the dis¬ 
ease pathogens that live with¬ 
in them. This work is vital, 
says Assistant Professor Liang- 
biao Zheng, Ph.D., because 
“many vector-borne diseases 
are coming back with a 
vengeance in parts of the 
world.” Diseases are not only 
re-emerging but spreading 
to new places, as with 
the West Nile virus 
discovered in 
New York City 
last summer. # 
Associate Pro¬ 
fessor Serap 
Aksoy, Ph.D., 
specializes in 
research on the tsetse 
fly, which carries the pro¬ 
tozoan that causes trypanoso¬ 
miasis, also known as African 
sleeping sickness. 
Largely under con¬ 
trol in the 1960s, 
trypanosomiasis 
is resurgent in 
central and East 
Africa, resulting 
in the worst epi¬ 
demic of the cen¬ 
tury, according to 
Aksoy. Infection is fatal 
to farm animals; in humans, 
it causes intermittent comas 
and kills its victims if left 
untreated. 
Aksoy is investigating how 
a naturally occurring bacteri¬ 
um that lives in the tsetse fly 
can be altered genetically to 
make the fly inhospitable to 
the protozoan that causes 
sleeping sickness. She and her 
lab team have managed to 
introduce genes into the sym¬ 
biotic bacteria and to place 
the bacteria into the flies. 
They are still working on 
finding genes whose expres¬ 
sion will block the parasite. 
Aksoy hopes that eventually 
“engineered” flies that resist 
the protozoan causing 
sleeping sickness 
can replace nat¬ 
ural popula¬ 
tions in the 
field, thus 
stemming 
the spread of 
illness. 
Associate 
Professor Scott L. 
O’Neill, Ph.D., head of 
the vector biology section, is 
hoping to interfere with 
disease transmission 
by using a bac¬ 
terial parasite 
found natu¬ 
rally in 
about one 
out of five 
insect species. 
The parasite, 
called Wolbachia, 
is able to actively 
invade field insect populations 
by manipulating the insects’ 
reproduction so as to favor its 
own vertical transmission. 
This ability, together with 
Wolbachias widespread distri¬ 
bution and ability to be intro¬ 
duced into new species in the 
laboratory, make it a very 
(continues on page 22) 
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above: A pre¬ 
cisely detailed 
view of a mos¬ 
quito anid its 
mouth parts 
as captured by 
a scanning 
electron micro¬ 
scope. 
OPPOSITE PACE: 
The Woibachia 
bacterium, bot¬ 
tom. shows 
promise as a 
candidate for 
genetic manip¬ 
ulation of a 
variety of 
pathogens, 
including Plas¬ 
modium, top, 
the protozoan 
responsible for 
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attractive tool to manipulate 
the genetics of a wide spec¬ 
trum of insect-disease vectors. 
O’Neill is proposing to use 
Wolbachia in two different 
ways. The first is to harness 
Wolbachia as a vehicle to 
express foreign genes within 
mosquitoes. These genes 
Principal inves¬ 
tigators in the 
vector biology 
section are, 
from left in top 
photo, Leonard 
Munstermann, 
Serap Aksoy, 
Durland Fish, 
Scott O'Neill 
and, with 
pipette above, 
Liangbiao 
Zheng. 
could then be introduced into 
populations of mosquitoes, 
using Wolbachia’s natural 
spreading ability. The genes 
of interest to be expressed by 
Wolbachia would be those that 
could prevent human patho¬ 
gens from being successfully 
transmitted by the vector— 
for example, single-chain anti¬ 
bodies that target the malaria 
parasite within the mosquito 
and prevent it from invading 
the insect’s salivary glands. 
Another, simpler strategy is 
to utilize virulent strains of 
Wolbachia to shorten the 
insect’s adult life. This 
approach exploits the fact that 
pathogens typically need a 
lengthy period to develop in 
the body of the insect before 
they can be transmitted to 
another human. (In any given 
mosquito population, only a 
small fraction, the oldest 
insects, is responsible for the 
majority of disease transmis¬ 
sion. Since these older insects 
contribute little to reproduc¬ 
tion, the mosquito population 
remains intact, but the 
pathogen is eliminated.) The 
O’Neill lab is currently evalu¬ 
ating the age-shortening strat¬ 
egy in tsetse flies and Aedes 
mosquitoes that transmit the 
dengue virus. They hope to 
extend this work to malaria 
vectors in the near future. 
Some Anopheles mosquitoes 
naturally resist the malaria 
protozoan. Zheng is explor¬ 
ing the genetic and molecular 
basis for the immune response 
that allows some mosquitoes 
to avoid infection. His 
group is zeroing in on the 
locus for the gene that deter¬ 
mines susceptibility. Could 
Anopheles mosquitoes be 
bred with immunity to the 
malaria protozoan? 
Associate Professor Durland 
Fish, Ph.D., in addition to his 
work on West Nile, has spent 
the past decade staking out 
the territory of the tiny deer 
tick that carries Lyme disease. 
Among the tools at his dispos¬ 
al is remote sensing data pro¬ 
vided by NASA, allowing Fish 
to use satellite images and 
other records to predict where 
the risk of tick-borne disease 
will be highest. This informa¬ 
tion is useful in planning pre¬ 
vention strategies, including 
use of the Yale-developed 
Lyme disease vaccine that 
became available last year. 
Research Scientist Leonard 
E. Munstermann, Ph.D., is 
doing basic research on sand 
flies, the vector for protozoa 
causing the two forms of 
leishmaniasis. One form caus¬ 
es disfiguring sores on the 
skin; the other leads to fatal 
disruptions ol liver and spleen 
function. Leishmaniasis causes 
between 1.5 million and 2 mil¬ 
lion new illnesses annually, 
according to the World 
Health Organization. The 
fatal form is epidemic in east¬ 
ern Brazil. (Ironically, when 
insecticide programs against 
malaria mosquitoes are termi¬ 
nated, it is the sand fly popu¬ 
lation that can surge to pro¬ 
duce the prevalent disease 
problem.) 
A population geneticist, 
Munstermann is interested in 
whether genetically distinct 
sand fly populations should be 
reclassified as subspecies, some 
of which carry the protozoan, 
some of which don’t. This 
would have implications for 
vector control; there is no 
need to kill subspecies that 
don’t carry disease. He turned 
an informal population study 
of his own into an exhibit at 
Yale’s Peabody Museum. 
There he has displayed over 
200 insects, from mayflies to 
butterflies, trapped in his sub¬ 
urban back yard. 
Munstermann is inspired 
not only by the possibility 
that he could help find a way 
to control the spread of leish¬ 
maniasis, but also by what 
the flies can tell us about all 
living organisms. “I’m inter¬ 
ested in how things work. 
Here are flies no one has ever 
looked at. They’re important 
to humans. What are they 
made of?” 
He is drawn to his work in 
part because understanding 
how genes interact in tiny par¬ 
asites and insects can provide 
information about human 
beings as well. As he says: 
“DNA is DNA. We’re just a 
more complex glop of DNA 
attempting to understand how 
less complex glops of DNA 
interact.” 
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Vector-borne 
illnesses such as 
malaria, Lyme dis¬ 
ease and West Nile 
encephalitis rely 
upon secondary 
organisms such as 
mosquitoes, ticks or 
tsetse flies to carry 
the pathogen from 
host to host. In 
nearly all cases, the 
vector plays an 
essential part in the 
infectious agent’s 
life cycle, in addi¬ 
tion to being a con¬ 
venient means of 
transportation. 
VECTOR + PATHOGEN DISEASE 
Malaria 
West Nile encephalitis 
Dengue and dengue hemorrhagic fever 
Yellow fever 
+ Plasmodium spp. 
+ West Nile virus 
+ Dengue virus 
+ Yellow fever virus 
African sleeping sickness TSETSE FLY + Trypanosoma spp 
Leishmaniasis SANDFLY + Leishmania spp. 
Chagas’ disease KISSING BUG + Trypanosoma cruzi 
+ Borrelia burgdorferi 
+ Ehrlichia spp. 
Lyme disease 
Ehrlichiosis 
Common vector-borne diseases 
On the rise throughout 
the world, malaria is _ 
commonplace in Africa, Asia, 
the Middle East and Latin 
America. More than 300 million 
new infections occur each year, 
resulting in 2 million deaths 
annually. Vector: Anopheles species 
of mosquito, especially Anopheles 
gambiae. 
Surveillance is poor; roughly 300,000 new cases 
are estimated each year. Occurs in tropical Africa 
and at epidemic rates in portions of East Africa. 
Vector: tsetse fly. 
Currently 500,000 people are hospitalized world¬ 
wide. Approximately 24,000 deaths each year. 
Prevalent in Africa, India, Southeast Asia, Latin 
America and Australia. Vector: Aedes species of 
mosquito, especially Aedes aegypti. 
Two million new cases reported each year. Twelve 
million infected now. Occurs in 88 countries, chiefly 
in South America, the Middle East (Gulf War 
veterans returned home with the disease) and 
India. Vector: sand fly. 
Occurs only in Western Hemisphere. Widespread in 
Central and South America, where more than 16 
million people are believed to be infected and 100 
million are at risk. Vector: Various species of triato- 
mid insects, also known as kissing bugs. 

Herbert S. Chase Jr., M.D., believes in bringing medicine to 
what he calls “the edge,” the constantly expanding outer limit 
of medical knowledge or “the most detailed explanation [of a 
given topic] that we have right now.” It is to the edge that 
doctors must now turn in treating their patients, says the new 
deputy dean for education. And as the edge of knowledge 
advances with each new discovery, medical students must 
learn how to find and evaluate it. 
It was "the edge"that brought Chase to Yale. Last April he 
came to the Cushing/Whitney Library to talk about the 
Internet as a research tool in medicine. In the audience were at 
least two members of the search committee for the deputy 
dean's position. At the time Chase had no plans to leave 
Columbia University College of Physicians and Surgeons, where 
he has spent 22 “absolutely fabulous years” and received high 
honors for his teaching, including the university's Presidential 
Teaching Award. The lure of spreading his vision for education 
across a broader canvas proved too great to resist, however. On 
July 1, he will formally begin his Yale duties. Until then Chase 
plans to visit New Haven once a week to meet with faculty and 
students. Chase will continue to live in New York City, where his 
wife is a lawyer and one of his sons is still in high school. He 
has another son in college. 
Medical education, Chase says, has become all consuming. 
He used to dabble in photography and play classical guitar, 
bassoon and clarinet. He still goes to the opera but has little 
time for activities outside his work and family. 
Staff Writer John Curtis visited Chase at Columbia recently. 
An edited transcript of their conversation follows. 
What are the challenges facing medical 
education, around the country and at Yale? 
The problem with medical school in general is 
that there is a language of between 15,000 and 
20,000 new words that must be learned by 
students before they can converse with their 
colleagues about patients. Because of the time 
pressure to learn that language during the first 
two years of medical studies, it’s hard to weave 
a meaningful clinical experience early on. But 
clinical studies can be put into those first two 
years. And after that there is no reason we 
can’t have a more fluid integration between 
clinical and basic science during the third and 
fourth years. 
One of the challenges of medical education 
is teaching the content at the right time. We 
have a pretty good view of what we need to 
teach. The problem is finding the right spot. 
We often teach genetics concepts in the first 
year, which is appropriate. Then we teach 
abnormal genetic makeup in the second year, 
and that is more suitable to the third and 
fourth year. A good deal of the basic science 
would be much more interesting to the stu¬ 
dent in the third or fourth year. 
Most medical schools are behind electroni¬ 
cally. Say you’re a patient and I’m your doctor. 
I have core knowledge, which allows me to 
figure out what you’ve got. It also allows me to 
find information in the library. Now my role 
is not to look into my brain and see what’s up 
there. That’s ludicrous. That’s likely to reveal 
old information. I go to electronic search 
engines right here at my fingertips. Finding 
the edge is a skill. Assessing the edge is a skill. 
Medical students must be provided adequate 
computing facilities. The curriculum must 
demand that they use computers. >>> 
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At Columbia, you directed interdisciplinary 
basic science courses for first-year students. 
Do you plan to encourage similar courses 
at Yale? 
It’s definitely on the table at many places. The 
basic principle—that basic science activities 
are confined to the first couple of years and 
clinical activities are confined to the third and 
fourth years—all emanated from the Flexner 
Report [of 1910]. I think that paradigm is no 
longer valid. There’s nothing preventing us 
from having a much more fluid curriculum, 
where we have basic science and clinical sci¬ 
ence interwoven throughout the four years. 
For a long time, the national boards were 
given in June of the second year. There was no 
compelling reason to have the students start 
the clinical years in March, April or May 
because their minds would not be on the task. 
That’s all changed. You can hook up online 
and make a date to take the boards in January. 
That alone, as absurd as it may sound, may be 
the linchpin of the whole reorganization 
nationwide in terms of fully integrating med¬ 
ical education—starting the clerkships earlier, 
starting the clinical material earlier and then 
bringing basic science into the clinical years. 
There’s nothing preventing 
us from having a much more 
fluid curriculum, where 
we have basic science and 
clinical science interwoven 
throughout the four years.” 
Traditionally, departments have determined 
course content. How do you secure depart¬ 
mental cooperation in integrating courses? 
Departments have a legitimate stake in the 
pedagogical process in terms of imprinting 
their vision of biology on the student. That is 
a very powerful vision. It should not be lost. 
An integrated course does not minimize that 
vision. In fact, it strengthens that vision. The 
individual disciplines maintain their identity 
by providing an essential piece to the mosaic 
which creates a vision of the patient as a 
whole entity. Departmental identity is also 
established and reinforced in problem-solving 
sessions that are central to an integrated pres¬ 
entation of human biology. 
The departments also play a critical role in 
helping the student develop medical decision¬ 
making skills. Why do we teach basic science? 
We obviously teach basic science so we know 
the molecules of the body and how they work. 
But there’s a much more important lesson 
from basic science, one that is long-lasting. 
We teach basic science so that the student 
learns the scientific method and how to apply 
the scientific method at the bedside. Yale has a 
leg up on everyone because it has the thesis. 
This, in spades, gets the student up to speed 
in terms of analyzing and assessing data. 
We need to divide the curriculum into two 
equally important units. One is content. You 
cannot proceed in medicine without a core of 
knowledge. A second, equally important goal 
is to provide process, to find ways for the stu¬ 
dent to master the scientific method. 
How can technology help us gain access to 
the latest knowledge derived from advances 
in research at the molecular level and the 
mapping of the human genome? 
We will reach a state where we will know 
every molecule in the human body. It is likely 
that we will know from a drop of blood that 
a patient has 14 of 19 genes for high blood 
pressure and we have 172 drugs that will inter¬ 
act with that. Only a computer will be able to 
organize this information. This, of course, 
poses a difficult challenge. The physician must 
be skilled at complex decision-making. The 
doctor’s role will now be one of judgment, 
where we look up the information on the 
patient, who is alive and breathing next to us, 
and we make an appropriate decision. 
Technology is creating the need for a rigorous 
medical decision-making curriculum. That 
does not exist in any medical school curricu¬ 
lum and Yale can lead this effort. 
How do you educate physicians to become 
more than technicians, and how do you 
ensure that they treat the patient, not just 
the disease? 
The medical school curriculum in general— 
and this is true nationwide—is one of decon¬ 
struction. The patient comes in and we look 
at the biochemistry, we look at molecules, we 
look at the organs. We have little pieces of the 
patient that we pull apart so we can study 
them. Then a process of reconstruction has to 
occur. That is what I think is lacking in med¬ 
ical schools. 
Graduates leave medical school feeling com¬ 
fortable with part of the patient rather than 
the whole patient. If you come to me with 
heart disease, am I more likely to give you a 
medicine than send you for an operation 
because I am an internist? If you go to a sur¬ 
geon are you more likely to be operated on 
than receive medicine? Activities that focus on 
the whole patient need to be built into the 
curriculum. Yale has this fantastic new elective 
called “Women’s Health.” It’s very successful. 
The focus is on the person. Yale could devise a 
number of short, meaningful whole-patient 
views of medicine. 
Integration of the basic sciences reinforces 
the whole-patient view as well. If one studies 
only the physiology of the system or the cell 
biology of the system, we are deconstructing. 
We could reconstruct these disciplines into a 
functional view of the whole patient as we 
rotate through the body. 
How can you instill in the faculty the notion 
that teaching, as well as clinical or research 
excellence, is a path to recognition and 
advancement? 
Teaching needs to be rewarded. There has to 
be daily recognition from the University that 
you are doing a great job. Those of us who 
are deeply committed do it for the satisfaction 
we get. At our level of teaching, yes, it is 
very important to serve as a role model to 
excite the students about what we do. That 
is the real skill of the charismatic teacher. 
Nevertheless, the University must recognize 
and encourage outstanding teaching. 
We need to define the career path for teach¬ 
ers. Who will lead the educational programs 
when we all retire? Faculty development of 
great educators is as important as the develop¬ 
ment of great scientists and clinicians. Yale has 
created a clinician-educator track and that is a 
major step forward. This will guarantee that 
Yale remains one of the great medical universi¬ 
ties in the world. YM 
“It is likely that we will know 
from a drop of blood that a 
patient has 14 of 19 genes 
for high blood pressure and 
we have 172 drugs that will 
interact with that. Only a 
computer will be able to 
organize this information” 
Chase and research librarian Charles Greenberg, left, 
talk with students in the Cushing/Whitney Medical 
Library."Technology,” Chase says,“is creating 
the need for a rigorous medical decision-making 
curriculum.That does not exist in any medical 
school curriculum and Yale can lead this effort.” 
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education 
The breathtaking discoveries of the last 
three decades and rapid change across all of 
medicine have called traditional models of 
medical education into question. At Yale, the 
debate is in full swing. By John Curtis 
The school was at a crossroad. Medical knowledge 
was growing at a startling pace. Wondrous new 
cures were in the making, and scientists were 
beginning to understand the complex workings of 
disease at a level of detail that was unprecedented. 
As a result, medical students had to master a stu¬ 
pefying mass of knowledge. A new way of teaching 
was needed. 
The time was 1922. The dean was Milton 
Winternitz, M.D. His solution was the Yale 
System of medical education. Eight decades later, 
students and faculty face similar problems— 
masses of new findings about disease and treat¬ 
ments and overwhelming amounts of knowledge 
to be learned,, compounded by the escalating 
speed of discovery and communications. Add to 
the mix changes in the economics of medicine 
and delivery of care, and what you have is a 
medical school at a crossroad, once again 
contemplating precisely what, and how, to teach, 
“Yale medical students love the Yale School of 
Medicine,” says immunologist Charles A. 
Janeway, M.D., “but they don’t love everything 
about a Yale medical education.” 
What’s not to love? Of the 3,500 applicants 
seeking a place in next year’s entering class, 
only 105 will be given the opportunity to study 
medicine here with more than 1,000 of the 
world’s most highly regarded clinicians and 
basic scientists. The school’s pioneering labora¬ 
tories churn out new discoveries about life at 
the molecular level at an astonishing rate. 
Articles by faculty appear almost daily in pres¬ 
tigious medical and scientific journals. 
Students learn from physicians at one of the 
nation’s top teaching hospitals. During the fall 
term this academic year, the school saw guest 
lectures by two Nobel laureates, one of the 
leading lights in gene therapy, and a slew of 
distinguished visitors from around the world. 
Then there is the Yale System of medical 
education, a unique approach to learning that 
remains strong after three-quarters of a centu¬ 
ry. Its elements—time for independent study, 
no grades or class rankings, treatment of stu¬ 
dents as mature adults responsible for their 
education—all add up to a unique atmos¬ 
phere. For one thing, says fourth-year student 
Evelyn Duvivier, “We’re not competing against 
one another. This is an environment where the 
focus is on learning. Students are driven by 
knowledge, not by grades.” 
With all this, in the view of many students 
and faculty, it’s still time for a change. Janeway, 
a professor of immunobiology and biology, is 
in a position to know. Since early last year, he 
and Ralph I. Horwitz, M.D., chair of the 
Department of Internal Medicine, have led an 
education committee convened by Dean 
David A. Kessler, M.D., with an eye to 
Jan. 3, 2000, third-floor anatomy 
laboratory, Sterling Hall of 
Medicine. As is tradition, students 
of anatomy become familiar with 
every inch of the body during the 
first year of their medical educa¬ 
tion. At left, professor William 
Stewart leads three students in a 
minute exploration of the lungs 
as a second group, above, exam¬ 
ines X-rays in preparation for 
their time with the cadaver. 
PHOTO ESSAY: A CLOSER LOOK AT TEACHING photographs by john curtis 
For much of the past year, a com¬ 
mittee of faculty, students and 
administrators has taken an 
exhaustive look at medical educa¬ 
tion at Yale, to ensure that teach¬ 
ing is as good as it can be and 
that Yale remains at the forefront 
of medical schools internationally. 
Of the many questions guiding 
the process, two are key: "What 
does a 21st-century physician need 
to know?"and "How should we 
teach it?" 
As the dean’s committee on 
medical education looked to the 
future, Staff Writer John Curtis 
went into classrooms, laboratories 
and clinical floors to take a closer 
look at teaching as it occurs 
day in and day out. During the 
course of several months, he pho¬ 
tographed students in many of 
the situations that comprise a 
Yale medical student’s educa¬ 
tion—from the first up-close view 
of human anatomy to the devel¬ 
opment of clinical skills with 
patients and colleagues. Here and 
on the pages that follow are pho¬ 
tographs that document impor¬ 
tant elements of a Yale medical 
education. 
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improving the curriculum as well as the 
school’s more general approach to education. 
Not all of the committee’s recommendations 
are new. Each decade since the 1920s, previous 
committees have made proposals on various 
facets of the educational experience without 
always seeing them implemented. But there is 
a sense this time that things are different. 
“There are both internal and external forces 
demanding a revision of the curriculum,” says 
Ashgar Rastegar, M.D., a professor of medi¬ 
cine and member of the education committee. 
“There has been a major revolution in science. 
There has been a major revolution in the 
delivery of care. Society is demanding that we 
look at whether we are training the right kind 
of physicians. Students and faculty are asking, 
‘Is this the best way to teach and to train 
physicians?’ ” 
Jan. 3,2000, third-floor anatomy 
laboratory, Sterling Hall of 
Medicine. Students work in 
teams of three or four as they 
learn to identify the thousands of 
nerves, tissues, muscles and 
organs that make up the human 
body. The course starts with an 
orientation to prepare students 
for their own reactions to dissect¬ 
ing a human body and ends with 
a ceremony honoring those who 
gave their bodies to medicine. 
(While Yale is a leader in comput- 
could be better. As its guiding principles, the 
committee proposes to enhance the education¬ 
al environment, refocus the educational 
process, strengthen the Yale System, enrich the 
er-based teaching, it remains 
committed to the use of cadavers 
for anatomy instruction.) 
Top right, Professor Shanta 
Kapadia helps a group of stu¬ 
dents understand the geography 
of the lungs at one table. 
Above, first-year student Marta 
Rivera and two classmates probe 
the lungs at another table while 
across the hall, students are 
engaged in a similar exercise. 
“There is change occurring everywhere we 
look,” says committee co-chair Horwitz, “not 
only in the health care system in which we 
practice, but in the medical schools that are 
our peers.” 
The committee’s charge, in the words of 
Kessler, was to inquire into “what we teach 
and how we teach.” The consensus of its 
members, after meetings with course directors, 
faculty members and students, and reviews of 
curricula at other medical schools, was that 
medical education at Yale is very good but 
John Curtis is a staff writer for Yale Medicine. 
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curriculum, redesign administrative oversight 
and implement new programs in medical 
informatics. Last fall it presented a list of ini¬ 
tial findings to department chairs and the fac¬ 
ulty. As Yale Medicine went to press, school¬ 
wide discussion of the issues raised by the 
committees was beginning in earnest. Kessler, 
who has not endorsed any specifics of the plan 
so far but supports the direction of the com¬ 
mittee, has held several meetings on the topic 
with the department chairs. A series of “town 
meetings” with faculty and students, begun in 
January, was to continue through the spring. 
“Yale School of Medicine,” says Horwitz, “is 
trying to find a way, given the extraordinary 
changes taking place in medicine, to renew 
the Yale System’s fundamental principles— 
independence, self-study, understanding the 
scientific method and applying science-based 
medicine to clinical problems.” When 
Winternitz introduced the Yale System in the 
1920s, he eliminated 1,200 hours of instruc¬ 
tion from the schedule. The crushing burden 
of the curriculum, he felt, stifled independent 
study, contemplation and initiative. Advocates 
of the Yale System felt that absorbing a mass 
of facts was less important than a grounding 
in fundamental principles, methods of investi¬ 
gation and the scientific method. 
Now the education committee’s goals are to 
integrate course materials across departmental 
boundaries, implement more case-based teach¬ 
ing, correlate the basic and clinical sciences, 
allow students more structured time to con¬ 
duct original research toward their thesis 
requirement, cut down on class hours, and 
restructure the program so that clinical studies 
begin on the first day of medical school and 
basic sciences continue to the last day. Clinical 
exposure in the first two years, the committee 
found, is insufficient and haphazard, and the 
third-year clerkships need a thorough review. 
Some peer institutions have already tackled 
these issues, Janeway and Horwitz note, and 
are moving toward a system of problem-based 
learning and small-group teaching, rather than 
large lectures. 
The committee also addressed the prevailing 
notion among the faculty that the road to 
recognition, advancement and tenure lies not 
in teaching, but in research and clinical work. 
“Nothing,” says Janeway, “undermines the 
success of medical education more than the 
perception that teaching is secondary.”>>> 
Feb. 8, 2000, histology laboratory, 
Lauder Hall. A month after their 
introduction to the lungs in the 
anatomy laboratory, first-year stu¬ 
dents continue their study of the 
pulmonary system under the tute¬ 
lage of cell biology professor 
Thomas Lentz. Looking through the 
microscope and at histology slides 
enlarged on a computer monitor, 
the students learned about the 
lungs at the cellular level. 
\ 
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In presenting their findings, Janeway and 
Horwitz made it clear they’re under no illu¬ 
sions about the complexity of their task. 
Making changes means placing authority for 
curriculum in the hands of the deputy dean 
for education, who, under their proposal, 
would be armed with a sizeable budget. The 
new deputy dean, Herbert S. Chase, M.D., 
was chosen in part because of his experience in 
curriculum design. At the Columbia 
University College of Physicians and Surgeons, 
where he has taught lor 22 years, he created 
courses that integrate basic and clinical 
sciences. He’s also very interested in applying 
information technology to medicine, to 
ensure that physicians have the best possible 
data when they’re treating patients. Chase, 
currently a professor of clinical medicine at 
Columbia, will officially begin his duties at 
Yale in July. One of his first, and most impor¬ 
tant, charges is to oversee the curriculum revi¬ 
sion process. “We live in an era in which we 
can easily discuss the molecular basis and the 
molecular treatment of very common dis¬ 
eases,” says Chase. (See Interview, page 24) 
“They really go hand in hand. There’s nothing 
preventing us from having a 
much more fluid curriculum 
where we have basic science 
and clinical science interwoven 
throughout the four years.” 
Past efforts at curriculum 
reform have generally stum¬ 
bled over departmental turf 
battles. “The curriculum too 
often finds itself responding to 
the needs of the department 
rather than what might be 
pedagogically sound,” says 
Robert H. Gifford, M.D., HS 
’67, who served as the school’s 
first deputy dean for education until his retire¬ 
ment in December. “It has been very difficult 
to convince basic science departments to 
reduce class hours, to introduce interdepart¬ 
mental teaching, to introduce case-based 
teaching and to form partnerships with clini¬ 
cal faculty.” 
Emile L. Boulpaep, M.D., professor of cel¬ 
lular and molecular physiology and the 
department’s interim chair, headed a curricu¬ 
lum committee a decade ago but found 
departmental and faculty resistance to reform 
too strong to overcome. “It touches on very 
special issues of identity,” he says. Frustrated 
in his attempts to forge wider interdepartmen¬ 
tal integration and coordination, he and col- 
Nov. 4,1999, seminar room, 
Sterling Hall of Medicine. Emile 
Boulpaep, professor of physiology, 
talks about chemical processes 
and their biological consequences 
during a seminar for first-year 
students. 
Dec. 14,1999, Room no, Jane Ellen 
Hope Building. In the semester’s 
final lecture in microbiology, 
second-year students learn about 
the practical aspects of treating 
viruses, including common 
childhood ailments. 
league James D. Jamieson, M.D., Ph.D., head 
of cell biology courses, did it themselves on a 
smaller scale. Physiology and cell biology are 
still separate courses, but lectures and classes 
are scheduled to complement, rather than 
repeat, each other. “We are here to make the 
optimal learning process for the students,” says 
Boulpaep. “If that learning process requires 
working together and integrating two fields of 
science and the student will reap the benefit of 
it, there is no reason we shouldn't do it.” 
There are other examples of integration. 
Second-year students take a course called 
“Mechanisms of Disease,” which takes a sys¬ 
tem- and organ-based approach to material 
traditionally taught in pathology, pharmacolo¬ 
gy, laboratory medicine and other disciplines. 
But some faculty would like to see much more 
collaboration. Jamieson, who won the 1999 
Bohmfalk Prize for excellence in basic science 
teaching, believes the basic core of what physi¬ 
cians must know hasn’t changed. “They need 
to have a solid grounding in cell biology, 
molecular genetics, pharmacology, physiology, 
biochemistry and pathology. You can’t be a 
doctor without those things,” he says before 
adding: “There is a lot of stuff that could be 
cut out if courses were better scheduled or bet¬ 
ter integrated.” Jamieson also stressed that as 
the number of students in the M.D./Ph.D. 
program increases from about 10 percent of 
the class to 15 percent, the school must contin¬ 
ue to emphasize a solid foundation in the 
basic sciences that will be required of physi¬ 
cian-scientists. 
In the classrooms along Cedar Street, faculty 
members employ a number of teaching 
approaches. Some classes follow a traditional 
undergraduate model of a large lecture fol¬ 
lowed by small-group meetings with a gradu¬ 
ate student. Boulpaep prefers the small groups 
of about 10 students he convenes every 
Thursday morning for lessons in physiology. 
He uses the Socratic method, tossing out 
questions, then questioning the answers. 
“Why would the blood not be saturated?” 
Boulpaep asked of a case of cystic fibrosis. 
“It’s not getting oxygen,” a student responded. 
“Why is it not getting oxygen?” Boulpaep 
asked, prodding the students. 
Across campus at the Yale Health Plan, 
medical student Duvivier, then in her third 
year, worked one-on-one with a physician- 
supervisor in internal medicine as part of her 
clinical clerkship. Typically, she would inter¬ 
view patients on her own, then present her 
findings and diagnosis to her supervisor. One 
Feb. 4,2000, clinical skills assess¬ 
ment lab, Farmington, Conn. 
During the second year, students 
prepare for the transition to full¬ 
time clinical studies. As they have 
for the last two years, a group of 
Yale medical students makes the 
40-mile trek to the University of 
Connecticut Health Center, where 
they are paired with “patient- 
instructors” who play the role of 
patients and drop clues intended 
to lead students to a correct diag¬ 
nosis. Only a handful of medical 
schools have developed assess¬ 
ment labs as sophisticated as the 
UConn program, which is housed 
in a former ob-gyn clinic with 12 
examination rooms.The history 
and physical exam are observed, 
videotaped and evaluated, giving 
the students an opportunity to 
get comfortable in the clinical 
setting and learn from their 
mistakes. Above and below: Kier 
Ecklund interviews one of the 
patient-instructors under the 
watchful eye of a video camera 
on the wall. 
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Feb. 14,2000, Yale-New Haven 
Hospital. Students advance their 
clinical skills in the second year 
with a doctor-patient encounter 
course. Andrew Norden, John Koo 
and Eileen Scully present cases to 
Howard Levitin, their clinical 
tutor. Teaching in the course 
depends on such sessions with 
clinical tutors, each of whom 
works with four students. 
case involved a 63-year-old police officer with 
a cough. Duvivier reported to David Smith, 
M.D., her suspicion that the officer was react¬ 
ing to the dander of a cat he’d acquired a 
month earlier. “I think it is very hard for 
someone to acknowledge that their symptoms 
might be caused by something they treasure,” 
Duvivier said. 
“It sounds very classic, doesn’t it?” Smith 
asked. “I think you did a very good presenta¬ 
tion formulation. Do you think we need to do 
any further work-up for the cough, a chest X- 
ray?” Smith wanted to rule out tuberculosis, a 
risk of the officer’s job. “You’re right,” 
Duvivier said. “A PPD skin test and a chest X- 
ray would rule that in or out." 
When it works, education in the clinical 
years is satisfying to those involved. “I feel that 
my opinion and my diagnosis are taken very 
seriously,” Duvivier says. “I’m still a student, 
but I am treated almost as a colleague.” 
That said, students and faculty have their 
gripes. Faculty complain about students who 
don’t show up for lectures and small-group 
seminars. Students cite examples of attendings 
who miss rounds. And there’s the evaluation 
system during the clinical years. “It is not 
based on anything scientific,” says Janeway. 
“It is based on residents liking you or not 
liking you.” 
Medical education throughout the country 
has its roots in the 1910 Flexner Report. 
Concerned about the rise of proprietary 
schools that were thought to be little more 
than diploma mills, the American Medical 
Association commissioned a study by 
Abraham Flexner, a noted education reformer. 
He took as his model Johns Hopkins in 
Baltimore, where the medical school was 
affiliated with a university and had a strong 
research component. Since then medical 
schools have, by and large, followed the same 
pattern—two years of basic sciences followed 
by two years of clinical studies. After the 
Flexner Report, the next big change in Yale 
medical education came in 1922, when 
Winternitz and his faculty began to imple¬ 
ment the Yale System. Faculty kept an eye on 
the system, monitoring it through the 1930s 
and 1940s. Despite some tinkering with its 
elements, it has survived largely intact over 
the years. 
“What is good about the Yale System is the 
collegial atmosphere,” says David Spiegel, an 
M.D./Ph.D. candidate and one of three 
student members of the education committee, 
“and the genuine proximity students have to 
faculty, especially in the basic science years.” 
Says second-year student and committee 
member Rebekah Gross, “It is much more 
humane in the sense that if you have a person¬ 
al problem or something going on with your 
family and you can’t learn something this 
week, then you can learn it next week. That is 
important in helping you stay focused.” 
Within weeks of donning their white coats, 
first-year students get a glimpse of how things 
could improve. “The education we get is 
great,” says Spiegel, “but it really could be 
made a lot more pleasant and a lot better if 
there were more coordination among depart¬ 
ments and faculty members.” During his first 
year of medical school four years ago, Spiegel 
says, students faced a parade of basic science 
lectures that often were redundant. The result? 
Overlap in material, boredom on the part of 
students and frustration on the part of faculty 
who wondered why attendance was low. 
How do students handle the sometimes 
overwhelming volume of information they 
must master? “You know what you should be 
reading and you just can’t do it,” says Gross. 
“So you pick and choose. The two words you 
hear most here are ‘high-yield.’ ” That’s stu¬ 
dent jargon for quality information that covers 
a variety of situations. The highest praise stu¬ 
dents accord professors is to say their lectures 
are “high-yield.” Said one second-year student 
in praise of a lecturer in microbiology, “She 
tells you what you need to know.” 
More integrated courses and more correla¬ 
tion of the basic sciences to clinical practice 
would ease the absorption of all that material, 
according to some faculty. “You don’t learn 
medicine by reading a textbook,” says Barry J. 
Wu, M.D., an assistant clinical professor of 
medicine and recipient of the 1999 Blake 
Award and the 1999 Bohmfalk Prize for excel¬ 
lence in clinical teaching. “You learn by seeing 
a patient with a particular disease and going to 
the textbook and reading about it. Then you 
have a connection in your brain.” Correlation 
of the basic to the clinical sciences is one of 
the goals of the curriculum review. It’s also the 
impetus behind starting clinical sciences early 
and continuing basic sciences until the end of 
the four-year program. 
While all involved in teaching support the 
goal of improving the framework for educa¬ 
tion, the debate over how to do that is just 
beginning. “There’s a concern,” says Jon 
Morrow, M.D., Ph.D., chair of the 
Department of Pathology, “that the time for 
basic science is contracting at the same time 
that the knowledge base is exploding. One 
could argue that it would be better to go in 
the opposite direction and increase the hours 
for basic science.” Chase notes that although 
time allotted to basic science might be reduced 
in the first two years, students will return to 
those subjects during their clinical years. 
“Some basic science topics will be a great deal 
more compelling when taught later on in the 
curriculum,” Chase says. 
That Yale’s medical curriculum needs some 
revision is no blemish on the way the school 
teaches physicians. As Dean Vernon W. 
Lippard, M.D., noted in 1954, “No education¬ 
al program worth its salt ever has or ever will 
be in final form. To be effective, it must be 
subjected to constant evaluation and improve¬ 
ment.” The “New Curriculum” that emerged 
14 years later included features current propo¬ 
nents of revision would recognize—reduction 
in basic science class hours, early introduction 
of students to clinical medicine, study of basic 
science after clinical clerkships and an extend¬ 
ed outpatient clinical experience. 
As the school stands at a crossroad, it has 
embarked on a dialogue about how and what 
to teach doctors. Over the winter, the educa¬ 
tion committee launched its series of “town 
meetings” to open discussion to a spectrum 
of stakeholders at the medical school—faculty, 
staff and students. At the first of these meet¬ 
ings in January, Horwitz outlined different 
scenarios for reconfiguring the curriculum. 
The discussion is expected to last for some 
time. “Our strategy from the very beginning,” 
says Kessler, “was to have this committee be a 
several-year effort.” The committee’s proposals, 
Janeway notes, are designed to focus the 
conversation that will follow. “We need to 
have the whole school come together over 
this,” he says. YM 
Jan. 18,2000, Primary Care Clinic. 
In their third and fourth years, 
students gain more independ¬ 
ence. They interview and examine 
patients on their own, then report 
to their supervising physicians. 
Top: During an elective in 
women’s health,fourth-year 
student Patricia Moore describes 
a patient’s rash to Stanley 
Lavietes and Rebecca Brienza. 
Brienza diagnoses psoriasis and 
suggests a treatment. 
Above: Her interview and exam 
complete, Moore writes up her 
notes in the patient’s chart. Like 
her father and sister before her, 
Moore plans to go into obstetrics 
and gynecology. 
35 YALE MEDICINE SPRING 2000 
Dean Milton Winternitz (top) introduced 
the Yale System in the 1920s. By the time the 
Class of 1948 (above) and the Class of 1943 
(right) graduated, this approach to medical 
education had become a tradition at Yale. 
' ■ 
REMI N ISCENC 
Ever since its implementation in the 1920s, the Yale System of medical education has been the 
point of common reference for alumni of the School of Medicine. Ralph I. Horwitz, M.D., chair 
of the Department of Internal Medicine, touched on its enduring qualities when he addressed 
faculty recently about the education-review process now under way. “I have not been able to 
find two people able to agree on exactly what the Yale System is, but there is a strong consen¬ 
sus on the essentials,” he said. It’s an approach to learning that is self-directed and collabora¬ 
tive, rather than competitive. The environment is that of a graduate school. Examinations are 
for self-assessment, not for grades or class ranking. Learning takes place in small groups rather 
than in large lectures. And the curriculum should allow free time for reading, independent 
research and reflection. 
Alumni have their own memories of how the Yale System shaped their careers in medicine. 
As the medical school takes an exceptionally thorough look at both how and what it teaches— 
all in the context of renewing the Yale System—we invited alumni to reminisce about what it 
meant to them. Their recollections follow. 
the Yale System 
A CONVERSATION THAT RESOUNDED DURING FOUR 
DECADES OF PRACTICE 
Morris A. Wessel, M.D. ’43 
My most striking memory as a medical student from 1939 to 
1943 is of the availability of faculty members when a student 
sought help. As a third-year student, I was frustrated at my 
inability to comfort an 8-year-old child in a cast with a frac¬ 
tured femur. 
I went to Dr. Edith Jackson in the pediatrics department, 
who was interested in children’s behavior during hospitaliza¬ 
tion and had returned recently from a six-year leave of absence 
spent in Vienna obtaining psychoanalytic training. 1 remember 
her warm greeting as I entered her office. I shared my frustra¬ 
tion about my patient—and remember suddenly describing 
bitter memories of my own tonsillectomy at the age of 8! 
Dr. Jackson showed me the Anna Freud-Dorothy 
Burlingham studies describing the behavior of children evacu¬ 
ated to the countryside from war-torn London. She offered to 
meet with me periodically to discuss these reports and my con¬ 
cerns about patients. 
These discussions led me to comprehend infant and child 
behavior in normal and stressful times. I applied this knowl¬ 
edge during every patient contact in my four decades of 
pediatric practice in New Haven. I appreciate having been 
introduced to this explanation of children’s behavior in my 
discussion with Dr. Jackson 58 years ago in the Department of 
Pediatrics. 
Wessel cared for generations of New Haven children as a 
pediatrician in practice from 1931 until his retirement in 1993. 
PROXIMITY WAS EVERYTHING FOR A ONCE-SHY STUDENT 
Richard W. Breck, M.D. ’45M 
The Yale System meant everything to this lecture-hall 
introvert. The WWII years of 1942-45 provided an exciting 
background in which to study medicine. The small-group 
instruction, either bedside or seminar, was the best part of the 
system for me. On rounds, standing inches from Drs. Blake, 
Peters, Powers, Geiger, Blumer and Tileston, I was in their 
debt; somehow, a bit of their intellectual dandruff fell on me 
and stuck. 
I didn’t know the words “role model" then, but Francis 
Blake was, to me, the clinician I wanted most to emulate. 
I have been guided many times since graduating 54 years ago 
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by thinking, “What would Dean Blake have done in a situa¬ 
tion like this?” 
I also “mourned” the passing of the smaller classes—I think 
ioo is too large for YSM. 
Breck, a long-time participant in alumni affairs and former 
secretary of the AYAM Executive Committee, retired font general 
practice in 1995. He lives in Wallingford, Conn., where he sees 
geriatric patients on a part-time basis. 
‘they treated us as responsible adults’ 
Laura White Neville, M.D. ’46 
The one major facet of Yale’s approach to medical education 
that impressed me was the way they treated us as responsible 
adults. We were told in the first week that we had all been 
selected with the confidence that we would all graduate. We 
were told that we were capable of studying on our own, taking 
only those tests we wished to take, except for Parts I, II and 
III of the national boards. The faculty would be available for 
counsel and for whatever help we thought necessary, and with¬ 
out outside pressure. 
I can still visualize our neuroanatomy professor as he stood 
at the blackboard, chalking an outline of the brain, using both 
hands to draw the left and right sides of the brain simultane¬ 
ously. He turned to us and said, “Ladies and gentlemen, you 
are now members of a learned profession, and you will be 
students for the rest of your lives.” 
Neville was in private practice in pediatrics and psychiatry for 
many years in Syracuse, N. Y., where she served on the clinical 
faculty of the SUNY Health Sciences Center. She and her 
husband, John F. Neville Jr., M.D. ’46, are retired and living 
in Cotuit, Mass. 
A TRUE UNIVERSITY APPROACH THAT 
FOSTERED INDEPENDENCE 
Olive E. Pitkin, M.D. ’4J 
Coming from a small-town high school in which most of what 
I learned was outside of school hours, and from Bennington 
College, which left its students pretty much on their own 
as well, I found the Yale System entirely congenial. We were 
offered the best of lectures, but as I became aware that I 
learned little from material I only heard, and that no one 
seemed to mind if I stayed away and concentrated on what 
was in the books, I was able to study in my own way with a 
clear conscience. In the clinical years we saw superlative 
physicians in action, and my images of most of them, more 
than 50 years later, are so vivid and still so admirable that I 
think we must have been given very generous exposure to 
these splendid role models. From them I really did learn what 
it means to be a good doctor. These experiences I did not 
stay away from; such apprenticeship can only be achieved by 
personal contact with a master. 
If by the Yale System it is meant this true university 
approach—treating the students as adults who are there to 
learn, making available to them the ingredients of a superb 
professional training, allowing them to take it in at their own 
pace and with techniques of their own devising—then it 
worked for me. My medical education has been, ever since, a 
matter for both gratitude and pride. 
Pitkin retired in 1984 from the New York City Department of 
Health, where she was assistant commissioner for maternal and 
child health services. She lives in Westerly, R. I. 
ANOTHER VIEW OF THE THESIS REQUIREMENT 
David E. Morton, M.D. ’48, HS ’55 
Having been a medical student, instructor in anatomy, and 
house officer at the School of Medicine in the 1940s and ’50s, I 
had considerable experience with the thesis requirement. I also 
received the Keese prize for the best thesis in 1948. 
Although times have changed, I concluded when I left the 
School of Medicine that the thesis requirement should be 
dropped except for those taking the combined M.D. and 
Ph.D. programs. My reasoning was that the thesis was truly 
useful only for those students planning to enter academic med¬ 
icine and research. And in my day only 5 to 10 percent of the 
class did so. I then felt that the considerable amount of time 
spent on the thesis would be better spent in the study of medi¬ 
cine. The volume of knowledge at that time seemed so great to 
cover in four years without spending time on a thesis, and 
think how much greater it is now! 
Morton, who retired ffom private practice in internal medicine 
in 1994, lives in Pueblo, Colo. 
A GOOD PLACE TO BE IN THE TURBULENT I96OS 
Ralph Falkenstein, M.D. ’69 
Historians have described the decade of the 1960s as one ot 
turbulence and upheaval among America’s youth. Beyond the 
cauldron of student protests, the Vietnam War and drug exper¬ 
imentation, there was a haven where those fortunate enough to 
gain admission to the Yale School of Medicine could achieve 
their goal of obtaining the finest education under the relatively 
tranquil canopy of the Yale System. 
As a member of the Class of 1969, I remain appreciative of 
Yale’s approach of allowing students latitude in balancing their 
interests and scientific pursuits with personal responsibility for 
absorbing course work through the guidance of concerned 
mentors who impart their knowledge and skills in a non-intim¬ 
idating fashion. We were, at a rather tender age and with limit¬ 
ed medical familiarity, considered responsible individuals, 
whose desire for learning was nurtured as thoughtfully as our 
hopes for developing into worthy physicians. In short, a digni¬ 
fied way to study a noble profession and a stark contrast to 
much of what was going on in the medical and nonmedical 
world around us. 
Falkenstein is an ophthalmologist in Danbury, Conn. 
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‘an ideal education’that emphasized 
RESPONSIBILITY 
Mary Lake Polar1, M.D. '75, Ph.D. ’70 
As someone brought up in the 1960s, the Yale System was a 
natural and very comfortable extension of the 60s sense of 
freedom and exploration. I graduated from Yale School of 
Medicine in 1975, having received my Ph.D. from Yale in 
molecular biophysics and biochemistry five years earlier. At the 
time I was in medical school, there were no grades and to grad¬ 
uate only required passing the boards and submitting a thesis. 
The system allowed me, during my first year of medical school, 
to continue working in a laboratory in the biology department, 
where I had been a postdoctoral fellow. I was paying for my 
education and Yale gave me the ability to learn and to structure 
that education in a way that was best for me. 
Because I had a Ph.D. and did not need to submit a thesis, 
the Yale System allowed me to read a book on pharmacology 
and take Part I of the boards before my class actually had the 
pharmacology course. Passing the boards that first year meant I 
could finish medical school in three years. I wanted to learn 
about how medicine was practiced in other countries and the 
Yale System allowed me to spend both my pediatric and obstet¬ 
rics and gynecology rotations at Oxford. 
The Yale System stressed freedom of choice in how you 
could educate yourself and along with that went the personal 
responsibility for doing it. My experience at Yale was that 
everyone in both the medical school and the graduate school 
was available to help with research, information, advice and 
mentoring. All you had to do was ask. It was an ideal educa¬ 
tion that taught not just the particulars of medicine, but 
allowed one to live through the process of real-life decision¬ 
making and responsibility—probably the very best preparation 
for a career in medicine. 
Polan is chair of the Department of Gynecology and Obstetrics 
at Stanford. 
A CHANCE TO BE S E L F - M OTI VAT E D AND REWARDED 
WITH KNOWLEDGE 
Thomas J. Smith, M.D. ’78 
The Yale System is why I came to Yale in 1974 and spent 
$10,000 a year more than to go to Ohio State. The flexibility oi 
a fifth year, which happened to be free, was also a major draw. 
The Yale System offered an opportunity to be self-motivated 
and rewarded with new knowledge (whatever its relevance) 
rather then punished for not knowing the answer to multiple- 
choice questions. The skills I honed during my time at Yale— 
going to the library, asking questions, not being satisfied until 1 
knew the material and the relevant answers—have served me 
well in my practice and academic careers. 
In addition, the thought that “Well, now I know it all and 
can stop studying’’ never crossed our minds. 
As we move into a system that can track medical outcomes, 
and compare us one to another based on our outcomes, 
adherence to “best medical practice” and the subsequent 
good medical results will become increasingly important. 
Since medical care advances, the only ones who will be able 
to keep up are those with a “Yale System" approach of adult, 
life-long learning. 
Smith is an associate professor of medicine and health 
administration at the Medical College of Virginia/ 
Virginia Commonwealth University in Richmond. 
TOOLS TO DEAL WITH A WORLD OF AMBIGUITY 
Joann Bodurtha, M.D. ’79, M.P.H. ’79 
What did the Yale System mean to me? It enabled me to get a 
firm foundation for life-long learning and adaptation to uncer¬ 
tainty. It gave us the freedom to take the time to understand 
something as well as it was currently understood with thought¬ 
ful teachers, small group discussion, and no preoccupation with 
“what’s on the test?” The memorable moments and experi¬ 
ences—announcement of the Nobel Prize in class, the chaplain 
in anatomy, a women-in-medicine lectureship, the thesis, a cer¬ 
tain bike-riding dean’s report of prostate discomfort, and many 
others—continue to provide ingredients for my current clinical 
care and teaching. 
Much of my happiness as a physician is due to the ongoing 
push to integrate all that medicine presents, from “marketing” 
public health to explaining molecular testing to a family. My 
Yale teachers inspired me to try to do my best with humor and 
caring and to learn from my mistakes. 
Bodurtha is an associate professor of human genetics, pediatrics 
and obstetrics/gynecology at the Medical College of Virginia/ 
Virginia Commonwealth University in Richmond. 
THE YALE SYSTEM PERSONIFIED 
Brian B. Adams, M.D. '95 
One can sum up the strength of the Yale System and the 
essential threads of Yale’s approach to medical education in two 
resounding words—Dr. Gifford. 
Adams is an assistant professor of dermatology at the University 
of Cincinnati School of Medicine and director of dermatology at 
the Veterans Hospital Medical Center in Cincinnati. YM 
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were on display the night of Oct. 31 when hundreds of people 
turned out to say farewell to Bob Gifford the friend At a 
buffet dinner in Harkness Lounge, students, alumni,faculty and 
family laughed over remembrances of Gifford's years at Yale, 
which started 33 years ago when he arrived to complete his 
residency. Former Dean Leon E. Rosenberg, M.D., recounted 
how Gifford pushed the school's educational agenda and how 
he, Gifford and others became the first faculty members to 
participate in the Second-Year Show. Current student and hock¬ 
ey teammate Michael Fehm joked about Gifford’s transfer of 
aggressive hockey moves from the ice to the bedside. Gifford’s 
son Bruce told how his father dissuaded him and his three 
siblings from smoking at an early age—by letting them 
try it. Dean David Kessler amused the crowd with anecdotes 
about Gifford's time at Yale. "Where did he get these stories?” 
Gifford wondered aloud. Although he no longer has an 
administrative post at the medical school, Gifford remains a 
fixture on campus, frequently sighted at lunch with students 
or at faculty functions. 
FACU LTY NOTES 
Issam 
Abdullah 
Awad, M.D., 
the Nixdorff- 
German 
Professor of Neurosurgery, 
was named president-elect 
for 1999-2000 by the 
Congress of Neurological 
Surgeons (CNS) at its annual 
meeting in Boston. He will 
assume the presidency in 
November. Awad has been 
active since 1990 in CNS, 
which was founded in 1951 
and serves approximately 
4,800 members. 
Sidney J. 
Blatt, Ph.D., 
chief of the 
psychology 
section of the 
Department of Psychiatry, 
received the Distinguished 
Scientific Contributions 
Award from the Division 
of Psychoanalysis of the 
American Psychological 
Association. Blatt also was 
appointed visiting professor 
at University College in 
London for a three-year term. 
There he will participate 
in a summer research-training 
program in psychoanalysis 
offered in collaboration 
with the International 
Psychoanalytic Association. 
James P. Comer, M.D., 
HS ’66, Maurice 
Falk Professor in the Child 
Study Center and of psychia¬ 
try and one of the nation’s 
leading experts on children, is 
serving on a national panel 
exploring the performance of 
minority students in schools. 
In a report issued in October, 
the College Board’s National 
Task Force on Minority High 
Achievement found that 
African Americans, Hispanics 
and Native Americans lag 
behind non-Hispanic whites 
and Asians. The report rec¬ 
ommends that schools share 
information on programs that 
boost minority achievement. 
Edmund W. Gordon, Ph.D., 
professor emeritus of psychol¬ 
ogy, is one of the co-chairs of 
the 31-member task force. 
John A. Elefteriades, M.D. ’76, 
HS ’83, professor and chief of 
the section of cardiothoracic 
surgery, delivered an invited 
address on “High Risk 
Myocardial Revascularization” 
in October at the American 
College of Surgeons’ annual 
meeting in San Francisco. 
Rosemarie L. Fisher, M.D., 
professor of medicine and 
director of graduate medical 
education for the School of 
Medicine and Yale-New 
Haven Hospital, has been 
named co-chair of the 
Advisory Council for the 
Connecticut Office of Health 
Care Access. The council will 
report annually to the Public 
Health Committee of the 
General Assembly on gradu¬ 
ate medical education, 
including its financial impli¬ 
cations for Connecticut’s hos¬ 
pitals and its effect on access 
to health care and on the suf¬ 
ficiency of the health care 
provider workforce. 
Roberta L. 
Hines, M.D., 
HS '77, chair 
of the 
Department 
of Anesthesiology, has been 
elected president of the 
Society of Academic 
40 
Anesthesiology Chairs 
(SAAC). The society repre¬ 
sents all academic anesthesiol¬ 
ogy departments in the 
United States and Puerto 
Rico. Hines will be responsi¬ 
ble for providing leadership 
for both the SAAC and 
its component councils for 
two years. 
Susan Hockfield, Ph.D., dean 
of the Yale Graduate School 
and professor of neurobiology, 
was elected a member-at-large 
of the Section Committee 
for the American Association 
for the Advancement of 
Science’s (AAAS) Section of 
Neuroscience for a four-year 
term. Hockfield has been a 
member of the AAAS for 
more than 20 years. Members- 
at-large also serve on the 
committee steering group that 
acts on policy matters and 
selects nominees for fellows 
of the AAAS. 
Jeannette R. Ickovics, Ph.D., 
associate professor of epidemi¬ 
ology and psychology, will 
receive the 2000 Early Career 
Award for Distinguished 
Contributions to Psychology 
in the Public Interest from the 
American Psychological 
Association (APA). The award 
will be presented in August at 
the 2000 APA Convention in 
Washington, where she will 
give an address entitled 
“Women and AIDS: Private 
Lives, Public Challenges.” 
Bruce L. McClennan, M.D., 
professor and chair of the 
Department of Diagnostic 
Radiology, collaborated with 
Walt Disney World to create 
an interactive exhibit on 
radiology that opened in 
October at Epcot Center in 
Orlando, Fla. “Radiology: 
Medicine’s New Vision,” 
which McClennan and col¬ 
leagues from the Radiologic 
Society of North America 
(RSNA) helped design, show¬ 
cases the role of radiologists in 
medicine and helps explain 
the many new uses of radiolo¬ 
gy for both treatment and 
therapy. The exhibit features 
an arcade with several video 
games, including “Cell 
Smash,” in which a guest can 
blast a cancer cell, and “Brain 
Game,” which offers a virtual 
ride through the brain as its 
parts are identified. Another 
display allows guests a realistic 
try at performing an angio¬ 
plasty. “I crashed the 
computer on my first try,” 
said McClennan. RSNA, the 
largest professional radiology 
society in the world, made 
initial contact with Disney 
to conceive the exhibit 
and invested $3 million in 
the project. 
James R. Merikangas, M.D., 
lecturer in psychiatry, 
spoke in September at the 
Neurosciences and Psychiatry 
Congress of History in 
Zurich. Merikangas gave the 
James Joyce Lecture on “The 
Mental Illness of Lucia Joyce” 
and the Adolf Meyer Lecture 
on “Crossing and Recrossing 
the Boundary of Neurology 
and Psychiatry in the USA.” 
Robert S. 
Sherwin, 
M.D., the 
C.N.H. Long 
Professor of 
Medicine and endocrinology 
and director of the Diabetes 
Endocrinology Research 
Center, was named president¬ 
elect of the National Board 
of Directors of the American 
Diabetes Association at its 
annual meeting in San Diego. 
Sherwin will assume the 
presidency in July for a term 
of one year. 
Albert J. Solnit, M.D., Sterling 
Professor Emeritus in 
the Child Study Center, 
Psychiatry and Pediatrics, was 
honored with a First for Kids 
Award in December by the 
Connecticut Voices for 
Children. Awards were 
presented at the New Haven 
Lawn Club on World AIDS 
Day and recognized efforts to 
help Connecticut children 
affected by the deadly virus. 
Solnit was recognized with a 
fellowship fund established in 
his name. Connecticut Voices 
for Children also established 
a merit award bearing his 
name, which was presented 
to state Rep. John Thompson, 
D-Manchester. Solnit is 
the commissioner of the 
Connecticut Department of 
Mental Health and was direc¬ 
tor of the Yale Child Study 
Center from 1966 to 1986. 
Richard S. Stahl, M.D., HS ’81, 
clinical professor of surgery 
(plastic surgery), has been 
appointed associate chief of 
staff of Yale-New Haven 
Hospital (YNHH). Stahl 
joined the faculty at the 
School of Medicine in 1983 as 
an assistant professor. He also 
serves as associate chief of sur¬ 
gery at YNHH. 
Eiji Yanagisawa, M.D., HS ’59, 
clinical professor of surgery 
and otolaryngology, received a 
Presidential Citation of the 
American Academy of 
Otolaryngology and Head and 
Neck Surgery in September at 
its annual meeting in New 
Orleans. The citation is in 
recognition of his efforts in 
the documentation of pathol¬ 
ogy and procedures, and for 
his talents as a teacher. 
Yanagisawa also was the guest 
of honor at the Eastern 
Section meeting of the 
Triological Society in January 
1999 in Providence, R.l. 
LABELED 
CHILDREN 
Rftet J. Member* I tbm L Cn^wcolo 
DEBRAWHA1TNER.up.il 
’"DATING 
A Ibreni's Guide to liaising 
Sexually Uealtliv Children 
The American Disease: Origins 
of Narcotic Control, 3rd ed„ 
by David F. Musto, M.D., HS '67, 
professor in the Child Study 
Center and professor of 
history of medicine and 
psychiatry, Oxford University 
Press (N.Y.), 1999. 
Earthdance, by Lynn W. Reiser, 
M.D. '70, clinical professor of 
psychiatry, Greenwillow Books 
(N.Y.), 1999. 
From Diapers to Dating: 
A Parent’s Guide to Raising 
Sexually Healthy Children, 
by Debra W. Haffner, 
M.P.H. '79, Newmarket 
Press (N.Y.), 1999. 
The Mysteries Within: A 
Surgeon Reflects on Medical 
Myths, by Sherwin B. Nuland, 
M.D. '55, HS ’6t, clinical 
professor of surgery, Simon 
and Schuster (N.Y.), 2000. 
Our Labeled Children: What 
Every Parent and Teacher 
Needs to Know About Learning 
Disabilities, by Robert J. 
Sternberg, Ph.D., IBM Professor 
of Psychology and Education, 
and Elena L. Grigorenko, Ph.D., 
research scientist in psycholo¬ 
gy, Perseus Books (N.Y.), 1999. 
NOTICES OF NEW BOOKS BY 
ALUMNI AND FACULTY MAY 
BE SENT TO CHERYL VIOLANTE, 
YALE MEDICINE PUBLICATIONS, 
P.O. BOX 7612, NEW HAVEN, CT 
06519-0612. 
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The student-run Hunger and Homeless 
Auction has become a yearly outlet for 
talent, exuberance and creativity. 
i Medical students Susan Rushing and 
Nduka Amankulor performed a duet 
from Don Ciovanni. 2 Dean David 
Kessler auctioned a puppet show, to be 
performed by Bob Gifford. 3 Second- 
year students Nikki Pinkerton and 
Mary-Ann Etiebet sat back and enjoyed 
the show. 
Gone! 
Student auction raises $26,000 for New 
Haven service organizations. 
An electric scooter, a week in a London 
townhouse and a squash game with the direc¬ 
tor of admissions were among the items 
that raised more than $26,000 in the seventh 
annual Hunger and Homelessness Auction 
on Nov. 19. 
Dean David A. Kessler, M.D., one of the 
event’s auctioneers, set the tone for the levity 
to follow when he addressed a spirited crowd 
from the stage. “There are four of us,” he said, 
resplendent in black tie and tails, “and we get 
graded by how much we raise.” 
As in past years, the auction is as much a 
fund-raising event as a chance to have fun. 
Kessler ruthlessly cajoled bidders into upping 
their own bids. When Special Advisor to the 
Dean Lawrence S. Cohen, M.D., HS ’65, bid 
$250 for a plane ride over New Haven, Kessler 
asked him for more money. “I can’t bid against 
myself,” Cohen protested. “Yes, you can,” the 
dean replied. 
Joining Kessler as auctioneers were Admissions 
Director Richard A. Silverman, Associate 
Dean for Student Affairs Nancy R. Angofif, 
M.RH. ’81, M.D. ’90, HS ’93, and Deputy 
Dean for Education Robert H. Gifford, M.D., 
HS ’67. Gifford entertained the crowd by 
donning a leather helmet and mounting the 
electric scooter for a ride to the foot of the 
stage. “You’ll do anything for a laugh,” scolded 
Margaret j. Bia, M.D., professor of medicine. 
Kessler bid $1,200 for roles in the Class of 
2002’s second-year show for himself, Angoff 
and Assistant Dean for Administration Ruth j. 
Katz, J.D., M.P.H. 
Second-year student Nduka Amankulor and 
first-year Susan Rushing, both accomplished 
opera singers, performed a duet from Don 
Giovanni. The Ultrasounds, an a cappella 
group comprised of students of medicine, 
nursing, public health and the Physician 
Associate Program, sang Van Morrison’s 
“Moondance.” Amankulor, second-year med¬ 
ical student Hung Nguyen and public health 
student Betsy Luo organized the auction. 
Proceeds will benefit Columbus House, 
Youth Continuum, New Haven Cares, 
Rachel’s Table and St. Luke’s Services. 
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Getting things 
done in the field 
Downs fellows return from 
their travels with an apprecia¬ 
tion for the practical. 
Foreign fieldwork sometimes 
requires seat-of-the-pants skills 
beyond drawing blood or craft¬ 
ing a health survey. During 
assignments that took them to 
Africa, Asia, Latin America and Russia last summer, students 
learned, as medical student Vivek Murthy put it, “who you 
need to know to get things done.” Good communication is 
also important, Murthy found when he asked villagers in India 
to participate in a study of iron-deficiency anemia among 
teenagers. As part of the study he requested matchbook-sized 
stool samples. “That information got lost,” Murthy said. “We 
went to one school and found students bringing in bags of 
stool. In another, we had students bringing in stools that you 
sit on.” 
Murthy and 14 other students traveled under the auspices of 
the Wilbur Downs International Health Travel Fellowship 
Program. They presented findings from their investigations in 
October at the annual fall symposium and poster session of the 
Committee on International Health. 
For 31 years, students in medicine, nursing, public health 
and the Physician Associate Program have received Downs 
grants for studies abroad. Topics presented in October includ¬ 
ed the use of female condoms in Kenya, the involvement of 
Egyptian men in reproductive health decisions, interventions 
in South Africa to reduce vertical transmission of HIV, 
women’s health in Mexico City and the impact of sanitary 
sewage disposal on children’s malnutrition in Kosovo. 
Erik Hett learned to improvise in Kenya when a sudden 
electrical failure sent him scurrying in search of a generator to 
power his centrifuge. Without power, hours of work dissecting 
and preparing tsetse flies for analysis would be lost. Hett, a 
student in public health, hoped to determine whether the 
Wolbachia bacterium could kill the tsetse fly before the fly grew 
old enough to transmit the parasite that causes sleeping sick¬ 
ness. (His faculty advisor was Scott O’Neill. See related story, 
page 16.) Hett and co-worker Rhoei Dinglasan, a doctoral can¬ 
didate in public health and previous Downs fellow, finally 
found a working electrical generator in a local hair salon and, 
despite language barriers and quizzical looks from patrons, 
secured permission to plug in their centrifuge. 
The two trapped their flies in the bush, where they learned 
another lesson not taught in school. “The flies tried to follow 
the buffaloes,” Hett said, “so we had to make sure the traps 
were close to the buffaloes.” 
Murthy, who enjoyed collaborating with health workers in 
India, including doctors and nurses, said it was important to 
weigh his priorities and needs against those of the local popu¬ 
lation. “It is always a struggle to find a balance between them,” 
he said. “Listening to the local people was a critical part to 
making this successful.” 
Healing after torture 
A Yale student looks at the link between scar and symptom. 
Shadowing clinicians at Bellevue Hospital in New York City 
last summer, medical student George Lui heard questions most 
doctors never have to ask their patients. 
“Who tortured you?” 
“Where and when did it happen?” 
“Can you tell me more about it?” 
Lui worked in the Bellevue/NYU Program for Survivors of 
Torture, which offers multidisciplinary services to people who 
have experienced physical or psychological torture. The pro¬ 
gram provides long-term treatment to patients and their fami¬ 
lies, combining medical, psychiatric, psychological and social 
services provided by a variety of health professionals. Working 
under program director Allen S. Keller, M.D., Lui’s task was to 
review charts of the approximately 250 active patients in the 
program and look for correlations between specific forms of 
torture and individual symptoms. Such information could help 
clinicians develop more effective strategies for working with 
victims of torture. 
His apparently straightforward review took some twists and 
turns, Lui said. Cultural and religious habits and beliefs often 
dictated how people responded to torture. Tibetan torture sur¬ 
vivors, he noted, do not often meet formal criteria developed 
in the west for a diagnosis of post-traumatic stress disorder 
because they don’t avoid thoughts or activities associated with 
the trauma. Avoidance, however, is one of the three pillars of 
PTSD diagnosis. 
Clinicians often were unable to distinguish between symp¬ 
toms that resulted from torture and psychosomatic symptoms 
resulting from psychological distress. Lui cited the case of a 57- 
year-old woman from Sierra Leone. Trapped in her village dur¬ 
ing a battle, she watched as rebels burned her house and mur¬ 
dered her relatives. After receiving death threats, she came to 
the United States. “Once this summer she came to the clinic 
complaining of abdominal pain,” Lui said, recalling the med¬ 
ical consultation he observed. “Is this a sequela of her trauma 
history or an unrelated medical manifestation?” 
In his report, funded by the David E. Rogers Student 
Research Fellowship from the New York Academy of Medicine 
and the Yale School of Medicine Summer Fellowship, Lui list¬ 
ed forms of torture applied, countries of origin of the survivors 
and how the trauma was manifested. Beatings were the most 
common form of torture, followed by deprivation of food and 
water. Imprisonment was the most common psychological tor¬ 
ture, followed by murder of relatives. Most survivors in the 
program, 39 percent, were from Africa, followed by Tibet, 34 
percent. And most, like the woman from Sierra Leone, suffered 
from PTSD. 
“She started to talk about her trauma history and she broke 
out in tears,” Lui said. “It’s really important to listen to these 
stories because that could greatly influence how you treat tor¬ 
ture survivors.” 
Public health student Anusha 
Sinha describes her research on 
"Antibiotic Prescribing Patterns in 
Nagpur,” which was supported by 
the Coca Cola World Fund. 
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ALUMNI NEWS 
CORRECTION 
Three photographs were 
transposed on page 43 of the Fall 
1999 | Winter 2000 issue of Yale 
Medicine. The correct identifica¬ 
tions appear at right. 
Valerie E. Stone, 
M.D., '84 
Representative 
to the AYA 
Susan J. Baserga, 
M.D. '88, Ph.D. '88 
Member, Executive 
Committee 
Alumni turn out for ‘The Game 
Among the crowd of thousands at the Yale 
Bowl who watched the football team squeak 
by Harvard in the annual November match 
known simply as"The Game”were 500 alumni 
of medicine, public health and the house staff. 
Over a lunch of barbecued chicken, hamburg¬ 
ers, veggie burgers and New England clam 
chowder, alumni renewed old ties with each 
other before moving into the stands for the 
game. A last-minute touchdown clinched 
Yale’s 24-21 victory. 
Christine A. Walsh, 
M.D. '73 
Member, Executive 
Committee 
McManus is familiar ro many 
Yale medical graduates who 
have attended alumni events 
or been assisted by the Office 
of Alumni Affairs in recent 
years. She came to the 
University in 1987 to join the 
staff of the Yale Alumni 
Fund, serving the graduate 
and professional schools; two 
years later, she moved to the 
medical school’s Office of 
Development. McManus 
joined the Office of Alumni 
Affairs in 1997 and was pro¬ 
moted from administrative 
associate to assistant director 
in the spring of 1999. 
In announcing the 
appointment, Associate Dean 
Jane E. Reynolds praised 
McManus as “a true profes¬ 
sional whose efficient, 
thoughtful and energetic 
presence will advance not 
only the goals of the alumni 
affairs office, but those of the 
entire enterprise.” Along with 
long-time staff member 
Patricia DiNatale, McManus 
will work closely with the 
Association of Yale Alumni in 
Medicine and the Medical 
Alumni Fund Board. A 
search is under way to fill 
McManus’ previous position. 
“I’m honored to be work¬ 
ing with the alumni of the 
medical school. The devotion 
they show to their alma 
mater is inspiring,’’ said 
McManus, who succeeds 
William K. Jenkins, 
now at Drew University. 
“Patty and I both want to see 
the alumni activities that we 
have in place continue, and 
we want to see what can be 
enhanced.” 
New projects under way 
include a Web-based program 
to enlist alumni as mentors 
for current students, especial¬ 
ly during the residency appli¬ 
cation process. In addition, 
several events bringing alum¬ 
ni and students together are 
planned for the remainder of 
the year. Alumni Reunion 
Weekend will be held June 2 
and 3 (See page 48). 
New alumni 
affairs director 
is named 
ALUMNI NOTES 
Roy C. 
Robison, M.D. 
’36, B.A. ’32, 
writes to 
say that 
he is living in Tucson, Ariz., 
after retiring in 1979 from 
his ob/gyn practice in 
Connecticut. During his 
career, he was vice president 
of St. Joseph’s Hospital in 
Stamford, Conn., from 1966 
to 1969. 
SOS QMarie-Louise 
Johnson,Ph.D. 
’54, M.D. ’56, 
HS ’59, 
a Kingston, 
N.Y., dermatologist, is the 
first woman to be elected 
president in the 123-year 
history of the American 
Dermatological Association. 
The announcement was made 
during a conference in Vienna 
in July. She is serving as presi¬ 
dent-elect until July 2000, 
when her one-year presidency 
begins. Since graduation from 
Yale School of Medicine, her 
professional career has been a 
series of first achievements by 
a woman in medicine. Those 
honors include being the 
first female dermatologist 
elected to the National 
Academy of Sciences, Institute 
of Medicine, and the first 
woman presidential candidate 
of the American Academy of 
Dermatology (AAD), both 
in 1981. In 1995 she was the 
first woman recognized by 
the AAD as a Master in 
Dermatology, and in 1997 
was the first woman to receive 
the Finnerud Award of the 
Dermatology Foundation for 
excellence in clinical practice, 
teaching and research. 
Johnson, also active in the 
Association of Yale Alumni 
in Medicine since 1985, 
was its president from 1993 
to 1995 and received the 
Distinguished Alumni 
Service Award in 1996. 
Kristaps J. Keggi, M.D. ’59, 
HS ’64, received the Fifth 
Class Order of the Estonian 
Red Cross in a ceremony at 
the Estonian Embassy in 
Washington. The award, pre¬ 
sented for outstanding med¬ 
ical service to that nation, is 
one of Estonia’s highest med¬ 
ical honors. Keggi also was 
recognized as an outstanding 
teacher by the residents in the 
Department of Orthopaedics 
and Rehabilitation at Yale for 
his continued contributions 
and dedication to the resident 
education program. 
James A. 
O’Neill Jr., 
M.D. ’59, 
chair of the 
section of 
surgical sciences and the John 
Clinton Foshee Distinguished 
Professor of Surgery at 
Vanderbilt University in 
Nashville, was installed as 
president of the Southeastern 
Surgical Congress in February 
at the annual meeting in Lake 
Buena Vista, Fla. The organi¬ 
zation, founded in 1930, meets 
the needs of general surgeons 
for continuing their education 
beyond medical school and 
represents over 3,000 general 
surgeons in the Southeast, 
Puerto Rico and the District 
of Columbia. 
60S 
Philip D. 
Manfredi, 
M.D. ’65, 
writes to say 
t ^ that he and 
his wife, Joann, had a wonder¬ 
ful time and met some great 
people on the Association of 
Yale Alumni’s Alumni College 
Abroad Program. Their trip 
was called “Autumn in 
Burgundy and Provence.” 
Clarence T. 
Sasaki, M.D. 
’66, HS ’73, 
the Charles 
W. Ohse 
Professor of Surgery and chief 
of Yale’s section of otolaryn¬ 
gology, was honored by the 
American Laryngologic 
Association with the 
Casselberry Award for leading 
research in the area of basic 
laryngeal function. His 
research focuses on motor 
innervation of the cricopha- 
ryngeus muscle, the muscle 
that controls the upper 
esophageal sphincter and is 
involved in breathing and 
swallowing. 
70S 
John D. 
Bullock, M.D., 
HS ’74, 
chair of the 
Department 
of Ophthalmology and 
professor of physiology and 
biophysics at Wright State 
University’s School of 
Medicine in Dayton, Ohio, 
received the university’s 1999 
Brage Golding Distinguished 
Professor of Research Award. 
His research uses mathematics 
and physics to explain how 
improper administration of 
anesthesia can lead to eye 
injury. 
80S 
Patrice K. Rehm, M.D. ’81, HS 
’87, assistant professor of 
radiology at Georgetown 
University Hospital, was 
named a fellow of the 
American College of 
Radiology for outstanding 
contributions to this specialty. 
The award was bestowed in 
September during the annual 
meeting held in Washington. 
90S 
Erika H. 
Newton, M.D. 
’90, sent us a 
postcard from 
Panama City 
to say that she is currently 
on extended leave from a staff 
position in the Emergency 
Department at Mount 
Auburn Hospital and a teach¬ 
ing appointment at Harvard 
Medical School. She is 
circumnavigating the globe 
in a 35-foot sailboat with her 
husband. They recently 
transited the Panama Canal 
and were due to cross the 
Pacific this spring. 
Redentor L. 
Galang, M.D., 
a postdoctoral 
fellow in 
geriatric psy¬ 
chiatry at Yale in 1999, was 
appointed assistant professor 
of psychiatry at Southern 
Illinois University School of 
Medicine in September. 
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In memoriam 
Miguel R. Alonso, M.D. 
Mae Rhend Gailani, M.D. 
William F. Heidenreich, M.D. 
i. Peter Murphy, M.D. 
Paul B. Sigler, M.D., PH.D. 
Maurice Van Lonkhuyzen, M.D. 
Brig. Gen. Thomas J. Whelan 
Jr., M.D. 
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Miguel R. Alonso, M.D, ’63, 
of Tampa, Fla., died Aug. 30 
of renal cell carcinoma. He 
was 61. 
A native of San Juan, 
Puerto Rico, Alonso followed 
in his father’s footsteps and 
studied otolaryngology. After 
graduating from the School of 
Medicine, he served his 
internship at St. Vincent’s 
Hospital and Medical Center 
in New York. From 1964 to 
1969 he was a resident at the 
Johns Hopkins Hospital. As 
an Air Force major treating 
the wounded in Vietnam, he 
received decorations from 
three governments—Korea, 
the Republic of Vietnam and 
the United States. Alonso 
served at the University of 
Texas Medical Branch as an 
assistant professor until 1972. 
In 1975 Alonso moved his 
family to Tampa, where he 
started his practice and began 
teaching at the University of 
South Florida. He was in pri¬ 
vate practice and an associate 
professor in the Department 
ot Otolaryngology at the uni¬ 
versity until his death. During 
his career he also served as 
president of the Hillsborough 
County Medical Association. 
Mae Rhend Gailani, M.D., of 
Guilford, Conn., died Nov. 
24. She was 39. 
Gailani came to Yale in 
1990 as a postdoctoral fellow 
in pediatrics. In 1993 she 
joined the faculty as an asso¬ 
ciate research scientist in 
pediatrics and became an 
assistant professor of pedi¬ 
atrics and neonatology in 
1996. In addition to her 
expertise in neonatal medi¬ 
cine, Gailani was a significant 
contributor to research on 
inherited cancers. To recog¬ 
nize her devotion to her 
patients and her outstanding 
research accomplishments, 
the Department of Pediatrics 
named the recently estab¬ 
lished Young Investigator 
Award in her memory. 
Gailani was the wife of 
Steven E. Pfau, M.D., assis¬ 
tant prolessor of medicine 
and cardiology at Yale. 
William F. Heidenreich, M.D. 
’55, died Sept. 30 at his home 
in Marquette, Iowa. 
Born in Pittsburgh, 
Heidenreich attended Yale 
University, receiving his bach¬ 
elor’s degree in 1951 and his 
medical degree in 1955. He 
did his residency at the 
University of Chicago from 
1956 to 1959. He served for 
two years with the Army in 
Panama, before returning to 
Connecticut to work at the 
Veterans Affairs Medical 
Center in West Haven. 
Heidenreich then moved 
his family to Dubuque, Iowa, 
where he practiced radiology 
and nuclear medicine at 
Mercy, Finley and the former 
Xavier hospitals. In 1978 they 
moved to Utah, where he was 
on the staff at the Cedar City 
Hospital. In 1981 they 
returned to Iowa, where he 
served on the staff in the 
community hospitals of 
Waukon, Elkader, Cresco, 
West Union and New 
Hampton. He retired from 
medical practice in 1987. 
J. Peter Murphy, M.D. ’39, died 
Jan. 13, 1999, in Bethesda, 
Md., after a prolonged illness. 
He was 82. 
Born in 1916, in Aitkin, 
Minn., Murphy graduated 
from St. Thomas College in 
1935. He graduated magna 
cum laude from the Yale 
School ol Medicine in 1939, 
receiving the Campbell Medal 
for the highest-ranking 
medical student. His post¬ 
graduate training, which 
began at the New Haven 
Hospital, included pathology 
and neuropathology and 
ultimately led to a career in 
neurosurgery. 
Murphy was an associate 
professor of neurological 
surgery at The George 
Washington University for 
many years and had a private 
practice at Suburban Hospital 
in Bethesda, Md. He also 
served at other hospitals in 
the Washington area. 
He authored many medical 
articles and one book, 
Cerebrovascular Disease. 
According to his son, 
Michael, Murphy was devot¬ 
ed to Yale and sent his three 
sons there for their under¬ 
graduate education. All three 
followed him into medicine. 
A major highlight of his life 
was attending his 55th 
medical school reunion, 
where he was able to renew 
acquaintances from his time 
in New Haven. 
Paul B. Sigler, M.D., Ph.D., 
died Jan. 11 after suffering 
a heart attack while walking 
to his laboratory at Yale. He 
was 65. 
Bom in Richmond, Va., 
Sigler received his medical 
degree from Columbia 
University in 1959 and a doc¬ 
torate in biochemistry from 
Cambridge University, 
England, in 1968. He served 
his internship and residency 
at Columbia-Presbyterian 
Medical Center. 
In the early 1960s, Sigler 
did research at the National 
Institutes of Health to unravel 
the secrets of enzyme func¬ 
tion. He then joined the staff 
of the Medical Research 
Council Laboratory in 
Cambridge, England, where 
in 1967 the research group he 
was working with succeeded 
in determining the atomic 
structure of the second 
enzyme to be solved. 
Later in 1967 Sigler joined 
the faculty of the University 
of Chicago, attaining the rank 
of professor of biochemistry 
and molecular biology. In 
1989 he joined the Yale facul¬ 
ty and the Howard Hughes 
Medical Institute, serving as a 
professor of molecular bio¬ 
physics and biochemistry 
until his death. The National 
Academy of Sciences selected 
Sigler, in 1992, as an advisor 
to the federal government. 
Among his technical 
achievements was the struc¬ 
ture determination of a large 
assembly of protein whose 
function was to form a 
machine that assures the cor¬ 
rect folding of other newly 
synthesized proteins into the 
proper three-dimensional 
structure. This macromolecu- 
lar machine is among the 
largest structures solved and 
provided unprecedented 
mechanistic insights into a 
catalyzed process unknown 
until recently. 
As one of the world’s lead¬ 
ing structural biologists, 
Sigler’s primary research inter¬ 
est was the chemistry of cellu¬ 
lar regulation, focusing on the 
mechanisms by which gene 
expression is controlled, how 
transmembrane signaling is 
accomplished and the way 
that an enormous protein 
machine called a chaperonin 
assists in the correct folding 
of the proteins. His goal in all 
of these studies was to pro¬ 
vide the basis of fundamental 
biological processes in terms 
of stereochemistry. 
Maurice Van Lonkhuyzen, 
M.D. ’52, HS ’56, of Falmouth, 
Maine, died Nov. 26 at a hos¬ 
pital in Portland. He was 77. 
Born in Chicago, Van 
Lonkhuyzen grew up in the 
Netherlands. In 1941 he 
returned to the United States 
and served in the Army dur¬ 
ing World War II. He gradu¬ 
ated from Michigan State 
University and in 1952 
received his medical degree 
from Yale. Van Lonkhuyzen 
served his internship at Maine 
General Hospital and was an 
ophthalmology resident at 
Grace-New Haven Hospital. 
In 1956 he opened his pri¬ 
vate practice in Portland and 
introduced corneal transplant 
surgery in that region. He 
retired in 1995. During his 
career Van Lonkhuyzen 
served as chief of the 
Department of 
Ophthalmology at Maine 
Medical Center, staff surgeon 
at Mercy Hospital and presi¬ 
dent of the Cumberland 
County Medical Society. He 
also served as president of the 
medical staff at Pineland 
Center and president of the 
board of directors of the 
Maine Institute for the Blind. 
Brig. Gen. Thomas i. Whelan 
Jr., M.D. ’46, of Honolulu, 
died on Sept. 10 after suffer¬ 
ing complications and a 
stroke following hip replace¬ 
ment surgery. He was 78. 
A native of Lynn, Mass., 
Whelan received his bache¬ 
lor’s degree in 1943 and his 
medical degree in 1946, both 
cum laude from Yale. He was 
captain of the Yale baseball 
team. Following his intern¬ 
ship and residency at Strong 
Memorial Hospital in 
Rochester, N.Y., he began his 
career as a military surgeon, 
which included service in the 
Korean War. 
Whelan was chief of sur¬ 
gery at Tripler Army Medical 
Center in Hawaii and later 
held the same post at Walter 
Reed Army Hospital. He was 
also a special assistant to the 
Army Surgeon General, 
responsible for positioning 
military physicians world¬ 
wide. He retired from the 
Army in 1973 and became 
affiliated with the University 
of Hawaii, where he served as 
chairman of surgery and 
director of internship/residen- 
cy programs until his retire¬ 
ment in 1990. 
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Yale University School of Medicine 
Alumni Reunion Weekend 
Program Highlights 
Friday and Saturday, June 2-3, 2000 
Friday, June 2 
MINORITY ALUMNI LUNCHEON 
ALUMNI FUND CLASS AGENTS & 
REUNION GIFT CHAIRS LUNCHEON 
AYAM EXECUTIVE COMMITTEE 
LUNCHEON MEETING 
CLASS REUNION PROGRAMS 
Class of i960 - 40th Reunion 
Class of 1995 - 5th Reunion 
The Many Faces of Medicine 
THE IMPORTANCE OF AFFIRMATIVE 
ACTION TO THE HEALTH CARE OF 
OUR NATION 
KEYNOTE SPEAKER 
Augustus A. White in, M.D., ph.d. 
THE STUDENT PERSPECTIVE: 
LIFE AT YALE TODAY 
moderator Nancy R. AngofF, m.d. ’90 
MINORITY STUDENT PANEL 
Paola Uranga ’03 
Kevin Johnson ’02 
Rashida N’Gouamba ’02 
lose Miranda 01 
THE ALUMNl/FACULTY PERSPECTIVE: 
LIFE AFTER YALE 
moderator Forrester A. Lee, m.d.'79 
PANELISTS 
Kamau B. Kokayi, m.d. ’82 
Yvedt L. Matory, m.d. ’81 
Donald E. Moore, m.d., m.p.h. ’81 
O'Dell M. Owens, m.d. ’76 
Saturday, June 3 
BREAKFAST 
MINORITY REUNION 
STEERING COMMITTEE BREAKFAST 
Mapping the Future: 
The Human Genome Project, 
Yale Perspectives 
Panel Discussion 
moderator Carolyn W. Slayman, ph.d. 
PANELISTS 
Richard Lifton, m.d., ph.d. 
Margretta R. Seashore, m.d. 
David C. Ward, ph.d. 
ANNUAL MEETING OF THE ASSOCIATION 
OF YALE ALUMNI IN MEDICINE 
SHERRY/BUFFET LUNCHEON 
CLASS REUNION PROGRAM 
Class of 1955 - 45th Reunion 
GUIDED TOURS 
Yale Center for British Art 
Historic Sections of New Haven 
PLANNED GIVING OPEN HOUSE 
For information contact: 
Sharon R. McManus, Director, 
Office of Alumni Affairs 
Yale University School of Medicine 
RO. Box 7613, New Haven, ct 06519 
(203) 785-4674 
(203) 737-5U3 fax 
email sharon.mcmanus@yale.edu 
YALE SURGICAL SOCIETY PRESENTATION 
AND RECEPTION 
DEAN’S RECEPTION 
NEW ENGLAND CLAMBAKE 
Continuing 
Medical Education 
at Yale 
Association of Yale Alumni 
in Public Health 
Spring Workshop and Annual Meeting 
The Future of Public Health 
in the 21st Century 
Water’s Edge Resort and 
Conference Center, Westbrook, cr 
Friday, June 2 
Workshop: Reinventing Health Care 
moderator Henry Dove, ph.d. 
PANELISTS 
Karen A. Coughlin, m.a., b.s.n. 
William L. Kissick, m.d. ’57, dr.p.h. ’61 
Timothy B. Norbeck, dms 
Bruce I. Taylor, clu, m.b.a. 
Gail Wilensky, ph.d. 
Alumni Reunion 
AWARDS luncheon 
KEYNOTE ADDRESS: 
Gail Wilensky, ph.d. 
The Future of Public Health in the 21st Century 
APPROACHING THE LIMITS 
OF GLOBAL HEALTH AND WELLBEING 
ALUMNI PANEL 
ALUMNI POSTER SESSION 
DEAN’S RECEPTION 
NEW ENGLAND CLAMBAKE 
FIRST ANNUAL JOHN THOMPSON 
HEALTH MANAGEMENT DINNER 
Registration for each of these events is separate. 
Please contact Dawn Carroll, Office of 
Community and Alumni Affairs, Yale School of 
Public Health, P.O. Box 208034, New Haven, ct 
06520, by phone (203) 785-6245, or e-mail 
dawn.carroll@yale.edu 
Parking will be available all day at Water’s Edge 
and after 5 pm at College Plaza and the Graduate 
Club. If you need transportation from eph to 
Water’s Edge you must register with Dawn Carroll 
by May 15, 2000. 
Yale University School of Nursing 
Alumnae/i Association 
43rd Annual Alumnae/i College Weekend 
June 10 (Saturday) 
"Primary Care Update 2000: 
Snoring & Sleep Apnea" 
Course Directors: 
Douglas Ross, M.D. 
Vahid Mohsenin, M.D. 
Clarence T. Sasaki, M.D. 
Foxwoods Resort and 
Conference Center, Ledyard, CT 
ysn in Y2K: 
High Tech, High Touch 
Friday, June 2 
MINIMIZING THE HUMAN 
COST OF ADVANCEMENT 
THE YEAR IN REVIEW 
LUNCH 
PLENARY SESSIONS 
CLASS AGENTS MEETING 
SOCIAL HOUR AND BANQUET 
Saturday, June 3 
CONTINENTAL BREAKFAST 
YUSNAA ANNUAL MEETING 
NEW WORLD OF DIABETES: 
ADVANCES IN CARE 
LUNCH 
For further information, contact Barbara F. Reif, 
Director of Student and Alumnae/i Affairs, 
Yale University School of Nursing, 
too Church Street South, P.O. Box 9740, 
New Haven, CT 06536-0740 
Tel. (203) 785-2389 
If 
September 8 (Friday) 
"Fourth Annual Yale 
Glaucoma Symposium" 
Course Director: 
M. Bruce Shields, M.D. 
Water's Edge, Old Saybrook, CT 
September 9 (Saturday) 
"Pulmonary Conference” 
Course Director: 
Carolyn M. DAmbrosio, M.D. 
Foxwoods Resort and 
Conference Center, Ledyard, CT 
September 14-16 (Thurs-Sat) 
"Technically Challenging 
Procedures in Adult 
Cardiac Surgery” 
Course Director: 
John A. Elefteriades, M.D. 
Foxwoods Resort and 
Conference Center, Ledyard, CT 
October 13 (Friday) 
"The Moshe Lahav Lecture in 
Ophthalmic Pathology” 
Course Director: 
M. Bruce Shields, M.D. 
Harkness Auditorium 
October 19 (Thursday) 
"Third Annual Frisbee 
Stem Cell Symposium" 
Course Director: 
Edward Snyder, M.D. 
Omni Hotel, New Haven, CT 
October 21 (Saturday) 
"EEG in Clinical Psychiatry" 
Course Director: 
Nash Boutros, M.D. 
Jane Ellen Hope Building, 
Room no 
For information, contact the 
Office of Postgraduate and 
Continuing Medical Education, 
Yale University 
School of Medicine 
333 Cedar Street 
New Haven, CT 06520 
Tel: (203) 785-4578 
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On the cover 
Georgeta Coleman is one of more than too children 
adopted from overseas who will receive an evalua¬ 
tion and care this year at the Yale International 
Adoption Clinic. Founded in 1998, the clinic helps 
parents and pediatricians address the health con¬ 
cerns that may accompany international adoption. 
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Bringing science 
into focus 
Matthew Weed has a unique perspective 
on the confluence of science, media 
and public policy. 
By Cathy Shufro 
A match made 
in New Haven 
46 Alumni News 
48 In Memoriam 
Finding the right residency requires stamina, 
endurance and a high tolerance for airline food 
(not to mention anxiety). If you thought the 
process leading to Match Day was a challenge, 
imagine doing it as a couple. 
By John Curtis 
The ins and outs of 
international adoption 
A new Yale clinic guides parents and 
pediatricians through the complicated 
terrain of adopting abroad. 
By Sandra Ackerman 
LETTERS 
The early days of antibiotics 
To the editor: 
I read with great interest John 
Curtis' recent article on the 
first use of penicillin in this 
country [“Fulton, Penicillin 
and Chance,” Capsule, Fall 
1999/Winter 2000]. It brought 
back memories of my own 
role in that event. 
Mrs. Miller was a private 
patient of Dr. John Bumstead 
in the old Isolation Building 
of the New Haven Hospital. 
As such she was under the 
direct care of Dr. Bumstead, 
assisted by the junior intern 
assigned to the isolation serv¬ 
ice. I was that low man on the 
house-staff totem pole. 
The more senior members of 
the house staff were not 
involved with the care of a 
private patient. 
I remember Dr. Bumstead 
giving me the small bottle of 
penicillin—a yellow powder 
—with instructions to take it 
over to Dr. Morris Tager’s lab¬ 
oratory in the bacteriology 
department of the medical 
school and dissolve it in saline 
solution and pass it through a 
Seitz filter. This removed bac¬ 
teria but not viruses. I then 
returned to the patient’s bed¬ 
side and under Dr. Bumstead’s 
supervision gave her 5,000 
Oxford units of penicillin 
intravenously. This dose was 
repeated every four hours for 
the rest of her hospital stay. 
Mrs. Miller said she liked my 
“needlework” and Dr. Bum¬ 
stead asked me to continue to 
give her the injections every 
four hours around the clock 
including days and nights 
when I was otherwise off duty. 
The intravenous route was 
chosen because, in our igno¬ 
rance, we were afraid that 
intramuscular injections 
might cause a sterile abscess. 
As Mr. Curtis reported, all 
of Mrs. Miller’s urine was sent 
to Merck in Rahway, N.J., so 
that the penicillin could be 
recovered and returned to us 
in New Haven. After Mrs. 
Miller had recovered and was 
discharged, we had enough 
penicillin left to treat and cure 
a man with septicemia due to 
Staphylococcus aureus. Finally 
we had enough penicillin to 
start treating a young man 
with subacute bacterial endo¬ 
carditis due to Streptococcus 
viridans. At that time this was 
a uniformly fatal disease. He 
improved, his blood cultures 
became sterile, but we ran out 
of penicillin completely and 
he relapsed and died. 
In the early 1970s the 
School of Medicine sponsored 
a documentary film on the 
first use of penicillin in this 
country at the New Haven 
Hospital. It featured an inter¬ 
view with Mrs. Miller and the 
film crew visited my office in 
Washington, D.C., and inter¬ 
viewed me regarding the 
events I described above. I was 
then chief of gastroenterology 
and clinical professor of medi¬ 
cine at George Washington 
University School of Medicine 
as well as in private practice. 
Thomas S. Sappington Sr., 
M.D., HS 45 
Randolph, N.H. 
Before penicillin, 
the sulfa drugs 
To the editor: 
Your story on the first use of 
penicillin bought back memo¬ 
ries of another first use, an 
earlier one, that of the first 
sulfa drug, which I adminis¬ 
tered to patients when I was 
an intern at the New Haven 
Hospital during 1936-1937. 
The first sulfa drug was called 
Prontosil; it was a red liquid 
and was given by intravenous 
infusion. I cannot claim I was 
the first to use it, but it was 
the first sulfa drug and the 
first antibiotic that was avail¬ 
able when I was on duty in 
the little isolation building 
next to the Fitkin pavilion. 
I doubt if anyone remem¬ 
bers whether there was an 
effective treatment for infec¬ 
tious disease before the first 
antibiotic, but it was available. 
If anyone wishes to pursue 
the question further, it is told 
in my story “Quellung,” 
which can be found in my 
Web page. The URL is 
http://www.azstarnet.com/ 
^jerritt/remember.htm 
Jerome Ritter M.D. ’46 
Tucson, Ariz. 
Eyewitnesses to disaster 
To the editor: 
Thank you for the fine article 
about the circus fire of 1944 
[“A Tragedy’s Medical After- 
Sorry to bug you 
To the editor: 
Oops! Someone pulled out the wrong slide.The image inside 
the cover of the spring 2000 issue of Yale Medicine is clearly 
that of a parasite belonging to the genus Trypanosoma, rather 
than Plasmodium. My guess is that it is either T. brucei gambi- 
ense or T. brucei rhodesiense, the causes of West African and 
East African trypanosomiasis respectively, although it could be 
Trypanosoma cruzi, the etiologic agent of Chagas disease. In 
any event, it’s not the cause of malaria as stated in the caption. 
Louis V. Kirchhojf, M.D. '77, M.P.H. 77 
Iowa City, Iowa 
Thanks to Dr. Kirchhojf for spotting the error. The image in 
question shows not a malaria-causing agent, but a member of the 
Trypanasoma genus, T. brucei brucei, which is carried by tsetse 
flies and causes sleeping sickness. 
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math,” Capsule, Spring 2000]. 
My late husband’s (Albert S. 
Atwood, M.D. ’45) account of 
his classmates’ help with the 
disaster obviously stirred up 
many vivid memories. 
I was a student nurse at 
Hartford Hospital at the time. 
I recall how uncomfortable 
and helpless the victims of the 
fire were and how much care 
they needed from the staff. I 
am grateful that the medical 
students’ part in the tragedy 
was able to be told. 
Harriet Atwood 
Stonington, Conn. 
Other hands helped 
with healing 
To the editor: 
At the proper interval after 
the Hartford circus fire several 
of the house staff and perhaps 
a few fourth-year students 
spent several one-day trips 
back and forth to Hartford 
skin grafting the fire victims. 
I was one, as was Philip 
Brezina, Guido DeBlasio and 
probably Gervase Connor, 
who might have been an 
attending at the time. There 
were others whom I cannot 
remember. 
We hoped we did a service, 
but we certainly learned 
how to use the Padgett 
Dermatome. 
F.J. Lepreau, M.D., HS ’40 
Westport, Mass. 
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Top: Faculty members from 
St. Petersburg State University 
attend a workshop in the Beau¬ 
mont Room on the administration 
of institutional review boards. 
Above: Natalia Khaldeeva has 
received training at Yale and at 
the Medical College of Wisconsin 
through the Fogarty Program. 
Preparing for 
a tidal wave 
With an epidemic in the making, Russian 
scientists come to Yale for training in HIV 
prevention. 
For decades the Iron Curtain limited personal 
freedoms within the Soviet Union and the 
Eastern Bloc, as well as social exchanges 
between East and West. Until it fell in the ear¬ 
ly 1990s, it also kept at bay the HIV/AIDS 
epidemic sweeping Western Europe. The num¬ 
ber of new HIV infections in Russia hovered 
at only 200 a year. By 1996, however, largely 
due to injection-drug use, the number of cases 
rose to 1,546. Last year 18,140 new cases were 
reported in Russia, where health authorities 
expect that total HIV infections will reach a 
million by the year 2002. 
“Russia is confronting what is a very early, 
but likely to be very massive HIV epidemic,” 
said Robert W. Ryder, M.D., John Rodman 
Paul Professor of Epidemiology and Medicine. 
He is also director of Training and Research in 
HIV Prevention in Russia, a training project 
for Russian physicians and scientists. Ryder 
and his Russian colleagues have established a 
multidisciplinary research center at St. Peters¬ 
burg State University to develop, conduct and 
evaluate HIV prevention programs. 
“The most pressing need,” Ryder said, “is to 
establish a cadre of young Russian scientists 
trained in modern public health methods who 
are committed to returning to Russia to fill the 
enormous void in this area.” 
Funded by the Fogarty AIDS International 
Training Program at the National Institutes of 
Health, the project has brought 10 Russian 
scientists and physicians to Yale for long-term 
training since 1998. In February of this year a 
four-day workshop brought top faculty from 
the university in St. Petersburg to Yale to 
learn about the institutional review board 
system that oversees many of the clinical trials 
conducted in this country. 
Among the Russian scientists at Yale is 
Natalia Khaldeeva, M.D., Ph.D., who has 
treated patients with the disease since 1989. 
“Our experience here in the United States has 
been extremely valuable,” she said, noting that 
many resources available here, such as anti¬ 
retroviral drugs, are scarce in Russia. 
During her 18-month stay at the School of 
Public Health, Khaldeeva has been learning 
how to conduct clinical trials with new anti¬ 
retroviral regimens in HIV-infected patients 
and has been studying HIV treatment stan¬ 
dards and research protocols. She also has 
received training in HIV prevention methods 
and studied at the Center for AIDS Interven¬ 
tion Research at the Medical College of Wis¬ 
consin, Yale’s partner in the program. 
Prevention efforts, Ryder believes, can have 
a broad impact in Russia. “There are few other 
countries of similar size where one has such 
enormous possibilities for HIV prevention,” 
he said. 
This year the project was extended to India 
and China and has begun short-term training 
of researchers who are involved in World Bank 
projects on HIV prevention. “In the next two 
years injection-drug use will be the major 
mode of transmission in China,” said Zunyou 
Wu, M.D., Ph.D., a research scientist at the 
Chinese Academy of Preventive Medicine. 
“We also expect that sexual transmission will 
increase dramatically.” 
“We have seen what this epidemic has done 
in sub-Saharan Africa,” said Michael H. Mer- 
son, M.D., dean of public health and princi¬ 
pal investigator of the Fogarty grant. “We hope 
that our efforts can help avoid a similar 
tragedy in Russia, India and China.” 
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et cetera 
Alan Mermann talks with students Pamina Kim 
and Dan Prince in his office in the basement of 
Sterling Hall of Medicine. For nearly two decades, 
its homey atmosphere has encouraged visits for a 
chat, a cup of coffee or a crossword puzzle. 
Never a cross word. 
Always a crossword. 
The medical school’s chaplain is moving on 
after 17 years of nurturing students. 
After a lifetime of tending first to children, 
then to young adults, Alan C. Mermann, 
M.D., M.Div., is about to embark on a third 
career, ministering to the elderly and the sick. 
Mermann, 76, retired in June as the medical 
school’s second chaplain, a post he assumed 
“temporarily” 17 years ago. 
With its pots of coffee and stacks of news¬ 
papers, magazines and crossword puzzles, Mer- 
mann’s basement office has offered students a 
respite from the rigors of medical education. 
Some have come for something to drink or to 
sack out on the sofas. Others have sought 
counseling about personal matters. The chap¬ 
lain also has chaired a committee on pediatric 
ethics and taught courses on serious and 
chronic illness, pairing students with patients 
who can talk about what it is like to have a 
life-threatening disease. “I found a patient for 
each student,” Mermann says. “It was a patient 
with something serious such as metastatic can¬ 
cer, AIDS, renal failure or leukemia. The 
patient taught the student what they were 
going through. They recounted their experi¬ 
ences with physicians such as the characteris¬ 
tics of the good doctor and the not-such-a- 
good doctor.” 
Mermann never has stopped studying and 
last year acquired a master’s degree in the his¬ 
tory of medicine. He has articulated his beliefs 
on faith and ethics in two books, Some Chose 
To Stay: Faith and Ethics in a Time of Plague 
and To Do No Harm: Learning to Care for the 
Seriously IIIand was the author of the Yale 
Physician’s Oath, which he administered to 
each graduating class at Commencement. 
Asked if his courses have helped shape more 
compassionate physicians, he answers, “It may 
be that the half of the class that takes the 
course is the half that doesn’t need to.” 
Mermann’s interest in the health of children 
led him to the Deep South in the 1960s at the 
peak of the civil rights movement. He testified 
before the Senate and co-authored the report 
on child malnutrition that helped launch Pres¬ 
ident Johnson’s War on Hunger. His travels 
through the South sent him on a search for 
answers to the question of good and evil that 
led him, at the age of 50, to the Yale Divinity 
School. In 1982 he gave up his pediatric prac¬ 
tice in Guilford and a year later took on the 
chaplaincy. It was to be a temporary position. 
continued on page 6 
CAB construction 
gets under way 
With an occupancy date of March 2003, 
construction of the Congress Avenue Building (CAB) 
continued on schedule in late June. The 450,000- 
square-foot building was designed to increase 
teaching and laboratory space and is part of a $500 
million investment in medical school facilities. After 
excavating the site, crews began foundation work, 
pouring vertical walls and footings.The work was 
expected to continue through August, and in 
September, delivery of steel beams is to pave the 
way for erection of the building’s skeleton. Updates 
on the construction as well as photographs can be 
accessed at http://info.med.yale.edu/cab. 
LAURELS FOR CUSHING Harvey 
Cushing, a legendary figure in 
American medicine who began 
and ended his academic life at 
Yale, has been honored as one of 
the two most influential neuro¬ 
surgeons of the 20th century. 
The Congress of Neurological 
Surgeons (CNS) honored the 1891 
Yale College alumnus as "Man of 
the Century, 1900-1949,” and 
devoted a recent cover of its 
journal to him and to M. Gazi 
Ya^argil, a pioneer in cerebrovas¬ 
cular microsurgery who was 
trained by a protege of Cushing’s 
pupil Hugh Cairns. Cushing’s one¬ 
time bursary student Lycurgus M. 
Davey, M.D. ’43 March, who 
helped catalogue his collection of 
books in the late 1930s as a Yale 
undergraduate, was one of four 
authors who paid tribute to 
Cushing in the November 1999 
issue of Neurosurgery.Vne 
journal’s editor, neurosurgeon 
Michael L.J. Apuzzo, M.D., HS ’73, 
also worked on the Cushing 
collection in 1958 as a Yale under¬ 
graduate. Yale professor Issam A. 
Awad, M.D., will become presi¬ 
dent of the 4,800-member CNS 
in November. 
BIG JUMP IN APPLICATIONS 
Yale bucked a national trend with 
a jump of 43 percent over last 
year’s 2,469 applications to 
3.53°—or nearly 34 applicants for 
each spot in the 105-member 
class entering this fall. Part of the 
increase was due to Yale’s first¬ 
time participation in the Ameri¬ 
can Medical College Application 
Service (AMCAS), which enables 
students to apply to multiple 
schools with a single computer¬ 
ized application. However, Yale’s 
increase comes as medical school 
applications continued a down¬ 
ward trend nationally. In addition 
to AMCAS, Director of Admissions 
Richard A. Silverman credits the 
appeal of the Yale System for the 
school’s increasing success in 
attracting applicants.“We’re 
pleased with the numbers, but 
even more thrilled with the quali¬ 
ty of the applicant pool,” he said. 
"They are a remarkably diverse 
group with outstanding academ¬ 
ic, research, and extracurricular 
leadership records and a wide 
variety of experiences.” 
VALE MEDICINE SUMMER 2000 
CHRONICLE 
Kathleen Carroll (left) and colleagues are building a clinical trials 
network to evaluate drug-treatment protocols. Gerald Friedland 
(right) and others will test the concept of peer intervention 
among drug users and others at risk for HIV infection. 
from page $ 
The chaplaincy was created 
in 1967 and first filled by 
David Duncombe. "One of 
the things the medical school 
has done in the past,” Mer- 
rnann says, “is to provide a 
number of places where stu¬ 
dents can seek advice. All the 
way from 'Where’s the best 
pizza?’ to ‘I need a psychia¬ 
trist.’ I think it’s a shame to 
lose one of the places where 
students can go to talk about 
things in depth that are 
important to them.” 
The office endured and so 
did Mermann, who, helped 
by students who rallied to its 
defense, survived an attempt 
in the early 1990s to abolish 
the office for budgetary 
reasons. 
After 17 years he felt it was 
time to move on. Although 
unsure of his plans, Mermann, 
a pro bono pastor at the 
Norfolk Congregational 
Church, hopes to continue 
ministering, possibly to the 
elderly. He also is at work on 
two books, one on the history 
of medicine, the other on 
depictions of disease in litera¬ 
ture. Looking back on his 
tenure as chaplain, he 
describes his interactions with 
students as “a gift.” “They are 
so bright and intelligent and 
questioning and hopeful that 
it has been a very encouraging 
experience to see them com¬ 
ing along with everything they 
have to offer.” 
Mermann was the second 
and last chaplain at the med¬ 
ical school, which decided not 
to fill the position after he 
left. According to Nancy R. 
Angoff, M.P.H. ’81, M.D. 
’90, HS ’93, associate dean for 
student affairs, Mermann, the 
man, can never be replaced, 
but the students have other 
resources for personal and reli¬ 
gious counseling. 
But Yale has not seen the 
last of Mermann. As he told a 
reporter several years ago 
when interviewed for an arti¬ 
cle on medical education, 
when he dies Mermann plans 
to be going “up there.” He 
was referring not to the Pearly 
Gates, but to the third-floor 
anatomy laboratory, to which 
he has bequeathed his earthly 
remains for the training of 
future physicians. 
Major awards 
to support work 
in addiction, HIV 
With $17 million in grants 
awarded this year, Yale investi¬ 
gators are furthering their 
efforts to slow the spread of 
AIDS and reduce drug abuse. 
Two grants will fund separate 
programs that rely on peer 
counseling as well as interven¬ 
tions involving physicians. 
The National Institute on 
Drug Abuse (NIDA) and the 
National Institute on Mental 
Health (NIMH) awarded the 
grants to Yale and other insti¬ 
tutions in Connecticut. 
One NIDA grant provides 
$11 million over five years to 
establish a clinical trials net¬ 
work to evaluate drug-treat¬ 
ment protocols. “Typically, 
clinical trials research is based 
on a small, often homoge¬ 
neous population,” said 
Kathleen M. Carroll, Ph.D., 
associate professor of psychia¬ 
try and principal investigator 
for the grant. “We will be 
able to evaluate a range of 
treatments in community 
treatment programs and reach 
a large, diverse population.” 
Yale is one of six regional cen¬ 
ters in the country working 
on this project. When it is 
complete, it is expected to 
include between zo and 30 
regional centers. Joining Yale 
in this national effort are the 
Connecticut Department of 
Children and Families, the 
Department of Mental Health 
and Addiction Services and a 
nonprofit managed care com¬ 
pany, Advanced Behavioral 
Health. 
NIDA and NIMH also 
have awarded the University 
of Connecticut (UConn) and 
the Yale School of Medicine 
$6 million for projects to stem 
the spread of AIDS. The 
NIDA grant will fund a study 
of a peer intervention group 
composed of active and recov¬ 
ering drug users who are HIV¬ 
positive. They will attempt to 
counsel fellow addicts and 
convince them to obtain treat¬ 
ment for HIV/AIDS. The 
study will measure enrollment 
in primary care services, 
adherence to HIV treatments, 
entry and retention in drug 
treatment, reduction of risky 
HIV behaviors and increase in 
medical knowledge. Robert 
Brodhead, Ph.D., a sociologist 
at UConn, is the principal 
investigator. 
Mermann, who practiced pediatrics for years in nearby Guilford before 
becoming chaplain, will miss his contact with medical students: 
“They are so bright and intelligent and questioning and hopeful.” 
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Student Sandy Scott asks a question of education committee 
co-chair Ralph Horwitz during a "town meeting” on the committee’s 
recommendations to restructure the medical school curriculum. 
The NIMH grant funds an 
effort to determine whether 
the doctor-patient relationship 
can be used to promote HIV 
risk reduction. Physicians 
worry that anti-retroviral 
therapies may lull patients 
into the false notion that their 
disease is no longer a threat. 
“Some still engage in risky 
behaviors, so we continue to 
see new infections, but with a 
virus that is more resistant to 
drugs,” said Gerald H. Fried- 
land, M.D., director of the 
AIDS Program at Yale, and 
co-investigator on the study. 
The principal investigator is 
Jeffrey Fisher, Ph.D., a psy¬ 
chologist at the University of 
Connecticut. 
Faculty, students 
react to proposals 
for curriculum 
Faculty and students have wel¬ 
comed proposals to revise the 
medical school curriculum 
even as they raise questions 
about some of the specifics, 
according to Asghar Rastegar, 
M.D., professor of medicine 
and a member of the Dean’s 
Committee on Medical 
Education. The committee, 
formed two years ago by Dean 
David A. Kessler, M.D., to 
take a thorough look at med¬ 
ical education, has recom¬ 
mended integrating the teach¬ 
ing of basic and clinical 
sciences, strengthening clinical 
experiences in the first two 
years and revisiting basic sci¬ 
ence in the clinical years. 
(Yale Medicine, Spring 2000, 
“Deconstructing Education.”) 
The committee plans to 
submit a draft report to 
Kessler by September 1. The 
report will include the com¬ 
mittee’s recommendations as 
well as input from faculty and 
students, said Rastegar, deputy 
chair of internal medicine. 
Kessler may send the report 
back to the committee for 
revisions, or pass it on to the 
new deputy dean for educa¬ 
tion, Herbert S. Chase Jr., 
M.D., for implementation. 
Led by Ralph I. Horwitz, 
M.D., chair of the Depart¬ 
ment of Internal Medicine, 
and Charles A. Janeway Jr., 
M.D., professor of immuno¬ 
biology, the committee has 
met weekly for more than a 
year to discuss a restructuring 
of the four years of medical 
school. Under the committee’s 
proposals, basic science course 
work would end in December 
of the second year, students 
would take a month-long 
course in clinical skills, then 
move on to laboratories or 
the wards. 
The committee has pro¬ 
posed a reduction in sched¬ 
uled hours in the basic science 
years from 1,400 to 1,100. 
During their clinical years stu¬ 
dents would have 12 months 
on the wards and an opportu¬ 
nity to schedule an uninter¬ 
rupted block of six months for 
thesis research. The committee 
is considering ways to inte¬ 
grate basic sciences in a mean¬ 
ingful way in both the third 
and fourth years. 
Faculty members want to 
ensure that adequate supervi¬ 
sion is built in to the six- 
month period proposed for 
thesis research, Rastegar said. 
At “town meetings” held to 
discuss the proposals some 
faculty expressed concerns 
that basic science departments 
would lose control of their 
courses. Others believe that 
meaningful support of faculty 
who have significant teaching 
roles is needed to improve the 
educational environment. 
Students, meanwhile, are 
concerned about the integra¬ 
tion of basic and clinical sci¬ 
ences. “They wanted to be 
assured that, by condensing 
the first two years into 15 
months, what would be 
achieved would be an 
enhancement of the quality 
and not just loss of time and 
material,” said Nancy R. 
Angoff, M.D. ’90, HS ’93, 
M.P.H. ’81, associate dean for 
student affairs. 
Issues for future discussion 
include governance of the cur¬ 
riculum, strengthening clerk¬ 
ships and the role of technolo¬ 
gy in medicine and teaching. 
FACULTY PRACTICE ELECTS 
GOVERNORS The Yale Faculty 
Practice, the multi-specialty aca¬ 
demic medical practice composed 
of over 650 School of Medicine 
faculty members, has elected its 
first board of governors, choosing 
10 physicians to set policy and 
oversee clinical and business 
activities. David J. Leffell, M.D., 
director of the Faculty Practice 
and associate dean for clinical 
affairs, said the elected represen¬ 
tation is needed to achieve the 
goals of the medical school’s 
clinical enterprise.The newly 
elected members of the board of 
governors include department 
chairs Gary E. Friedlaender, M.D.; 
Ralph I. Horwitz, M.D.; Jon S. 
Morrow, M.D.; Dennis D. Spencer, 
M.D.; and Robert M. Weiss, M.D. 
Clinical faculty representatives are 
Zeev Kain, M.D.; Norman J. Siegel, 
M.D.; Barbara A.Ward,M.D.; 
Madeline S. Wilson, M.D.; and 
Barry L. Zaret, M.D. The board’s 
appointed members are Leffell, 
Mama P. Borgstrom, executive 
vice president and chief operating 
officer of Yale New Haven Health 
System: Peter N. Herbert, M.D. ’67, 
senior vice president and chief of 
staff of Yale New Haven Health 
System; Irwin M. Birnbaum, 
chief operating officer of the 
School of Medicine. 
A CHANGING TERRAIN IN THE 
TOBACCO WARS In the mid- 
1990s it seemed unthinkable that 
the Food and Drug Administration 
might regulate tobacco, but Dean 
David A. Kessler, M.D., then FDA 
commissioner, did just that. One 
might have expected disappoint¬ 
ment in March of this year when 
the Supreme Court, in a 5-4 deci¬ 
sion, overturned federal regula¬ 
tion of tobacco products. But 
Kessler found cause for optimism. 
"We’re in a very different place 
than we were five years ago,” he 
told The New York Times on the 
day of the decision. 
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Web site offers 
a wealth of data 
about the heart 
A tour through the heart and 
chest, with side trips into a 
wide range of diseases and 
diagnostic and therapeutic 
tools, is now as close as a 
computer keyboard for med¬ 
ical students and physicians. 
Introduction to Cardiothoracic 
Imaging, a new Web site 
developed at the School of 
Medicine, has drawn visitors 
from along Cedar Street and 
around the world since its 
debut in December. 
Visitors to the site can 
explore the material, which is 
organized under five topics: 
anatomy, techniques, findings, 
cases and references. Under 
anatomy, viewers can see 
drawings of the heart and 
chest, then click to an X-ray 
image. A click on the left 
pulmonary vein brings a brief 
explanation to the screen. 
The text, charts, X-rays and 
drawings are designed for a 
variety of uses, said John 
Paton, director of academic 
computing and media servic¬ 
es. Lecturers can pull individ¬ 
ual slides and transfer them to 
a PowerPoint presentation. 
Teachers can download images 
for inclusion in quizzes and 
students can pull out the 
pages they need for study. 
“It is an effort to get all the 
material in one place and 
allow people to get whatever 
they feel would be helpful,” 
Paton said. 
The site is a Web version 
of a CD-ROM produced in 
1994 by C. Carl Jaffe, M.D., 
professor of medicine, and 
Patrick J. Lynch, M.S., design 
director at the Center for 
Advanced Instructional 
Media. The CD-ROM used 
artwork, diagnostic images 
and text entirely generated at 
the School of Medicine. 
Rathef than continually 
update the CD-ROM, they 
decided to convert it to a Web 
format. After four months of 
work on the conversion, the 
site, at http://info.med.yale. 
edu/intmed/cardio/imaging/, 
was launched in December. 
Visitors made about 10,000 
page requests from the site 
that month. A fifth of the 
visitors were from education 
sites in the United States. By 
May, monthly page requests 
had increased to 17,000 pages, 
making it one of the most 
visited sites at the medical 
school. 
Office provides 
new support 
for telemedicine 
For many, the notion of 
telemedicine evokes the image 
of a doctor in the wilds, 
armed with only a cell phone, 
a stethoscope and a laptop, 
transmitting medical data to a 
modern hospital and receiving 
life-saving information in 
return. Two recent expeditions 
that took Yale physicians to 
Mt. Everest to test telemedi¬ 
cine concepts and tools have 
cemented that concept, as has 
Yale’s participation in a mobile 
surgical unit that uses tele¬ 
medicine to bring health care 
to the jungles of Ecuador. But 
practitioners say telemedicine 
also may be as mundane as a 
second opinion obtained over 
the phone or consultations 
with physicians in rural areas 
where specialists are scarce. 
Spyros G. Condos, D.Med., 
M.B.A., the director of the 
newly created Yale Office of 
Telemedicine, is in no hurry 
to define the topic. “The 
moment you define it,” he 
says, “you start limiting it.” 
The School of Medicine 
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Heavy hitter: C/AIM’s content-rich cardiothoracic resource is one of the 
top-drawing Web sites at the medical school. 
recently announced the 
appointment of Condos, an 
assistant professor of surgery, 
as director. Also appointed 
were Johanna Selles, R.N., 
Ed.D., as business manager, 
and Richard S. Stahl, M.D., 
M.B.A., as medical director. 
According to Joseph B. 
Warshaw, M.D., deputy dean 
for clinical affairs, the new 
office formalizes and coordi¬ 
nates what had been a diffuse 
set of projects throughout the 
medical school. “It was 
departmental,” said Condos, 
“and sometimes one depart¬ 
ment doesn’t know what the 
other is doing.” The office will 
serve as a clearinghouse and 
resource center for telemedi¬ 
cine programs throughout the 
medical school. Its goal is a 
marriage ol medical knowl¬ 
edge and information technol¬ 
ogy that will provide the best 
in clinical care domestically 
and overseas, while also train¬ 
ing physicians around the 
world. Selles said the office is 
developing projects in Saudi 
Arabia, the Philippines, 
Greece, China, South Africa 
and India. 
“We want to help people by 
providing information on how 
to accomplish their goals in 
telemedicine projects,” says 
Stahl, “This medical center is 
rich in educational content 
and has a lot to offer people 
and places.” 
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KLAUSNER BRANDLING-BENNETT HORTON PETERMAN FLORES 
An organizing principle for cancer therapeutics 
As knowledge of the human genome advances, physicians are 
finding ways to tailor cancer prevention and treatment to spe¬ 
cific molecular targets, according to Richard Klausner, M.D., 
director of the National Cancer Institute. Speaking at grand 
rounds in February on The Taxonomy of Molecular Targets, 
Klausner said, "I think we are beginning to see ways that we 
can organize the extraordinary complexity of genetic change in 
cancer.” The challenge for oncology and general medicine, he 
said, is to develop a usable, meaningful phenotypic database. 
“We are going to have a hard time developing successful thera¬ 
pies if we can’t understand the targets we’re looking at.” 
The uneven distribution of health care 
Wealth is more concentrated in Latin America and poverty 
rates are four times those of countries with similar gross domes¬ 
tic products, said David Brandling-Bennett, M.D., deputy 
director of the Pan American Health Organization, speaking at 
grand rounds at Epidemiology and Public Health in February. 
That adds up to poor health care for large segments of the pop¬ 
ulation. “We are not attending to the needs of those who are 
the neediest,” he said. Governments, he continued, must 
ensure that basic health services of adequate quality are provid¬ 
ed equitably. Of the $2.3 trillion spent on health care annually 
around the world, 90 percent is spent in industrialized nations. 
“We are not addressing the issue of disparity in health.” 
Where Harley Street crosses Fleet 
As editor of The Lancet, Britain’s leading medical journal, 
Richard Horton, M.D., finds himself straddling two worlds. 
“Editors have one foot in the perfumed halls of academia and 
the other in the sewage-strewn gutters of the press,” he said in 
April at the 52nd annual meeting of the Associates of the Cush¬ 
ing/Whitney Library. His journal’s readership is a broad clinical 
audience. Only 300 of the 6,000 manuscripts submitted each 
year are published, Horton said, and they must meet journalis¬ 
tic as well as scientific criteria. When they find their way into 
the hands of the lay press, misinterpretations can have unfortu¬ 
nate results. One study published in his journal described a 
possible link between submissiveness in women and lower rates 
of heart disease. The resulting newspaper headline? “Put down 
that rolling pin, darling, it’s bad lor your heart." Another press 
report, however, led parents to the mistaken belief that child¬ 
hood vaccinations could cause developmental disorders. “There 
was a panic, a serious drop in the uptake of the vaccine,” 
Horton said. “The effect was catastrophic.” 
Linking HIV care to socioeconomics 
Many interventions aimed at stemming the spread of AIDS 
miss the point, says Tom Peterman, M.D., chief of the pre¬ 
vention studies section at the Centers for Disease Control and 
Prevention. They assume, he said during a talk to Yale AIDS 
researchers in March, that individuals are in control of them¬ 
selves and their environment. But in this country the disease is 
increasingly associated with high rates of poverty, homicide, 
teen pregnancy, drug abuse and other sexually transmitted dis¬ 
eases. “It is hard to ignore race and racism as a factor in public 
health in the United States,” he said. “It is a pretty consistent 
finding that income inequality, more than income, determines 
health.” 
Communicating in the clinic, across cultures 
Language and culture can come between patients and care¬ 
givers, sometimes with disastrous clinical consequences, said 
Glenn Flores, M.D., co-director of the Pediatric Latino Clinic 
at Boston Medical Center. “Culture affects clinical care,” Flores 
said during his talk in March, “Culture and Patient-Physician 
Relationships: Achieving Cultural Competency in Health 
Care,” sponsored by Y-NHH Ambulatory Services. “It affects 
outcomes and it affects quality of care.” He cited the example 
of a physician who failed to grasp the severity of a Mexican 
girl’s abdominal pain because her parents spoke no English. 
After two return visits to the emergency room she was diag¬ 
nosed with peritonitis. In another case, a mistranslation led to 
suspicions of abuse and a mother’s uninformed consent to turn 
her daughter over to child welfare officials. Caregivers, he said, 
must be familiar with the language and culture of their 
patients. “What is not going to work,” he said, “is to say, ‘Let’s 
all be sincere, let’s hold hands and sing ‘We Are the World.’ 
We need to have a more diverse work force.” 
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Above: Stefan Somlo heads Yale's 
new PKD center of excellence, one 
of four in the nation devoted to 
research on the inherited fatal 
kidney disorder. 
Top: PKDi and PKD2 and their 
related proteins interact with 
each other either physically or 
through signals. When the PKDi 
or PKD2 genes malfunction and 
fail to produce functional pro¬ 
teins, cyst formation may result. 
NSH funds $5.6 
million center 
for PKD research 
A five-year, $5.6 million grant 
awarded by the National Insti¬ 
tutes of Health has established 
Yale as one of four centers of 
excellence for the study of a 
kidney disorder that is the 
nation’s most common life- 
threatening genetic disease. 
The new center brings togeth¬ 
er investigators from several 
departments to focus on poly¬ 
cystic kidney disease (PKD). 
Plans also are in the works to 
add a clinical component to 
speed translation of research 
discoveries into treatment 
advances. 
Although not all people 
with the disease are aware of 
the diagnosis, PKD is believed 
to affect some 600,000 Amer¬ 
icans. The inherited disorder 
causes cysts to develop in the 
kidneys, interfering in their 
normal functioning and fre¬ 
quently resulting in the need 
for dialysis or transplantation. 
There is no treatment or cure 
for the disease, which results 
in about 1,000 deaths each 
year due to kidney failure. 
According to nephrologist Ste¬ 
fan Somlo, M.D., associate 
professor of medicine and 
genetics and head of the cen¬ 
ter, “We’re now able to bring 
in new investigators and new 
approaches to study a disease 
for which there are currently 
no specific treatments.” When 
it opens, the clinical center 
“will take advantage of the 
basic-science expertise here 
and make it more accessible 
for patients.” 
Yale has long been active in 
PKD research. In 1996 Somlo 
and colleagues discovered 
PKD2, which is one of the 
two genes known to cause the 
disease. The other is PKDi. In 
January, Somlo and colleagues 
published findings in Nature 
Genetics about some of the 
previously unknown normal 
functions of PKDz. “We 
know that loss of function of 
either PKDi or PKDi causes 
the disease,” he said. “We 
don’t know what the genes’ 
normal functions are, but 
we’re getting much further 
along.” By understanding 
those functions, new avenues 
for treatment, prevention and, 
perhaps, a cure for PKD may 
emerge. 
Mental illness 
a barrier to 
cardiac care 
In a first-ever study of the role 
mental illness plays in cardio¬ 
vascular care, a team of Yale 
psychiatric and public health 
experts found that mentally ill 
patients receive significantly 
fewer cardiovascular proce¬ 
dures following a heart attack 
than other patients. Previous 
studies have shown that race 
and gender are important fac¬ 
tors in the treatment of car¬ 
diovascular patients, but this 
is the first study to show that 
mental health also plays an 
important role in cardiovascu¬ 
lar care unrelated to the 
patient’s other health and 
social issues. 
The study’s findings, which 
appeared in the January 26 
issue of the Journal of the 
American Medical Association, 
showed that a mental disorder 
Psychiatrist and epidemiologist 
Benjamin Druss wondered if men¬ 
tal illness prevents some patients 
from receiving adequate coronary 
care. Analysis of 113,000 cases 
indicates that it does. 
10 
reduces a patient’s chances of 
receiving otherwise standard 
cardiovascular procedures, 
including angioplasty, coro¬ 
nary-bypass surgery, and car¬ 
diac catheterization, by up to 
32 percent. According to the 
director of the study, Ben¬ 
jamin G. Druss, M.D., 
M.P.H. ’93, assistant professor 
of psychiatry and of public 
health, “It’s analogous to find¬ 
ings in the race and gender lit¬ 
erature about differences in 
practices. This difference in 
care was not based on the 
severity of cardiac illness, or 
socioeconomic, hospital or 
regional differences between 
groups.” The study looked at 
a range of serious mental dis¬ 
orders, including schizophre¬ 
nia, anxiety, depression and 
substance abuse. “We saw a 
similar pattern across the spec¬ 
trum,” said Druss. 
The causes for the differ¬ 
ences in care are not entirely 
clear. “It’s complicated,” said 
Druss. “Our best guess is that 
it’s something going on at the 
level of the patient-provider 
interaction. There’s obviously 
something going on that mer¬ 
its a closer look, and efforts 
should be made to raise 
patients’ and physicians’ con¬ 
sciousness about the issue.” 
Druss is now leading fol¬ 
low-up studies looking into 
longer-term outcomes and 
quality of care for patients 
with mental illness and ways 
of overcoming barriers to 
their care. 
Anti-cocaine 
vaccine passes 
first hurdle 
Most of the 900,000 cocaine 
abusers who seek treatment 
for their addiction each year 
in the United States eventually 
find their need for the drug 
irresistible and begin to use it 
again. An experimental vac¬ 
cine designed to suppress the 
high that users get from tak¬ 
ing cocaine may one day 
prove a tool for reducing that 
relapse rate. A Yale clinical 
study of the vaccine, TA-CD, 
found that it produced 
cocaine antibodies that could 
potentially keep the drug from 
reaching the brain and inhibit 
its effect. 
Thomas R. Kosten, M.D., 
HS ’81, professor of psychiatry 
and chief of psychiatry of the 
VA Connecticut Healthcare 
System, and his team adminis¬ 
tered the vaccine to 34 cocaine 
abusers who had three- to 
10-year cocaine habits and 
were living in a residential 
treatment facility. Supported 
by the National Institute on 
Drug Abuse, the study 
showed that TA-CD generated 
drug-specific antibodies, 
which bind to cocaine and 
may prevent it from traveling 
through the bloodstream to 
the brain, neutralizing its psy¬ 
choactive effect. The vaccine’s 
effectiveness in producing 
cocaine antibodies persisted 
throughout the trial. 
“The vaccine is very safe, 
and we did not observe any 
major side effects,” said 
Kosten. “TA-CD offers the 
potential for a completely new 
and highly viable approach to 
a very serious problem for 
which there are no alternative 
medication therapies available. 
But we just don’t know yet 
about its benefits for prevent¬ 
ing cocaine relapse.” 
He believes there is widespread 
agreement on what should con¬ 
stitute FDA regulation of tobacco. 
Tobacco should, he said, be regu¬ 
lated as a drug as a unique prod¬ 
uct, there must be constraints on 
marketing to youth, the FDA 
should be empowered to remove 
harmful agents from tobacco, and 
a regulatory process should 
encourage the development of 
"safer" cigarettes. He also noted 
that the justices acknowledged 
the dangers of smoking and that 
one tobacco company has agreed 
that the FDA should regulate its 
product. "Today’s decision really 
puts the issue squarely in the lap 
of Congress,” Kessler said. “The 
Supreme Court really has said 
that Congress has a moral 
responsibility to act.” 
A QUARTER-CENTURY OF 
TRAINING PHYSICIAN- 
SCIENTISTS The Medical Scien¬ 
tist Training Program will cele¬ 
brate its 25th year of training 
physician-scientists at the Yale 
University School of Medicine 
with a reunion this fall. Scheduled 
for Nov. 3-4,2000, the reunion 
will be open to current trainees as 
well as graduates. It will feature 
scientific talks by graduates and 
panel discussions on the future 
training of physician-scientists 
and career pathways taken by 
graduates. A poster session 
will highlight the work of current 
students. 
The program, generally referred 
to as the M.D./Pb.D. Program, 
trains medical students in the 
basic sciences through comple¬ 
tion of a Ph.D. Since 1975 it has 
been funded by the National 
Institute of General Medical 
Sciences of the National Institutes 
of Health. Most of the program’s 
160 graduates have gone on to 
conduct biomedical research. 
Eighty students are currently 
training in the program and par¬ 
ticipation is expected to increase 
to 90 over the next five years, 
with continuing support from the 
NIH and funds from the School of 
Medicine. 
For further information regard¬ 
ing the M.D./Ph.D. reunion, con¬ 
tact Susan Baserga, M.D./Ph.D. 
’88, associate director of academic 
development at {203) 785-4403. 
Cocaine addiction is the target of an experimental vaccine that 
generates antibodies specific to the drug. Investigators will next look 
to see whether TA-CD can prevent cocaine from reaching the brain, 
thus inhibiting or neutralizing its effects. 
YALE MEDICINE SUMMER 2000 
*1 
Rachel Lampert set out to 
explore the ways in which 
mental stress can influence the 
heart’s electrical system, with 
the ultimate goal of better 
predicting and managing 
cardiac arrhythmias. 
Stress worsens 
arrhythmias, 
increasing risk 
of sudden death 
Stress is as much a part of 
daily life as traffic jams and 
taxes. For those susceptible to 
arrhythmia, an abnormal 
heart rhythm, psychological 
stress can be especially danger¬ 
ous because according to a 
Yale study, it alters the charac¬ 
teristics of the arrhythmias, 
making them potentially 
deadly. 
The study sought to explore 
how mental duress affects the 
hearts of patients with 
implantable cardioverter- 
defibrillators. Using a pro¬ 
grammed stimulation system, 
the researchers triggered 
arrhythmias as part of routine 
testing of the defibrillators. 
Then they induced mental 
stress by asking the patients to 
discuss upsetting or frustrating 
situations and by grilling 
them with rapid-fire arith¬ 
metic problems, again trigger¬ 
ing arrhythmias with pro¬ 
grammed stimulation. The 
results, published in the Janu¬ 
ary 18 issue of Circulation, a 
journal of the American Heart 
Association, showed that not 
only did programmed stimu¬ 
lation during mental stress 
induce faster arrhythmias than 
those induced during rest, but 
these arrhythmias were also 
more difficult to terminate. 
According to cardiologist 
Rachel J. Lampert, M.D., 
assistant professor of medicine 
and the study’s principal 
investigator, “This shows that 
mental stress situations that 
raise adrenaline levels alter the 
behavior of arrhythmic cir¬ 
cuits, making them potentially 
more deadly.” Lampert hopes 
to develop preventive thera¬ 
pies and prognostic tools for 
at-risk patients. “For people 
with arrhythmias,” she said, 
“interventions aimed at block¬ 
ing responses to stress may be 
helpful.” 
Rate of tick- 
borne disease 
higher than 
suspected 
Ehrlichiosis, a disease carried 
by the same tick that trans¬ 
mits Lyme disease, is occur¬ 
ring at much higher rates than 
previously suspected. A three- 
year surveillance study of 
southeastern Connecticut resi¬ 
dents found annual rates of 
ehrlichiosis ranging from 24 
to 51 cases per 100,000 inhabi¬ 
tants. As happened with Lyme 
disease after it was first 
described by Yale scientists in 
the mid-1970s, rates of report¬ 
ing of ehrlichiosis are expected 
to rise rapidly. The annual rate 
of Lyme disease in the same 
survey area is 300 cases per 
100,000 persons, up front the 
50 cases per 100,000 people in 
the 1970s, according to associ¬ 
ate research scientist Jacob 
IJdo, M.D., who was the lead 
author of the study. 
Conventional 
Lyme treatment 
found effective 
Patients who undergo conven¬ 
tional antimicrobial treatment 
for Lyme disease report no 
greater level of health prob¬ 
lems years later than compara¬ 
ble groups who did not have 
the disease, according to the 
largest study to date of long¬ 
term effects of the disease. 
“The outcomes of the vast 
majority of patients with 
Lyme disease were excellent 
and not much different front 
those who had not had the 
condition,” said one of the 
study’s authors, Eugene D. 
Shapiro, M.D., professor of 
pediatrics and of epidemiology. 
As reported in the February 
2 issue of the Journal of the 
American Medical Association, 
the study looked at 678 
patients. “The degree of anxi¬ 
ety about Lyme disease that 
many people have doesn’t 
appear to be justified, given 
the positive, long-term out¬ 
comes of treated patients that 
we have observed,” said 
Shapiro. “The prognosis for 
the vast majority of Lyme dis¬ 
ease patients who receive con¬ 
ventional antibiotic treatment 
is excellent.” 
Lyme disease has been a 
lightning rod for controversy 
for years, with a vocal group 
of patients and some physi¬ 
cians insisting that the disease 
is underdiagnosed and under¬ 
treated. Many physicians, 
however, counter that a short¬ 
term regimen of antibiotics is 
adequate to treat the disease. 
FINDINGS 
Bench discovery raises 
hopes for therapy 
in spinal cord injuries 
Scientists can regrow severed brain and spinal 
cord axons in the laboratory, but something in 
the adult central nervous system prevents their 
regeneration in humans. As a result, paralysis 
and other disabilities resulting from brain or 
spinal cord trauma are irreversible in most cas¬ 
es. Three separate research teams, including a 
group from Yale and Harvard, have identified 
a gene and its protein that appear to block 
axon regeneration. The discovery of what is 
termed “Nogo” raises the possibility of devel¬ 
oping a therapeutic means of inhibiting its 
activity, increasing the hopes that brain and 
spinal cord injuries might one day be 
reversible. 
Previous experiments have shown that the 
natural adult brain environment contains one 
or more substances that inhibit the regrowth 
of central nervous system axons, unlike nerve 
cell connections in other parts of the body. 
Three papers published in the January 27 issue 
of Nature, including the Yale-Harvard group’s, 
reported the cloning of Nogo and identified 
its activity as an inhibitor present in the brain 
and very likely responsible, at least in part, for 
the failure of axons to regenerate. 
The Yale-Harvard study showed that the 
Nogo protein, by itself, stops axon growth in 
laboratory conditions. The protein is found 
only in those areas of the brain which are most 
hostile to axon growth. 
“Is this the answer?” asks Stephen M. 
Strittmatter, M.D., Ph.D., associate professor 
of neurology and of neurobiology, leader of 
the Yale team. “We’re pursuing experiments 
that will take things to the next step.” These 
include generating a mouse model in which 
the Nogo gene will be “knocked out” or dis¬ 
abled, and then inducing central-nervous-sys¬ 
tem injuries to see if axons regenerate. The 
Yale members of the group also are trying to 
develop a possible blocker for the action of 
Nogo and to identify the receptors mediating 
its activity. 
The discovery of the nerve growth inhibitor Nogo has introduced a potential avenue for restoring function 
in spinal cord injury cases. Stephen Strittmatter and colleagues will next use a mouse model to better 
understand Nogo’s behavior. 
NEW HAVEN HEALTH 
INFORMATION AT THE CLICK 
OF A MOUSE Two years after its 
introduction, a Web site designed 
to provide users with everything 
from health statistics to listings 
of regional public health services 
had its official launch in January. 
The New Haven Health site, 
http://info.med.yale.edu/ 
newhavenhealth, provides access 
to University, local, state and 
national resources describing 
New Haven’s public health and 
serves as a repository for health 
data, documents and directories 
of community organizations. Over 
the past two years staff at the 
Cushing/Whitney Medical Library 
and the Epidemiology and Public 
Health Library, who created and 
maintain the site, improved on its 
basic structure by adding infor¬ 
mation such as historical images 
related to New Haven’s health 
history and annual reports from 
the city. In addition, links to other 
health sites were added. By the 
fall, library staff hope to add a 
geographic information system 
with maps that pinpoint pockets 
of disease in the New Haven area. 
The site was funded by the 
National Library of Medicine. 
HIGH SCHOOLERS GET DOWN 
TO THE MICRON Most high 
school students work with low- 
powered microscopes and magni¬ 
fying glasses in their science proj¬ 
ects. Students at Hill Regional 
Career Magnet High School near 
the School of Medicine are learn¬ 
ing from a research-quality Zeiss 
EMiog electron microscope, an 
instrument capable of viewing 
molecular structures.The micro¬ 
scope was donated to the school 
by Yale in conjunction with the 
Connecticut Electron Microscopy 
Society. Yale and Career High 
already have an extensive part¬ 
nership for teaching area stu¬ 
dents about biomedical science. 
A Yale-directed team, including 
Barry Piekos, supervisor of the 
electron microscope laboratory in 
the Department of Molecular, 
Cellular and Developmental 
Biology, maintains the instrument 
and trains teachers and students 
in its use. 
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Barry Green found that test subjects perceived “thermal taste” 
differently in different parts of the tongue. 
The “taste of 
temperature” 
not such an 
odd notion 
What does a change in tem¬ 
perature taste like? According 
to a study by Yale investiga¬ 
tors, the same salty, sweet or 
sour tastes that are normally 
caused by food, drink and 
other chemical substances on 
the tongue. 
“We’ve discovered that spe¬ 
cific tastes can be produced by 
temperature stimulation, just 
as certain chemicals can evoke 
only certain taste qualities,” 
said Barry G. Green, Ph.D., 
professor of surgery in the sec¬ 
tion of otolaryngology and a 
fellow of the John B. Pierce 
Laboratory, who directed the 
study. The paper, which was 
published in the February 24 
issue of Nature, is the first to 
show how the brain interprets 
thermal stimulation of the 
tongue. The investigators 
cooled and warmed various 
areas of the tongue under pre¬ 
cisely controlled conditions to 
study what taste sensations 
subjects experienced. 
Individuals perceived “ther¬ 
mal taste,” as it is called, dif¬ 
ferently on different parts of 
the tongue. Warming the 
front of the tongue induced 
sweetness and cooling it pro¬ 
duced a salty or sour taste, 
while chilling the back of the 
tongue created a sour or bitter 
sensation. However, not every¬ 
one experiences thermal taste 
and the exact temperature 
conditions needed to produce 
it are rarely encountered in 
daily life. 
The close relationship 
between temperature and taste 
qualities suggests that recep¬ 
tors in the tongue that 
respond to chemicals have cer¬ 
tain properties that make 
them vulnerable to specific 
kinds of temperature change. 
This information may provide 
clues to understanding the 
nature of these receptor 
processes, as well as potential 
therapies for when they 
go awry. 
Animal model 
developed for 
Type I diabetes 
Insulin-dependent, or Type I, 
diabetes is one of the most 
common and potentially dev¬ 
astating chronic diseases. Yale 
investigators took a step 
toward unlocking the mecha¬ 
nisms behind it by creating an 
animal model showing one 
gene can cause the disease, 
while another gene can pro¬ 
vide resistance to it. The find¬ 
ings were made when the 
researchers induced diabetes 
in a mouse with HLA-DQ8 in 
the presence of the B7 co¬ 
stimulatory molecule. HLA- 
DQ8 is a human gene long 
suspected of being a factor in 
the disease. They also prevent¬ 
ed diabetes from developing 
in a transgenic mouse express¬ 
ing the HLA-DQ6 gene. 
Type I diabetes is an 
autoimmune disease in which 
the body produces an immune 
reaction that attacks its own 
tissues, eventually preventing 
the pancreas from producing 
insulin, which is necessary for 
the body to metabolize sugars. 
Researchers have previously 
shown in the laboratory that 
HLA-DQ8 is associated with 
diabetes. The study’s lead 
author, immunologist Li Wen, 
M.D., Ph.D., assistant profes¬ 
sor of medicine, said: “This is 
the first time it has been 
shown in vivo that HLA- 
DQ8 causes Type I diabetes 
and HLA-DQ6 confers 
resistance. Not only can we 
now study the molecular 
mechanism in more detail in a 
living organism, this is also 
very important for work in 
preventing and even curing 
the disease.” 
The study was published 
January 3 in the Journal of 
Experimental Medicine. Wen 
and colleagues are now look¬ 
ing further into the roles of 
both genes in diabetes. 
A new form of 
Ras is identified 
A Yale molecular biologist in 
collaboration with a colleague 
in Korea has identified a new 
type ol Ras protein, a class of 
genes known to be involved in 
nearly a third of all cancers. 
Because the new protein is 
different from the other 
known Ras proteins, the find¬ 
ing opens up a new area of 
study. 
Sankar Ghosh, Ph.D., asso¬ 
ciate professor of immunobi¬ 
ology and an associate investi¬ 
gator in the Howard Hughes 
Medical Institute, and his col¬ 
league found the new protein, 
kB-Ras, during studies of 
NFkB, a factor involved in 
relaying genetic information. 
kB-Ras regulates the action of 
NFkB. “What was surpris¬ 
ing,” said Ghosh, “was that 
other Ras proteins have char¬ 
acteristic mutations that cause 
cancer, but kB-Ras has the 
mutation in its natural form.” 
Unlike the others, however, 
kB-Ras lacks essential compo¬ 
nents for traveling to the cell 
membrane, which would be 
necessary for it to cause can¬ 
cer. The finding was reported 
in Science in February. 
The scientists are now 
studying various aspects of the 
gene and making an animal 
model. “We want to find out 
if there are mutated states in 
which it could become an 
oncogene,” Ghosh said. 
m 
Patricia Goldman-Rakic directed two recent neurobiological studies, one on a compound 
that reverses memory loss, the other on the brain’s dopamine receptor system. 
A drug that 
may reverse 
memory loss 
Short-term, or working, 
memory is often lost due to 
age, mental illness and long¬ 
term treatment with antipsy¬ 
chotic drugs. A Yale study 
found that an experimental 
drug provided long-lasting 
reversal of memory loss in pri¬ 
mates, offering hope for 
humans suffering from work¬ 
ing memory loss. 
In the study published in 
the March 17 issue of Science, 
Yale investigators found that 
even short-term treatment 
with the experimental drug 
ABT-431 reversed memory loss 
in monkeys that were being 
administered haloperidol, an 
antipsychotic compound that 
causes loss of short-term 
memory in these animals. The 
principal investigator for the 
study, Patricia S. Goldman- 
Rakic, Ph.D., professor of 
neurobiology, neurology and 
psychiatry said, “What's 
remarkable about this particu¬ 
lar drug is that patients would 
only need to use it for a short 
period of time to achieve 
long-lasting effects. 
Experiments at Yale are inves¬ 
tigating the cellular and 
molecular mechanisms of this 
drug’s actions and it is not 
currently available for clinical 
application.” 
Protein plays 
role in regulation 
of dopamine 
Researchers at Yale and the 
Medical College of Georgia 
have taken an important step 
in unraveling the complex 
molecular interactions in the 
brain’s dopamine receptor sys¬ 
tem. The discovery by Clare 
Bergson, Ph.D., formerly at 
Yale and now at the Medical 
College of Georgia, of a new 
protein in the dopamine sig¬ 
naling pathway, calcyon, could 
pave the way for new treat¬ 
ments for mental illness, 
including Parkinson’s disease, 
schizophrenia and possibly 
attention deficit hyperactivity 
disorder. 
The protein is named for 
“calcium on” because it inter¬ 
acts with one of the known 
dopamine receptors in the 
brain, the Di receptor, to 
enhance release of calcium, 
which increases dopamine’s 
activity. Low levels of 
dopamine activity are associat¬ 
ed with mental illness. The 
work was done with brain 
cells in the laboratory. “The 
next step,” said Patricia S. 
Goldman-Rakic, Ph.D., pro¬ 
fessor of neurobiology, neurol¬ 
ogy and psychiatry, and pri¬ 
mary investigator at the Conte 
Center for the Neuroscience 
of Mental Disorders, “is to 
learn if calcyon can increase 
the response of these neurons 
in the living animal.” 
LIGHT AT THE END OF THE 
CARPAL TUNNEL The conven¬ 
tional surgical procedure for 
alleviating the severe pain and 
disability associated with carpal 
tunnel syndrome requires an 
incision into the sensitive palm. 
Associate Professor of Plastic 
Surgery 1. Grant Thomson, M.D., 
is one of the few surgeons using 
and training surgical residents in 
an alternative procedure that 
does not require surgery on the 
palm. This system utilizes one 
incision at the wrist into which an 
endoscope is introduced to re¬ 
lease the carpal tunnel. “It’s much 
less painful and it avoids a scar on 
the palm,"Thomson, director of 
the Yale Hand and Comprehensive 
Microsurgery Center, said. “People 
can use their hands almost imme¬ 
diately, and they return to work 
much quicker.” 
NO LINK FOUND BETWEEN 
PCBS, DDE AND BREAST 
CANCER Many have suspected 
that exposure to polychlorinated 
biphenyls (PCBs) or the pesticide 
DDE was linked to an increased 
risk of breast cancer in women. In 
the largest controlled study to 
date, Yale researchers found no 
link between the toxins and 
breast cancer. Blood serum levels 
of PCBs and the organochloride 
compound DDE in nearly 1,000 
Connecticut women were ana¬ 
lyzed for association with breast 
cancer risk. No significant differ¬ 
ence in serum levels was found 
between the women with breast 
cancer and a control group with¬ 
out the disease. 
The study, directed by 
Tongzhang Zheng, Sc.D., associate 
professor of epidemiology, 
appeared in the February issue of 
Cancer Epidemiology, Biomarkers 
& Prevention. 
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In determining the atomic struc¬ 
ture of a complex involved in 
labeling cell products for proper 
distribution, Jennifer Doudna, 
above, and Robert Batey made an 
unexpected finding about SNPs. 
Molecular ‘ZIP 
coding' system 
speeds proteins 
to their appointed 
destinations 
From brain receptors to hor¬ 
mones, nearly half of the pro¬ 
teins in the body serve to 
transport biochemical infor¬ 
mation from one cell to 
another. Yale researchers have 
now described a major com¬ 
ponent of the molecular 
machinery for reading the 
“ZIP code” that guides a pro¬ 
tein’s movement from the 
inside to the outside of the 
cells. The findings open up a 
new window on evolution and 
offer possible novel targets for 
drug discovery. 
In a cover story in the Feb¬ 
ruary 18 issue of Science, the 
study revealed the molecular 
details of the machinery that 
identifies and delivers proteins 
to their correct destination. A 
protein first must be identi¬ 
fied for transport, then find 
the right target and, finally, be 
transported through cellular 
membranes to its destination. 
Under the direction of Jen¬ 
nifer A. Doudna, Ph.D., pro¬ 
fessor of molecular biophysics 
and biochemistry and an asso¬ 
ciate investigator of the 
Howard Hughes Medical 
Institute, co-investigator 
Robert Batey, Ph.D., deter¬ 
mined the atomic structure of 
the protein-RNA complex 
that recognizes an amino acid 
ZIP code tag, or signaling 
sequence, that identifies pro¬ 
teins to be transported to the 
cell membrane for secretion. 
This complex, part of the 
signal recognition particle, or 
SRP, was already known to 
serve a recognition function, 
but the discovery suggested a 
previously unknown and sur¬ 
prising role for RNA in the 
direct recognition of the 
amino acid ZIP code, or sig¬ 
nal peptide, in the protein 
being identified for transport. 
“We think that the RNA and 
the protein in the SRP work 
together to recognize the sig¬ 
nal peptide,” Doudna said. 
“Previously it’s been thought 
that the functions of the 
proteins and the RNA were 
separate. Here we are seeing 
an example of true molecular 
collusion.” 
i6 
Preventive factor 
may be a cause 
of heart disease 
According to a Yale study, a 
key immune factor produced 
by white blood cells that was 
thought to prevent hardening 
of the arteries may actually 
cause arteriosclerosis, one of 
the most common contribu¬ 
tors to potentially lethal heart 
disease. An interdepartmental 
team of surgeons and scien¬ 
tists found that interferon- 
gamma, which is produced by 
white blood cells and was pre¬ 
viously believed to inhibit the 
processes responsible for arte¬ 
riosclerosis, increased block¬ 
ages in animal models. 
The researchers were look¬ 
ing to develop new animal 
models to assess human trans¬ 
plantation responses. Heart 
transplants frequently result in 
the greatly accelerated devel¬ 
opment of arteriosclerosis. 
The scientists inserted seg¬ 
ments of arteries from pig or 
human hearts into the major 
blood vessel of mice that 
lacked immune systems and, 
as such, could not reject the 
foreign arteries. When the 
mice were treated with injec¬ 
tions of pig or human inter¬ 
feron-gamma, the grafts devel¬ 
oped arteriosclerotic lesions. 
“This observation,” said team 
member George Tellides, 
M.D., Ph.D., assistant profes¬ 
sor of cardiothoracic surgery, 
“may improve our ability to 
develop treatments for arte¬ 
riosclerosis. Also, we may be 
able to identify methods to 
genetically alter pigs to serve 
as organ donors of hearts 
resistant to arteriosclerosis.” 
The study was published in 
the January 13 issue of Nature. 
Donald Engelman and a Rochester colleague have shown there’s more 
than one way to fold a protein. Engelman used a small-angle X-ray 
scattering instrument, pictured here, to measure the size and shape of 
proteins in solution. 
A new twist on 
protein folding 
As disordered, one-dimension¬ 
al strings of amino acids, pro¬ 
teins cannot carry out their 
essential work in cells. In 
order to function, these com¬ 
plex molecules must first fold 
into stable, three-dimensional 
structures. 
It has long been assumed 
that proteins must have an oily 
core to reach a stable configu¬ 
ration. But Donald M. Engel¬ 
man, Ph.D., professor of 
molecular biophysics and bio¬ 
chemistry, and Shoei Koide, 
Ph.D., a collaborator at the 
University of Rochester Med¬ 
ical Center, have shown that 
the process can indeed vary. 
Their findings represent 
a major shift in the previously 
standard view of protein 
folding. 
Protein folding is a subject 
of intense scientific interest, 
because incorrect folding is a 
factor in chronic diseases 
including adult-onset diabetes 
and Alzheimer’s disease. Med¬ 
ical researchers hope to under¬ 
stand protein folding not only 
to develop diagnostic tools 
and therapies for diseases 
caused by failure of the 
process, but to understand the 
information in the genome. 
Previously it was believed 
that proteins organize them¬ 
selves by first forming a long, 
stringy polypeptide that then 
collapses into a compact shape 
by separating its oily parts 
from water. At that point, the 
proteins organize themselves 
into functional structures. 
In an article that appeared in 
the January 27 issue of Nature, 
the two scientists reported 
that they had modified a pro¬ 
tein in such a way that it 
organized itself without use of 
the hydrophobic, collapsing 
mechanism. “There is at least 
one alternative way of folding 
a protein without this feature 
that everyone thought was the 
key,” said Engelman. “This is 
a paradigm shift.” 
AN AT-HOME TEST FOR 
glaucoma A postdoctoral fel¬ 
low in ophthalmology, Marcio 
Marc Abreu, M.D., has designed a 
new device that allows patients 
to test themselves at home for 
glaucoma, an eye disorder which 
can lead to blindness. Currently, 
detection of glaucoma requires a 
visit to the eye doctor. "There is 
the potential to completely 
change the way glaucoma is 
treated, diagnosed and moni¬ 
tored,” said Abreu.“The technolo¬ 
gy allows for a completely auto¬ 
mated system without the need 
for any drops to anesthetize the 
eye for measurement. And the 
whole system is affordable.” 
Abreu’s system, which has been 
licensed to a private company for 
development, does not require 
direct contact with the eye, which 
is necessary for current test pro¬ 
cedures. Patients with glaucoma 
will be able to check their own 
condition at home as frequently 
as needed. "The device,” said 
Abreu,“is planned to provide the 
doctor with a whole history of 
pressure changes when the 
patient is not in the doctor’s 
office.” 
JOB PICTURE BRIGHT FOR 
RADIOLOGISTS Who says man¬ 
aged care is bad for doctors’ 
employment prospects? It’s not if 
you’re a radiologist, according to a 
job market study done by Howard 
P. Forman, M.D., vice chair of 
finance and administration in the 
Department of Diagnostic Radiol¬ 
ogy, and others. The investigators 
surveyed positions advertised in 
professional publications from 
January 1991 through December 
1998. Following a dramatic 
decrease to a low of 37 advertised 
positions in July 1995, the market 
has dramatically rebounded to its 
highest levels ever, with more 
than 300 advertised openings by 
the end of 1998. "Despite 
decreased reimbursement for 
exams,” said Forman, "there is a 
substantial increase in total vol¬ 
ume, so there is a need to hire 
more radiologists.”The study 
appeared in April in the American 
Journal of Roentgenology. 
Why are we so tasty to 
bugs? A genetic basis 
emerges in the lab 
Insects devour up to 40 percent of the world’s 
crops and spread disease to hundreds of 
millions of humans and livestock every year. 
Controlling pests has proven difficult at best, 
and current methods often have significant 
environmental side effects. The discovery of 
insect taste receptor genes by Yale scientists 
gives researchers new tools for understanding 
insect taste systems, and possibly for develop¬ 
ing novel means of pest control. 
John R. Carlson, Ph.D., professor of molec¬ 
ular, cellular and developmental biology, 
directed a research group that, for the first 
time, has identified insect taste receptor 
genes—nearly 40 for the fruit fly Drosophila. 
The discovery, published in Science in March, 
follows up on Carlson’s study detecting insect 
odor receptors that was published last year. 
The finding could lead both to a fundamental 
understanding about the physiology of 
taste systems and to development of nontoxic 
compounds to apply to crops, livestock 
and humans that would taste repulsive to 
the insects. 
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Abby Pease, who graduated from Yale College in May, 
met Matthew Weed two years ago when she volunteered 
to help prepare his insulin injections. Although she 
thought it was a crazy idea, Weed, who is blind and 
severely diabetic, insisted that she teach him inline 
skating. A year ago the two completed a 26-mile skating 
marathon in New York City. 
Matthew Weed has a unique 
perspective on the confluence of 
science, media and public policy. 
By Cathy Shufro 
Photographs by Gale Zucker 
In an office two levels below the reference room in the 
Cushing-Whitney Medical Library, Matthew Weed is reading a 
copy of Cell. He is listening to it, really, with the help of a 
Macintosh computer and software that converts text into elec¬ 
tronic speech. Think of a robot conversing in Portuguese, at 
quadruple speed, and you’ll have a rough idea of what Weed’s 
computer sounds like to the uninitiated. But he understands 
every word, even as he cranks the program as fast as it will go. 
Over the course of a year, Weed will absorb 10,000 journal 
pages in this way, by ear. 
His life as a blind (and severely diabetic) third-year graduate 
student in the Department of Genetics continually presents 
logistical problems, such as how to follow a discussion about a 
gene map that he cannot see, how to stay alive while crossing 
three lanes of traffic on South Frontage Road, and which way 
to feed a dollar bill into a Coke machine. (“Experimentation is 
the spice of scientific life,” he jokes when the machine spits the 
bill back at him and he has to try again.) 
The technology that translates the written word to the spoken word is Weed’s link to scientific literature and 
much of academia. Unintelligible to the untrained ear because of its speed, his computer's voice program 
sounds like an audiotape running amok in a foreign language. To hear a sample, point your Web browser to 
http://info.med.yale.edu/ymm/media and select "Bringing Science into Focus” on the contents page. 
Without sight, he is sharply aware of the visual basis for 
communicating ideas in the life sciences. The findings reported 
in journal articles often depend on evidence found in the charts 
and photographs accompanying the text, and Weed is constant¬ 
ly working from incomplete information. “Most of the evi¬ 
dence that we generate could be represented verbally,” he says, 
“but it’s usually represented visually because it can be done 
more efficiently. It leaves me trying to go back and get the 
words out of the pictures. I’m not getting the visuals; I’m only 
getting one stream of information.” 
Weed’s acute sensitivity to missing information has provided 
the foundation for his academic work: He is studying how 
missing information about science affects society. His disserta¬ 
tion will explore how key decisions are made in the lab and 
clinic and attempt to show how findings in the scientific litera¬ 
ture are often distorted by the news media—and consequently 
misunderstood by politicians and the public. “I’m as 
interested in how society answers its questions as in how sci¬ 
ence answers its questions,” Weed says. 
Building on a strong foundation in political science (includ¬ 
ing his undergraduate degree from Yale and a master’s degree 
from Princeton’s Woodrow Wilson School of Public and Inter¬ 
national Affairs), the 29-year-old Weed will examine how pub¬ 
lic understanding of science influences funding decisions. Weed 
says that reporters often make incremental advances sound 
more definitive—and relevant to human health—than they 
really are. Reporters suppress what scientists understand implic¬ 
itly, which is: “This is true in the lab. We don’t know yet what 
we’ll see out in the real universe.” Weed says that the inaccura¬ 
cy and distortion common in news coverage of biomedical sci¬ 
ence can have far-reaching consequences. “Policy and funding 
decisions are based on what the general public and Congress 
think,” he says, “not necessarily what scientists think.” 
On a more fundamental level, he is interested in the factors 
that influence decision-making within the basic sciences and 
clinical medicine. “In the lab, it could be ‘What model organ¬ 
ism does one choose to study a problem?’ In the clinic, it could 
be a case such as the Penn trial,” he says, referring to the clini¬ 
cal gene therapy research that resulted in the death last fall of 
18-year-old Jesse Gelsinger. “Why did the people doing the 
work choose an adenovirus as opposed to some other kind of 
vector? It may have been the only one they could have used. 
But adenoviruses are known to have fairly severe side effects, 
and, at dosages high above those in the protocol, those side 
effects killed the patient. Why were those choices made?” 
Weed’s advisor in the Department of Genetics is Professor 
Kenneth K. Kidd, Ph.D., who studies the genetics of complex 
human disorders and the organization of the human genome— 
areas that raise ethical issues akin to those that interest Weed. 
“I’ve been very involved with these ethical issues in trying to 
communicate good science to the public,” says Kidd, a leader 
in the fields of molecular and evolutionary genetics, “and that 
naturally overlaps with a lot of Matt’s interests.” Weed’s disser¬ 
tation committee includes faculty members from five disci¬ 
plines, including political science, management and the history 
of medicine. 
Ultimately, Weed hopes to serve as a mediator between scien¬ 
tists and the nonscientists who make public policy. A small, fit 
man with thinning brown hair and an alert manner, Weed 
would like to be the commentator journalists call upon to put 
advances in perspective. He imagines himself on television, say 
The NewsHour with Jim Lehrer, as the expert “who pushes sci¬ 
entists to be truthful in what they say and who also pushes the 
media to slow down a little bit in the conclusions that they are 
drawing about the sciences.” Weed hopes to advocate for fund¬ 
ing decisions based on the promise of research rather than on 
how well special-interest groups sway people in power. 
His sense of politics is well developed, and Weed himself 
knows how to identify and enlist key players in order to get 
things done. It was this astuteness that allowed him a decade 
ago, as an undergraduate at Yale, to radically expand resources 
available to the blind. Hugh Flick, dean of Yale’s Silliman Col- 
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Weed says his life is more complex, not more difficult, because of his blindness. 
He relies on volunteers, such as medical student Matthew Kronman, to prepare 
his insulin (above) and help him make his way (opposite) from classrooms and 
labs in the Sterling Hall of Medicine to his room in the Harkness dormitory. 
lege, recalls that when Weed was admitted to Yale College in 
1989, “I think they accepted him expecting he would take 
advantage of the accommodations Yale had offered [to blind 
students] in the past, which was mostly Braille and recordings 
for the blind.” 
“he changed yale” 
Weed was frustrated by the cumbersome process of using audio 
tapes to “read” textbooks and journals. So in 1990 he and 
friend Victor Grigorieff, a computer science major, linked an 
image scanner with software that could convert the print to 
ASCII text and then to synthesized speech. Weed says that 
Yale’s willingness to provide the equipment for high-volume 
scanning made it a pioneer among universities. Scanning texts 
allowed him to cover material much faster than he could by lis¬ 
tening to tapes, and locating quotations and statistics to use in 
papers became “infinitely easier.” By persuading faculty 
members and administrators to help him pursue his academic 
interests fully, Weed set a precedent that has helped disabled 
students who have followed. “He changed Yale,” Flick says. 
Weed has also enlisted allies to help him manage his dia¬ 
betes, which can be difficult to accomplish on his own because 
of his blindness. 
He and a coordinator provided by the medical school have 
assembled a group of student volunteers who monitor Weed’s 
blood-glucose levels. The students take turns meeting Weed at 
his dormitory room morning and evening to prepare his twice- 
a-day insulin injections. (Weed was diagnosed with diabetes 
when he was a year old and developed glaucoma as a pre¬ 
schooler, possibly as a complication of diabetes. By fifth grade 
he had lost his vision completely.) 
One of the students who has prepared Weed’s insulin over 
the past several years is Abby Pease, who graduated from Yale 
College in May. She heard about Weed through Flick and 
signed on as a volunteer two summers ago because of her inter¬ 
est in medicine. An ice hockey player, Pease commuted on 
inline skates from the undergraduate campus to Weed’s room 
at the medical school. One day Weed asked her to teach him to 
skate. Pease recalls saying, “‘You’re crazy. I’ll see you later. ” But 
Weed prevailed. They began by practicing in the Payne Whit¬ 
ney Gymnasium, with Pease skating backward while holding 
Weed’s hands. Pease never thought they would graduate to the 
rougher terrain of city pavement. But they did, and a year ago 
a team of students, including Pease, guided Weed through a 
marathon, skating 26 miles along the streets of Manhattan, to 
New Jersey through the Lincoln Tunnel, and back to the city 
over the George Washington Bridge. (Learning to skate was 
similar to the process Weed went through when, at age 4, he 
learned to ski in his native Colorado. A few times a year he hits 
the slopes in Vermont, guided on the novice and intermediate 
trails by friends who call out voice commands.) 
Although Pease found Weed to be patient when he taught 
her to prepare his insulin, she also thought him brash. (Or as 
Flick puts it, “He doesn’t suffer fools easily.”) “I think it’s partly 
who he is and partly because he’s had to fight for what he’s 
done,” says Pease. “You need to earn his respect. He challenges 
you. He doesn’t think twice about asking the tough questions.” 
She has come to value Weed’s intensity. “I really feel like I’ve 
made a friend for life.” 
Weed’s friends and colleagues have learned what kind of help 
Weed needs. People tell him their names when they say hello in 
a hallway or join him in the cafeteria. Fellow students at lab 
meetings help Weed to visualize a graph or chart by guiding his 
hand along its contours. Friends sort his paper money so he 
knows a dollar bill from a twenty. 
Weed has become increasingly comfortable with this reliance 
on others, arguing that he is no more dependent than are the 
people around him—who eat food grown by others, rely on 
computers they couldn’t build themselves, and stay warm by 
burning oil delivered by tanker. “You are just as dependent on 
other people as I am, but it’s not in your face,” he says. Fie 
does not consider his life more difficult than the lives of those 
around him, just more complex. “Everything requires an extra 
step, or two, or 20. It’s not an impossible way of life,” he says. 
“It just requires planning.” 
A GREAT, INTERESTING JOURNEY 
It is a life Weed would not have known without advances in 
computer technology and the advent of laws requiring accom¬ 
modations for the disabled. Had he been born just a generation 
earlier or not had sophisticated parents (a banker, who died 
when Weed was in college, and a teacher). Weed believes he 
would have spent his life in an institution. He seems unper¬ 
turbed by the thought, saying, “We’re playing with alternate 
universe scenarios here. In an alternate universe where I didn’t 
have the resources of a powerful family and technology and the 
law coming to hand just at the right time, I wouldn’t have 
known what it would be like to have these opportunities.” 
Weed’s mother, Patricia, resembles her son in choosing not to 
dwell on what might have been, for better or worse. She didn’t 
always see life that way. When her first (and only) child was a 
very sick infant and his survival was uncertain, she felt tremen¬ 
dous loss—the loss of the life she’d imagined with him. “It was 
scary. It was not what I had expected.” Over time she realized 
that she had to enjoy the moment without trying to picture 
the future. 
“My life is so much better than I ever could have imagined. 
At 23, I would not have envisioned the happiness and sense of 
abundance and joy that we both have,” she says. “I’m so grate¬ 
ful that Matthew is part of my life. It’s been a great, interesting 
journey so far.” 
A high-school French teacher in Colorado Springs, Patricia 
Weed hears from her son often, sometimes daily. They debate 
politics and philosophical issues, and work through any prob¬ 
lems that arise. “Matt and 1 have always gone through prob¬ 
lem, process, solution. We always go as quickly as possible to 
solution.” 
This pragmatic approach and sense of adventure have shaped 
how Matthew Weed views science. Just as he faces his own lim¬ 
itations head on and solves the problems they present, he 
embraces the moral dilemmas posed by scientific advances such 
as genetic engineering and cloning. He acknowledges their dan¬ 
gers, but asks, “Wouldn’t it be worse for society to run away 
from a piece of knowledge just because we fear something bad 
might happen?” He hopes his perspective will help society to 
respond to change with courage and clarity of vision. “I can act 
as society’s lens, looking at what we do and why we do it.” YM 
Cathy Shufro is a free-lance writer and a tutor in the Bass Writing 
Program at Yale. Gale Zucker is a corporate and editorial photographer 
based in Branford, Conn. 
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Finding the right residency requires stamina, endurance a: 
a high tolerance for airline food (not to mention anxiety), 
If you thought the process leading to Match Day was a 
challenge, imagine doing it as a couple. 
By John Curtis 
Photographs by Gale Zucker 
A letter in a mailbox ends art anxiety-ridden journey 
that starts months before as medical students struggle 
to find the right residency.Tanya Smith and Jose Prince, 
who met in their first year of medical school, 
complicated their search by matching as a couple. 
Along with 14,356 other fourth-year medical students in the 
United States, Tanya Smith and Jose Prince took time off from 
school this winter to make one of the most important, and 
long-lasting, decisions of their careers—choosing a residency. 
Because they will spend the next few years of their lives learn¬ 
ing their specialties, they wanted programs that would offer the 
best training possible with top faculty. They also stirred into 
the blend personal considerations such as geography and 
lifestyle. Then they further complicated the mix—they applied 
as a couple. 
That meant they would have to find medical centers with 
strong programs in obstetrics and gynecology, as well as sur¬ 
gery, the specialties Smith and Prince are pursuing. They 
would have to agree not only on a list of up to 20 programs 
they found desirable, but rank them in the same order of 
preference. Then, one of those programs would have to accept 
both of them. 
In the 48 years since the National Resident Matching Pro¬ 
gram began pairing residency programs and newly graduated 
physicians, much has changed. Applications are filed electroni¬ 
cally, rather than on paper. Applicants get their first view of 
programs on the Internet rather than in a brochure or on a 
campus tour. Applicants are increasingly likely to be women 
and more likely to marry other physicians. Although the Match 
has always tried to keep couples together, in the early 1980s a 
new computing algorithm for couples formalized the process. 
This year, according to the NRMP, 508 couples entered the 
match and 475, or 95.3 percent, were successful. 
Cynthia Andrien, assistant dean of student affairs, and 
Nancy Angoff (right), associate dean of student affairs, 
carry the letters to the mailroom. 
But it’s not easy. Between Dec. 3, 1999, and Feb. 4, 2000, 
Smith and Prince visited a total of 38 residency programs. 
Smith started at the University of Connecticut, flew to North 
Carolina the next day, then returned to Hartford for a three- 
hour layover before catching a plane to St. Louis. From there 
she flew to Michigan, interviewed in Ann Arbor and returned 
to Connecticut. She had interviews on Dec. 9, 10, 13, 15, 17 and 
18 and Jan. 3, 4, 7, 8, 10 and 29. 
Prince drove to Boston three times, crossed the country 
twice and racked up more than 20,000 travel miles. "You end 
up flying into one place,” said Prince, “then immediately flying 
out to another place.” He once left his parents’ home in New 
York City at 3:30 a.m. to drive to Pittsburgh and save on lodg¬ 
ing. He managed to avoid hotels throughout his interview 
marathon by staying with friends. In early February he spent 
his first night in New Haven in six weeks. 
INCREASING THE ODDS 
Smith and Prince, who met in their first year of medical school 
(they were elected co-presidents of their class), hedged their 
bets when matching. Instead of the dozen applications a single 
student might make, Smith applied to 30 medical centers and 
Prince to 25 before they narrowed their choices. By Jan. 29 the 
traveling was over for Smith and she turned her attention to 
completing her thesis. Prince finished his interviews on Feb. 4, 
at Yale. But the hard part lay ahead—considering their choices 
and making a priority list. “We agreed on number one, but 
couldn’t agree on two, three, four and five,” Smith said. “We 
tried to come up with the best combinations so that one of us 
wouldn’t have to compromise.” 
Both decided in their undergraduate years to become doc¬ 
tors. Prince, whose 90-year-old grandfather retired as a pedia¬ 
trician in Cuba just four years ago, said he’d always enjoyed sci¬ 
ence and believed medicine “was a wonderful way of spending 
my life, helping other people.” As an undergraduate at George¬ 
town University he majored in biology. Smith, also a biology 
major, originally planned on becoming a pediatrician and spent 
the year following her graduation from the University of Cali¬ 
fornia at Berkeley doing research in a children’s hospital. In 
medical school her interest shifted to obstetrics and gynecology. 
Both she and Prince took a fifth year to complete their medical 
studies. Smith worked in a lab studying breast cancer, where 
she co-authored a paper on the genetic basis of the disease that 
was published last year in the Journal of Clinical Oncology. 
Prince spent a year doing basic science research on diabetes at 
the National Institutes of Health. 
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As they investigated residency programs, they looked for 
more than good training. Just as it is for many in today’s work¬ 
force, lifestyle is an important factor for medical students. They 
want a program that will allow them to become highly skilled. 
Reputation is important, as is stability. Given the volatile 
finances of academic medicine in recent years, they want to be 
certain the program will last. Single students may prefer large 
cities, where they have a better chance to make another kind 
of match. Some students avoid programs with reputations as 
“boot camps.” Others may want to be near family or otherwise 
ensure that the program is in a desirable place to live. Both 
Smith, who grew up in the Bay Area of California, and Prince, 
from New York City, were under pressure to be near their 
families. 
“The thing everyone is looking for is a place with a strong 
reputation in whatever field it is that you’re in,” Prince said. 
“The most important thing for me,” says Smith, “is a place 
where I can fit in, get very good clinical training and that will 
give me options for the future.” 
This is perhaps a lot to ask for, but at Yale most students 
match to one of their top choices. According to Cynthia 
Andrien, assistant dean of student affairs, 90 percent of this 
year’s class matched at one of their first three choices, and 94 
percent got one of their top five. Nationwide, about 86 percent 
of the more than 20,000 U.S. and foreign medical students 
who applied matched to one of their top three choices at 3,769 
residency programs in the country. 
STREAMLINING THE PROCESS 
The Match began in 1952, an answer to the frustrations of 
medical students who too often felt pressured to take a bird in 
the hand. Programs offered positions and demanded immediate 
acceptances before students knew all their options. The Match 
ensured that everyone learned where they had been accepted on 
the same day, the third Thursday in March. 
At Yale the process starts in the third year of medical school 
with faculty-led workshops describing the process and prepar¬ 
ing students for interviews. It ends almost a year later when 
students open the letters that tell them where they’ve been 
accepted. Those letters are final. Upon entering The Match, 
students agree to abide by its decision. “If you make the wrong 
call and end up at the wrong place, it’s a big chunk of time,” 
says Prince. 
Making the perfect match begins and ends on the Internet. 
Smith and Prince started with tours of Web sites, and by the 
Nov. 19 application deadline they had narrowed their choices. 
Like most Yale medical students, they filed their applications 
electronically, submitting them on computer disk to the Office 
of Student Affairs, which added deans’ letters and supporting 
documents to the file. 
One thing hasn’t changed in the electronic age. Applicants 
still have to travel to interviews that afford them a chance both 
to make a good impression and take a look at residency pro¬ 
grams. Along the interview trail they run into the same people 
again and again. First viewing them as competitors, Prince and 
Smith began to see their peers as future colleagues and friends. 
“You think, 'I hope I end up with this guy because he will be 
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fun to work with,”’ Prince said, adding that he kept in touch 
with his new acquaintances by e-mail and often made dinner 
dates at future interview locations. New friends on the trail also 
provided information they couldn’t get elsewhere. “They were 
one of the most valuable resources,” Smith said. “They had 
been to the same places as I had been, but had different 
impressions or met a different faculty member.” 
Medical students and residents provided a fuller picture of 
each program. “People are so eager to tell you about the posi¬ 
tive components of their program and they are very slow about 
telling you their faults. Caveat emptor,” says Prince. “It’s usual¬ 
ly a red flag if you don’t get to meet the residents.” 
Interviews followed a pattern—an introduction and orienta¬ 
tion over coffee and donuts, a round of three or four inter¬ 
views, lunch and a tour. Some interviewers were familiar with 
his resume, said Prince, while others appeared to be leafing 
through it for the first time. The first set of interviews in 
December was daunting, he said. By February the trick was to 
answer a question for the umpteenth time without sounding 
rehearsed. 
With interviews over, the Match’s final deadline loomed in 
February. By 11:59 P m- on Feb- 16, Smith and Prince had to 
log onto the NRMP’s Web server and submit their list of 
choices, in order of priority. Number one on their list was the 
University Health Center in Pittsburgh. 
THE MATCH 
The day of reckoning arrived on March 16. Assistant Dean 
Andrien, accompanied by Nancy R. Angoff, M.P.H. ’81, M.D. 
’90, HS ’93, associate dean of student affairs, carried a stack of 
about 100 letters to the ground-floor mailroom at Harkness 
Hall. Ignoring the eager and expectant faces around her, 
Jody Levine celebrates with one of her two children. 
Andrien closed the mailroom door and began placing letters in 
slots. Outside, the tension was growing. “You could not pay me 
enough to relive this week,” said Megan Lisska, who, along 
with her boyfriend, Matthew Falk, had sought a pediatrics resi¬ 
dency. They weren’t matching as a couple, as Prince and Smith 
had done, so there was a chance they would end up apart. 
“This process is brutal,” said Lisska. 
Prince arrived, gave Smith a hug, and the two went off to 
find their friends. Along with their classmates, they had been 
relieved to learn on Monday that they had avoided The Scram¬ 
ble. Although most Yale medical students get one of their first 
choices, the occasional few fail to match anywhere. They may 
have chosen only the top programs in highly competitive spe¬ 
cialties, or they may have decided not to include a safe program 
on their list and been unpleasantly surprised. The Scramble is a 
last-minute race to find a residency slot. Students may opt to 
spend a year doing research or accept a preliminary residency 
for a year before trying again. 
A few minutes before noon, an over-eager student popped 
his head into the mailroom. He was shooed out. “I have 11:59,” 
said Angoff with a mock frown, as she and Andrien slipped let¬ 
ters in mail slots. Then she laughed. “OK,” Andrien said. “Let 
the craziness begin.” 
The students started streaming in. Some were in tears before 
they even got to their mail slots. Others held hands with 
friends. Some ripped open their letters and started cheering. 
Others left the mailroom with their letters unopened. 
Lisska and Falk had reason to celebrate. They both would be 
going to Stanford University in California. “We got our first 
choice,” Lisska said. 
This year’s class continued a trend away from specialties and 
towards some form of general medicine. About two-thirds of 
the students chose residencies in internal medicine, primary 
care, pediatrics or obstetrics and gynecology. Programs in 
Boston drew the most students in this class, 21, followed by 
New York City, where 17 students found residencies. Sixteen 
students chose to stay in New Haven for residencies at Yale- 
New Haven Hospital. (For a complete list of placements, see 
page 42.) 
Outside the mailroom, Smith and Prince were celebrating 
their joint acceptances at University Medical Center in Pitts¬ 
burgh, their first choice. “It’ll be a great place for us,” Prince 
said. “The professors are down to earth. They have a good 
sense of balance between work and play.” Tanya nodded, tears 
in her eyes. “I’m so happy,” she said, ym 
John Curtis is the associate editor of Yale Medicine. Pem McNerney, a 
free-lance writer in Connecticut, contributed to this article. Gale Zucker 
is a corporate and editorial photographer based in Branford, Conn. 
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A happy ending for Smith and Prince as a " 
match made In New Haven leads to their first 
choice—“Pittsburgh, 
PEDIATRICS 
THE INS AND OUTS OF 
internatio 
A new Yale clinic guides parents 
and pediatricians through the 
complicated terrain of adopting 
abroad. 
By Sandro J. Ackerman 
Photographs by Robert Lisak 
When parents bring their young children to the International 
Adoption Clinic at Yale, they arrive with questions, often by 
the dozen. When will my child begin walking? Is his eating 
normal? Is this behavior normal for her age? Are his size and 
weight within range? Some of the questions are typical of any 
routine visit to the pediatrician; others could only be posed by 
families that have adopted from overseas. Underlying all oi 
them is one fundamental concern: Will my child be normal 
and healthy? 
If having a baby opens an ordinary Pandora’s box of ques¬ 
tions and concerns, then adopting a child from another coun¬ 
try opens an even larger one. In addition to the normal adjust¬ 
ments of parenthood, parents who adopt from abroad must 
take into account the social and cultural heritage of their 
child’s homeland, along with any medical issues that are specif¬ 
ic to that country. For pediatricians, these questions have aris¬ 
en more and more frequently. In 1992 the U.S. Department of 
State counted 6,536 international adoptions; by 1997 the num¬ 
ber had more than doubled, to 13,620. According to the Joint 
Council on International Children’s Services, 16,396 children 
were adopted from abroad by U.S. parents in 1999. This small 
but growing population of young patients brings with it some 
unfamiliar medical challenges, ranging from iodine deficiency 
to incomplete vaccination records and obsolete screening tests. 
Georgeta Coleman, 2, arrived from Eastern Europe 
in May and visited the Yale International Adoption 
Clinic shortly thereafter. During their evaluation 
physicians found Georgeta to be in good health, 
despite a common intestinal parasite and slight 
developmental delays. "She's doing just fine,” says 
her mother, Mary Ellen Coleman. 
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“In some cases there has tc 
that takes place before the childi 
Margaret Hostetter, left, the clinic’s director, and colleagues 
are at work on a study that will track adopted children well into 
the future to identify factors that may lead to developmental 
problems. 
Since its formation in 1998, the Yale clinic has offered new 
resources to pediatricians and adoptive families throughout 
Connecticut and parts of New York. Led by Margaret K. 
Hostetter, M.D., professor of pediatrics, the Yale International 
Adoption Clinic combines up-to-date tracking of diseases that 
are common outside the United States with a thorough under¬ 
standing of how a child’s previous living situation and care may 
affect his or her physical, mental and emotional development. 
“Development is not like a clock that just slows down in 
difficult circumstances. In some cases there has to be an 
unlearning that takes place before the child can go forward,” 
says Hostetter’s colleague Carol Cohen Weitzman, M.D., an 
assistant professor of pediatrics who specializes in developmen¬ 
tal and behavioral issues. 
Parents who come to this clinic, like any parents of young 
children, have at least as many questions about their children’s 
behavior as about their general health. Often, however, they 
raise issues that rarely crop up in general pediatrics in this 
country. For example, if the child hoards food in his room or 
hides it throughout the house (a habit often seen in older chil¬ 
dren coming from orphanages), that may actually be a reason¬ 
able but misplaced response to a scarcity of food sometime in 
his past. As the child learns to trust his parents to provide 
enough food every day, the hoarding may gradually stop. “It’s a 
matter of teasing out what’s normal growth and development 
from what has to do with the fact that the child has come 
from adverse circumstances,” says Betsy Groth, A.P.R.N., a 
nurse practitioner in the clinic. 
“A parent may ask, ‘My two-year-old is saying “no” all the 
time. Does it have anything to do with her upbringing in Chi¬ 
na?” says Groth. “I tell the parent, ‘Well, no, it’s because she’s 
a two-year-old.’ But if someone asks, ‘Do you think it’s normal 
that a three-year-old wouldn’t try to feed himself at all?’ I 
would say, ‘That isn’t normal, but it may have been appropri¬ 
ate in an orphanage where the children were always fed by the 
staff and not encouraged to feed themselves because that 
would have been too slow and messy.’” 
STANDARDS OF CARE 
Based on the second floor of Yale-New Haven Children’s Hos¬ 
pital, the Yale International Adoption Clinic practices pedi¬ 
atrics at a pace rarely seen since the advent of managed care. 
Three or four appointments make for a full morning, and the 
routine allows for plenty of discussion between clinicians and 
families. Clinic director Hostetter is thoroughly familiar with 
the requirements of this specialized medical field—in fact she 
is one of the founders of the field, having worked with Dana 
Johnson, M.D., Ph.D., to establish the country’s first interna¬ 
tional adoption clinic, at the University of Minnesota, in 1986. 
32 
De an unlearni 
:an go forward 
She and Johnson, together with several colleagues, published 
a 1989 paper titled “International Adoption: An Introduction 
for Physicians” and a later paper on unexpected medical diag¬ 
noses that emerged when internationally adopted children 
received their first medical evaluations in the United States. In 
1992, when the surge of adoptions of Romanian children was 
at its height, Hostetter, Johnson and others published a case 
series of 65 Romanian orphans who had been brought to the 
United States for adoption in the previous year. They found 
high rates of hepatitis B, intestinal parasites and developmental 
retardation, leading them to the sad conclusion that Romanian 
adoptees at that time were “an extraordinarily high-risk pedi¬ 
atric group as a consequence of government-sanctioned child 
neglect and abuse.” They also developed a list of seven essential 
screening tests, which the American Academy of Pediatrics 
endorsed in 1991 as the standard of care for adoptees. 
ASSESSING THE RISK 
Two years ago, with the Minnesota clinic well established as a 
center of both treatment and consultation for internationally 
adopted children, Hostetter was recruited to launch a similar 
clinic at the School of Medicine. Here, she and Michael Cap- 
pello, M.D., associate professor of pediatrics (infectious dis¬ 
eases) and of epidemiology, carry out a careful physical exam 
of each child who comes to the clinic, while Weitzman evalu¬ 
ates the children for possible developmental problems and 
Groth handles the medical history and general information 
intake. 
The clinic currently sees patients one morning each week, 
for a total of about 10 to 12 children per month. Hostetter also 
leads a collaborative group of seven basic investigators and 
their laboratory staffs at the Yale Child Health Research Cen¬ 
ter and heads up the Department of Pediatrics immunology 
section. She also serves on the National Advisory Child Health 
and Human Development Council, the principal advisory 
body of the National Institute of Child Health and Human 
Development. 
Children adopted overseas, says Carol Weitzman, often don’t fit 
into traditional patterns of American babies. Each child will 
adapt at his or her own pace. 
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"Should an orphanage stay 
Are the children of one 
of more 
country 
Michael Cappello sees himself and his colleagues as 
a resource to other doctors.“Our role should not be 
to supplant the community physicians,” he says. 
“We want to supplement them.” 
Together with her colleagues at the Yale clinic, Hostetter 
continues to investigate issues that have proved central to 
international adoption. Says Weitzman, “Wed really like to 
find out who are the children having difficulties and which 
factors tend to be associated with these difficulties.” To that 
end, she and Hostetter have designed a small study to follow a 
group of internationally adopted children at six-month inter¬ 
vals far into the future. Seeking to identify good predictors of 
risk for developmental problems, the study will collect any 
available details of the child’s life before adoption and assess 
the child’s development, his level of social and emotional 
organization, and his relationship with his adoptive family. It 
will also assess physical growth, language development, behav¬ 
ior and issues of adjustment in the family. 
If this preliminary project goes well, Hostetter and Weitz¬ 
man plan to follow it with a larger one that would combine 
the efforts of six other major international-adoption clinics to 
study some 500 children all over the country. “Again, the idea 
would be to try to pinpoint, by statistical analysis, some of the 
factors that seem to predict developmental problems,” says 
Hostetter. “Should an orphanage stay of more than two years 
be a red flag? Are males more at risk for certain problems than 
females? Are the children of one country more at risk than 
those of another? We’re particularly interested in factors that 
can vary within one country of origin—for instance, if we 
were to find that, of all the children coming from Romania, 
the only ones with normal development are those from foster 
homes, this could have important implications for Romania’s 
policies on the care of orphans and also for people who are 
considering adopting from Romania.” 
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than two years be a red flag? 
more at risk than those of another?” 
Behavior as well as health issues concern parents who bring 
their children to the adoption clinic. “It’s a matter of teasing 
out what's normal growth and development,” says nurse 
practitioner Betsy Groth,"from what has to do with the fact 
that the child has come from adverse circumstances." 
A SPECIALIZED ROUTINE 
Even though a typical appointment at the Yale International 
Adoption Clinic includes a standard pediatric exam, the focus 
is always on the specialized medical issues that go along with 
international adoption. Cappello, who shares the disease¬ 
screening procedure with Hostetter, sees himself and his col¬ 
leagues as consultants, offering a new resource to the many 
primary-care physicians in the area. “We feel very strongly that 
our role should not be to supplant the community physi¬ 
cians—we want to supplement them instead,” he says. 
For each young patient, the file will hold any medical 
records, however scant, that have accompanied the child from 
his native country; information about the birth mother that 
may hold medical significance (e.g., age, prenatal care received, 
number of previous pregnancies, any indications of substance 
abuse); and a full history of any recent symptoms. The Yale 
physicians give the child a thorough physical exam, checking 
for conditions that are common all over the world among peo¬ 
ple who have lived in institutions: lice, scabies, rickets and 
infectious diseases. And they look very carefully for signs of 
fetal alcohol syndrome— “a particularly difficult diagnosis to 
make,” says Cappello, “because it’s a syndrome with a wide 
range of severity rather than a disease [that can be diagnosed] 
with a simple yes-or-no test.” 
The exam concludes with screening tests to detect ailments 
ranging from hepatitis B and C to tuberculosis, HIV and exces¬ 
sive lead levels. “For the most part, the countries we see chil¬ 
dren from are doing tests to the best of their ability,” Hostetter 
says, but sometimes that ability does not match current Ameri¬ 
can standards. For example, tests for hepatitis B, if improperly 
performed, can give a false-negative result. Hostetter estimates 
that this happens in 6 to io percent of cases. “It’s a tough test 
to do because it has a number of steps and the result requires a 
special calculation in order to read it correctly,” she explains. 
To be safe, therefore, the Yale clinic tests again for hepatitis B. 
Likewise, children coming from Russia often show a record 
of having been tested for syphilis, but Hostetter prefers to 
test them again because the standard Russian method, the 
Wasserman test, which dates back to 1906, has a false-negative 
rate of about 5 percent. Newer tests (RPR and VDRL) are 
more reliable. 
Intake information and medical history are handled by 
Groth, who says, “My session with an international adoptive 
family is an adaptation of what I would do during any well- 
child visit. I am always concerned with what the parents’ ques¬ 
tions are. In this clinic I concentrate a little more on eating, 
digestion and nutrition.” 
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IN A CRAY ZONE 
The focus of Weitzman’s exam is on the child's development, 
adjustment and emotional well-being. She says, “From my 
own observation I note whether the child is very clingy or is 
having difficulty letting anyone touch him, and whether he is 
able to seek out physical comfort or soothing when distressed. 
And I look at the early attachment relationship between the 
child and the parents. Does the child preferentially look to the 
parents, then to me? Do parents and child appear comfortable 
with each other? In other words, is this relationship taking a 
healthy turn?” 
Weitzman’s questions point toward an important principle 
of international-adoption medicine: These children do not fit 
the pattern of American babies to begin with, and each indi¬ 
vidual can only grow into that pattern at his or her own pace. 
“You can’t use normative standards—not at first,” Weitzman 
emphasizes. She goes on, “Of course, this leaves you in a gray 
zone. When is it okay to say, ‘This child needs a little more 
time (to experiment with walking and running, to be willing 
to sleep in a room by himself, to start speaking English, to 
understand that this is his permanent family),’ and when 
should we recommend counseling or early intervention?” 
Such a recommendation from the clinic can be an important 
guide for adoptive families in getting their child the help he or 
she needs. It is also a fairly common matter since, as Hostetter, 
Johnson and several colleagues found in a 1997 study of chil¬ 
dren adopted from Eastern Europe and the former Soviet 
Union, a child's growth and development are delayed by one 
month for every three to five months he or she lived in an 
orphanage. Thus, a child brought home from an orphanage 
abroad at 12 months may seem more like a 9-month-old Amer¬ 
ican baby, and a child adopted from an orphanage at age two 
may look, act, and think more like an American 18-month-old. 
Nevertheless, some parents struggle with the idea that their 
child may need special attention. “A lot of families want to 
believe that that part of the child’s life is all gone once they get 
her home,” says Weitzman. Of all the families who come to 
the clinic, she sees about one-fourth for follow-up care. She 
says, “I try to help these families understand what they may be 
facing—and also to give them a break, to let them realize that 
with all their love and care there may still be phases where 
their child needs additional services to help her catch up or to 
deal with the effects of early trauma or deprivation. ” 
Jerri Jenista, M.D., a longtime colleague of Hostetter now 
on the faculty at the University of Michigan, takes a similar 
realistic stance. “We would not expect to adopt a child in the 
United States without any issues,” she says, “so why should we 
expect a child from another country to come without any 
issues?” The most important step that adoptive parents can 
take to help their new child, even before they bring him home, 
is to gather plenty of information, both about the experience 
of adoption in general and about conditions that may have 
When Dianna Piazza returned from China in April 
with Nancirose, 2, her adoption agency recommended 
she have a specialized checkup and developmental 
assessment. Nancirose, Piazza says, is thriving. "She’s 
a typical 2-year-old with a mind of her own." 
affected their child’s health in his country of origin. At Yale, the 
staff of the International Adoption Clinic likes to serve as a 
major resource for information. “I feel very strongly that good 
preparation beforehand is essential,” says Groth, herself the 
adoptive mother of a boy and a girl from Korea. If the family 
has not been well prepared by the time they arrive at the clinic 
with their child, she says, “It’s still possible to steer them 
toward sources of information—at least to advocacy groups or 
to support groups so they can meet with other adoptive parents 
and exchange their stories.” 
Sharing experiences, information and helpful tips with other 
adoptive parents can certainly help with the day-to-day man¬ 
agement of a family situation that can be as challenging as it is 
joyful. But there is one key piece of information that is best 
delivered by the international adoption clinic, even though 
adoptive parents may have known it for some time. In Weitz¬ 
man’s words, “By far the most important intervention for these 
children is being placed with a family that loves them and pays 
attention to them.” YM 
Sandra J. Ackerman is a free-lance medical writer in Durham, North 
Carolina. She and her husband recently adopted a baby girl from Russia 
who is now thriving, they report, thanks in part to the excellent care 
she has received at the Duke International Adoption Clinic. Robert Lisak 
is a photographer based in New Haven, Conn. 
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the not-yet-home movie: 
A MEDICAL DOCUMENT 
The “referral” videos, key elements in the packet of information 
sent to prospective adoptive parents about a particular child, 
may be some of the most closely watched films in the world. 
No aspiring filmmaker could outdo a family-in-waiting when it 
comes to microscopic, frame-by-frame scrutiny of a referral 
video—all two or three minutes of it. When my husband and I 
finally received our referral video from Russia after many 
months' wait, we both dropped work for the day and sat down 
to meet our new daughter. Like most families in this situation, 
we played and replayed the brief encounter, searching for signs 
that this small, faraway person might one day feel at home 
with us. We felt inexplicably relieved when we noticed that the 
baby in the video not only looked bright and healthy, but also 
happened to have the same cleft chin sported by my husband, 
his mother and all their forebears. 
The other, equally important audience for the referral video 
is a physician who knows how to read it as a medical docu¬ 
ment. Margaret K. Hostetter, M.D., director of the Yale Interna¬ 
tional Adoption Clinic, has seen hundreds of referral videos, 
both in preplacement evaluations for families that will later 
come to the Yale clinic with their new child and in consulta¬ 
tions for families all across the country who seek an expert 
opinion. "An informative video, made to show what the baby 
can do, can be encom¬ 
passed in two to three 
minutes,” she says. 
Colleague Carol Cohen 
Weitzman, M.D., 
describes the range of 
criteria that are used to 
assess several important 
areas of a child’s develop¬ 
ment. Often children who 
have been in institutional 
care will show some 
evidence of developmen¬ 
tal delay on these 
brief videos. 
Before traveling to Russia, author 
Sandra Ackerman and her husband 
viewed this video of the girl they 
would later adopt. 
According to Weitzman, the criteria that are assessed include: 
Cross motor skills "We assess a child for the normal unfolding 
of motor milestones as a child develops increasing strength, 
flexibility of movement and mobility,” says Weitzman. "We look 
for the presence of unusual or atypical movements, and assess 
a child for excessive weakness or stiffness." 
Fine motor skills "A child should increasingly develop the abili¬ 
ty to manipulate objects and explore their environment with 
growing precision,” she says. "We assess if this is happening in 
a predictable way or if there is deviation." 
Language development "Children should make a range of 
sounds, and the complexity of the sounds should increase with 
time. Children should show evidence that they are hearing the 
sounds in their environment and responding to these sounds 
and words. We assess how children are communicating their 
needs to others and whether they are invested in communicat¬ 
ing with others." 
Cognitive development "As children grow, they should develop 
an increasingly complex repertoire of problem solving skills — 
from mouthing and banging objects to testing cause-and- 
effect "theories.” We assess whether children demonstrate a 
curiosity to explore, any novel exploration of materials and 
their ability to imitate others’ actions" 
Social development "Children should be invested in human 
relationships. We look for evidence of their desire to interact 
with others and gain satisfaction from a human relationship. 
This would include assessing children’s ability to make eye con¬ 
tact, to gesture to others and to seek caregivers out for pleas¬ 
ure and comfort in times of distress. Ideally, we would like to 
assess whether the child is developing discrimination in their 
relationships.” 
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Janeway elected to NAS 
Charles A. Janeway, Jr., M.D., professor of immunobiology, 
biology and dermatology, was elected to the National 
Academy of Sciences during its annual meeting in May, for 
distinguished and continued achievements in original 
research. Janeway is known for both his theoretical insights 
in understanding immune responses and his experimental 
skills and was first to advocate that new thought be given to 
the role of inherited defense against common microorgan¬ 
isms. Janeway theorized that innate immunity is the body’s 
first line of defense against infection before the body’s adap¬ 
tive immune system takes up the battle. 
Janeway, co-author of one of the leading textbooks in 
immunology, recently attended his daughter’s graduation 
from medical school, making her the fifth consecutive gen¬ 
eration in his family to enter medicine. 
Doudna receives Waterman Award 
Jennifer A. Doudna, Ph.D., professor of molecular 
biophysics and biochemistry, whose leading work in struc¬ 
tural biology provided an answer to how RNA can act like 
an enzyme, has been awarded the Alan T. Waterman Award 
from the National Science Foundation. 
The award, instituted by Congress, is made each year to 
an outstanding scientist or engineer, 35 or younger, and 
includes a grant of $500,000 over three years for scientific 
research or advanced study in any field of science. She is the 
25th recipient of the award, established in 1976, and only 
the third woman to be so honored. 
Her work explains how RNA can act like an enzyme to 
catalyze specific biochemical reactions and how polyanionic 
RNA forms a three-dimensional structure. Doudna’s most 
recent work has to do with the structure of the signal recog¬ 
nition particle, showing how this recognition takes place on 
a molecular level (see page 16). 
A colleague who nominated Doudna for the award, 
Professor Joan Steitz, also of the Department of Molecular 
Biophysics and Biochemistry, said, “There can be no ques¬ 
tion that her pioneering accomplishments have changed the 
way the scientific community thinks about RNA molecules. 
Such exceptional achievements are precisely what the 
Waterman Award was created to recognize.” 
Doudna’s laboratory is continuing to build on the RNA 
research, focusing on two questions: how RNA played a 
role in evolution, and what can be learned about how life 
evolved by looking at RNA protein machines that exist in 
modern biology. 
School of Medicine faculty 
elected to CASE 
The Connecticut Academy of 
Science and Engineering 
recently announced the elec¬ 
tion of new members, includ¬ 
ing several faculty members. 
Gabor Huszar, 
M.D., senior 
research scientist 
in the Depart¬ 
ment of Ob¬ 
stetrics and Gynecology; Sally 
E. Shaywitz, M.D., professor of 
pediatrics and pediatric neu¬ 
rology; and John F. Tallman, 
Ph.D., associate professor 
adjunct of psychiatry at Yale 
and executive vice president 
and scientific director of 
Neurogen Corporation. 
Joseph S. Fruton, Ph.D., the 
Eugene Higgins Professor 
Emeritus of Biochemistry and 
senior research scholar in the 
history of medicine received 
the 1999 Association of 
American Publishers 
Professional/Scholarly Pub¬ 
lishing Award in the History 
of Science and Technology for 
his book Proteins, Enzymes, 
Genes: The Interplay of 
Chemistry and Biology. The 
book was published by Yale 
University Press in 1999. 
Patricia S. Goldman-Rakic, 
Ph.D , professor of neurobiolo¬ 
gy, neurology and psychiatry, 
was awarded a degree of doc¬ 
tor honoris causa in biology, 
in March, from the University 
of Utrecht, the Netherlands. 
Aging Research Award from 
the American Federation for 
Aging Research in April. The 
award provides $450,000 in 
research funding over three 
years to outstanding junior 
physician faculty committed 
to academic careers in aging- 
related research, teaching and 
practice. The focus of 
Hisama’s research is Werner 
syndrome. People with this 
syndrome begin to age rapidly 
in their late teens and early 
20s. The disease, named for 
the German physician Otto 
Werner, is rare and caused by 
a mutation in a single gene. 
Frederic L. 
Holmes, 
Ph.D., Avalon 
Professor and 
chair of the 
Section of History of 
Medicine, was elected one of 
47 new members of the 
American Philosophical 
Society (APS), at its annual 
general meeting held in 
Philadelphia in April. 
Founded by Benjamin 
Franklin in 1743, the APS is 
the oldest learned society in 
the United States devoted to 
the advancement of scientific 
and scholarly inquiry. Holmes 
has written six books and 
countless articles in which he 
explores how major discover¬ 
ies are made. “Knowledge is 
cumulative,” he said, noting 
that all research depends on 
what came before. 
Fuki M. 
Hisama, M.D., 
assistant pro¬ 
fessor of neu¬ 
rology, 
received the Paul Beeson 
Physician Faculty Scholar in 
Marina A. 
Picciotto, 
Ph.D., assis¬ 
tant professor 
of psychiatry 
and pharmacology, was one of 
60 young researchers present- 
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ed the Presidential Early 
Career Award for Scientists 
and Engineers, the highest 
honor bestowed by the United 
States government to young 
professionals at the outset of 
their independent research 
careers. The annual awards, 
established by President 
Clinton in February 1996, 
were presented in April in a 
White House ceremony. 
Picciotto received the award 
for research that identified a 
molecular receptor in the brain 
that is believed to be responsi¬ 
ble for nicotine addiction. 
Albert i. 
Solnit, M.D., 
has retired 
after nine 
years as com¬ 
missioner of Connecticut’s 
Department of Mental Health 
and Addiction Services, but he 
remains active. Gov. John 
Rowland has appointed him 
chair of a commission that is 
examining the state’s mental 
health services. Solnit also 
continues to work in the Yale 
Child Study Center, where he 
teaches, sees patients and con¬ 
ducts research. “As you get 
older, work is a good friend,” 
says Solnit, Sterling Professor 
Emeritus of Pediatrics. “You 
may get tired, but you won’t 
be lonely.” 
The Stolwijk Fellowship has 
been established in honor of 
Jan AJ. 
Stolwijk, 
Ph.D., profes¬ 
sor emeritus 
and former 
chair of the Department of 
Epidemiology and Public 
Health. Each year up to three 
fellowships of $2,500 will be 
awarded to students 
completing their first full year 
in the master’s program in 
public health. 
Robert I. White, M.D., profes¬ 
sor and past chair of the 
Department of Diagnostic 
Radiology, received a 2000 
Gold Medal Award from the 
Society of Cardiovascular and 
Interventional Radiology. 
White, director of the 
Cardiovascular Diagnostic 
Laboratories at Johns Hopkins 
University Hospital for 17 
years, led the development of 
therapies for two congenital 
heart diseases: pulmonary 
valvular stenosis and aortic 
coarctation. 
Edward F. Zigler, Ph.D., who is 
Sterling Professor of 
Psychology and has an 
appointment in the Yale Child 
Study Center, received two 
major awards this year. In 
February he received an unre¬ 
stricted $250,000 award from 
the Heinz Family Foundation 
for his contributions in the 
area of public policy. And in 
June he was named the first 
recipient of the Early 
Childhood Leadership Award 
from the A.L. Mailman 
Family Foundation. The 
award is accompanied by a 
$50,000 grant. Zigler has ded¬ 
icated more than 30 years to 
the development of sound 
programs for at-risk children, 
among them the Head Start 
program and family-leave 
policies. In 1970 he became 
the first director of the U.S. 
Office of Child Development 
(now the Administration for 
Children, Youth and 
Families). Zigler also helped 
write the first child-abuse law 
in 1974. 
THE 
DEFINITIVE 
GUIDE TO WHOLE 
SKIN CARE 
FOR LIFE 
SKIN 
HOW TO LOOK RADIANT AND FEEL YOUNGER 
COMMON SKIN PROBLEMS AND IlOW TO FIX THEM 
LASERS 
ALTERNATIVE SKIN CARE 
SKIN CLUES ABOUT YOUR HEALTH 
SKIN CARE PRODUCTS 
DAVID J. LEFFELL, M 
Prolessor ol Dermatology & Surgery at Yale School ol M 
Total Skin: The Definitive Guide 
to Whole Skin Care for Life, by 
David J. Leffell, M.D., professor 
of dermatology and surgery, 
Hyperion Books (N.Y.), 2000. 
Fatherneed: Why Father Care is 
as Essential as Mother Care for 
Your Child, by Kyle D. Pruett, 
M.D., clinical professor of 
psychiatry in the Child Study 
Center, Free Press (N.Y.), 2000. 
Preventive Cardiology, edited 
by Nathan D. Wong, M.P.H. ’87, 
Henry R. Black, M.D., HS 75, 
and Julius M. Gardin, M.D., 
McGraw Hill (N.Y.), 1999. 
Pursuing Perfection: People, 
Croups and Society, by the late 
Leonard W. Doob, Sterling 
Professor Emeritus of 
Psychology, Praeger Publishing 
(Conn.), 1999. 
Foundations of Anesthesia: 
Basic and Clinical Sciences, by 
Hugh C. Hemmings Jr., M.D. 
’87, and Phil M. Hopkins, 
Mosby (London), 1999. 
Fatherneed 
Kyle D. Pruett, M.D. 
PREVEN 
CARDIOI 
. D. 
The Golf Story: An Anecdotal 
History of Golf by Ray 
Gagliardi, M.D. '45M, Dorrance 
Publishing Co. (Penn.), 2000. 
Historical Landmarks in Head 
and Neck Cancer Surgery, by 
Donald P. Shedd, M.D. ’46, 
American Society for Head 
and Neck Surgery (Penn.), 
2000. 
Surgery Clinical Companion, by 
Christopher P. Coppola, M.D., 
HS '00, and Seth A. Spector, 
M.D., HS ’00, Lippincott, 
Williams & Wilkins (Md.), 
1999. 
NOTICES OF NEW BOOKS BY 
ALUMNI AND FACULTY MAY 
BE SENT TO CHERYL VIOLANTE, 
YALE MEDICINE PUBLICATIONS, 
P.O. BOX 7612, NEW HAVEN, CT 
06519-0612. 
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STUDENT NEWS 
Top: John Forrest (left), Dean 
David Kessler (right), and speaker 
Harold Varmus (center), former 
head of the National Institutes of 
Health, joined presenters Max 
Kelz, Elizabeth Harrold, Hanna 
Kim, Aaron Milstone and John 
Coombes 
Above: John Mahoney explained 
his research project, Proximal Pole 
Scaphoid Fractures: Arthroscopic 
Reduction and Dorsal 
Percutaneous Cannulated Screw 
Fixation, to Gerard Burrow. 
At Student Research Day, 
a primer on the scientific method 
When medical student Edwin Anderson of Wilmington, N.C., 
wrote his Yale thesis in 1837, he would not have expected it to 
generate excitement a century and a half later. Bearing the 
Latin title De Calculo Vesicae, Anderson’s treatise on bladder 
stones made its case in 155 pages and 40 chapters and contained 
two pages of references, not unusual for its day. What set it 
apart 152 years later was its discovery among the archives by a 
professor tracing the roots of student research at Yale. 
The professor, John Forrest, M.D. ’67, came across the slim 
volume in 1989 while preparing remarks for the 150th anniver¬ 
sary of the thesis requirement, first documented in the medical 
school Bulletin in 1839. (Anderson’s work, the earliest bound 
thesis that has been located, is among a handful known to pre¬ 
date the requirement; the earliest was written in 1823.) 
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In early May, Forrest brought Anderson’s work to Student 
Research Day, the annual celebration of scientific inquiry by 
students. What began in 1987 as a yearly poster session has 
become one of the brightest days on the academic calendar. It 
is also an opportunity for medical students to sit at the feet of 
leading figures in science and medicine who visit under the 
auspices of the Lee E. Farr, M.D. ’33, Lectureship. This year, 
Nobel laureate and former NIH Director Harold Varmus deliv¬ 
ered a talk entitled “Genes and Cancer: The Quest Continues.” 
Forrest told students and faculty who gathered to hear pre¬ 
sentations of five outstanding works that “the value of the the¬ 
sis is to teach that all physicians are scientists. It is a way,” he 
said, “to help ensure that Yale medical students learn the scien¬ 
tific method from the inside out.” 
Graduate research conference 
links students across campus 
With 100 posters on display and 370 registrants, this year’s 
Graduate Student Research Symposium on May 4 and 5 
achieved the greatest participation in its five-year history. For 
the first time, the symposium was open to submissions by post¬ 
doctoral fellows as well as graduate students. Faculty members 
led mini-symposia in each of 10 research categories. 
“We modeled it like a national conference,” said Shilpa Patel, 
who organized the conference with fellow pharmacology stu¬ 
dent Helen Seow. In a break from past years, posters were 
organized by interdisciplinary topics and presenters discussed 
their particular disciplines during poster mini-symposia. This 
allowed researchers to break out of their specialties and meet 
others at Yale who are working on a different aspects of com¬ 
mon fields, Patel said. “Yale is a very collaborative environment 
to do science,” she added. 
The event also featured talks by Nobel laureate Gunter 
Blobel, M.D., Ph.D., and MIT biology professor Harvey 
Lodish, Ph.D. Lodish studies two classes of membrane pro¬ 
teins: transporters which move nutrients into and out of cells, 
and receptors which bind chemical signaling molecules in the 
environment of a cell and transmit these signals to the cell’s 
interior. 
Blobel, a cell and molecular biologist at Rockefeller 
University, won the 1999 Nobel Prize in physiology or medi¬ 
cine for his discovery that proteins have intrinsic signals that 
govern their transport and localization in the cell. During the 
symposium he gave the first George Palade Lecture, sponsored 
by the Department of Cell Biology in conjunction with the 
GSRS. The lecture honors Palade, the founder of the section of 
cell biology. Palade, himself a Nobel laureate in 1974, intro¬ 
duced Blobel via videotape from his home in California. In his 
talk, Blobel discussed the research that led to his discovery 
about signals in protein transport. He began in the 1970s by 
finding the signal that guides newly synthesized proteins 
through the membrane of the endoplasmic reticulum. “What 
wasn’t known were the molecular mechanisms by which this 
pathway operated,” Blobel said. His pursuit of an answer to 
this question led to his subsequent discoveries. 
Cell biology chair Pietro De Camilli (left) and James Jamieson, (right) 
director of the M.D./Ph.D. program, joined Nobel laureate Gunter 
Blobel before his talk, offered in conjunction with the Graduate 
Student Research Symposium. 
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Class of 2000 takes to the 
generalist disciplines 
As went the nation, so went the Class of 2000 on Match Day 
this year, with half the class matching to one of the 
“generalist” disciplines, such as internal medicine or primary 
care. Nationwide, reported the National Resident Matching 
Program, 51 percent of this year’s matches entered internal 
medicine, family practice or pediatrics. Of the 108 Yale medical 
students in the Match this year, 29 chose internal medicine, 
five chose primary care and 20 chose pediatrics. Six students 
matched with orthopaedics programs and nine matched in der¬ 
matology, an increase over previous years in both specialties. 
Ten students entered obstetrics and gynecology residencies and 
six went into general surgery. 
Cynthia Andrien, assistant dean for student affairs, said 90 
percent of the class matched to one of their top three choices 
and 94 percent matched to one of their top five. 
2000 residency placements for 
Yale medical students 
The Office of Student Affairs has provid¬ 
ed the following list, which outlines the 
results of the National Resident 
Matching Program for Yale's medical 
school graduates. Some names appear 
twice because the graduate is entering 
a one-year program before beginning a 
specialty residency The transitional 
designation is a one-year program with 
three-month rotations in different 
specialties. 
CALIFORNIA 
Harbor - UCLA Medical Center, 
Torrance 
Anne Uyei, internal medicine 
Santa Clara Valley Medical Center, 
San Jose 
Amy Jan, transitional 
Stanford University Programs 
Donna Akutagawa, pediatrics 
Matthew Falk, pediatrics 
Albert Kao, internal medicine 
Megan Lisska, pediatrics 
Neda Pakdaman, internal medicine 
Russell Woo, general surgery 
UCLA Medical Center - Los Angeles 
Darcy Bryan, obstetrics and gynecology 
Julian Martinez, pediatrics 
University of California - San Diego 
Victoria Morrison, ophthalmology 
University of California - San Francisco 
Lauren Goldman, internal medicine 
Amy Levin, internal medicine 
Royce Lin, internal medicine 
Theodore Ruel, pediatrics/primary 
Darcy Thompson, pediatrics/primary 
CANADA 
McMaster University, Hamilton, 
Ontario 
Julie-Ann Francis, obstetrics and 
gynecology 
University of Toronto 
Evelyn Maxwell, obstetrics and 
gynecology 
COLORADO 
University of Colorado School of 
Medicine, Denver 
John Coombes, internal medicine 
Sereena Tamburri, obstetrics and 
gynecology 
CONNECTICUT 
St. Vincent’s Medical Center, 
Bridgeport 
Brian Egan, transitional 
Yale-New Haven Hospital 
Alicia Arbaje, internal medicine 
Matthew Cooperberg, surgery, urology 
Amin Fazeli, medicine 
Dawn Grosser, orthopaedics 
Ophir Klein, pediatrics 
Rachel Lovins, internal medicine/ 
primary 
Michele Mak, medicine 
Yoon Mo Myung, medicine/primary 
Amy Nuernberg, internal medicine 
Gilbert Ortega, orthopaedics 
Maya Salameh, internal medicine 
Julie Schaffer, dermatology, pediatrics - 
preliminary 
Meredith Talbot, internal medicine 
Melissa Wolfe, pediatrics 
DISTRICT OF COLUMBIA 
George Washington University 
John Mahoney, orthopaedics, surgery 
ILLINOIS 
Children’s Memorial Hospital, Chicago 
Michal Radzynski, pediatrics 
McGaw Medical Center, Northwestern 
University, Chicago 
William Poster, dermatology, medicine 
Ronald Yap, surgery 
Northwestern University Medical 
Center, Chicago 
Ronald Yap, urology 
Rush-Presbyterian - St. Luke’s, Chicago 
Dirk Johnson, surgery 
University of Illinois College of 
Medicine, Chicago 
Rebecca Dubowy, obstetrics and 
gynecology 
IOWA 
University of Iowa Hospitals and 
Clinics, Iowa City 
Robert Kadoko, orthopaedics 
MARYLAND 
Johns Hopkins Hospital, Baltimore 
Wendi Brown, obstetrics and 
gynecology 
Simon Yoo, dermatology 
Johns Hopkins University/Sinai 
Hospital, Baltimore 
Brian Calbut, medicine 
Johns Hopkins University, Baltimore 
Constance Nduaguba, ophthalmology 
Maryland General Hospital, Baltimore 
Constance Nduaguba, transitional 
University of Maryland Medical Center, 
Baltimore 
Marlon Maragh, surgery 
MASSACHUSETTS 
Beth Israel Deaconess Medical Center, 
Boston 
Phillip Chan, internal medicine 
Jersey Chen, medicine 
David Friedman, internal medicine 
Liza Halpern, internal medicine 
Naomi Katz, obstetrics and gynecology 
Ashish Patel, general surgery 
Boston Combined Residency Program 
in Pediatrics (Childrens Hospital) 
Laurie Hickey, pediatrics 
Brigham & Women’s Hospital, Boston 
Karin Andersson, internal medicine 
Kathryn Cunningham, internal medi¬ 
cine/primary 
Brian Egan, anesthesiology 
Azita Hamedani, emergency medicine 
Simon Yoo, medicine 
Harvard Combined Medicine/Pediatrics 
Program (Massachusetts General 
Hospital) 
Candice Camacho, medicine/pediatrics 
Harvard Longwood Psychiatry, Boston 
Jessica Morgan, psychiatry 
Harvard Medical School, Boston 
John Abraham, orthopaedics 
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ar left: Their children in their 
rms, Jody and Elie Levine opened 
heir envelopes together. 
eft: Kate Langworthy, Megan 
isska and Matthew Falk compare 
lotes on their matches. 
Massachusetts General Hospital, 
Boston 
Amin Fazeli, dermatology 
Ara Feinstein, general surgery 
Carl Seashore, pediatrics 
Deborah Wexler, internal medicine/ 
primary 
New England Medical Center, Boston 
Elizabeth Egan, internal medicine 
Lisa Natkin, pediatrics 
Tufts University Family Practice 
Residency, Malden 
Johnathan Henderson, family practice 
NEBRASKA 
Lincoln Medical Education Foundation, 
Lincoln 
Bridgett Broz, family practice 
NEW YORK 
Albany Medical Center Hospital, 
Albany 
Michele Mak, dermatology 
The Mount Sinai Hospital 
Kerin Adelson, internal medicine 
Daniel Caplivski, internal medicine 
Daniel Jacoby, internal medicine 
Elie Levine, plastic surgery 
Jody Levine, pediatrics/primary 
Jonathan Ripp, internal medicine 
Joanna Sheinfeld, internal medicine 
Stacey Weiss, internal medicine 
New York Presbyterian Hospital - 
Columbia 
Amy Dudenhoefer, internal medicine 
Lisa Eiland, pediatrics 
Melissa Ellis, pediatrics 
Elizabeth Harrold, internal medicine 
New York Presbyterian Hospital - 
Cornell 
Evelyn Duvivier, internal medicine/ 
primary 
New York University Medical Center 
Leslie Boyd, obstetrics and gynecology 
Kenneth Harris, internal medicine/ 
primary 
Hanna Kim, dermatology 
St. Vincent’s Hospital 
Alison Cruen, medicine 
SUNY Health Science Center at 
Brooklyn 
Alison Cruen, dermatology 
NORTH CAROLINA 
Duke University Medical Center, 
Durham 
Christopher Chang, otolaryngology, 
surgery 
Leigh Elmore, obstetrics and gynecology 
OHIO 
Cleveland Clinic Foundation, Cleveland 
Saba Kaiseruddin, pediatrics 
The University Hospital, Cincinnati 
Jason Sluzevich, dermatology 
Arvind Venkat, emergency medicine 
Jennifer Yee, medicine 
OREGON 
Oregon Health Sciences University, 
Portland 
Gregory Austin, internal medicine 
Julie Davis, pediatrics 
PENNSYLVANIA 
Children’s Hospital of Philadelphia 
Aaron Milstone, pediatrics 
Amy Winkelstein, pediatrics 
Hospital of the University of 
Pennsylvania, Philadelphia 
Jersey Chen, diagnostic radiology 
Thomas Courtney, orthopaedics 
Lee Goldstein, general surgery 
Max Kelz, anesthesiology 
Andrew Resnick, general surgery 
Grace Shih, internal medicine 
Jakub Svoboda, internal medicine 
University Health Center of 
Pittsburgh 
Jose Prince, general surgery 
Tanya Smith, obstetrics and gynecology 
University of Pennsylvania Health 
Systems/Presbyterian Hospital, 
Philadelphia 
Max Kelz, transitional 
PUERTO Rico 
University of Puerto Rico 
Cristina Ferrari, ophthalmology, 
transitional 
RHODE ISLAND 
Brown University/Rhode Island 
Hospital, Providence 
Yoon Mo Myung, ophthalmology 
Memorial Hospital of Rhode Island, 
Pawtucket 
Angela Rubineau, family practice 
SOUTH CAROLINA 
Medical University of South Carolina, 
Charleston 
Masha Huseinovic, internal medicine 
TEXAS 
Baylor College of Medicine - Houston 
Katherine Langworthy, pediatrics 
UTAH 
University of Utah Affiliated 
Hospitals, Salt Lake City 
Victoria Morrison, medicine 
WASHINGTON 
University of Washington Affiliated 
Hospitals, Seattle 
Jennifer Dorosz, internal medicine 
Amy Jan, dermatology 
WISCONSIN 
University of Wisconsin Hospital and 
Clinics, Madison 
Jennifer Griffiths, family practice 
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Songs and dance 
to benefit minority 
high school students 
Medical students strutted their stuff in 
January at the Seventh Annual Grannum 
Jamboree, showing once again that they are 
as familiar with a guitar or dance steps as 
they are with the 206 bones in the human 
body. The jamboree's selections ranged from 
songs by the Yale Gospel Choir to a humorous 
song about life in New Haven performed by 
Mike Fehm and accompanists. La Lisa Alita 
Anderson read from her collection of oral 
histories, On the Other Side: African Americans 
Tell of Healing, to be published next spring 
by Westminster John Knox Press. Rashida 
N’Gouamba choreographed a dance set 
to kweito music from South African black 
townships. 
The show's proceeds benefit HPREP, the 
Health Professions Recruitment and 
Enrichment Program, a 10-week program that 
brings area high school students to the med¬ 
ical school on Saturday mornings for classes 
on health-related topics. This year 43 high 
school students participated and at the end of 
the program the top students received college 
scholarships. 
The jamboree is held in honor of the late Dr. 
Peter Grannum, former director of medical 
studies in the Department of Obstetrics and 
Gynecology, and two-time winner of the 
Francis Gilman Blake Award for outstanding 
teaching in the medical sciences. 
Performers at the Grannum 
Jamboree included the Yale 
Gospel Choir (top); La Lisa 
Anderson reading from her collec¬ 
tion of oral histories; and the 
Ultrasounds, an a capella group 
that featured Ada-Nkem Nwaneri, 
singing the solo. 
A A 
Top: Tracey Cho and Scott 
Berkowitz, the show’s producers, 
led the cast in the finale,“We're 
on the Wards,'' sung to the tune 
of “We Are the World.” 
Above: Matt Stiebel, Greg DeBlasi, 
James Schafer and Anil Shivaram 
played the “Cedar Street Boys,” 
singing about life on the wards to 
the tune of “Larger than Life”, the 
hit by the Backstreet Boys. "All you 
teachers, can’t you see, can’t you 
see, how a lack of sleep affects 
how we be?” they sang. 
Right: Marlyanne Pol and Claire 
Stylianopoulos sing and dance in 
the opening scene. 
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I Know What You Did Last Semester 
Early in the first act of / Know What You Did M.D., depicting it as TV’s obnoxious Jerry 
Last Semester, the Class of 2002’s second-year Springer Show. Another skit made fun of the 
show, a heckler in the balcony shouted, TV quiz show Who Wants To Be a Millionaire?, 
“Where’s the plot?” It soon became apparent with contestants answering medical exam 
that this year’s show had none. Presented in questions and others on the order of “Which 
February, the show offered a series of songs, third-year student soiled his pants during the 
dances, skits and videos stitched around the boards?” One contestant made the mistake of 
theme of accreditation. LCME accreditors, turning to “lifeline” Pietro De Camilli, M.D., 
played by Max Laurans and Premila Bhat, chair of cell biology, for help in choosing 
wandered through scenes of the school, between GTP and GDP. For at least three years 
comparing the official view to their own in a row the show has poked fun at his inflec- 
observations. "This medical school is out of tion, which allegedly renders the two abbrevi- 
control!” said the accreditor played by Bhat. ations indistinguishable to students. 
“There is an utter lack of discipline!” During the second act, first-year students 
The dazzling opening number, choreo- took the stage briefly to sing an unintelligible 
graphed by Jacqueline Park, offered a wild ode to Robert H. Gifford, M.D., HS ’67, the 
view of life on Cedar Street, with male med recently retired deputy dean for education, 
students as leering Lotharios and the females to the tune of a Tom Petty ballad. For a second 
as gum-chewing schoolgirls dressed in Mary prank, first-year students hiding in light 
Janes.The show featured appearances by fixtures above the ceiling dropped ping-pong 
Dean David A. Kessler as himself, plus cameos balls on the stage. Second-years refused to 
by Nancy R, Angoff, M.D. ’90, I IS ’93, M.P.H. ’81, let that pass. A quickly typed message of 
associate dean for student affairs, and Ruth congratulations soon flashed on the screen 
Katz, J.D., M.P.H., associate dean for adminis- behind the stage, followed by a note of sur- 
tration, also mocking themselves, Kessler prise. "We didn’t know you had any balls.” 
mimicked himself giving a speech and, The show ended with the entire Class of 
departing from the script, announced to 2002 singing “We’re on the Wards,” to the 
cheers as well as boos,“This show is the best I tune of "We Are the World.” “We’re on the 
have ever seen since coming to Yale.” wards,” they sang, “but we’re not doctors. 
The show, produced by Scott Berkowitz and We’re the ones in your hospital rooms asking 
Tracey Cho, also targeted a doctor-patient dumb questions.” 
encounter course conducted by Thomas Duffy, 
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ALUMNI NEWS 
Fitness center dedicated 
For years the only exercise facility available on the medical school 
campus was an airless weight room in the basement of Harkness 
dormitory. Now, thanks to the efforts of the Class of 1958, 
students can work out in a new fitness center equipped with 
weights, treadmills and a variety of exercise machines. 
Spearheading the initiative was Gerard Burrow, former dean and 
currently special advisor to the president of the University for 
health. Among Burrow’s motivations was a sense of guilt, he con¬ 
fessed. "When I was an assistant professor I lobbied the dean very 
hard to protect the two squash courts that were there," he said. 
"Then when I was dean I found it necessary to take out the last 
squash court." 
David Carlson, Burrow, Andrew McGowan, John Creatura, Robert 
Donohue and (pumping iron) Michael Kashgarian, celebrated the 
opening of the Class of 1958 Student Fitness Center on Feb. 9. 
ALUMNI NOTES 
Leo H. 
Berman, M.D., 
HS ’53, 
writes to say 
that 51 years 
after graduation from medical 
school, he is still active in the 
practice of psychiatry. “Why 
retire when one can still grow 
in one’s profession?” he asks. 
Arnold D. Welch, M.D., M.A.H. 
’53. at age 91, sent us a greet¬ 
ing from his new home in San 
Diego, where he moved three 
years ago. Welch was the third 
chair of the Department of 
Pharmacology at the School of 
Medicine, a post he held for 
14 years. He introduced a 
molecular approach to phar¬ 
macology and, with his eye for 
spotting and recruiting talent¬ 
ed researchers, led the depart¬ 
ment to national prominence. 
He left Yale in 1967 to become 
vice president for research and 
development at Bristol-Myers 
Squibb. After a mandatory 
retirement in 1976, he became 
chair of a new department 
of pharmacology at St. Jude 
Children’s Research Hospital. 
In 1984 he joined the staff 
of the National Cancer 
Institute in Bethesda. He 
retired in 1989. 
Harry C. Miller Jr., M.D. ’54, 
emeritus professor and chair 
of the Department of Urology 
at George Washington 
University, received the 2000 
Gold Cane Award in May 
from the American Urological 
Association (AUA) at its 
annual meeting in Atlanta. 
Miller, now retired and enjoy¬ 
ing his leisure time with his 
family, was honored for his 
distinguished service as an 
outstanding clinician, acade¬ 
mician and teacher in urology, 
and section representative to 
the AUA. 
60S 
Herbert W. 
Boyer, Ph.D., 
postdoctoral 
fellow ’63-66, 
and the late 
Robert A. Swanson, 
cofounders of Genentech, 
Inc., were honored as the 
recipients of the second annu¬ 
al Biotechnology Heritage 
Award. Presented in March by 
the Chemical Heritage 
Foundation and the 
Biotechonology Industry 
Organization, the award rec¬ 
ognizes the extraordinary 
achievements of individuals 
whose careers helped shape 
the biotechnology revolution. 
Boyer’s work with Stanley 
Cohen, M.D., led to the 
invention of recombinant 
DNA technology, an advance 
that signaled the beginning of 
genetic engineering and trans¬ 
formed the basic science of 
molecular biology. 
Charles D. Cook, M.D. ’64, 
of Old Lyme, Conn., writes to 
say that he is “Finally com¬ 
pletely retired and enjoying 
it!” Cook has been in academ¬ 
ic pediatrics his entire profes¬ 
sional life, first at Harvard, 
then as chair of pediatrics at 
Yale University School of 
Medicine and at the State 
University of New York 
Health Science Center at 
Brooklyn. He was also chief 
of pediatrics at Rochester 
General Hospital in New 
York. In 1992 he returned ro 
Connecticut and the Hill 
Health Center, which he had 
been instrumental in founding 
more than 30 years ago. Since 
1993 Cook has raught in the 
Pediatric Primary Care Unit at 
Yale-New Haven Hospital and 
was a lecturer at Yale School 
of Medicine. Last year he 
attended his grandson’s gradu¬ 
ation from University of 
Vermont College of Medicine. 
Jason Cook, shown with his 
father, Andrew, and grandfa¬ 
ther, Charles, is a 12th genera¬ 
tion physician. 
Diane K. Shrier, M.D. ’64, 
clinical professor of psychiatry 
and pediatrics at George 
Washington University 
Medical Center, and Lydia A. 
Shrier, M.D., M.P.H. ’87, HS 
’94, on the faculty of Harvard 
Medical School and in 
Adolescent/Young Adult 
Medicine at Boston Children’s 
Hospital, are seeking data 
from mothers and daughters 
in medicine for their research 
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project, “Generation to 
Generation, Mother-Daughter 
Physicians.” Information can 
be sent to Diane K. Shrier, 
M.D., 1616 18th St., NW, 
Suite 104, Washington, DC 
20009; e-mailed to 
diane.shrier.med.64@aya.yale. 
edu, or faxed to 202-965-2942. 
Lydia Shrier recently was 
awarded a five-year career 
development award from the 
National Institute of Mental 
Health for her research on 
mental health and sexual risk 
behavior in adolescents. 
Charles F. Stevens, M.D. ’60, 
investigator at the Howard 
Hughes Medical Institute and 
professor at The Salk Institute 
for Biological Studies in La 
Jolla, Calif., received the 
National Academy of Sciences 
Award for Scientific 
Reviewing. Stevens was cho¬ 
sen for his numerous “News 
and Views” articles in Nature 
that, for more than a decade, 
reviewed nearly all of the 
major advances in molecular 
neuroscience. The award, 
which has been presented 
since 1979, was established by 
Annual Reviews Inc. and the 
Institute for Scientific 
Information in honor of J. 
Murray Luck. 
70S 
£ ' 74 R. Michael 
Buckley, M.D., 
’72, has been 
named chair 
H of the 
Department of Medicine at 
Pennsylvania Hospital and 
vice chair of the Department 
of Medicine at the University 
of Pennsylvania Health 
System. Buckley is also a clini¬ 
cal professor of medicine at 
the University of Pennsylvania 
and maintains an active clini¬ 
cal practice specializing in 
internal medicine and infec¬ 
tious diseases. 
H. Steven Moffic, M.D. ’71, vice 
chair for managed care and 
professor of psychiatry, behav¬ 
ioral medicine, and family and 
community medicine with the 
Froedtert Behavioral Health 
Center at the Medical College 
of Wisconsin, has served as 
president oi the American 
Association for Social 
Psychiatry (AASP), for the 
past two years. He has pro¬ 
posed a new health reform 
plan named Universal 
Accountable Healthcare and 
established the Moffic Award 
for Ethical Practice in Public 
Sector Managed Behavioral 
Healthcare with the AASP. 
80S 
Alan M. Gruenberg, M.D., HS 
’85, professor of psychiatry 
and human behavior at 
Jefferson Medical College and 
president of Gruenberg and 
Summers, P.C., a clinical and 
consulting psychiatric practice 
in Bryn Mawr, Penn., has 
been named top doctor 
among psychiatrists and top 
doctor for women by 
Philadelphia magazine. 
John T. Whalen, M.D. ’89, of 
Albany N.Y., was inducted in 
March as a fellow of the 
American Academy of 
Orthopaedic Surgeons during 
ceremonies at the Academy’s 
67th annual meeting in 
Orlando. 
90S 
Susan G. 
Anderson, 
M.D. ’90, 
clinical assis- 
rant professor 
at Stanford University School 
of Medicine, and co-director 
of the new Stanford Travel 
Medicine Service, is senior 
editor for the Women’s Travel 
Center section of the medical 
Web site, www.medicine 
planet.com. The site, which 
opened in March, offers 
health information for over¬ 
seas travelers, including coun¬ 
try-specific data on infectious 
disease. 
Mary Gilbert Lawrence, M.D., 
M.P.H. ’98, has been appoint¬ 
ed associate professor of oph¬ 
thalmology at the University 
of Minnesota School of 
Medicine. She also is an 
attending surgeon for the 
Glaucoma Service, director of 
the Visual Rehabilitation 
Service and associate chief at 
the Minneapolis Veterans 
Affairs Medical Center. 
Honoring alumni, students 
and benefactors 
Two events on May 6 honored alumni, benefactors and recipients of 
endowed scholarships. A ceremony dedicated a garden bench in honor 
of the late John B. Ogilvie, M.D. ’34, "distinguished surgeon, dedicated 
and generous alumnus, friend to Yale Medical students." Above left: 
Donna Brace Ogilvie and Knowles B. Lawrence, M.D. ’34, one of her hus¬ 
band’s classmates, attended the dedication. Later that day the inaugu¬ 
ral Celebration of Scholarship luncheon recognized donors who make 
possible endowed scholarships and the students who have benefited 
from them. Last year 67 students received financial aid from 41 
endowed scholarships. M. Felix Freshwater, M.D. ’72, whose class estab¬ 
lished a fund in 1997, gave a talk entitled, "Establishing an endowed 
scholarship—charity or moral imperative?” Below left: Among those 
attending the luncheon were Robert Kadoko, M.D. ’00, recipient of the 
Freshwater-Class of 1972 Scholarship, and former deputy dean Arthur 
Ebbert Jr., M.D. 
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Daniel Bergsma, M.D. ’36, of 
Raleigh, N.C., died Nov. 23 at 
Rex Hospital in Raleigh at the 
age of 90. 
After Bergsma received his 
medical degree from Yale he stud¬ 
ied public health at the University 
of Michigan, where he received 
his degree in 1946. He was the 
New Jersey State Director ol 
Health for many years and later 
worked for the National 
Foundation (NF), now known as 
the March ol Dimes. At the NF, 
he first oversaw medical care for 
polio patients and later edited a 
compendium on birth defects. 
Joseph A. Criscuolo, M.D. ’38, 
of Wabasha, Minn., died Jan. 2. 
He was 87. 
Criscuolo received a bachelor’s 
degree from Yale University in 
1934 and his medical degree from 
the School of Medicine, where he 
was inducted into the Alpha 
Omega Alpha Honor Society. 
During World War II he joined 
the Army and served as com¬ 
mander of the troop hospital ship 
Ernest Korinda. He left the mili¬ 
tary in 1945 with the rank of 
major. Criscuolo was assistant 
professor of surgery at Cornell 
Medical College and served on 
the staff of both Doctor’s and 
Roosevelt hospitals in New York 
City Irom 1946. He moved to 
Palm Springs, Calif., in 1965, 
where he both served as director 
of emergency services at Desert 
Hospital and had a private prac¬ 
tice as a trauma surgeon. 
Guido A. DeBlasio, M.D. ’37, of 
Pelham, N.Y., died on April 18. 
He was 89. 
DeBlasio graduated from 
Cornell University in 1933. After 
receiving his medical degree from 
Yale School of Medicine, he 
stayed in New Haven for his 
internship and residency training 
in pediatrics, surgery and ob/gyn 
until 1944. He also was an assis¬ 
tant in surgical bacteriology at 
Yale Irom 1941 until 1943. 
DeBlasio served as a major in 
the Army Medical Corps during 
World War II and was a practic¬ 
ing surgeon at Mt. Vernon 
Hospital for 40 years. 
Eloise ‘Tommy’ Haywood 
Heath, Ph.D. ’30, died Jan. 2 at 
the Veteran’s Home in South 
Paris, Maine. She was 95. 
Heath graduated from Vassar 
College in 1926 and received her 
Ph.D. in public health (bacteriol¬ 
ogy) from Yale. From 1927 until 
1930 she was a research assistant 
in public health at Yale. In 1933, 
Heath became chief chemist at 
the New Haven, Conn., Water 
Company; at the time she was 
said to be the only woman serv¬ 
ing in such a position in the 
United States. She later joined the 
staff of the Connecticut 
Tuberculosis Association. 
She and her husband retired to 
Chapel Hill, N.C., in 1972. 
David W. Marby, M.D. ’93, a 
pediatric physician from Boston, 
died Jan. 8 in New York. 
He was 41. 
Born in France, Marby 
received a bachelor’s degree in 
psychology from Boston College 
and was a mental health worker 
at McLean Hospital in Belmont, 
Mass. He later graduated from 
Yale School of Medicine and 
served his internship and residen¬ 
cy in pediatrics at Massachusetts 
General Hospital. Marby then 
entered a fellowship program in 
pediatric emergency medicine at 
New York-Presbyterian Hospital. 
He also served as assistant clinical 
professor of pediatrics and as a 
pediatric emergency-attending 
physician lor Babies and 
Children’s Hospital of New York 
at New York-Presbyterian 
Hospital. 
Joe D. Morris, M.D. ’46, of Ann 
Arbor, Mich., died Jan. 8 of can¬ 
cer at the Arbor Hospice 
Residence. He was 78. 
Morris served as a captain in 
the Army Air Corps in San 
Antonio from 1947 to 1949. He 
resumed his surgical training at 
Baylor University in Houston and 
thoracic surgery training at 
University Hospital in Ann 
Arbor. 
Morris, a pioneer in heart sur¬ 
gery, was a professor of surgery at 
University Hospital until 1973. 
He served as head of thoracic sur¬ 
gery at St. Joseph Mercy Hospital 
until he retired in 1985. During 
his career he helped develop and 
improve the Sarns’ heart lung 
machine and with his friend and 
neighbor, Richard Sarns, devel¬ 
oped other surgical instruments, 
such as the sternum saw. 
Irving M. Polayes, D.D.S., M.D., 
one of the early founders of plas¬ 
tic surgery in New Haven, died 
on Dec. 10. He was 72. 
Polayes, who began his career 
as a dentist, graduated Irom Duke 
University in 1948. He received 
his doctor of dental science 
degree from Columbia University 
School of Dental and Oral 
Surgery in 1953 and after his 
internship and residency at 
Presbyterian Hospital of New 
York, he served as a lieutenant 
commander in the U.S. Navy 
Dental Corps 
Polayes received his medical 
degree at the Albany Medical 
College of Union University in 
1959. After completing his intern¬ 
ship, residency and fellowships in 
1965 he opened a practice in New 
Haven with Marvin Arons, 
D.M.D., M.D. ’57. During more 
than 30 years on the Yale faculty 
he served as associate section 
chief of plastic surgery at Yale- 
New Haven Hospital and clinical 
professor of plastic surgery. He 
also was an accomplished violinist 
and author. 
John J. Sullivan, M.D. ’51, died 
Feb. 10 in Bridgeport Hospital. 
He was 80. 
A Connecticut native, Sullivan 
attended Providence College 
before enlisting in the U.S. Navy, 
where he served as a pharmacist’s 
mate first class on the U.S.S. 
Thomas Stone in the 
Mediterranean in Operation 
Torch. He graduated from Tufts 
University rnagna cum laude in 
1947 and then received his med¬ 
ical degree from Yale School of 
Medicine. Sullivan spent 48 years 
in private practice as a family 
physician and was past president 
of the medical staff at Bridgeport 
Hospital. 
Francis M. Woods, M.D. ’33, of 
Needham and Jaffrey, N.H., died 
of pneumonia on Jan. 24 at 
Brigham and Women’s Hospital 
in Boston. He was 91. 
Woods, son ol Dr. Andrew H. 
Woods, a medical missionary, 
spent much of his childhood in 
China. He was a 1930 Yale 
College graduate and received his 
medical degree from the School 
of Medicine. In 1946, after serv¬ 
ing residencies in Rochester, N.Y., 
and Cincinnati, he joined the 
Overholt Thoracic Clinic in 
Boston until 1973. After his retire¬ 
ment from the clinic, he contin¬ 
ued to practice medicine in 
Peterborough, N.H. 
Early in his career as a thoracic 
surgeon, he became aware of the 
correlation between smoking and 
lung cancer. After retiring, he 
continued to visit primary and 
secondary schools in New 
England to deter young people 
from smoking. 
Throughout his career. Woods 
reached out to medical students 
and needy patients in Nicaragua, 
Sri Lanka, Brazil and Jamaica 
through Project Hope. He also 
worked with patients and stu¬ 
dents in Haiti. He was on the 
clinical faculty at Tufts and 
Harvard medical schools. 
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Continuing Medical Education at Yale__ 
For information, contact the Office of Postgraduate and 
Continuing Medical Education, Yale University School of 
Medicine, 333 Cedar Street, New Haven, CT 06320. 
Tel: (203) 785-4578 
September 8 (Friday) Fourth Annual Yale Glaucoma Symposium 
Course Director: M. Bruce Shields, M.D. 
Water's Edge, Old Saybrook, CT 
September 9 (Saturday) Sleep Medicine: An Update for Primary Care 
Providers, Pediatricians and Family Physicians 
Course Directors: Carolyn M. D’Ambrosio, M.D. 
and Lewis Kass, M.D. 
Foxwood’s, Ledyard, CT 
September 9 (Saturday) The NeuroTherapeutic Effects of Music 
Course Director: Nash Boutros, M.D. 
Jane Ellen Hope Building Room no 
September 14-16 (Thursday-Saturday) Technically Challenging Procedures 
in Adult Cardiac Surgery 
Course Director-. John A. Elefteriades, M.D. 
Foxwood's, Ledyard, CT 
September 20-24 (Wednesday Sunday) The 24th Yale PA Board Review/ 
Primary Care Conference 
October 13 (Friday) The Moshe Lahav Lecture in Ophthalmic Pathology 
Course Director: M. Bruce Shields, M.D. 
Harkness Auditorium 
October 19 (Thursday) Third Annual Frisbee Stem Cell Symposium 
Course Director: Edward Snyder, M.D. 
Omni Hotel, New Haven, CT 
October 19 (Thursday) Frontiers in Cancer Cytotherapy 
Course Director: Edward L. Snyder, M.D. 
Omni Hotel, New Haven, CT 
Yale Medicine 
P.O. Box 7612 
New Haven, CT 06519-0612 
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